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HOW DO EARLY ENVIRONMENT, DIET AND PHYSICAL ACTIVITY INTERACT TO 
DETERMINE BONE GROWTH IN YOUNG CHILDREN? 
By Zoë Annalise Cole 
 
Aims: To examine the interaction of maternal factors (body composition, physical 
activity, diet and cigarette consumption) with childhood factors (body composition, 
diet & physical activity) in the determination of bone mineral accrual by aged 6 
years, assessed by a) bone densitometry b) hip structural analysis c) pQCT 
measurement of the tibia in children born to mothers from the Southampton 
Women‟s Survey. 
 
Methods: Children were recruited at 6 years old from the Southampton Women's 
Survey.  Their mothers‟ diet, lifestyle and anthropometry had previously been 
characterised before and during pregnancy. The children underwent measurement 
of bone mass by DXA, including hip structure analysis (HSA), and by pQCT at the 
tibia. Physical activity was assessed by accelerometry (Actiheart) for 7 continuous 
days. Diet was assessed using a validated food frequency questionnaire and 
detailed anthropometric data was also collected. 
 
Results: There were 530 children who attended for a DXA scan. Of these, 148 also 
underwent pQCT assessment. Increased childhood height, weight and milk intake 
were associated with increased measures of bone size; increased physical activity 
levels and greater lean mass were positively associated with increased volumetric 
BMD. Fat mass was negatively associated with volumetric BMD. Whilst maternal 
height, weight, exercise in late pregnancy and pre pregnancy calcium intake were 
associated with increased bone size in the offspring, this association was removed 
after adjusting for childhood factors suggesting that maternal body composition 
and lifestyle may predict the child‟s body composition and lifestyle.  
On assessment of growth patterns in this cohort, children were who born small 
tended to remain small at aged 6 years. Increased catch up growth was associated 
with increased maternal height and total milk intake at aged 3 years. Rapid weight 
gain during childhood was associated with maternal smoking during pregnancy.  
 
Conclusions: We have demonstrated that maternal and childhood factors influence 
bone mineral accrual and bone strength, in the developing child. Whilst many 
important maternal determinants measured (such as physical activity levels) were 
shown to influence the corresponding determinants in the offspring, other factors 
such as maternal cigarette smoking were shown to have persistent independent 
effects on post-natal growth and body composition.   
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Glossary 
 
DXA (Dual X ray absorptiometry) indices 
BA:     Bone area 
BMC:     Bone mineral content 
aBMD:     Areal bone mineral density 
vBMD:    Volumetric bone mineral density 
BMAD:    Bone mineral apparent density 
WB:     Whole body 
LS:     Lumbar spine 
 
HSA (Hip axis software) indices 
CSA:     Cross sectional area 
CSMI:    Cross sectional moment of inertia 
Z:     Sectional modulus (bending strength) 
NN:     Narrow neck 
IT:     Intertrochanteric 
FS:     Femoral shaft 
 
PQCT (peripheral quantitative computed tomography) indices 
SSI:     Stress strain index 
 
Biochemical measurements 
IGF 1:     Insulin like growth factor 1 
PTH:     Parathyroid hormone 
PTHrP:    Parathyroid hormone related protein 
GH:     Growth hormone 
HPA:     Hypothalamic pituitary adrenal axis 
 
Other 
TSF:     Triceps skinfold thickness 
PBM:     Peak bone mass 
FFQ:     Food frequency questionnaire 
 
   1 
 
1  BACKGROUND 
 
1.1  Introduction 
 
Osteoporosis is a major cause of morbidity and mortality through their association 
with age related fractures. Bone strength in later life depends upon the peak bone 
mass accrued during childhood and adolescence, and the subsequent rate of bone 
loss. Whilst most treatment strategies for osteoporosis have been targeted at retarding 
bone loss, optimising peak bone mass remains an equally effective preventative 
strategy. 
 
 Evidence is accruing to suggest that environmental factors in early life have a 
critical influence on the magnitude of peak bone mass achieved, and on the 
subsequent risk of fractures. The underlying hypothesis (often termed programming) 
is that persisting changes in structure and function are caused by environmental 
stimuli at critical periods during early development.  
 
Skeletal bone consists of both trabecular and cortical bone. Bone structures that 
withstand vertical loading, for example vertebrae, derive a substantial proportion of 
their strength from a system of horizontal, cross bracing trabeculae. Severance of 
such connections in postmenopausal women results in an increased risk of fracture. 
An increased risk of fracture is also associated with altered bone geometry, in 
particular shorter hip axis length and increased cross sectional area are associated 
with an architecturally stronger structure for any given BMD. 
 
 This thesis explores the influence of environmental factors, both in utero and during 
early childhood, important for skeletal growth and body composition using DXA. It 
also explores the relationships between both cortical and trabecular bone densities, 
area and geometry to further understand the mechanisms behind how bones develop 
their strength, using pQCT and hip structure analysis, which may influence an 
individual‟s future risk of fracture. 
 
   2 
1.2  Osteoporosis 
1.2.1  Definition 
Osteoporosis is a systemic disorder characterised by low bone mass and micro-
architectural deterioration of bone tissue with a consequent increase in bone fragility 
and susceptibility to fracture
1. The World Health Organisation have defined 
osteoporosis clinically as a DXA derived T score of less than –2.5
2. It is important to 
realize that this definition does not reflect decline in bone micro-architecture. 
 
1.2.2  Epidemiology 
Fracture incidence in the community is bimodal, showing peaks in youth and the 
very elderly (figure 1). In young people, fractures of the long bones predominate, 
usually after substantial trauma, and they are more frequent in males than females. 
Over the age of 35 years fracture incidence in women rises steeply so that rates 
become twice those of men. At age 50 years a UK study has shown that one in two 
women will have an osteoporotic fracture in their remaining lifetime; the figure for 
men is one in five
3. The combined annual costs of all osteoporotic fractures have 
been estimated to be $20 billion in the USA and $30 billion in the European Union
4 
 
Figure 1: Incidence of osteoporotic fractures
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The most common sites for osteoporotic fracture are the vertebrae, hip and distal 
forearm although prospective studies have shown a heightened risk of almost all 
types of fracture in individuals with low bone density. The most frequent site of 
fracture is the thoraco-lumbar spine, with the age standardised prevalence in Europe 
12.2% for men and 12.0% for women aged 50-79 years
5. Only a third of all 
radiographically identified vertebral deformities come to clinical attention acutely. 
Hip fractures are the most devastating result of osteoporosis; resulting in inevitable 
hospital admission and significant morbidity and mortality. The remaining lifetime 
risk of hip fracture for a 50 year old in the UK is 11.4% and 3.1% for women and 
men respectively. Most of this risk is accrued in old age, such that a 50 year old 
woman‟s 10 year risk of hip fracture is 0.3% rising to 8.7% at aged 80 years
3. 
 
Wrist fractures show a different pattern of occurrence to hip and vertebral fractures. 
There is an increased incidence between the ages of 45-60 years followed by a 
plateau. This may relate to altered neuromuscular reflexes with aging, and as a result, 
a tendency to fall sideways or backwards, thus not breaking the fall by an 
outstretched arm. 
 
Whilst all fractures are associated with significant morbidity, both hip and vertebral 
fractures are also associated with excess mortality. Although this may represent 
complications of the fracture and subsequent surgery for hip fractures, it is likely to 
reflect coexisting co morbidity in persons experiencing vertebral fracture. By two 
years after hip fracture morality rates decline back to baseline, however mortality 
after vertebral fracture seems to increase progressively after diagnosis of the fracture 
probably as a result of their co-morbid conditions
3. 
 
1.2.3  Pathophysiology 
Fracture risk ultimately depends upon two factors: the mechanical strength of the 
bone and the forces applied to it. During the first three decades of life, fractures are 
considered to arise from a higher energy trauma compared to fractures occurring in 
later life. Most hip and forearm fractures occur when falling from standing height 
whereas vertebral fractures occur from routine activities such as bending and lifting 
light objects.   4 
 Bone mineral density is the major determinant of bone strength and risk of fracture.  
There is evidence for a genetic contribution for variation in bone density, with 
hereditability estimates between 0.6-0.8
6.  It is also influenced by environmental and 
medical factors. Other independent risk factors that are strongly associated with 
osteoporotic fractures include age, chronic glucocorticoid use, prevalent vertebral 
fracture and recent prior clinical fracture
7. Maternal and paternal history of hip 
fracture
8, physical activity
9, impaired neuromuscular function and menopause before 
age 45
10 retain a moderate relationship with incident fracture whilst cigarette 
smoking has only a weak relationship
11. 
 
Bone density in later life is a function of both the peak bone mass attained during 
childhood and adolescence and the subsequent rate of bone loss. Even in the 7
th 
decade, half of the variance in bone mineral density is accounted for by peak bone 
mass
12. Other aspects of bone structure that determine bone strength include 
geometry, micro-architecture and turnover.   
 
There is growing realisation that adult bones do not merely lose mass as they age, but 
that they alter the distribution of the remaining material in order to preserve strength.   
Long bones generally expand their outer dimensions with age due to periosteal 
apposition . In both genders BMD trends downward more quickly than bone mass. 
There is a significant upward trend in the femoral neck bone area (explained by an 
expansion in the outer diameter of the femoral neck). Figure 2 shows that whilst the 
BMD declines with age the resulting change in structure leads to a relative 
preservation of  section modulus (strength)
13.   5 
 
Figure 2 Weight corrected age trends in BMD and section moduli in non-
Hispanic white males and females
13. 
 
   
 In adults both intertrochanteric and femoral shaft sub-periosteal width (hazard ratio 
1.61 and 1.43 for each SD increase) and buckling ratio (hazard ratio 1.36 and 1.24 
for each SD increase) were predictors of hip fracture independent of body size, age, 
clinical risk factors and conventional aBMD in 10,290 postmenopausal women 
followed up over 11 years as part of the Women‟s Health Initiative
14. 
 
1.3  Peak bone mass 
 
The human foetal skeleton accretes four fifths of the total calcium during the third 
trimester of pregnancy. Bone mass then increases during childhood largely as a result 
of longitudinal growth. A rapid gain occurs during adolescence and up to 25% of 
peak bone mass (PBM) is accreted during the 2 year period across peak height 
velocity
15. At least 90% of PBM is acquired by the age of 18 years, the rest being 
achieved in the twenties. However the exact timing appears to vary with skeletal site 
and gender. Following achievement of peak bone mass there is a steady decline, 
accelerated in women at the menopause due to loss of the protective effect of 
oestrogen (figure 3). 
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Figure 3: Bone mass with age in men and women 
   
 
 
1.3.1  Bone growth in utero 
In utero, the skeletal system develops in a carefully coordinated series of events from 
the aggregation of mesenchymal cells to the laying down of osteoid and subsequent 
mineralisation to form mature bone. 
 
 The skeleton develops in two distinct components, intramembraneous (the skull and 
facial bones) and endochondral (the remainder of the skeleton) ossification. 
 
1.3.2  Intramembraneous ossification 
Intramembraneous ossification begins with a layer of mesenchymal cells which 
become highly vascular, the mesenchymal cells then differentiate into isolated 
osteoblasts, which begin to secrete osteoid. The osteoid matrix is mineralised at the 
end of the embryonic period to form bony spicules, which are precursors of the 
lamellae of the Haversian systems. There is no cartilage model preceding ossification 
in this type of bone development. 
 
1.3.3  Endochondral ossification 
Endochondral ossification is responsible for the formation of bones that are the main 
sites of fragility fracture in later life. This begins with condensation of the 
mesenchyme to form a cartilaginous model of the bone to be formed. Mesenchymal   7 
cells undergo division and differentiate into prechondroblasts and then into 
chondroblasts. Beginning in the centre of the cartilage model, at what is to become 
the primary ossification centre, chondrocytes differentiate and become hypertrophic. 
During this process, hypertrophic cells deposit an extracellular matrix rich in 
cytokines, which facilitate vascular invasion and mineralization. Mesencymal 
progenitor cells in the perichondrium differentiate into osteoblasts and form a bone 
collar around the diaphysis of the cartilage analogue. Following calcification of this  
bone, blood vessels, preceded by the osteoclasts entering the primary ossification 
center, will penetrate this bone and the calcified cartilage, forming the blood supply 
which will allow seeding of the hematopoietic bone marrow and invasion of 
osteoclasts to resorb the calcified cartilage. Secondary ossification centers begin to 
form at the epiphyseal ends of the cartilaginous model, and by a similar process, 
trabecular bone and a marrow space are formed at these ends. Between the primary 
and secondary ossification centres, epiphyseal cartilage remains until adulthood. The 
continued differentiation of chondrocytes, cartilage mineralisation and subsequent 
remodelling cycles allows longitudinal bone growth to occur. 
 
 
Figure 4 Endochondral Ossification, adapted from endotext.org 
 
 
 
Chondrocyte differentiation is regulated by a number of factors, the first being 
parathyroid related peptide (PTHrP) which is secreted by the perichondral cells
16.   8 
This factor prolongs chondrocyte proliferation. Other proliferative stimuli include 
cytokines of the GH/IGF axis
17, 1,25(OH)
2 vitaminD3
18, tri-iodothyronine
19, FGF
20 
and bone morphometric proteins
21;22.Cbfa1 mediates mesenchymal differentiation 
into osteoblast progenitors as well as permitting terminal differentiation of 
chondrocytes
23. 
 
1.3.4  Mineralization of the foetal skeleton 
 Whilst a miniature version of the skeleton is laid down in the embryonic period and 
primary ossification centres form in the vertebrae and long bones between the 8
th and 
12
th weeks it is not until the third trimester that the bulk of mineralization occurs
24. 
The main determinant of skeletal mineralization in utero appears to be the foetal 
plasma calcium concentration. To supply this demand, there is a requirement for an 
adequate maternal supply of calcium to the placenta and increased placental calcium 
transfer to maintain a higher foetal calcium concentration than the mother. This 
materno-foetal gradient emerges as early as 20 weeks gestation
25.  
 
 Low levels of foetal PTH activity influence foetal calcium levels
26. Maternal PTH 
does not cross the placenta however both hypo and hyperparathyoidism appear to 
affect the foetus via decreasing or increasing the calcium load presented to the foetal 
circulation and suppression of foetal PTH.  
 
PTHrP is a polyhormone coded on chromosome 12. It is produced by the foetal 
parathyroid gland, with some production by the placental syncytial and trophoblasts, 
it plays multiple roles during embryonic and foetal development. It is a major 
determinant of placental calcium transport, possibility through its interactions with 
the calcium sensing receptor (CaSR), which appropriately suppresses PTH in 
response to elevated calcium. 
 
It seems likely that other factors also affect maternal calcium levels and foetal 
mineralization, such as 1,25(OH)2 vitamin D3. There is evidence to suggest vitamin 
D deficiency during late pregnancy results in impaired BMC of the offspring at age 9 
years
27. In addition, expression of an active placental calcium transporter (PMCA3) 
is positively correlated with whole body BMC in the offspring at birth
28. This   9 
observation may suggest a possible mechanism for the influence of maternal vitamin 
D status on placental calcium transport and accrual of bone mineral. 
 
Finally there is evidence that PTH and PTHrP differentially affect mineralization of 
cortical and trabecular bone and thus are also attractive candidates for the 
physiological investigation of programming
29. 
 
1.3.5  Bone mineral accrual in infancy and childhood 
Childhood and adolescence are characterised by longitudinal growth as well as 
changes in skeletal size and shape. Skeletal mass increases from ~70-95g at birth to 
2400-3300g in young women and men respectively
30. 
 
 Bone length increases by either intramembranous ossification of the distal end of the 
craniofacial bones, or endochondrial ossification of the remainder of the axial 
skeleton, through the growth plate. Here chondrocyte division on the metaphyseal 
surface of the growth plate leads to longitudinal growth. A sleeve of cartilage around 
the epiphysis forms the perichondral ring, which influences both the diameter and 
shape of the growth plate
31. During puberty, the rate of chondrocyte division slows 
more than endochondral ossification leading to complete replacement of the growth 
plate by bone and the achievement of skeletal maturation. 
 
1.4  Determinants of postnatal bone growth 
 
After birth, growth can be divided into three phases: infancy, childhood, and puberty 
reflecting changes in the height velocity during these ages.  
 
The speed of physical growth is rapid during the first two years of life. Birth weight 
is doubled in the first four months, tripled by age 12 months, but not quadrupled until 
24 months. Growth then proceeds at a slower rate during childhood until shortly 
before puberty (between about 9 and 15 years of age), when a period of rapid growth 
occurs. Growth is not uniform in rate and timing across all body parts. For example, 
at birth the head size is already relatively near to that of an adult, but the lower parts 
of the body are much smaller. In the course of development the head grows relatively 
little, whereas the torso and limbs undergo a great deal of growth
32.   10 
 
Genetic factors play a major role in determining the growth rate. However, genetic 
factors can  only produce maximum growth if the environmental conditions are 
adequate; for example, poor nutrition and chronic disease may  both reduce an 
individual's adult stature. 
 
1.4.1  Catch up growth 
Catch-up growth is defined as height velocity above statistical limits of normality for 
age and/or accelerated maturity during a defined period, following a transient period 
of growth inhibition. 
 
Tanner suggested that catch up growth occurs in two different temporal patterns. In 
the first, the individual shows an early, marked growth acceleration that reduces the 
deficit rapidly within a few years. The child then grows along this improved 
percentile until adult height is achieved. In the second pattern, the child stays at a low 
percentile for many years, growing at normal velocity for chronological age. 
However bone maturation remains delayed so that growth continues beyond the 
usual age, leading to improved adult height
32. 
 
Babies who are short or light at birth may have experienced poor intrauterine growth 
and have a period of accelerated growth postnatally, this maybe described as catch 
up growth. However, it is becoming clear that this pattern of growth is distinct from 
the above examples of catch up growth. Firstly, the onset of accelerated height 
velocity is some time after the end of the insult and, more importantly, there may not 
be a period of regulated growth deceleration.  
 
 The tempo of postnatal weight gain is emerging as particularly important in the 
relationship between birth weight and adult disease. Barker showed that excessive 
weight gain during childhood and adolescence in individuals who were born small at 
birth predicted a heightened risk of coronary heart disease in later life
33. It has also 
been shown that small for gestational age adults continue to gain greater fat mass in 
early adulthood suggesting that the consequences of foetal growth restriction on body 
composition are evolving beyond the period of early postnatal catch-up
34. 
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Recent systematic reviews have identified consistent associations between postnatal 
rapid weight gain during the first 1-2 years of life and later obesity in children and 
adults
35;36. Overall there was a 2-3 fold increase in overweight or obesity risk in 
those individuals whose weight crossed upward by at least one major band between 
birth  and ages 1 or 2 years
35. There is still debate as to the exact timing of rapid 
postnatal weight gain, Ong et al found that faster weight gain between ages 0-2 and 
2-9 months was associated with increased body fat mass relative to lean mass at aged 
10 years, but not between 9-19 months in 2715 girls
37. Whereas Yliharsilia et al 
showed that rapid gain in BMI before the age of 2 years increased adult lean body 
mass without excess fat accumulation. He also reported that rapid gain in BMI in 
later childhood, despite the concurrent rise in lean mass, resulted in relatively larger 
increases in fat mass in 885 men and 1032 women born during 1934-1944
38. 
 
The endocrine mechanisms governing catch up growth are still poorly understood. 
However there is evidence to suggest that insulin like growth factor (IGF-1) plays a 
major role in the regulation of growth during infancy and childhood. Higher 
concentrations at 3 months predicted greater subsequent gains in body length and 
slower gains in BMI and adiposity
39. Whilst there is evidence to suggest abnormally 
low IGF levels in infants born SGA, these levels increase rapidly after birth. 
However the levels remain lower than children born appropriate for gestational age
40, 
which may account for some of the increased risk of cardiovascular disease
41. 
 
1.4.2  Genetic determinants 
 
Heredity factors are important determinants of bone mass. Convergent data from 
mother daughter pairs, sibling pairs and twin studies have estimated the heredity of 
bone mass to account for 60 – 80% of its variance
42;43. The magnitude of the effect 
varies with age and between skeletal sites; it is higher in the young than in the elderly 
and in the spine than in the extremities. Further support for this genetic influence 
comes from studies showing reduced bone mass in daughters of osteoporotic women 
compared with controls
43, and in men and women with first degree relatives that 
have osteoporosis
44. However the magnitude of genetic effects on bone mass may be 
overestimated due to similarities in environmental influences between parents and 
offspring.   12 
 
Currently, genetic polymorphisms have been found to make only a modest 
contribution to bone mass in populations
45. Differences in Vitamin D receptor (VDR) 
polymorphisms at the BsmI restriction site accounted for differences in BMD in pre-
pubertal and adolescent girls. Girls with BB genotype had significantly lower spinal 
BMD than girls with the Bb or bb genotypes
46. In contrast polymorphisms at the start 
codon of the VDR gene show no association with BMD at any skeletal site
47.  
 
Recent technological and scientific advances have provided the tools needed to 
rapidly scan the genome for genetic variants affecting osteoporosis.  Genomewide 
association studies (GWASs) have identified several associations contributing to risk 
of fracture and related traits. These discoveries promise to illuminate important new 
pathways in bone metabolism, contribute to the development of novel therapeutics 
and possibly harbour prognostic value. 
 
Since May 2008 10 GWASs have identified nearly 30 independent loci  affecting 
BMD and/or fracture
48.  Strong associations for BMD have been confirmed in or 
near many previously suspected candidate genes, such as the estrogen receptor 
(ESR1)
45;49 TNF receptor superfamily, member 11a (TNFRSF11A; RANK)
45;50, TNF 
(ligand) superfamily, member 11 (TNFSF11; RANKL),
45;49SP7 transcription factor 
(SP7),
45;50;51 and low-density lipoprotein receptor-related protein 5 
(LRP5).
45;52However, most of the associations exceeding stringent genome-wide 
significance thresholds have been with novel genes, such as family with sequence 
similarity 3, member C (FAM3C)
53 and MAP/microtubule affinity-regulating kinase 
3 (MARK3),
50among many others. These novel genes have no known connection to 
bone and, once validated, their discovery should highlight important new biological 
mechanisms impacting bone metabolism.  
 
The results to date explain only a small fraction of the genetic component for traits 
such as BMD. For example, a large-scale meta-analysis of 19,195 individuals 
identified a total of 15 SNPs associated with lumbar spine BMD, however these only 
explained 2.9% of the variance
45. The undiscovered genetic component is likely to 
consist of a combination of many more common variants with increasingly smaller 
effects and the contributions of rare variants. It is also likely that inherited epigenetic   13 
modifications and gene by gene and gene by environmental interactions are 
significant sources of variation. The key limitation of GWASs is they are not capable 
of providing information on the context in which those genes function, their 
relationships with other genes, or how these relationships change over time, in 
different environments or during disease. 
 
1.4.3  Nutrition 
 
The earliest data suggesting an influence of dietary calcium on  peak bone mass 
(PBM) came from a study of two Croatian populations with substantially different 
calcium intakes. The differences seen in bone mass were present at aged 30 years, 
suggesting that the effects of dietary calcium probably occurred during growth rather 
than adulthood
54. Moreover some epidemiological studies have shown an increased 
prevalence of osteoporosis in regions where dietary calcium intake is low
55. 
 
The nature of infant feeding has been shown to influence bone mineral accrual, with 
a positive correlation between formula fed babies and infant bone mass
56. Much of 
this work has been carried out in premature infants, who tend to be small and have 
reduced BMD. However, one study in term infants found that, although at 6 months 
infants fed a high calcium formula had greater BMD that those fed breast milk, when 
they were all put onto normal formula for the next 6 months, the differences 
disappeared
57, consistent with post-natal tracking along the growth trajectory. Further 
studies have since confirmed no difference in bone mass at age 4 years and duration 
of breastfeeding
58. 
 
The most convincing evidence that calcium consumption influences rates of bone 
mineral accrual rates comes from controlled supplementation trials in young healthy 
subjects. These studies have shown that subjects given additional calcium, whether 
as calcium salts, milk minerals or dairy products for 1-7 years had greater gains than 
controls
59-63. Although bone size increased as a result of added dietary calcium, the 
response to calcium varied with skeletal site, pre-treatment calcium consumption and 
pubertal stage. Greater bone mineral gains were reported at cortical skeletal sites, in 
pre-pubertal subjects and in girls whose habitual dietary intake was <850mg/day
59;62. 
Whether these short-term increases will translate into clinically relevant reduction in   14 
osteoporosis risk is yet unknown. Most studies have suggested that the beneficial 
effect of calcium supplementation does not last and report that the benefits of 
intervention stopped once the treatment had stopped
64;65. Studies that showed 
benefits which persisted 12 months after discontinuation, supported the use of milk 
products
66. A key aspect of dairy food supplementation studies is the failure to 
influence dairy intakes in children after the study; participants typically return to 
their pre-supplementation dietary intake within one year
67. In studies which have 
looked at habitual milk intake among women aged 20-49 y, bone mineral content 
was 5.6% lower in those with low intakes of milk during the ages 5-12 years. In 
addition low intakes were associated with a 2 fold greater risk of fracture indicating 
that childhood milk intake has persisting effects on the skeleton in adult life
68
. 
Studies looking at habitual milk intake have found effects of increased intake on 
skeletal size in children as young as 5 years. Interestingly they found the effect was 
only seen for milk and not other dairy products
69. 
 
Scientifically there are credible explanations for why milk is a good supplement. 
Insulin like growth factor 1 (IGF-1) is part of the protein fraction of milk. It is a 
potent growth factor of bone, contributing to osteoclast proliferation, differentiation 
and matrix formation and in addition mediates the effect of growth hormone. In 
studies of children increased milk consumption, circulating IGF-1 and height are all 
positively correlated
70. In addition milk supplementation has been shown to increase 
IGF-1 levels
61. Another possible mechanism is that milk supplies calcium 
hydroxyapatite, which contains calcium and phosphate, a key constituent of bone 
mineral. The calcium: phosphate ratio may be important as dietary phosphate, found 
in carbonated drinks, is known to bind to calcium in the gut to produce a non-
absorbable salt.  
 
Although most studies have focused on the effect of calcium on bone accrual there is 
increasing evidence to suggest a role of dietary fruit and vegetables. Jones et al first 
reported cross sectional data that showed a positive link between the consumption of 
fruit and vegetables and BMD in 10 year old girls
71. A further study in girls aged 8-
13 years found a positive association between fruit and vegetable consumption and 
bone area and BMD
72. A positive association has also been seen in a study of boys 
aged 8-20 years and whole body BMC
73.  In addition a recent study of 198 mother   15 
child pairs showed that dietary patterns consistent with a healthy diet during 
pregnancy was associated with increased BMC, BA and aBMD in her offspring at 
aged 9 years
74. One explanation to account for some of this effect is that fruit and 
vegetables provide organic salts of potassium and magnesium that have a buffering 
effect against the acid load from the ingestion of western type diets which is believed 
to lead to bone loss
75;76. Natural antioxidants and phytoestrogen compounds in some 
vegetables may also have some bone protective effects
77. 
 
1.4.4  Exercise 
The beneficial effects of exercise on bone mass have been well documented through 
multiple observational and retrospective studies indicating that weight bearing 
activities increase bone mass. Bone adapts to increased loading in order to maintain 
efficiency in providing structural, functional support to the skeleton without injury or 
fracture. The adaptation of the bone to loading will be to increase its size, change 
geometry and increase the amount of mass within the periosteal envelope. 
 
Studies of pre-pubertal gymnasts showed a larger cross sectional area of the forearm 
despite a shorter stature
78. They have also shown a greater cortical area and thickness 
in both the forearm and tibia as well as increased lumbar BMC and BMAD
79. In 
addition there was no diminution across the twenty years since retirement with 
aBMD higher than the controls at all sites except the skull despite the lower 
frequency and intensity of exercise
78.  A study of Australian children confirmed that 
childhood fitness levels at aged 9 years were associated with increased bone mass as 
measured by calcaneal ultrasound densitometry 20 years later, independent of adult 
performance
80. This suggests that increased skeletal loading in early childhood leads 
to an increase in peak bone mass. The Iowa bone development study provides some 
limited data on hip structural analysis (HSA) use in children aged 4-12 years, The 
data adjusted for height, age and weight showed that children who participated in 40 
minutes of moderate and vigorous activity had 3% greater cross sectional area (CSA) 
and 5% greater bending strength (Z modulus) compared to those who did only 10 
minutes daily
81 
 
Studies comparing the effects of different physical exercises on bone indicate that it 
is the high impact exercise that results in the greatest increases in bone mass; one   16 
example is the finding of higher whole body aBMD among amateur athletes involved 
in weight bearing sports (rugby, football, endurance training, bodybuilding) than 
amateur sportsmen involved in active loading activities (swimming, rowing)
82. 
 
Several randomised trials involving weight bearing interventions on bone mass have 
been conducted in children and adolesence
83-88. Overall weight bearing exercise 
appeared to enhance bone mineral accrual. Adjusting studies to 6 months enabled a 
comparison of effects between studies. Increases in bone mass (BMC and aBMD) 
were 0.9-3.9% for studies conducted in pre-pubertal children, 0.9-6.2% in early 
pubertal children and 0.4 to 1.4% in pubertal children
89. While it is not yet possible 
to see if these beneficial effects are maintained into and throughout adulthood, Fuchs 
and colleagues undertook a randomised control trial of jumping in children, and 
reported that 14 months after the finish of this trial after a period of detraining, the 
actively treated group maintained a 4% increased BMC and bone area at the hip
90. 
The combination of exercise with calcium supplementation appeared to increase 
BMC more than exercise alone
83;85;86;88. The reason for the combination is unclear. 
However the most likely explanation is that exercise induced osteogenesis requires 
calcium and thus the osteogenic adaptation may be comprised in the presence of 
inadequate calcium. 
 
What these studies have failed to show is the specific type of exercise, intensity and 
duration that will provide the optimum stimulus for peak bone mineral accretion. 
This requires further investigation as well as the measurement of bone quality 
parameters and volumetric BMD to provide a greater insight into the mechanisms 
implicated in the adaptation of bone to exercise. 
 
1.4.5  Childhood obesity 
Obesity is now a major cause of preventable health problems in the UK and 
worldwide. The rise in the prevalence of overweight and obesity has extremely 
serious implications, not only for individual health, but also for the nations health 
and economy. There has been a rapid increase in the prevalence of obesity in all age 
groups across the UK over the last 20 years. For example, according to the latest 
Health survey for England between 1993 and 2002 the proportion of overweight and 
obese adults rose from 62 to 70% among men and from 56 to 63% among women.   17 
Obesity in children is also increasing at an alarming rate. In 2-4 year old children 
rates almost doubled (5-9%) between 1989-1998 and obesity in 6-15 year old trebled 
(5-16%) between 1990-2001. Overweight children have a 50% chance of being an 
overweight adult. If current trends continue at least one fifth of boys and one third of 
girls will be obese by 2020. 
 
Weight and body composition, particularly lean mass, are among the strongest 
determinants of bone mass throughout life, largely reflecting adaptation of skeletal 
modelling to loading. However whether fat mass affects skeletal development 
independently of lean mass remains controversial. 
 
When regarding the crude values, obese children seemed to have denser bones than 
controls suggesting that body weight might improve bone mineralization by 
increasing the mechanical loading on weight bearing bones
91;92. However more 
recent studies suggest that when adjusted for body size the skeleton may be under 
mineralised. Weiler et al showed in girls aged 10-19 years increasing percentage 
body fat was positively associated with bone area but had a negative impact on 
BMC, mineral content corrected to bone area (r=0.33, p<0.01) and bone density
93. 
This was supported by another study of children aged 3-5 years
94, in which the 
authors report an association between percent body fat and bone area, but not BMC 
indicating that children with higher body fat will have larger bones which are 
undermineralized, Periosteal and endosteal circumferences were inversely correlated 
with body fat resulting in reduction of cortical bone area
94. 
 
 Whether fat mass has differing effects on trabecular and cortical bone is unclear. A 
study by Rocher et al, who looked at obese pre-pubertal children, showed that whilst 
BMC adjusted for weight and BMAD were significantly reduced compared to the 
controls, lumbar spine BMAD was in fact increased
92. However a study comparing 
obese children with a history of fracture found that lumbar spine BMAD was reduced 
by 2-3SD compared to the non obese but history of fracture control group. 
Worryingly 18% of the obese children in this study fulfilled the criteria for 
osteoporosis
95. A recent study by Wetzsteon demonstrated significantly higher bone 
strength at the distal and midshaft sites of the tibia in overweight children aged 10 
years
96. These differences were accounted for by higher total and cortical area, but   18 
not cortical density. Over a 16 month follow up, the bone strength increased more in 
the overweight children due to greater changes in total and cortical area and not 
cortical density, thus the overweight children had a greater increase in both periosteal 
appostion and cortical thickness over this period
97. Once adjusted for overall weight 
or fat mass, the bone strength index was reduced in the overweight children (19% 
and 50% respectively) 
 
Cohort studies have likewise yielded conflicting results. In 1068 men aged 19 years, 
fat mass was positively correlated with tibial cross sectional area, whereas a negative 
association was seen at the radius, suggesting that adipose tissue acts to stimulate 
growth of weight bearing bones only. In contrast a study of 3032 children aged 9.9 
years showed that fat mass was positively related to BMC at the total body, upper 
and lower limbs.  
 
A possible explanation for these conflicting results is that the relationship between 
fat and bone mass is subject to confounding, which distinct studies may adjust for to 
differing degrees, for example; diet, physical activity, socio economic factors, 
puberty, lean mass and illness. In terms of the true nature of any functional 
relationship, overweight children probably stimulate bone growth through a direct 
mechanical action of increased load as a result of their increased lean mass
98.  
Furthermore adipose tissue is known to express aromatase enzymes that convert 
steroid precursors to oestrogen, which has been reported to both stimulate
99 and 
suppress
100 periosteal bone growth in children. Increased leptin levels secondary to 
higher fat mass have been suggested to mediate the negative association between fat 
mass and periosteal growth observed at non weight bearing sites
101. Defects in the 
leptin-proopiomelanocortin pathway cause severe obesity; the commonest defect is 
the melanocortin 4 receptor (MC4R)
102. In a study of 5300 children aged 9.9 years   
MC4R polymorphisms mirrored the effect between bone mass and fat mass
103. 
Another gene polymorphism (Fat mass and obesity associated gene, also known as 
FTO) is associated with increased weight gain in both childhood and adults
104. This 
was also seen to mirror the effects between bone mass and fat mass in the 5300 
children, suggesting that fat mass is on the causal pathway for bone mass
103. 
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There are no studies looking at the long-term consequences of childhood obesity on 
subsequent adult bone mass and geometry. It is also unclear whether there is a 
persistent increase risk of future fracture in individuals that have been overweight 
since early childhood. 
 
1.5  Childhood fracture 
 
Fractures during childhood cause pain and loss of mobility and independence. They 
also result in time off school, activity restricted days and long term consequences 
arising from complications such as secondary osteoarthritis
105.  A large study within 
the UK between 1988-1998 of 84,129 boys and girls suggest that fractures are a 
common problem
106. By the age of 16, 42% of boys and 27% of girls had suffered at 
least one fracture. The male incidence rates peak later than those among females (14 
years vs. 11 years respectively). Indeed, at this age, the incidence of childhood 
fractures (3% among boys and 1.5% among girls) is only surpassed at 85 years of 
age among women and never among men. The most common site affected in both 
sexes is the radius/ulna (almost 30%), closely followed by the small bones of the 
hand and wrist. Within the UK there was pronounced geographic variation in 
childhood fracture incidence with almost 50% higher rates observed in Northern 
Ireland, Scotland, Wales, and north England compared with London and southeast 
England. This might reflect a contribution of socio-economic status to fracture risk 
(accidents as a whole are known to be highly correlated with social class)
107.  
 
Whilst historically fractures are associated with trauma, studies have also shown 
other risk factors including lower BMD
108;109, lower milk intake
110, lower levels of 
physical activity
109, a higher BMI 
111and a higher consumption of carbonated 
beverages
109. 
 
In one large prospective cohort study of 6213 children age 9 years there was a small 
inverse relationship between BMD and subsequent fracture risk (OR per SD decrease 
1.12, CI 1.02-1.25). Fracture risk was also inversely related to BMC adjusted for 
bone area, height and weight (OR = 1.89, CI 1.18-3.04)
108. In a follow up of 2692 
children from this study, children that fractured in the next two years participated in   20 
higher amounts of time spent in vigorous activity. This was despite higher bone mass 
associated with increased physical activity; however this increased mass did not 
adequately compensate for the risk caused by increased exposure to injuries
112. In a 
smaller case controlled study of 90 children aged 5-19 years, who had sustained two 
or more fractures, four risk factors were identified: early age of first fracture (27.7% 
vs. 11.3%) adverse symptoms to cow milk (22.2% vs 6.7%) low dietary calcium 
(20% vs. 4.5%) and overweight (33.3% vs. 15.5%)
111.  In a case controlled study by 
Manias et al, 100 children aged 4-16 years who had sustained a fracture had lower 
BMC and aBMD, lower milk intake, higher BMI and lower levels of physical 
activity compared to controls. There was, however, no difference in adjusted bone 
mass between children with one and those with recurrent fractures. Similarly not 
having been breastfed, maternal smoking and carbonated drink intake were 
associated with recurrent fractures
109. 
 
Whether peak bone mass is low among children with fractures remains uncertain. In 
a cohort of 125 girls followed over 8.5 years, 42 subjects reported 58 fractures. 
Among those, BMC gain at multiple sites and vertebral bone size at pubertal 
maturity were significantly decreased
113. Hence, childhood fractures may be markers 
of low peak bone mass acquisition and persistent skeletal fragility. 
 
1.6  Developmental plasticity and intrauterine programming 
1.6.1  Overview 
The term developmental plasticity describes the ability of a single genotype to 
produce more than one alternative form of structure, physical state or behaviour in 
response to environmental conditions
114. This enables the production of phenotypes 
that are better suited to their environment than would be possible if the same 
phenotype was produced regardless of their genotype, hence improving the survival 
of the species. In the natural world there are numerous examples of developmental 
plasticity allowing organisms to adapt to the prevailing environmental conditions. 
One example of this is the water flea Daphnia; if the mother is exposed to traces of a 
predator; the young are born with a protective helmet
115. The problem arises when 
the developing organism is then exposed to a mismatch between the expected and   21 
actual environment: the protective helmet of the water flea actually reduces 
reproductive competitiveness in the absence of a predator.  
 
Programming is defined as persisting changes in structure and function caused by 
environmental stimuli acting at critical periods during early development
116. 
Programming of adult disease is a consequence of growth strategies made by the 
developing foetus and infant in response to the early environment, causing 
permanent changes to structure or physiology. Whilst such adaptations may be 
appropriate during early life, they may be inappropriate in later life and lead to 
increased disease in adulthood; low birth weight, a surrogate marker for an adverse 
early intra uterine environment, has been shown to be associated with coronary heart 
disease, hypertension, type II diabetes and hypercholesterolaemia
116. 
  
Evidence is accruing that for diseases like osteoporosis, where genetic variance 
makes a relatively small contribution, that environmental factors in early life have a 
critical influence on the magnitude of peak bone mass achieved, and on the 
subsequent risk of fractures. During early life there are tissue specific periods of 
rapid cell division called critical periods. Tissues differ in the timing of their critical 
window; for example the long bones accelerate their rate of growth during the second 
trimester, while bone mineralization occurs during the third trimester. The main 
adaptive response to a lack of nutrients and oxygen during this period of growth is to 
slow the rate of cell division. This reduction in cell division is either direct or 
mediated through altered concentrations of growth factors or hormones. The 
programming of bone growth during these critical periods is likely to explain some 
of the differences in bone mineral accrual during subsequent childhood and 
adolescence. 
 
The data to support the programming of bone mass and the subsequent risk of 
osteoporotic fractures will now be reviewed. These include epidemiological studies 
of BMD and fracture in cohorts whose early life records have been preserved, 
physiological studies exploring relationships between candidate endocrine systems 
that might be programmed and age related bone loss, exploration of maternal 
determinants of childhood growth and studies of potential underlying mechanisms 
using animal models.   22 
  
1.6.2  Prenatal growth, infant growth and bone mass 
The first epidemiological evidence that osteoporosis risk might be programmed came 
from a study of 153 women born in Bath during 1968-69 who were traced and 
studied at age 21 years
117. Data on childhood growth were obtained from linked birth 
and school records. There were statistically significant associations between weight 
at one year and adult BMC but not density, at the lumbar spine and femoral neck 
independent of adult weight and BMI. The association between weight in infancy 
and adult bone mass was replicated in a second cohort study of 238 men and 201 
women aged 60-75 years, who were born and still lived in Hertfordshire
118. In this 
study, there were highly significant relationships between weight at one year and 
adult bone area at the spine and hip, the relationships with BMC at these two sites 
were weaker but remained statistically significant. They also remained after 
adjustment for lifestyle characteristics in adulthood which might have influenced 
bone mass (physical activity, dietary calcium intake, cigarette smoking and alcohol 
consumption) and genetic markers including polymorphisms in the gene for the 
vitamin D receptor
119 and for collagen 1A1. 
 
Further work has looked at critical periods, which may be involved in programming 
and their relative contribution to bone mass in later life. In a further study from the 
Hertfordshire cohort, birth weight was associated with lumbar spine and hip BMC in 
both men and women. A weaker relationship was seen for hip BMD in men only. 
Relationships between weight at one year and adult BMC were even stronger  In 
men, 18% of the variance in proximal femoral bone area was explained by a model 
that included birth weight, weight at one year and adult weight, with the relative 
contributions attributed to each being 2.8%, 6.8% and 8.2% respectively. In women, 
similar modelling produced figures of 6.7%, 4.2% and 3.9% (overall variance of 
15% in proximal femoral bone area). Hence weight at each of these three points in 
the life course was important in the determination of adult bone mass, with greater 
contributions of earlier growth to skeletal size than to volumetric bone mineral 
density
120. Data using pQCT in 313 men and 318 women  from this cohort showed 
that birth weight and weight at one year were strongly related to radial and tibial 
length in both sexes and to measures of bone strength (fracture load X, fracture load 
Y and polar strain index ) at both of these sites, but not volumetric density
121.   23 
 
These finding have been replicated in other countries; Yarborough et al found, in 305 
postmenopausal Caucasian women (mean age 70 years)
122, that birth weight was 
positively correlated with BMC at the forearm, hip and lumbar spine, and that the 
age-adjusted mean BMC increased significantly from the lowest to the highest tertile 
of birth weight. Adjusting for adult weight diminished this association at the forearm 
and hip, but not at the spine. Birth weight was not independently correlated with 
BMD. A similar dichotomy between BMC and BMD, related to birthweight, was 
found in a cohort of adolescent boys and girls in Sweden
123. Table 1 shows the 
results from a meta analysis of 10 observational studies from different populations 
around the world confirming the significant associations of body build in early life 
and skeletal status in individuals in childhood, young adulthood and the elderly 
124. 
 
TABLE 1: Growth in Infancy and adult bone mass 
Site
Adult 
BMC
Lumbar spine 0.15 (0.10 - 0.20) 0.25 (0.19 - 0.32)
Femoral neck 0.12 (0.07 - 0.18) 0.2 (0.14 - 0.27)
Whole body 0.19 (0.10 - 0.28) 0.44 (0.35 - 0.52)
Adult 
BMD
Lumbar spine 0.12 (0.07 - 0.16) 0.11 (0.04 - 0.18)
Femoral neck 0.12 (0.07 - 0.16) 0.05 (-0.02 - 0.12)
Whole body 0.24 (0.17 - 0.30) 0.25 (0.15 - 0.35)
Legend: Correlation coefficients with 95% C.I. are shown
 Data are derived from published studies (n=10) relating weight in infancy and adult bone mass 
Birth weight Weight at one year
 
 
Both the genome and the intrauterine environment influence birth weight. In twins 
only 10% of the variance in birth weight is thought to be heritable. A  study using 
4008 white female twins confirms that differences in birth weight do lead to 
differences in adult bone mass and density after adjustment for height and weight 
even among monozygotic twin pairs
125. These observations support the important 
environmental influences on both foetal growth and persisting alterations in postnatal 
growth.   24 
A further study from Hertfordshire assessed proximal femoral geometry. Weight at 
one year in the 333 men and women was associated with increased femoral width as 
well as intertrochanteric cross sectional moment of inertia (CSMI) at ages 60-70 
years, independent of current body weight and BMC, supporting the hypothesis that 
early growth leads to persisting differences in proximal femoral geometry
126. 
 
1.6.3  Childhood growth and hip fracture 
Most evidence relating the intrauterine environment to later osteoporosis, stems from 
studies utilising non-invasive assessment of bone accrual. The clinically important 
consequence of reduced bone mass is fracture; data is available which directly link 
growth rates in childhood with the subsequent risk of later hip fracture. Studies of a 
unique Finnish cohort in whom birth and childhood growth data were linked to a 
later hospital discharge records for hip fracture
127 have permitted follow up of around 
7000 men and women who were born in Helsinski University Central hospital during 
1924-33. Body size at birth was recorded and an average of 10 measurements were 
obtained of height and weight throughout childhood. After adjustment for age and 
sex, there were two major independent determinants of hip fracture risk: tall maternal 
height and low rate of childhood growth. In addition hip fracture risk was also 
elevated among babies born short but of average height by age 7 years. There was no 
relationship observed between birth weight and risk of fracture however there was a 
suggestion that babies who measured less than 49 centimetres at birth had an 
increased risk of fracture (HR: 1.5 CI: 0.9-2.5). Levels of crowding in the house 
during childhood or social class also made no difference to fracture risk. 
 
Further work in this Finnish cohort showed a relationship between poor growth in 
infancy and increased risk of hip fracture in later life
128, with a 6.4 fold increase in 
risk for those subjects in the lowest quartile of weight gain between 1 and 12 years. 
These findings are interesting as they suggest several paths to increased fracture risk. 
Thus a low rate of childhood growth, both in early and late childhood, could lead to 
poorer mineralization of bone tissue, and/ or decreased bone width and thus lower 
bending strength. Greater maternal height may act via a longer femoral neck, or 
faster catch-up growth, particularly in those children who were smaller at birth and 
of average size by age 7 years, whose skeletal growth may have been pushed beyond 
its capacity to mineralise. This concept is supported by the observation that fractures   25 
in children most frequently happen in early puberty, where linear growth velocity is 
high and ahead of volumetric mineralisation
129. 
 
1.6.4  Maternal influences during pregnancy 
The third piece of epidemiological evidence that osteoporosis might arise in part 
through developmental maladaption stems from the investigation of a series of 
mothers through pregnancy. In 145 infants born at term in Southampton UK, the 
birthweights of both parents and the height of the father positively correlated with 
neonatal whole body BMC, independent of the infant‟s duration of gestation.  In 
addition mothers who smoked during pregnancy had on average, babies with a 7.1g 
(11%) lower whole body BMC than mothers who did not smoke. Mothers who 
indulged in vigorous activity in late pregnancy, had a faster walking pace, or had 
lower triceps skin fold thickness (reflecting lower fat stores) had babies with a  lower 
BMC and BMD
130. Similar results were found in a more recent mother offspring 
cohort, the Southampton‟s Women‟s Survey
131. In this study of 448 mother baby 
pairs the independent predictors of greater neonatal whole body BA and BMC, after 
adjustment for gestational age and age at DXA scan, included greater maternal 
birthweight, height, parity, triceps skinfold thickness, and lower walking speed.  
There was also a weaker trend toward lower percentage fat and greater percentage 
lean in the offspring of mothers who smoked during pregnancy. The authors 
postulate that the relationship with maternal height is likely to be largely genetic, 
although taller mothers might have greater capacity to nourish the foetus and thereby 
directly influence foetal growth. Maternal smoking has previously been shown to 
impair calcium transport by trophoblast cells
132, which make up the transporting 
epithelium of the placenta,  it also influences placental vascular function through the 
effect of carbon monoxide. It is postulated that this results in the reductions in both 
birth weight and size and the increased risk of intrauterine growth retardation
133. 
Triceps skinfold thickness is a reflection of current maternal nutritional status, 
together with the effect of exercise, the association between maternal fat stores and 
neonatal BMC may result from competition between the maternal and foetal skeleton 
for finite mineral resource. 
 
Recent evidence from a study of 380 mother offspring from the Southampton 
Women‟s Survey suggests that differing patterns of growth in utero predict bone   26 
mass; hence the velocity of foetal femur length growth from 19-34 weeks gestation 
predicted childhood skeletal size, whereas velocity of abdominal growth ( a measure 
of liver volume and adiposity) predicted volumetric density at age 4 years
134. 
     These data provide evidence that environmental modulation in utero, in 
combination with genetic factors, has an effect on neonatal bone indices. 
 
1.6.5  Physiological and mechanistic studies 
The exact mechanisms that underlie the programming of bone mass are unknown at 
present. One hypothesis suggests local control of bone growth. As bone growth in 
utero is determined by the expansion of the growth plate by proliferating 
chondrocytes, such a mechanism could involve alteration in the number of cells in 
the proliferating chondrocyte zone by altering chondrocyte apoptosis, changing the 
growth trajectory of an individual throughout life. Alternatively the mechanism may 
involve resetting endocrine responses that alter the balance between proliferation and 
differentiation of chondrocytes. For an endocrine axis to be involved, it must firstly 
be able to influence bone growth and secondly be able to be set by early 
environmental factors. Hormones that satisfy these criteria are the glucocorticoids, 
growth hormone, leptin and vitamin D.  Two possible explanations, which explain 
differences in hormone levels are firstly genetic polymorphisms and secondly 
epigenetic modification of DNA resulting in altered phenotypes. 
 
1.6.5.1  Hypothalalamic-pituitary-adrenal axis 
The relationship between birthweight as an indicator of the adult hypothalalamic-
pituitary axis (HPA) is unclear, partly as a result of the use of different cortisol 
measures. A recent meta analysis of eleven studies and 2301 subjects has showed a 
significant inverse relationship between low birth weight and circulating cortisol 
level. A 1 kg decrease in birth weight was associated with a 23.5nmol/l higher 
cortisol level
135. A further study of 6470 subjects from the 1958 British birth cohort 
showed that reduced head circumference at birth as well as short stature at aged 7 
years was associated with greater cortisol levels at aged 45 years
136, suggesting that 
delayed growth resulting from early life deprivation has long lasting effects on 
cortisol metabolism.   27 
A study has suggested that glucocorticoid receptor (GR) gene polymorphisms from 
163 men and 274 women born in Helinski, Finland during 1924-1933, may modify 
this link
137.   
 
A relationship between adult skeletal status and cortisol secretion has been 
demonstrated in a series of 151 men and 96 women aged 61 to 73 years
138. In this 
prospective study over four years there was a significant association between 
elevated peak plasma cortisol levels and accelerated loss of lumbar BMD in men 
(r=0.22, p=0.01) after adjustment for testosterone, ostradiol, 25(OH) vitamin D3, and 
PTH levels. In contrast, in women elevated peak plasma cortisol was associated with 
lower baseline femoral BMD (r = -0.23, p=0.03) and greater femoral neck loss 
(r=0.24, p=0.02).  
 
1.6.5.2  Growth hormone/Insulin like growth factor-1 
Growth hormone, both directly and through the promotion of IGF-1 secretion is a 
major regulator of growth in late infancy and abnormalities of GH metabolism are 
known to give rise to osteoporosis. Data looking at growth hormone concentrations 
and bone mass appear contradictory. In the UK 37 men aged 63-73 years, whose 
weight gain in infancy had been recorded, had venous blood samples taken every 20 
minutes over 24 hours. A statistically significant association was shown between 
both peak GH concentration and fasting IGF-1 concentration with femoral neck 
BMD. After allowing for peak GH concentration, median GH was negatively 
associated with BMD. Weight at 1 year was related to median, but not peak GH 
concentration
139. These observations are consistent with a dual effect of GH secretion 
on bone density. High peak GH values drive IGF-1 production and maintain bone 
mineralization in adult life; while integrated GH secretion (after adjusting for the 
effect of pulse amplitude), is negatively associated with bone density in later life. A 
later study in 38 women from the same cohort found that lumbar spine BMD and 
BMC were positively associated with all measures of GH concentration, although 
relationships were strongest for BMC with trough GH. Total daily GH concentration 
tended to increase with rising birth weight, while IGF-1 concentration fell with rising 
birth weight, lending further support to a role for the GH/ IGF-1 axis in the 
programming of adult bone mass
140. 
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In order to further understand the possible role of GH/IGF-1 in the programming of 
bone mass a study of 119 newborn infants in Southampton UK, whose mothers 
pregnancies had been characterised were enrolled in a population based study to look 
at the relationship between cord serum IGF-1 and neonatal body composition as 
measured by DXA
141. There were strong positive associations between cord serum 
IGF-1 concentration and whole body BMC (r = 0.38, p<0.001), whole body lean 
mass (r = 0.40, p<0.001) and whole body fat mass (r = 0.5, p<0.001) after adjusting 
for gestational age and sex. There was no association between IGF-1 and BMC 
adjusted for bone size for which the authors concluded that cord serum IGF-1 is 
more closely related to the size of the neonatal skeleton than to its degree of 
mineralization. Documented maternal determinants of neonatal bone mass seemed to 
mediate their effects independently of variations in cord serum IGF-1. 
 
Further substudies of the Hertfordshire cohort have subsequently looked for 
associations between common single nucleotide polymorphisms in the growth 
hormone 1 gene (GH1), growth hormone releasing hormone gene (GHRH), growth 
hormone releasing hormone receptor gene (GHRHR), the growth hormone 
secretagogue receptor gene (GHSR) and the growth hormone receptor gene (GHR) 
and weight in infancy, adult bone mass and bone loss rates
142;143. Homozygotes at 
loci GH1 A5157G and T6331A displayed low baseline bone density and accelerated 
bone loss: there was also a significant interaction among weight at 1 year, GH1 
genotype and bone loss rate. Furthermore there was a graded association between 
alleles and circulating GH concentration among men
142. Allelic variation in the gene 
encoding GHRH was associated with BMC and BMD at the proximal femur and 
lumbar spine. In women, the mean BMC lumbar spine within the GHRH 11 
genotype was 56.9 g, while that of the GHRH 12 genotype was 68.4 g. 
Corresponding figures for BMD lumbar spine (GHRH 11 genotype) were 0.96 g/cm
2 
versus 1.10 g/cm
2 143  . 
 
1.6.5.3  Vitamin D 
Vitamin D is a key hormone for the regulation of bone growth and mineralization 
during life leading to rickets or osteomalacia in cases of deficiency. It can be 
synthesised in the skin to form vitamin D3, or absorbed from the diet and is 
metabolised in the hepatic and renal parenchyma to form 1,25 (OH) vitamin D3, the   29 
most active moiety. Vitamin D deficiency and insufficiency are common; in one 
study of young women in Southampton 31% of women were classed as insufficient 
and 17% as deficient
27. 
 
 The first evidence to suggest that vitamin D levels in early life might be associated 
with change in bone mass in healthy children came from a study by  Zamora et al. In 
a retrospective cohort study of 106  Caucasian girls aged 7-9 years they showed that 
vitamin D supplementation in the first year of life was associated with an 8.5% 
increase in areal BMD (p = 0.03) at the femoral neck and a 9% increase in lumbar 
spine BMC (p<0.05) after adjusting for potential confounders
144. 
 
Further support for the role of vitamin D came from a longitudinal study of 198  
children aged 9 years whose mothers‟ pregnancies had been characterised for body 
build, nutrition and vitamin D status. Reduced maternal concentration of 25(OH)-
vitamin D during late pregnancy was associated with reduced whole-body and 
lumbar-spine BMC in children at age 9 years
27. This association seemed to be partly 
mediated by venous umbilical cord calcium. Mothers who delivered in the winter 
months had lower estimated exposure to ultraviolet B radiation during late 
pregnancy. Both the estimated exposure to ultraviolet B radiation during late 
pregnancy and the maternal use of vitamin D supplements predicted maternal 
25(OH)-vitamin D concentration and childhood bone mass. Further work looking at 
424 normal pregnancies within Southampton UK found that insufficient/deficient 
maternal 25-hydroxyvitamin vitamin D concentrations found in over one third of 
these women and was associated with greater femoral metaphyseal cross-sectional 
area and a higher femoral splaying index as early as 19 weeks gestation
145. A recent 
study from Finland looked at pQCT measures of the tibia in 125 newborns whose 
mothers had been characterised for 25(OH) vitamin D in the first trimester, 
postpartum and from umbilical blood. The median levels of these three timepoints 
were taken and the infants compared to above and below the median value. Tibia 
bone mineral content was 0.047g/cm higher and cross-sectional area was 12.3 mm
2 
larger in above median compared with below median group, however no difference 
in bone mineral density was observed
146. 
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Serum 1,25 (OH) vitamin D concentration have been shown to be higher in those 
with lower birthweight and weight at 1 year in data from the Hertfordshire  UK 
cohort, suggesting an increased sensitivity of renal 1 alpha hydrolylase in those who 
were small in early life
147. Further work in this cohort looked  at the association 
between polymorphisms of the gene for the vitamin D receptor (VDR) and adult 
bone mass and VDR genotype
148. Among individuals in the lowest third of 
birthweight, spine BMD was higher (p = 0.01) in individuals of genotype 'BB' after 
adjustment for age, sex and weight at baseline. In contrast, spine BMD was reduced 
(p = 0.04) in individuals of the same genotype who were in the highest third of the 
birthweight distribution. A significant (p = 0.02) statistical interaction was also found 
between VDR genotype and birthweight as determinants of BMD. These results 
suggest that genetic influences on adult bone size and mineral density may be 
modified by undernutrition in utero. Vitamin D supplementation of pregnant women, 
especially during winter months, could lead to long-lasting reductions in the risk of 
osteoporotic fracture in their offspring. 
 
1.6.5.4  Leptin 
Leptin is a peptide hormone encoded by the obese gene (ob) and is a candidate for 
involvement in foetal programming.  Leptin is one of the most important adipose 
derived hormones, it plays a key role in regulating energy intake and energy 
expenditure, including appetite and metabolism. Leptin acts on receptors in the 
hypothalamus where it inhibits appetite. Absence of leptin or its receptor leads to 
uncontrolled food intake and resulting obesity. Although the role of leptin in bone 
metabolism is not fully elucidated, results from animal studies showed that mice 
deficient in leptin signalling have higher trabecular bone mass. There is also recent 
evidence that adults who had low birth weight have higher levels of leptin than 
would be expected from their adult level of obesity
149. However data looking at 
serum leptin concentrations and bone mass appear contradictory. Data, again from 
Hertfordshire, showed a strong positive correlation between adult plasma leptin 
concentration and BMC  (r= 0.24, p<0.001). However the negative association with 
rate of bone loss was significant only at the femoral neck in women (p<0.01) and all 
associations were explained by the association of leptin with obesity
150.  
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In Sweden a study of 1068 men aged 18-20 years showed that leptin was found to be 
a negative independent predictor of whole body, lumbar and femoral neck aBMD 
(p<0.01) as well as of the cortical bone size of both the radius and tibia (p<0.01) but 
not cortical or trabecular vBMD once adjusted for lean and fat mass, height, physical 
activity and smoking as covariates
101. 
 
Data from a Southampton UK cohort of 117 neonates showed a positive association 
between umbilical venous leptin and whole body BMC (r =0.42, p<0.001) and 
estimated vBMD (r =0.21, p=0.02). Among the maternal determinants of neonatal 
bone mass, cord leptin explained the relationship with maternal fat stores implying 
that maternal fat stores may mediate their effect on foetal bone accrual through 
variation in foetal leptin
151. 
 
1.6.5.5  Epigenetic mechanisms 
The concept of environmental plasticity provides useful insights into potential 
mechanisms by which the environment may interact with the genome. Epigenetics is 
the study of inherited changes in phenotype or gene expression caused by 
mechanisms other than changes in the underlying DNA sequence.  These changes 
may remain through cell divisions and for the remainder of the cells life and may 
also last for multiple generations. However there is no change in the underlying 
DNA sequence of the organism. 
 
The molecular basis of epigenetics is complex. Three mechanisms are thought to 
contribute to epigenetic control; these are genomic imprinting, X chromosome 
inactivation, and metabolic differentiation. Metabolic differentiation is thought to 
mediate epigenetic imprinting by several interrelated processes
152. The 
autoregulation of transcription factor levels produces a complex feedback mechanism 
for regulating gene expression within a cell. The DNA chromatin structure 
determines its configuration; and therefore the accessibility of protein binding sites to 
transcription factors. These mechanisms further interact with DNA methylation 
(which also blocks transcription factor binding) to produce an integrated control of 
gene transcription
152.   32 
The gene silencing effect of DNA methylation is dependant on the formation of the 
DNA chromatin structure. This methylated chromatin structure binds transcriptional 
repressors such as MeCP2  and methylated CpG binding proteins (MBDs)
153 .  
During germ cell and preimplantation embryo development there are waves of 
genome wide demethylation and de novo methylation. This provides a vulnerable 
period during embryonic life in which the methylation status of the genetic code (and 
therefore its resulting phenotype) may be influenced by environmental factors. 
The potential for nutrition and dietary supplementation during pregnancy to 
influence adult phenotype via DNA methylation has been demonstrated. For example 
Lillycrop et al showed that protein restriction of rat dams during pregnancy altered 
the methylation status of specific hepatic genes
154. This same data also indicated that 
addition of folic acid to the diet of the protein restricted dams reversed the effect. 
Waterland, in an experiment using yellow agouti (A
vy/a) mice, indicted that the 
mutation could be silenced and a brown phenotype induced by adding methyl donors 
(including folic acid, vitamin B12, choline and betaine) to the diet of the dams before 
and during pregnancy and lactation. Further more they showed that this change was 
due to an increase in methylation at the A
vy locus
155.  
 
Further work is needed to explore possible epigenetic mechanisms in which both 
maternal and childhood diet and lifestyle affect the skeletal growth trajectory. 
 
1.6.6  Animal models 
Over the last 40 years, animal studies have proved informative over the role of 
nutrition in skeleton development. Seminal studies from Widdowson and McCance 
demonstrated that programming of growth may arise through nutritional modulation 
during critical windows of early life
156. They demonstrated that rats undernourished 
early on in bone development (3-6 weeks after birth) lost weight compared to control 
groups, permanently remaining smaller, even after resumption of a normal diet. In 
contrast, rats undernourished later in bone development (9-12 weeks post birth) 
initially lost weight but regained their normal growth trajectory on resumption of a 
normal diet with catch up growth. 
 
Amman et al investigated the effects of four isocaloric diets with varying levels of 
protein content (15, 7.5, 5, and 2.5% casein) on areal bone mineral density (BMD),   33 
bone ultimate strength, histomorphometry, biochemical markers of bone remodeling, 
plasma IGF-1, and sex hormone status in adult female rats
157. After 16 weeks on the 
lowest protein diet, BMD was significantly decreased at all skeletal sites assessed. 
Plasma IGF-1 was decreased by 29-34%. Using the same protocol the authors 
investigated the effect of protein restriction on ovariectomized and sham operated 
rats, pair-fed with isocaloric diets containing either 15 or 2.5% casein. Trabecular 
BMD was decreased by either manipulation, with effects appearing to be additive. 
Cortical BMD was decreased only in rats on a low-protein diet. This was 
accompanied by an increased urinary deoxypyridinoline excretion without any 
change in osteocalcin levels, suggesting an uncoupling of resorption and formation. 
Isocaloric protein undernutrition decreased bone mineral mass and strength. Thus 
there is good evidence of the importance of adequate dietary protein in an otherwise 
energy-replete diet. 
 
Mehta et al looked at the effect of maternal protein restriction to evaluate bone 
density of the offspring in rats. The pregnant rats were fed a isocaloric diet 
containing 180g casein (normal protein) or 90g casein (low protein). After delivery 
all mothers were fed the control diet, as were the pups on weaning. The mean bone 
area of the offspring born to dams fed a low protein diet was around 10% lower than 
of the offspring born to those on a normal protein diet. A similar magnitude of 
difference was observed for whole body BMC, whereas there was no difference 
observed in BMD
158. Furthermore, offspring of the protein-restricted mothers had 
abnormally widened growth plates compared with the offspring of controls 
(p<0.001). It was suggested that this reflected programming of chondrocyte function. 
 
Oreffo et al examined the cellular mechanisms involved in the programming of bone 
development using pregnant rats that were either fed normal or low protein diets as 
described above. Offspring that were born to those who had a maternal restriction of 
protein had delayed skeletal maturity with a 40 % reduction in colony formation  
(colony-forming unit fibroblastic, CFU-F) indicative of the efficiency and 
proliferation potential of the mesenchymal  stem cells at 8 weeks, compared to 
control, there was no difference at 12 weeks but a 111% increase at 16 weeks (catch 
up growth). Similar results were observed following examination of alkaline 
phosphatase positive CFU-F number, indicative of osteogenic potential and   34 
differentiation. The addition of osteogenic growth factors (growth hormone, IGF-1 
and 1,25 (OH)2 vitamin D3) were insufficient to overcome or reverse the effects of 
maternal dietary manipulation
159. 
 
 More recently the effect of maternal dietary fat excess was assessed using offspring 
from mouse dams fed either standard chow (C) or lifetime high-fat diet (HF). The 
offspring were maintained on a HF diet to adulthood. Femur samples were taken at 
30 weeks of age and bone structure, adiposity and strength analysed. Offspring from 
HF-fed dams showed increased adiposity in the femur (bone marrow adiposity) in 
comparison to offspring from C-fed dams. Female offspring from HF dams exhibited 
altered trabecular structure indicative of in utero programming
160. 
 
There is limited data on either maternal protein malnutrition or dietary fat excess in 
humans although healthier eating patterns with higher intake of protein and low 
saturated fats has been shown to increase bone mass in the offspring at aged 9 
years
74. This thesis aims to look further at maternal diet and bone mass of the 
offspring. 
 
 
1.7  Measurement of childhood body mass 
 
1.7.1  Dual energy  X-ray absorptiometry 
DXA is considered by most clinicians to be the gold standard in bone densitometry 
and is the most widely used technique for measuring bone mass and density. There 
are however several drawbacks to the use of DXA in children. In DXA the body is 
assumed to consist of two compartments, bone and non-bone. Using this model and 
measuring at two different energy levels we can calculate the amount of bone within 
the field of view. From this we can obtain BMC and bone area. BMD is determined 
by dividing the BMC by the projected area. Although this is suitable for an adult 
population, in which we assume that the volume of a bone remains stable over time, 
in children this approach is not suitable because as the child grows so does the 
volume of the bone. This means that for a constant bone density, a larger vertebra 
(seen in tall stature) would typically yield higher areal BMD results than a smaller 
one (short stature). There are many different reported methods for adjusting the   35 
derived DXA measurements to estimate vBMD. These include using BMC adjusted 
for apparent volume to give bone mineral apparent density (BMAD) using the 
method of Carter
161, BMC adjusted for bone area using the method of Horlick and 
BMC adjusted for bone area /height and weight using method of Prentice
162. The 
method of Prentice was used as the primary estimate of volumetric BMD as it was 
felt to most effectively control for body size. However all these adjustments are still 
only estimates of volumetric density as they assume the bone to be cylindrical in 
shape. 
  
1.7.2  Peripheral quantitative computed tomography 
 
There has been interest in using CT images to determine trabecular bone structure; 
however, ionising radiation dose constrains such applications in central skeletal sites. 
Dedicated peripheral CT (pQCT) scanners to measure BMD and bone morphology in 
the radius and tibia are now available. They are smaller, more mobile and less 
expensive that whole body CT scanners. They also use only very small doses of 
radiation. 
 
Peripheral quantitative computed tomography (pQCT) differs in that it measures true 
volumetric density and is not affected by bone size since the images are 3-
dimensional. It also has the ability to differentiate cortical from trabecular bone 
structure. This is important as a reduced BMD can be due to either to insufficient 
mineralization (mineral per volume) or a reduced structural density (decreased 
trabecular thickness) resulting from insufficient physical activity or muscular 
disorders. Other parameters such as cortical density, total cross sectional area, 
cortical bone area and cortical thickness can also be assessed using pQCT helping to 
determine the geometry of the bone as well as fracture load.  
 
pQCT has been successfully validated in children as young as 3 years. A study of 
101 children aged 3-5 years using the XCT 2000 accurately measured total cross-
sectional area, cortical area, and cortical thickness in children. A coefficient of 
variation of 3.1% for total area, 4.5% for cortical area and 6.8% for cortical thickness 
was demonstrated
163 Total cross-sectional area, cortical area, and cortical thickness   36 
correlated with weight and height. Furthermore, as the children got older, precision 
improved still further due to less movement artefact.  
 
1.7.3  Hip structure analysis 
The measurement of bone density is a surrogate for the measurement of bone 
strength. Bone strength is comprised of many components including bone 
architecture, geometry, cortical porosity and tissue mineralization density. A new 
application for DXA called hip structural analysis (HSA) allows the measurement of 
geometric contributions to bone strength in the proximal femur. With HSA, 
measurements or estimates of the mineralised bone surface cross sectional area 
(CSA) the cross sectional moment of inertia (CSMI), the section modulus (Z), the 
buckling ration (BR) and cortical thickness can be quantified. 
 
The techniques were first described by Martin and Burr in 1984
164. The bone profile 
generated during DXA can be used to derive information on the distribution of mass 
and diameter of the cross section. After making assumptions regarding the shape and 
symmetry of the bone in cross section, estimations of cortical thickness can also be 
obtained. 
 
The technique uses three regions of interest at which the various geometric 
parameters are calculated. The first region of interest (ROI), the narrow neck (NN) is 
placed at the narrowest portion of the femoral neck. The intertrochanteric ROI is 
essentially a bisector of the intersection of the femoral neck and shaft axis. The last 
ROI, the shaft region, is placed 1.5 times the femoral neck width distal to the 
intersectional of the neck and shaft axes. The NN and IT regions contain cortical and 
trabecular bone whereas the shaft region is considered to contain cortical bone only. 
 
Whilst this technique has been used extensively in adults, only one study to date has 
looked at children of similar age to our cohort. This group were able to successfully 
show a relationship between physical activity and cross sectional area and section 
modulus
81. 
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1.8    Outstanding areas of research 
 
Whilst maternal lifestyle and anthropometric characteristics during pregnancy have 
been identified that predict neonatal bone mass, it is not known how they interact 
with early childhood lifestyle characteristics to influence childhood bone accrual. 
Furthermore there has been no research to date that determines whether maternal 
characteristics may be related to bone strength and geometry in the offspring. Finally 
it is not known how childhood and maternal characteristics interact to determine 
bone strength.  38 
 
2  OBJECTIVES 
 
The following hypotheses will be explored using the Southampton Women‟s Survey; 
a unique mother offspring study: 
 
 
1)  Do maternal lifestyle factors (diet, smoking, exercise) and body composition 
influence both childhood bone mineral accrual and the mechanical strength of bone?  
 
2)   Do childhood lifestyle (diet, activity) and body composition influence 
childhood bone mineral accrual and mechanical strength of bone? 
 
3)   Do both maternal factors (body build, physical activity, diet and cigarette 
consumption) and childhood factors (dietary calcium intake & physical activity) 
determine rates of childhood growth and bone mass?  
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3  OVERVIEW OF THE SOUTHAMPTON WOMENS SURVEY 
Figure 5 Outline of SWS bone study, from preconception to 6 years 
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3.1  Pre conception phase 
The Southampton Women‟s Survey (SWS) is a well-established prospective cohort 
of around 12,500 women aged 20- 34 years
165. Run by the Medical Research Council 
(MRC) and the University of Southampton, the study was set up to assess diet, body 
composition, physical activity and hormone levels in a large group of non-pregnant 
women. For those women who became pregnant, the aim was to investigate the 
influence of these maternal factors on the development of the child throughout its 
early life. 
 
Women were recruited via their general practitioners (GPs): a letter was sent to each 
woman from her GP‟s surgery and this was followed up with a telephone call. Self-
referrals were encouraged via a local advertising campaign, with the aim of catching 
those women not registered with a GP, or whose contact details were out of date. 
Approximately 75% of women approached agreed to participate in the study. 
Because of out-of-date address information with GP practices, it was difficult to 
exactly quantify total number of possible participants. 
 
The women underwent an initial interview by a trained research nurse. At this visit, 
an interviewer administered questionnaire was used to assess diet (validated 100 item 
food frequency questionnaire (FFQ)
166), and other factors such as the woman‟s 
physical activity, smoking, family background, education, ethnicity, housing, 
household composition, childcare arrangements, benefits, general health, menstrual 
and obstetric history, and her own and her partner‟s occupation. Detailed body 
composition measurements were taken, including weight, height, waist and hip 
circumference, and skinfold thickness at four sites (triceps, biceps, subscapular and 
supra-iliac regions). The nurses were carefully trained and regular inter-observer 
variability studies performed to ensure measurements were as accurate as possible. 
Venous blood has been collected and stored at -70˚C.   41 
 
3.2  Pregnancy follow up 
 
The recruited women were asked to inform the study coordinators immediately if 
they became pregnant, and also to give written consent for their GP or hospital 
doctor to communicate this information. Pregnant women were then invited to attend 
interviews in early (11 weeks) and late (34 weeks) pregnancy. At these visits, diet 
and lifestyle factors were assessed in a similar way to the initial visit. The detailed 
anthropometry was repeated, and venous blood was collected and stored at -70˚C.  
The women additionally had high resolution ultrasound scans at 11, 19 and 34 weeks 
using a Kretz Voluson 730 or Acuson sequola 512 which were cross calibrated. After 
establishing correct positioning according to the standard anatomical landmarks, 
measurement of femur length (measure of skeletal size) and abdominal 
circumference (a composite of adiposity and liver size) were made on the frozen 
images using electronic callipers according to internationally and validated 
methodology. Each measurement was made in triplicate and the mean used for 
analysis. The coefficient of variation for triplicate measures of femur length was 
0.6% at 19 weeks and 0.4% at 34 weeks. In women with a reliable date of last 
menstrual period, Royston models were fitted to foetal measurements of femoral 
length and abdominal circumference at 19 and 34 weeks to create Z scores for size 
and conditional growth. 
 
 
Pictures 1: Ultrasound images of abdominal circumference (AC) and femoral 
length (FL) 
AC is determined at the skin line on a true transverse view at the level of the junction of the umbilical 
vein, portal sinus, and fetal stomach. FS is most accurately measured with the beam of insonation 
being perpendicular to the shaft, excluding the distal femoral epiphysis   42 
 
3.3  Childhood follow up 
3.3.1  Birth 
At birth, the babies were measured (length, head and abdominal circumference) 
weighed, and skinfold thickness measured (triceps, sub-scapular and thigh). Samples 
of cord blood were also collected and again stored at -70˚C. After birth, the mother 
was asked to agree for her baby to undergo assessment of bone mass, within 2 weeks 
of birth, using a Lunar DPX DXA instrument with specific paediatric software (GE 
Corporation, Madison, Wisconsin, USA). The instrument was located in the Princess 
Ann Maternity Hospital, Southampton, and underwent daily quality assessment, and 
was calibrated against a water phantom weekly. The mothers could attend either as 
an inpatient, or return from home within the two-week time period. At the visit to the 
scan room, the baby was pacified and fed if necessary, undressed completely, and 
then swaddled in a standard towel. It was placed on a waterproof sheet in a standard 
position on the scanner. Whole body measurement was performed first, followed by 
lumbar spine, using specific software protocols. The baby was kept in position using 
rice bags placed over the bottom end of the towel for whole body, and either side for 
the lumbar spine scan. A print out of the whole body scan was given to the mother as 
a momento of the occasion. The baby was weighed at the end of the visit on 
calibrated digital scales, and this weight and the previously recorded length were 
entered into the DXA record on the computer. The manufacturer‟s short-term and 
long-term coefficients of variation (CV) of the DXA instrument were 0.8% and 1.4% 
respectively. When a spine phantom was repeatedly scanned in the same position 24 
times the CV was 0.15%. 
  
3.3.2  6 and 12 month follow up 
The mothers of the children were contacted when the child reached 6 months, 12 
months, 2  and 3 years. Permission to contact the women by telephone was obtained 
when the baby was born. After an appointment was made, a trained research nurse 
visited the mothers and children in their own homes. A questionnaire was 
administered at each of these visits, which included questions about diet, feeding 
patterns, overall health of the child, activity and sleep patterns. In addition various 
infant measurements were taken which included weight, crown heel length or height,   43 
head circumference, abdominal circumference, triceps skinfold and subscapular 
skinfold thickness. Each of these measurements were repeated in triplicate. The 
nurses who did these visits underwent regular training in anthropometric 
measurements in order to optimise accuracy and repeatability, with periodic 
assessment of inter-observer differences.  
 
3.3.3  Determinants of 4 year bone mass 
The mothers were once again contacted on their children becoming 4 years old by 
letter and information sheet telling them about this part of the study and inviting 
them to take part. Soon after this the mother was telephoned at home to see whether 
she was willing for her child to participate. If the response was positive, a time for 
the visit to the Osteoporosis Centre at Southampton General Hospital was organised 
and a letter confirming this appointment in writing was sent out. 
 
At the visit to the Osteoporosis Centre, informed written consent for the DXA scan 
was obtained from the mother or father. The child‟s height (using a Leicester height 
measurer) and weight were measured and recorded. The child was then invited to lie 
down on the DXA couch. Whole body, lumbar spine and left hip scans were taken, 
using a Hologic Discovery instrument (Hologic Inc., Bedford, MA, USA). To make 
this more appealing, a suitably bright sheet with appropriate pictures was laid on the 
couch first. To help reduce movement artefact, the children were shown a suitable 
DVD cartoon. The whole body DXA scan took around 5 minutes. After this, the 
children underwent lumbar spine and left hip scans, each of which took around 20 
seconds. The total radiation doses for the scans were as follows; whole body 
(paediatric scan mode) 4.7 microsieverts, spine (L1-L4) 1.5 microsieverts, hip 7.3 
microsieverts (total dose 26.7 microsieverts). This is equivalent to three days 
background radiation and is significantly less than that for a chest radiograph. The 
manufactures coefficient of variation (CV) for the instrument was 0.75% for whole 
body, and the experimental CV when a spine phantom was repeatedly scanned in the 
same position 16 times was 0.68%. 
 
After the scan the child‟s mid-upper arm circumference was measured in triplicate on 
the left side, and further measurements were taken until three readings within 5% of   44 
each other were obtained. Grip strength was measured three times on either side, 
alternating between sides, with the child‟s arm in a standard position. 
 
The child‟s diet (focusing on calcium and vitamin D intake), exercise and illnesses 
(including  fractures)  were  assessed  by  an  interviewer  led  questionnaire  for  the 
mother, father (if mother was absent) or carer . 
 
In a subset of children and mothers, an Actiheart combined accelerometer and heart 
rate monitor (Cambridge Neurotechnology Ltd, Cambridge, UK) was fitted to both 
mother and child. They were asked to wear these continuously for 7 days and then 
post back in the envelopes supplied. 
 
Pictures 2: Actiheart monitor 
 The unit comprised a small disc, 1.5 cm across and 3mm thick, and a short lead. 
Both  of  these  parts  were  secured  to  the  skin  via  clipping  onto  standard 
electrocardiograph electrode pads. The disc was positioned in the midline just below 
the xiphisternum and the lead going out horizontally to the left chest wall. 
 
3.4  Determinants of 6 year bone mass 
The parents of the children were then contacted again once the child had reached the 
age of 6 years giving them an information sheet about the next part of the study 
(appendix A and B). They were then contacted by telephone to see whether they 
were willing to take part and to organise the first part of this next study, the home 
visit. This study was part of a much larger study, which also looked at allergy and 
asthma  in  these  children  (appendix  C:  study  protocol).  A  letter  confirming  this 
appointment  in  writing  was  sent  out  to  the  mother,  containing  a  direct  contact 
telephone number in case of problems attending.   45 
 
At the home visit informed written consent was obtained from the parent, specifically 
related to skin prick testing and lung function that was also carried out at this visit. 
The child‟s diet using a food frequency questionnaire, exercise and illnesses were 
assessed by an interviewer led questionnaire from the parent or carer (appendix D). 
 
The child‟s height (using a Leicester height measurer) and weight using calibrated 
digital scales (Seca Ltd)) were measured. After the scan the child‟s mid-upper arm 
circumference was measured three times on the left side, and further measurements 
were taken until three readings within 5% of each other were obtained. 
 
The  Actiheart  combined  accelerometer  and  heart  rate  monitor  (Cambridge 
Neurotechnology Ltd, Cambridge, UK) was then fitted to the child and their mothers. 
This was positioned in the midline just below the xiphisternum and the lead going 
out horizontally to the left chest wall. They were asked to wear these continuously 
for 7 days and then post back in the envelopes supplied. A information sheet was 
provided giving further information of how to change the electrodes, they were also 
asked to record times were the monitor had been removed (appendix E). 
 
At the end of this visit they were given further information about the next part of the 
study, the clinic visit (appendix F and G). If they agreed to this the research nurse 
arranged an appointment with them whilst they were still in the child‟s home. A 
letter confirming this visit was then sent out giving them directions to come to the 
osteoporosis centre (appendix H). 
 
At the visit to the Osteoporosis Centre, informed written consent for the DXA scan 
was obtained from the mother or father (Appendix I). The child‟s height (using a 
Leicester height measurer) and weight (using calibrated digital scales (Seca Ltd)) 
were measured. The child was then invited to lie down on the DXA couch having 
taken off any metal items, which would appear on the scan. Whole body, lumbar 
spine and left hip scans were taken, using a Hologic Discovery instrument (Hologic 
Inc., Bedford, MA, USA).  To make this more appealing, a suitably bright sheet with 
appropriate pictures was laid on the couch first. To help reduce movement artefact, 
the children were shown a suitable DVD, which they had been asked to bring with   46 
them. The whole body DXA scan took around 5 minutes. After this, the children 
underwent lumbar spine and left hip scans, each of which took around 20 seconds. 
The total radiation dose for the scans were as follows; whole body (paediatric scan 
mode) 4.7 microsieverts, spine (L1-L4) 1.5 microsieverts, hip 7.3 microsieverts (total 
dose 26.7 microsieverts). This is equivalent to three days background radiation and is 
significantly less than that for a chest radiograph. 
 
 During the scan the parents were asked a very short questionnaire about their child‟s 
fracture  history  and  whether  there  was  a  history  of  osteoporosis  in  the  family 
(appendix J). They were also told about a substudy, which involved pQCT to look 
into the strength of the child bone in more detail. An information leaflet was given to 
the parent and child about this (Appendix K and L), the parent was then contacted by 
phone a short time after to see whether they wanted to take part in this substudy and 
to make an appointment. 
 
At  the  end  of  this  visit  grip  strength  was  measured  three  times  on  either  side, 
alternating between sides, with the child‟s arm in a standard position. The child was 
then  given  a  copy  of  their  scan  as  a  momento  and  a  certificate  of  achievement 
(Appendix M and N). 
 
3.4.1  Determinants of volumetric bone mass and bone strength 
If the parent had agreed to take part in the substudy at aged 6 years, an appointment 
reminder with directions to the osteoporosis centre was sent out to them by post. At 
this visit informed written consent for the pQCT scan was obtained from the mother 
or father (Appendix O). The child‟s height (using a Leicester height measurer) and 
weight, using calibrated digital scales (Seca Ltd) were measured as part of this visit. 
The child was then asked to put their right lower leg into the pQCT machine. The leg 
was secured into place in order to reduce movement artefact.   47 
 
Pictures 3  PQCT in child 
 
A suitable DVD was used in order to occupy the child and again reduce movement 
artefact. The scan took approximately 5 minutes and during this time four  sites of 
the tibia were scanned (4%, 14%, 38% and 66% of the total length). The 4% and 
14% sites were used to assess trabecular content and density, the 38% site cortical 
content, density and bending strength whereas the 66% site was used to look at the 
muscle, fat and bone ratios.  
 
In order to obtain the exact measurements of the tibia the lower leg was first 
measured from the medial malleolus to the tibial tuberosity.  When the lower leg was 
placed into the machine, it was positioned using a laser beam at the distal end of the 
medial malleolus. A scout view was then obtained to find the distal end of the tibia 
(picture 4). A reference line was then positioned to bisect the medial border of the 
articular surface; the 4 sites to be scanned were calculated from this line and the 
length measurement of the lower leg.   48 
 
Pictures 4: Scout view of distal tibia with reference line placement 
 
 
 The total radiation dose for the scans were 1.5 microsieverts, which is equivalent to 
less than half a day background radiation. 
 
The parent and child were then thanked and the child given a further certificate of 
achievement and copies of the scan results if requested (appendix P and Q). 
 
Full ethics and NHS R and D approval had been gained for this study (appendix R). 
 
 
3.5  Analysis 
 
The DXA and pQCT data were transferred regularly to secure servers at the MRC 
unit via an encrypted memory stick. 
 
 The DXA scans were analysed at the visit by a trained DXA technician using the 
automated paediatric software (Vertec Scientific Ltd, Reading, UK) In addition an 
interactive computer program (hip structural analysis, HSA) was used to derive a 
number of structural variables from the femoral DXA scans. The program analyses 
the proximal femur at three locations as shown in figure 6.   
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Figure 6: HSA position on scan 
 
 
 
 
 
 
The regions that were analysed included the narrow neck (NN), measured across the 
narrowest diameter of the femoral neck, intertrochanteric (IT) along the bisector of 
the neck shaft angle and the femoral shaft (FS) 2cm distal to the midpoint of the 
lesser trochanter. For each region the HSA program generates a projection of the 
bone cross section from a line of pixel values traversing the bone width.  The blur 
corrected sub periosteal bone width, bone cross sectional area (CSA) and cross 
sectional moment of inertia (CSMI) for bending in the image plane were measured. 
The section modulus (Z), an index of bending strength can be calculated from 
CSMI/dmax, where dmax is the maximum distance from the centre of mass to the 
medial or lateral cortical margin. An estimate of cortical thickness was calculated by 
modelling cortices of femoral shaft cross sections as concentric circles. In addition 
the method measures neck shaft angle and the femoral neck length. It should be 
noted that since  the HSA algorithm assumes a tissue mineralization of adult cortical   50 
bone, the CSA and Z will be systemically underestimated in the less mineralised 
bones of growing children; however experience in elderly adult populations indicates 
that the precision is 2.8% and 3.4% for CSA and Z respectively
167. 
 
The pQCT data was analysed using an XCT-2000 scanner (Stratec, Pforzheim, 
Germany software version 5.50d) that showed any sign of movement were omitted 
from all analyses.  
 
3.6  Statistical methods 
 All data was anonymised, coded and double-punched onto computer.  The data were 
amalgamated with parental pre-, early and late pregnancy data, and neonatal, 4 and 6 
year old bone mass, lifestyle and dietary data. Statistical analysis utilised tests for 
comparing mean in different populations and linear regression for univariate 
exploration.  Multivariate models (multiple linear regression, logistic regression and 
conditional analyses) were used to study relationships between maternal factors, 
foetal and infant growth and bone mass/body composition at age 6 years. 
 
  Prior to starting the study a power calculation was performed. This suggested that 
by studying 228 children there was 90% power to detect a difference in whole body 
BMC of 10% between the highest and lowest quartiles of the distribution of maternal 
triceps skinfold thickness in early pregnancy, at the 5% significance level. We 
therefore aimed to study over 250 children as part of this thesis. 
 
 All data were analysed in Stata V11.0 (Statacorp, Texas, USA). All data were 
checked for normality and transformed if necessary. It was apparent that there was 
some unreliability in the DXA software analysis of measurements of bone mineral at 
the femoral neck, trochanter and Ward‟s triangle sites. Measurement at the total hip 
site appeared more uniformly reliable, and so this site was used exclusively. 
Movement artefact was most apparent at the head; this bone mineral accounts for a 
high percentage of whole body BMC, but not much to linear growth. Thus at 6 years, 
the whole body measurements are for whole body minus head.  
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3.7  Role of candidate 
This thesis involved the 6 year follow up of children from the Southampton 
Women‟s study. The data from the mothers and children at younger ages had already 
been collected as part of the previous study. 
 
 My role in the 6 year study included the design and writing of protocols (Appendix 
C), the writing of parent and child information leaflets for both the DXA and pQCT 
sub studies (Appendix F, G, K and L) and ethics submission. In addition I attended 
over 300 clinic visits for DXA and all pQCT visits, where consent was obtained, the 
short questionnaire administered and measurements of anthropometry and grip 
strength obtained.  While DXA was carried out by a trained technician, all femoral 
neck analyses were carried out my myself. I checked the DXA and pQCT data for 
outliers, movement and foreign objects.  In addition I was responsible for contacting 
mothers for the pQCT study. 
 
The dataset was checked for outliers and all statistical analysis was carried out 
myself using STATA V11.0. A trained statistician checked the results. The results 
interpretation is entirely my own work. 
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4  RESULTS: SIX YEAR FOLLOW UP OF THE CHILDREN IN THE 
SOUTHAMPTON WOMEN’S SURVEY 
 
4.1  Aims 
  To describe the women and children who took part in this follow up of the 
Southampton Women‟s Survey. 
 
  To test the hypothesis that childhood lifestyle factors and body composition 
predict childhood bone mineral accrual. 
 
  To test the hypothesis that maternal lifestyle factors (diet, smoking, exercise) 
and body composition influence childhood bone mineral accrual. 
  
 
 
4.2  Methods 
 
The parents of the children from the SWS cohort were contacted once their child had 
reached the age of 6 years.  The children were visited by research nurses in their own 
home, in order to assess diet, lifestyle, anthropometry and fit an activity monitor. 
They were invited for a further clinic visit at the osteoporosis centre where 
measurements of bone mass and grip strength were obtained. The methods are 
described fully in chapter 3.   53 
4.3  Results: Descriptive statistics 
4.3.1  Study group: responders vs. non responders 
1268 eligible   families were contacted during the study period. Of these 780  
(61.5%) agreed to a home visit. Of these 780 families, 530  (67.9%) attended a clinic 
visit. We were unable to contact a large number of the families despite numerous 
messages and postal reminders. Other reasons for non-attendance included parents 
working, parents reluctance to take children out of school and children not wanting 
to participate. A significant number gave no reason. Table 2 shows the maternal 
characteristics of responders/non responders for the clinic visit follow up. 
 
TABLE 2: Maternal demographics between responders and non responders 
 
         Responders Non Responders
  number number p value
Age, years (mean, sd) 28.4 (3.7) 530 27.8 (3.8) 738 0.99
Birthweight,g (mean,sd) 3243 (510) 486 3237 (562) 644 0.58
Percentage nulliparous 46.4 246 41.9 309 0.054
Qualifications % None 1.89 10 4.88 36
CSE 9.06 48 10.99 81
O levels 29.62 157 29.85 220
A levels 28.49 151 28.63 211
HND 7.74 41 6.24 46
Degree 23.21 123 19.4 143
530 737 0.005
Social Class % I 4.82 25 5.71 40
II 38.34 199 31.1 218
IIIN 37.19 193 37.38 262
IIIM 6.94 36 9.27 65
IV 11.37 59 13.55 95
V 1.35 7 3 21
519 701 0.01
Height, cm (mean, sd) 163.6 (0.28) 528 162.8 (0.24) 734 0.049
PP weight, kg (Median, IQR) 65.7 (59.2-73.7) 527 63.7 (57.2-72.4) 732 0.0072
PP BMI kg/m
2 (Median, IQR) 24.3 (22.4-27.5) 526 23.9 (21.5-27.2) 732 0.0315
PP triceps skinfold, mm  (Median, IQR) 19.5 (15-25.3) 527 18.4 (14.3-23.5) 726 0.043
EP triceps skinfold, mm  (Median, IQR) 19.3 (15.4-24.7) 422 18.3 (14.9-23.7) 568 0.059
LP triceps skinfold, mm  (Median, IQR) 20.8 (16.5-25.8) 512 20.3 (16.3-25.1) 697 0.32
PP smoking,% 25.7 136 31.3 231 0.014
EP smoking, % 14.2 74 19.9 144 0.004
LP smoking, % 13.2 68 19.2 135 0.003
Units of alcohol per week  (Median, IQR) 4.4 (1.5-10.3) 530 4.3 (1-10.5) 737 0.62
living with partner % 84.7 449 80.1 591 0.034  
 
Mothers that agreed to participate in the 6 year follow up tended to be of higher 
social class (p=0.01), had a higher educational attainment (p=0.005), were less likely 
to smoke (p=0.014) and tended to be taller and heavier (p=0.049, p=0.007 
respectively) (table 2).   54 
Despite the differences in the mothers there was no difference in the anthropometry 
of the children when they were seen at birth or at aged 1 year (table 3). 
 
TABLE 3: Childhood characteristics between responders and non responders 
 
Responders Non Responders
number number p value
Gestational age (weeks) mean, sd 39.7 (1.8) 530 39.6 (2.1) 738 0.71
Birthweight (g) mean, sd 3442(536) 524 3404 (602) 728 0.88
Crown heel length birth(cm) mean, sd 49.8(2.1) 513 49.7 (2.2) 692 0.84
Weight at one year (kg) Median, IQR 10 (9.2-10.7) 526 10 (9.3-10.8) 652 0.31
Crown heel length age one (cm) mean, sd 75.5 (2.7) 520 75.7 (2.9) 639 0.08  
 
 
4.3.2  Maternal characteristics 
Data on 530 mother child pairs were available. The mean age of the mothers at the 
time of the child‟s birth was 30.6 year and 46% were in their first pregnancy. 42% of 
the mothers were in social class I and II, whereas only 12% were in social class IV 
and V. The majority of mothers (59%) had attained an educational qualification at A 
level or higher.  
 
 Table 4 shows maternal anthropometry prior to pregnancy. The average height and 
weight of the mothers was 163.6cm and 65.7kg respectively. The average weight 
gained during pregnancy up to 34 weeks was 11.9kg. Maternal triceps skinfold 
thickness increased from a median of 18.5mm prior to pregnancy to 20.8mm in late 
pregnancy. 
   55 
TABLE 4: Maternal anthropometry before (PP) early (EP) and late pregnancy (LP) 
 
Characteristic n
Height, cm (mean, sd) 163.6 (6.5) 528
PP weight (Median, IQR) 65.7 (59.2-73.7) 526
PP BMI, kg/m
2  (Median, IQR) 24.3 (22.4-27.5) 526
Weight gain during pregnancy, kg  (mean, sd) 11.9 (5.9) 516
PP triceps skinfold, mm (Median, IQR) 19.5 (15-25.3) 527
EP triceps skinfold, mm (Median, IQR) 19.3 (15.4-24.7) 422
LP triceps skinfold, mm (Median, IQR) 20.8 (16.5-25.8) 512               
 
 
The majority of women consumed less than one unit of alcohol per week during 
early and late pregnancy; 29% consumed up to 7 units in early pregnancy and 27% in 
late pregnancy. Mothers tended to drink less alcohol in pregnancy compared to 
before. No association was seen between alcohol consumption and social class. 
Overall 25.7% of mothers smoked before pregnancy however this reduced to 14.1% 
in early pregnancy and 13.3% in late pregnancy. Mothers that smoked tended to be 
of lower social class. Women of lower social class were also less likely to give up 
smoking during pregnancy (table 5). 
Mothers that had a high intake of milk prior to pregnancy were more likely to have a 
higher consumption during early and late pregnancy (r=0.51, p<0.001; r=0.41, 
p<0.001).  
 Both maternal walking speed and strenuous activity levels reduced during 
pregnancy.  However women that exercised prior to falling pregnant were more 
likely to continue exercise particularly during early pregnancy.   56 
TABLE 5: Maternal lifestyle characteristics 
Characteristic PP EP LP
Units of alcohol per week % 0-1.0 105(19.8) 283 (67) 366(71.9)
to 7 270 (50.9) 124 (29.4) 138(27)
to 14 83 (15.7) 5(1.2) 6 (1.2)
>14 72 (13.6) 10 (2.4) 0
Pints milk per day % <0.25 120 (22.6) 127 (30.1) 76 (14.8)
to 0.5 201 (37.9) 125 (29.6) 161 (31.5)
to 1.0 176 (33.2) 117 (27.7) 204 (39.8)
>1 33 (6.23) 53 (12.6) 71 (13.9)
Walking Speed % V slow 2 (0.4) 3 (0.7) 85 (16.6)
Easy pace 32 (6.0) 49 (11.6) 260 (50.8)
Normal 201 (37.9) 227 (53.8) 135 (26.4)
Brisk 269 (50.8) 127 (30.1) 30 (5.9)
Fast 26 (4.9) 16 (3.8) 2 (0.4)
Strenous activity, hrs/week (%) 0 203 (38.6) 233 (55.2) 369 (72.1)
to 0.25 67 (12.7) 69 (16.35) 56 (10.9)
to 1.5 178 (33.8) 85 (18.7) 64 (11.3)
>1.5 78 (14.3) 35 (8.3) 23 (4.51)
Smoking % by social class I and II 39 (17.4) 18 (8.1) 18 (8.2)
III 66 (28.8) 35 (15.4) 29 (13.2)
IV and V 27 (40.9) 19 (30.6) 19 (25.7)
table shows number and percentage  
 
4.3.3  Childhood characteristics 
There were 530 children with 6 year DXA data; of these 399 (75%) had undergone 
DXA assessment at age 4 years; 214 (40%) had undergone DXA assessment at birth 
and 170 (32%) had DXA at all three time points. 
 
Not all the 6 year children had useable scans of whole body, lumbar and hip scans at 
the visit; one child was in a plaster cast, and several scans were excluded due to 
either movement artefact or metal found on clothing. In total 511 scans were 
available for whole body bone analysis, However due to clothing artefact only 499 
were suitable for analysis of body composition. There were 526 good quality scans 
available for lumbar spine analysis and 526 available for hip analysis. 
  
Despite similar height and weight at aged 6 years boys had higher grip strength 
scores compared to the girls (p=0.01), in addition to higher whole body and hip BMC 
(p=0.008 and 0.005 respectively), higher whole body (p<0.001), lumbar spine   57 
(p=0.003) and hip aBMD (p<0.001) and higher bone area in the lumbar spine 
(p<0.001).  Girls had higher fat mass (p=0.0001) compared to the boys and also had 
higher triceps skinfold thickness (p=0.0001) (table 6). 
 
TABLE 6: Childhood characteristics of participants at age 6 years 
Characteristic Boys Girls P difference
n n
Gestational age weeks, (mean, sd) 39.7 (1.6) 273 39.7 (2.0) 257 0.7
Birthweight g (mean, sd) 3482 (521) 268 3401 (549) 256 0.08
Age at DXA  years, (mean, sd) 6.6 (0.2) 273 6.6 (0.2) 257 0.7
Height cm, (mean, sd) 120.3 (4.6) 257 119.7 (5.5) 235 0.2
Weight kg, (median, IQR) 22.7 (21.2-24.9) 256 23.2 (21.2-25.4) 236 0.33
BMI, kg/m
2, (median, IQR)
Triceps skinfold thickness mm, (median, IQR) 8.7 (7.4-10.5) 214 11.0 (8.9-13.8) 196 0.0001
Grip strength R kg, (mean,sd) 9.0 (2.4) 224 8.5 (2.3) 228 0.01
Grip strength L kg, (mean,sd) 8.3 (2.3) 224 7.9 (2.3) 228 0.03
WB BMC (g) (mean, sd) 832.6 (95.1) 259 804.2 (95.8) 252 0.0008
WB Bone area cm
2 (mean, sd) 1139.0 (69.1) 259 1133.0 (73.4) 252 0.34
WB BMD g/cm
2, (mean, sd) 0.73 (0.05) 259 0.71 (0.05) 252 <0.00001
Total fat mass g, (median, IQR) 4605 (3795-5524) 253 5937 (4857-6504) 246 0.0001
Total lean mass g, (median, IQR) 17605 (16271-18940) 253 16660 (15106-18055) 246 0.0001
LS BMC g, (mean, sd) 18.1 (2.8) 272 17.6 (2.7) 254 0.07
LS Bone area cm
2, (mean, sd) 34.0 (3.0) 272 32.3(3.2) 254 <0.00001
LS BMD g/cm
2, (mean, sd) 0.53 (0.06) 272 0.55 (0.06) 254 0.003
Hip BMC g, (mean, sd) 11.4 (2.2) 272 10.9 (2.0) 254 0.005
Hip BA cm
2, (mean, sd) 16.6 (2.2) 272 16.9 (2.3) 254 0.1
Hip BMD g/cm
2, (mean, sd) 0.69 (0.06) 272 0.64 (0.06) 254 <0.00001
  
           
4.3.3.1  Diet and lifestyle at age 6 years 
Daily milk was not normally distributed and was therefore grouped into quartiles. 
Total daily milk intake (a sum of all different types of milk drunk) was higher in 
boys compared to the girls (p=0.007) (table 7).  
 
TABLE 7 Childhood milk intake at age 6 years  (p value for trend  0.007 ) 
 
Daily Milk Intake, pints Boys Girls Total
<0.25 40 (18) 52 (25) 92 (22)
-0.5 87 (39) 89 (44) 176 (41)
-1 76 (34) 56 (27) 132 (31)
>1.0 18 (8) 7 (3) 25 (6)
table show number (percent)  
 
 
Measurements of physical activity were available on 238 children using an actiheart 
monitor. Of these, 4 were excluded, as there was less than an average of 120   58 
minutes/day; 19 were excluded as the subjects wore the monitor for less than 3 days. 
The main reason for taking the monitor off early was a skin reaction to the electrodes 
used to place the monitor. Minutes spent in vigorous and very vigorous activity were 
higher in boys compared to the girls (p= 0.008 and <0.0001 respectively) while girls 
spent more time in light activity. There was no difference between time spent in 
sedentary or moderate activity  between the two sexes (table 8).  
 
TABLE 8: Minutes spent in different types of activity per day (n=215) 
 
 
4.3.3.2  Fracture history 
In total 52 children reported a previous fracture. There was no significant difference 
seen between the boys and girls. A small number of these children had sustained 
more than one fracture (table 9). One child sustained two fractures at the time of 
injury. There were no statistically significant associations between childhood fracture 
and maternal social class, birthweight, diet, current activity levels and 
anthropometry. The small number of fractures limits the power to look at the 
determinants of fracture in this cohort. 
TABLE 9: Total number of fractures 
Number of fractures Boys Girls Total
0 230 227 457
1 25 23 48
2 2 0 2
3 1 1 2
table show number (percent)  
 
Table 10 displays fracture site by sex in this cohort. Wrist fractures was the most 
commonly reported, other upper limb fractures were also relatively common. Lower 
limb fractures were substantially less frequently reported. 
 
Childhood activity  Boys Girls P value
Minutes per day
sedentary 878 (78.1) 870 (83) 0.53
light 475 (66.7) 497 (69.1) 0.02
moderate 37.8 (12.4) 35.1 (12.4) 0.1
vigorous 20.3 (7.5) 17.6 (7.1) 0.008
very vigorous 28.7 (13.2) 21 (12.5) <0.0001
table show number (percent)  59 
 
 
TABLE 10 Subtypes of fractures seen in the girls and boys 
Fracture Type  Boys  Girls  Total 
 
Wrist  10  10  20 
Elbow  6  1  7 
Humerus  5  2  7 
Clavicle  3  6  9 
Metatarsal  2  0  2 
Finger  2  2  4 
Foot / Ankle  1  1  2 
Femur  2  1  3 
Tibia  0  1  1 
Pelvis  0  1  1 
Nose  1  2  3 
 
 
4.4  Results: Determinants of 6 year bone mineral 
 
4.4.1  Statistical analysis 
Since both age at DXA and gender of the child were associated with bone mass 
(table 11), all DXA indices were adjusted for age at DXA and gender. For scans of 
the whole body the head was excluded in accordance with usual practice. All 
predictors and outcomes were checked for normality.  Maternal and childhood 
triceps skinfold thickness, weight, BMI and fat mass were log transformed. 
 
TABLE 11: Relationship of age and gender on whole body, lumbar spine and 
hip 
BA, cm2 BMC,g BMD, g/cm2
 (CI)  (CI)  (CI)
Whole body
age (years)  59.9 (35.4,84.4)*** 75 (48.2,101.9)*** 0.04 (0.03,0.06)***
sex 7.5 (-3.9,18.9) -0.09 (-12.7,12.5) -0.005 (-0.01,0.003)
Lumbar spine
age (years)  1.3 (0.09-2.5)* 1.6 (0.5,2.6)** 0.03 (1.1,2.7)*
sex -1.7 (-2.2, -1.2)*** -0.4 (-0.9,0.04) 0.02 (0.005,0.03)**
Hip
age (years)  2 (1.2,2.8)*** 1.9 (1.1,2.7)*** 0.03 (-0.05,-0.03)*
sex 0.3 (-0.06,0.7)* -0.5 (-0.9,-0.2)** -0.04 (-0.05,-0.03)***
table shows ; *p<0.05, **p<0.01, ***p<0.001  
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Childhood determinants of bone mass were explored first using univariate analysis. 
The determinants that showed statistically significant associations were then 
explored further using multivariate models. The univariate and multivariate maternal 
determinants were then explored before finally combining a multivariate model of 
childhood and maternal predictors. 
 
4.4.2  Childhood determinants of 6 year bone mineral 
 The following childhood determinants of 6 year bone mass were considered; the 
child‟s lifestyle at age 6 years including diet and activity, and childhood 
anthropometry including height, weight, skinfold thickness and grip strength. (Early 
childhood anthropometry including birth weight and early growth will be considered 
separately in Chapter 7). 
 
4.4.2.1  Childhood dietary influences 
Milk intake was associated with increased whole body BMC, and bone area but 
neither aBMD nor vBMD. Milk intake was also associated with lumbar spine BMC 
and aBMD (p<0.01) and vBMD (p<0.05) and hip BMC and aBMD (p=0.01) 
Similarly, daily milk intake was associated with increased vBMD at both sites in this 
study (p<0.05) (table 12). 
 
TABLE 12: Total milk intake at 6 years and whole body, lumbar spine and hip 
bone mass 
 
 
There was a small association between fruit intake and whole body BMC (r=0.1, 
p=0.04), spinal BMC (r=0.12, p=0.01) and vBMD (r=0.12, p=0.01) and hip BMC 
(r=0.11, p=0.03) and vBMD, (r=0.13, p=0.01). No associations were seen between 
vegetable intake or carbonated drink intake and any measure of bone mass.  
BA, cm2 BMC,g BMD, g/cm2 vBMD
 (CI)  (CI)  (CI)  (CI)
cm2/pt g/pt g/cm2/pt g/pt
Whole body
Daily milk (pints) 9.9 (2.8-16.9)** 10 (2.3-17.7)* 0.005 (-0.0004-0.01) 0.2 (-2.7 3.1)
Lumbar spine
Daily milk (pints) 0.3 (-0.06-0.62) 0.4 (0.14-0.72)** 0.008 (0.002-0.01)** 0.2 (0.03 0.4)*
Hip
Daily milk (pints) 0.2 (-0.3-0.4) 0.3 (0.06-0.5)* 0.009 (0.002-0.02)* 0.1 (0.01 0.2)*
table shows and 95% CI; *p<0.05, **p<0.01, ***p<0.001  61 
 
Duration of breastfeeding was not associated with the child‟s bone mass. However 
these children had reduced total fat mass (r=-0.1, p=0.02) and increased percentage 
lean mass (r=0.13, p=0.003) at aged 6 years. Whilst individual nutrients were not 
available for analysis, principal component analysis was used to obtain a measure of 
dietary patterns. A high score was associated with increased intake of fruit, 
vegetables and cereals whereas low score was associated with increased intake of 
fatty foods and low consumptions of fruit and vegetables. An increased score at aged 
3 years was associated with increased whole body, lumbar spine and hip BMC and 
BA after adjustment for the child‟s weight at 6 years (table 13). These children also 
had a lower fat mass and higher percentage lean mass.  
 
 
TABLE 13: Whole body, lumbar spine and hip BA, BMC, aBMD and vBMD at 
age 6 years per standard deviation increase in 3 year prudent diet score 
adjusted for weight 
BA, cm2 BMC,g BMD, g/cm2 vBMD
 (CI)  (CI)  (CI)  (CI)
cm2/pt g/pt g/cm2/pt g/pt
Whole body
3 year prudent diet score (sd) 6.0 (0.9,11.0)* 6.7 (2.2,11.3)** 0.004 (0.0008,0.006)* 0.8 (-1.7,3.3)
Lumbar spine
3 year prudent diet score (sd) 0.5 (0.2,0.8)*** 0.4 (0.2,0.6)*** 0.003 (-0.002,0.008) 0.05 (-0.1,0.2)
Hip
3 year prudent diet score (sd) 0.3 (0.1,0.5)*** 0.3 (0.1,0.5)*** 0.005 (-0.0004,0.01) 0.02 (-0.08,0.1)
table shows p<0.05, **p<0.01, ***p<0.001  62 
 
4.4.3  Influence of childhood activity 
 
  Valid activity data was available for 215 subjects. The results of different intensities 
of physical activity and measures of bone mass are summarised in table 14. High 
intensity exercise was associated with increased measures of vBMD for whole body 
(r=0.32, p<0.001) lumbar spine (r=0.16, p=0.02) and hip (r=0.15, p=0.03). 
Conversely high amounts of time spent in sedentary activity were associated with 
lower volumetric BMD for whole body and spine (r=-0.21, p=0.004; r=-0.14, 
p=0.05). Children engaged in higher intensities of activity appeared to have a lower 
whole body and lumbar spine bone area (r=-0.16, p=0.02; r=-0.13, p=0.04 
respectively) compared to their contemporaries. Figure 7 uses barcharts to show the 
relationship between either vigorous or sedentary activity and whole body, lumbar 
and hip vBMD.   63 
 
TABLE 14: Daily physical activity at age 6 years and whole body, lumbar spine and hip bone
Activity mins per day BA, cm2 BMC,g BMD, g/cm2 vBMD, g
 (CI)  (CI)  (CI)  (CI)
Whole body
sedentary 0.1 (-0.01,0.2) 0.04 (-0.09,0.2) -0.00002 (-0.0001-0.00005) -0.7 (-0.1,-0.02)
light -0.06 (-0.2,0.07) -0.03 (-0.2,0.1) 0.000007 (-0.00008,0.00010) 0.04 (-0.02,0.10)
moderate -0.9 (-1.6,-0.2)* -0.3 (-1.1,0.5) 0.0003 (-0.0002,0.0008) 0.7 (0.4,1.0)***
vigorous and very vigorous -0.6 (-1,-0.09)* -0.2 (-0.7,0.4) 0.0002 (-0.0001,0.0005) 0.4 (0.3,0.6)***
lumbar spine
sedentary 0.004 (-0.001,0.009) 0.001 (-0.003,0.006) -0.0004 (-0.0001,0.00007) -0.003 (-0.006,-0.00005)
light -0.002 (-0.008,0.003) -0.001 (-0.007,0.004) -0.00000003 (-0.0001,0.0001) 0.002 (-0.001,0.006)
moderate -0.04 (-0.07,-0.004)* -0.009 (-0.04,0.02) 0.0003 (-0.0003,0.0010) 0.02 (0.0007,0.04)*
vigorous and very vigorous -0.02 (-0.04,-0.0006)* -0.003 (-0.02,0.02) 0.0003 (-0.0001,0.0007) 0.01 (0.002,0.03)*
Hip
sedentary -0.0002 (-0.004,0.004) -0.0008 (-0.004,0.003) -0.0004 (-0.0001,0.00007) -0.001 (-0.003,0.0005)
light -0.0005 (-0.005,0.004) -0.00008 (-0.004,0.004) 0.00001 (-0.0001,0.0001) 0.0008 (-0.001,0.003)
moderate 0.005 (-0.02,0.03) 0.009(-0.02,0.03) 0.0003 (-0.0004,0.001) 0.01 (-0.001,0.02)
vigorous and very vigorous 0.007 (-0.008,0.02) 0.01(-0.004,0.03) 0.0004 (-0.0001,0.0008) 0.008 (0.0006,0.02)*
table shows and CI; *p<0.05, **p<0.01, ***p<0.001  64 
 
 
Figure 7: Barcharts to show the relationships of time spent in sedentary and vigorous activity on volumetric BMD at age 6 years  
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4.4.4  Childhood anthrometric influences 
At 6 years height, weight, BMI, total fat mass, total lean mass, triceps thickness and 
grip strength were all strongly associated with 6 year bone mass.  (See table 15 and 
figure 8) 
  
 Height, weight and BMI were all positive predictors of whole body, lumbar spine 
and hip BA, BMC and aBMD (all p<0.0001) but not volumetric density. 
 Figure 8 shows scatterplots between fat and lean mass and whole body BMC and 
vBMD. Fat and lean mass were also positively associated with whole body, lumbar 
spine and hip BA, BMC and aBMD; however, whilst total lean mass was positively 
associated with whole body, spine and hip vBMD (p<0.001), fat mass was a negative 
predictor of both whole body and lumbar spine vBMD (p<0.001). 
Triceps skinfold thickness was positively associated with whole body BMC, BA, 
aBMD and hip BMC, however there was a negative association between vBMD at 
all sites. 
 
Figure 8: Scatterplots to show the relationship between total fat and lean mass 
and whole body BMC and vBMD
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TABLE 15:  Childhood anthropometry and 6 year whole body BMC, BA, aBMD and vBMD
BA (cm
2) BMC (g) BMD (g/cm
2) vBMD  (g)
Whole body
Height (cm) 9.1 (8.4,9.9)*** 10.4 (9.6,11.2)*** 0.006 (0.005,0.006)*** -0.1 (-0.6,0.3)
Log: Weight (kg) 245.5 (212.7,278.3)*** 350.5 (321.1,379.9)*** 0.2 (0.2,0.2)*** -0.2 (-16.0,15.6)
BMI (kg/m
2) 7.8 (4.3,11.3)*** 16.9 (13.3,20.5)*** 0.01 (0.01,0.02)*** 0.3 (-1.2,1.9)
Total fat (g) 0.007 (0.005,0.009)*** 0.01 (0.010,0.01)*** 0.000009 (0.000007,0.00001)*** -0.002 (-0.003,-0.0009)**
Total Lean (g) 0.02 (0.02,0.02)*** 0.03 (0.02,0.03)*** 0.00002 (0.00002,0.00002)*** 0.002 (0.0010,0.003)***
Triceps thickness (mm) 2.2 (0.3,4.1)* 4.8 (2.7,6.8)*** 0.004 (0.003,0.005)*** -1.2 (-2.0,-0.4)**
Grip strength (kg) 9.8 (7.5,12.0)*** 13.7 (11.4,16.0)*** 0.009 (0.007,0.01)*** 2.2 (1.2,3.2)***
Lumbar spine
Height (cm) 0.4 (0.3,0.4)*** 0.3 (0.3,0.4)*** 0.004 (0.003,0.005)*** 0.004 (-0.03,0.03)
Log: Weight (kg) 10 (8.3,11.7)*** 10.6 (9.2,11.9)*** 0.2 (0.1,0.2)*** -0.01 (-1.1,1.0)
BMI (kg/m
2) 0.3 (0.1,0.5)*** 0.4 (0.3,0.5)*** 0.007 (0.004,0.01)*** -0.01 (-0.1,0.09)
Total fat (g) 0.0002 (0.00007,0.0003)** 0.0002 (0.0001,0.0003)*** 0.000004 (0.000001,0.000006)** -0.0001 (-0.0002,-0.00006)***
Total Lean (g) 0.0008 (0.0007,0.0010)*** 0.0009 (0.0008,0.0010)*** 0.00001 (0.00001,0.00002)*** 0.0002 (0.00008,0.0002)***
Triceps thickness (mm) 0.03 (-0.06,0.1) 0.04 (-0.04,0.1) 0.0007 (-0.001,0.002) -0.1 (-0.1,-0.04)***
Grip strength (kg) 0.4 (0.3,0.5)*** 0.5 (0.4,0.6)*** 0.008 (0.006,0.01)*** 0.1 (0.07,0.2)***
Hip
Height (cm) 0.3 (0.2,0.3)*** 0.2 (0.2,0.3)*** 0.003 (0.002,0.004)*** -0.005 (-0.02,0.01)
Log: Weight (kg) 7.8 (6.7,8.9)*** 7.3 (6.3,8.4)*** 0.1 (0.09,0.2)*** 0.09 (-0.5,0.7)
BMI (kg/m
2) 0.3 (0.1,0.4)*** 0.3 (0.2,0.4)*** 0.006 (0.003,0.009)*** 0.004 (-0.05,0.06)
Total fat (g) 0.0002 (0.0001,0.0003)*** 0.0002 (0.00010,0.0003)*** 0.000003 (0.0000002,0.000005)* -0.00004 (-0.00008,0.000002)
Total Lean (g) 0.0006 (0.0005,0.0007)*** 0.0006 (0.0006,0.0007)*** 0.00001 (0.000010,0.00001)*** 0.00006 (0.00002,0.0001)**
Triceps thickness (mm) 0.06 (-0.004,0.1) 0.05 (-0.01,0.1) 0.0005 (-0.001,0.002) -0.03 (-0.06,-0.000009)*
Grip strength (kg) 0.3 (0.2,0.4)*** 0.3 (0.2,0.4)*** 0.006 (0.003,0.008)*** 0.03 (-0.01,0.07)
table shows and CI; *p<0.05, **p<0.01, ***p<0.001  67 
 
 
Figure 9: Scattergraphs to show the relationship of childhood height, weight, 
BMI, fat mass, lean mass and grip strength aged 6years on whole body BMC(g) 
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4.5  Mutually independent determinants of childhood bone mass 
The factors above which showed statistically significant associations with 6 year old 
bone mineral were explored in multivariate models. 
 
Since childhood height and weight appeared to be the strongest predictors of bone 
mass in univariate analysis, all other significant predictors were explored separately 
and then in models including these. Triceps skinfold thickness and total fat mass 
were strongly correlated (r=0.79), as were grip strength and lean mass (r=0.55). 
Since these would show co-linearity in further analysis, grip strength and triceps 
thickness were chosen to be included in the multivariate analysis models. 
 
Table 16 shows the multivariate analysis results from 157 subjects when grip 
strength, milk intake, triceps skinfold thickness and vigorous activity were all 
included in the model. 
 
Grip strength was positively associated with whole body, lumbar spine and hip BA, 
BMC, a BMD and vBMD (all p<0.05). When height and weight were included in the 
model, grip strength remained positively associated with whole body and lumbar 
spine BA, BMC, aBMD and vBMD ( all p<0.0001) and aBMD and vBMD of the hip 
(both p=0.03). Higher milk intake was positively associated with both whole body 
BA and BMC (p<0.05) once height and weight were included in the model, it 
remained associated with BA (β=9.1, p=0.04). 
 
Triceps skinfold thickness was positively associated with whole body BA, BMC and 
aBMD (all p<0.05).  Once height and weight were included, triceps skinfold 
thickness was negatively associated with lumbar spine aBMD (p=0.05) and hip BMC 
and BA (both p=0.04). There was a trend towards higher triceps skinfold thickness 
being associated with reduced whole body BMC and vBMD (both p<0.1). 
 
Vigorous exercise was positively associated with whole body aBMD and vBMD  
(p<0.001). This association remained when height and weight were included in the 
model (p<0.05). In addition vigorous activity was also associated with lumbar spine 
vBMD (β=0.02, p=0.02) and hip BA, BMC, aBMD and vBMD (all p<0.05) when 
height and weight were included in the model.   69 
 
TABLE 16: Mutually independent childhood determinants of bone mass at age 6 
years 
BA, cm2 BMC,g BMD, g/cm2 vBMD (prentice) (g)
Whole body
R
2 for model, % 27 39.7 43.6 22.1
Grip strength 13.8 (10,17.6)*** 19.3 (15.4,23.3)*** 0.01 (0.01-0.01)*** 3.8 (2.2,5.3) ***
Milk intake 13.4 (2,24.7)* 13 (1.3,24.6)* 0.006 (-0.007,0.01) 1.7 (-9.8,13.1)
Triceps thickness 41.8 (7.1,76.5)* 67.3 (31.6,102.9)*** 0.0004 (0.00004,0.0007)* -4.6 (-19.5,10.3)
Vigorous activity -0.3 (-0.8,0.2) 0.2 (-0.3,0.7) 0.04 (0.02, 0.07)*** .0.4 (0.2-0.6) ***
Lumbar Spine
R
2 for model, % 13.7 26 21.2 13.7
Grip strength 0.4 (0.3,0.6)*** 0.6 (0.4,0.7)*** 0.01 (0.007,0.01)*** 0.2 (0.06,0.3)**
Milk intake 0.4 (-0.1,1) 0.2 (-0.2,0.7) 0.001 (-0.009,0.01) -0.02 (-0.3,0.3)
Triceps thickness 1.6 (-0.9,3.3) 0.7 (-0.7,2.1) -0.006 (-0.03,0.02) -1.2 (-2.2,-0.3)*
Vigorous activity -0.1 (0.04, 0.01 -0.002 (-0.02, 0.02) 0.0001 (-0.0003,0.0006) 0.009 (-0.007,0.04)
Hip
R
2 for model, % 10.9 16 13 5.7
Grip strength 0.2 (0.2,0.5)*** 0.4 (0.2,0.5)*** 0.01 (0.005,0.01)*** 0.08 (0.01,0.1)*
Milk intake 0.3 (-0.1,0.7) 0.3 (-0.09,0.7 0.006 (-0.006,0.02) 0.05 (-0.15,0.2)
Triceps thickness 0.3 (0,1.6) 0.4 (-0.8,1.6) 0.1 (-0.02,0.05) -0.2 (-0.77,0.4)
Vigorous activity 0.0008 (-0.02,0.02) 0.006 (-0.1,0.02) 0.0003 (-0.0002,0.0009) 0.006 (-0.004,0.02)
table shows and 95% CI; *p<0.05, **p<0.01, ***p<0.001  
 
 Table 17 shows the effect when both height and weight are added to the four 
predictors in the multivariate model described in table 16. The child‟s height was 
positively associated with whole body BA, BMC (both p<0.001) lumbar spine BMC, 
BA (p<0.05) and hip BA and BMC (p<0.05). However a negative relationship was 
seen between the child‟s height and whole body vBMD (β=-2.1, p=0.002).  Higher 
weight was positively associated with whole body BA, BMC and aBMD (all 
p<0.05), lumbar spine BMC and aBMD (p<0.05) and hip BA, BMC and aBMD 
(p<0.05). 
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TABLE 17: Mutually independent childhood determinants of bone mass at aged 
6 years including height and weight 
 
BA, cm2 BMC,g BMD, g/cm2 vBMD (prentice) (g)
Whole body
R
2 for model, % 60 71 68 28
Log child's weight 112.2 (2.3,222.1)* 291.6 (185.6,397.6)*** 0.2 (0.2,0.3)*** 60.6 (-2.5,123.7)
Child's height 6.1 (3.8,8.4)*** 3.2 (1.0,5.4)** -0.0003 (-0.002,0.001) -2.1 (-3.4,-0.8)**
Grip strength 4.4 (0.8,7.9)* 7.2(3.8,10.6)*** 0.005 (0.003,0.007)*** 3.9 (1.9,5.9)***
Milk intake 9.1 (0.5,17.6)* 6 (-2.3,14.2) 0.001 (-0.004,0.007) -0.8 (-5.6,4.0)
Triceps thickness 0.8 (-35.3,36.9) -15 (-49.8,19.8) -0.02 (-0.04,0.004) -17.6 (-37.9,2.8)
Vigorous activity -0.07 (-0.5,0.3) 0.3 (-0.1,0.6) 0.0003 (0.00007,0.0006)* 0.3* (0.05,0.5)
Lumbar Spine
R
2 for model, % 43 47 26 15
Log child's weight 5.1 (-0.8,11.0) 7.3 (2.4,12.3)** 0.1 (0.02,0.3)* 0.6 (-3.7,4.8)
Child's height 0.3 (0.1,0.4)*** 0.1 (0.02,0.2)* -0.0004 (-0.003,0.002) -0.06 (-0.2,0.03)
Grip strength 0.05 (-0.1,0.2) 0.3 (0.09,0.4)** 0.007 (0.003,0.01)** 0.2 (0.07,0.3)**
Milk intake 0.3 (-0.2,0.8) 0.1 (-0.3,0.5) -0.001 (-0.01,0.009) -0.02 (-0.3,0.3)
Triceps thickness -0.3 (-2.2,1.7) -1.5 (-3.1,0.2) -0.04 (-0.08,-0.0003)* -1.3 (-2.7,0.05)
Vigorous activity -0.004 (-0.03,0.02) 0.002 (-0.02,0.02) 0.0001 (-0.0003,0.0006) 0.006 (-0.01,0.02)
Hip
R
2 for model, % 44 40 17 8
Log child's weight 5.7 (1.3,10.0)* 6.6 (2.3,11.0)** 0.2 (0.010,0.3)* 1 (-1.7,3.6)
Child's height 0.2 (0.09,0.3)*** 0.1 (0.01,0.2)* -0.0008 (-0.004,0.002) -0.05 (-0.1,0.009)
Grip strength -0.01 (-0.2,0.1) 0.08 (-0.06,0.2) 0.006 (0.0006,0.01)* 0.09 (0.010,0.2)*
Milk intake 0.2 (-0.2,0.5) 0.2 (-0.2,0.5) 0.003 (-0.009,0.02) 0.04 (-0.2,0.2)
Triceps thickness -1.5 (-2.9,-0.09)* -1.5 (-2.9,-0.07)* -0.03 (-0.08,0.02) -0.3 (-1.2,0.5)
Vigorous activity 0.007 (-0.009,0.02) 0.009 (-0.007,0.02) 0.0003 (-0.0003,0.0008) 0.004 (-0.006,0.01)
table shows and 95% CI; *p<0.05, **p<0.01, ***p<0.001  
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4.6  Maternal determinants of 6 year bone mass 
 
4.6.1  Introduction 
Maternal information was categorised as dietary, anthropometric and lifestyle data. 
The information was collected prior to conception, early pregnancy (14 weeks) and 
late pregnancy (34 weeks). Since much of the dietary data was not normally 
distributed, it has been log transformed where appropriate. As before 6 year DXA 
was adjusted for age and sex. 
 
4.6.2  Maternal diet as a predictor of 6 year bone mass 
Diet can be split into macro and micronutrients as well as individual food types and 
groups. 
 
 The only macronutrient that was associated with bone mass of the child was protein 
intake prior to pregnancy (table 18). On univariate analysis, pre pregnancy protein 
intake was associated with whole body BMC (r=0.1, p=0.02), BA (r=0.13, p=0.002), 
lumbar spine BMC (r=0.1, p=0.02) and BA (r=0.1, p=0.03) as well as hip BA 
(r=0.08, p=0.05). This relationship was not observed during early pregnancy and was 
only seen in late pregnancy for whole body BA (r=0.1, p=0.03). 
 
For micronutrients all predictors were logged, as nutrient intake was not normally 
distributed. The overall results are displayed in table 19. Calcium intake prior 
pregnancy was positively associated with whole body BMC (r=0.13, p=0.002), BA 
(r=0.12, p=0.006) and aBMD (r=0.11, p=0.01). It was also associated with increased 
lumbar spine BMC (r=0.17, p<0.0001), BA (r=0.18, p<0.0001) aBMD (r=0.17, 
p=0.03) and hip BMC (r=0.11, p=0.01) and BA (r=0.11, p=0.009).  There was no 
relationship seen in early pregnancy and only a weak relationship was seen for whole 
body BA in late pregnancy (r=0.09, p=0.04). Although calcium intake prior to 
pregnancy was strongly correlated with intake in early (r=0.52, p<0.0001) and late 
pregnancy (r=0.54, p<0.0001) there was some difference seen in the amount of 
calcium consumed.   72 
A relationship was also observed for pre pregnancy intake of vitamin B12 for whole 
body BMC (r=0.11, p=0.01), BA (r=0.12, p=0.005) and lumbar spine BMC (r=0.11, 
p=0.009) and BA (r=0.11, p=0.01). No relationship was seen in early or late 
pregnancy. 
 
Although dietary patterns were explored there was no significant relationship 
between a healthy diet (calculated using principal component analysis) and measures 
of bone mass. However mothers that had a higher score, consistent with a healthier 
diet had children with a higher percentage lean mass (r=0.11, p=0.01).  73 
 
  TABLE 18: Maternal macronutrient intake in pre, early and late pregnancy and bone mineral at age 6 years 
 
Whole body  Lumbar spine Hip
BA, cm2 BMC,g BMD, g/cm2 vBMD, g BA, cm2 BMC,g BMD, g/cm2 vBMD, g BA, cm2 BMC,g BMD, g/cm2 vBMD, g
Pre Pregnancy n=526
Total protein (g/day) 31.5 (11.3,51.7)** 26.9 (4.6,49.1)* 0.008 (-0.006,0.02) -1.8 (-10.5,6.9) 1.1 (0.1,2.1)* 1 (0.2,1.9)* 0.01 (-0.005,0.03) 0.2 (-0.4,0.8) 0.7 (-0.008,1.3)* 0.6 (-0.07,1.2) 0.008 (-0.01,0.03) -0.06 (-0.4,0.3)
Total fat (g/day) 15.6 (-2.2,33.3) 11.8 (-7.7,31.3) 0.002 (-0.01,0.01) 1.9 (-5.7,9.4) 0.2 (-0.7,1.0) 0.6 (-0.1,1.4) 0.02 (-0.0007,0.03) 0.4 (-0.1,0.9) 0.08 (-0.5,0.7) 0.05 (-0.5,0.6) 0.000006 (-0.02,0.02) -0.07 (-0.4,0.2)
Total carbohydrate (g/day) 17.3 (-1.4,36.1) 18.2 (-2.4,38.7) 0.008 (-0.005,0.02) 4.3 (-3.5,12.2) 0.6 (-0.3,1.5) 0.9 (0.06,1.6)* 0.02 (-0.0006,0.03) 0.5 (-0.05,1.0) 0.4 (-0.3,1.0) 0.2 (-0.4,0.8) 0.0004 (-0.02,0.02) -0.1 (-0.4,0.2)
Total energy (kcal/day) 23.6 (3.0,44.3)* 21.7 (-1.0,44.4) 0.008 (-0.007,0.02) 3.1 (-5.7,11.8) 0.6 (-0.4,1.6) 1 (0.08,1.8)* 0.02 (0.0004,0.04)* 0.5 (-0.1,1.1) 0.4 (-0.3,1.1) 0.3 (-0.3,1.0) 0.002 (-0.02,0.02) -0.1 (-0.5,0.2)
 
Early Pregnancy n=420  
Total protein (g/day) 12.0 (-8.6,32.7) 13.8 (-9.3,36.9) 0.007 (-0.008,0.02) 1.3 (-7.9,10.4)  0.6 (-0.3,1.6) 0.4 (-0.5,1.3) 0.0008 (-0.02,0.02) -0.03 (-0.6,0.6)  0.4 (-0.3,1.2)  0.4 (-0.3,1.0)  0.005 (-0.02,0.03)  -0.1 (-0.5,0.2)
Total fat (g/day) 6.6 (-12.8,26.0) 5.4 (-16.3,27.2) 0.001 (-0.01,0.02) -0.8 (-9.3,7.6) 0.4 (-0.6,1.3) 0.2 (-0.7,1.0) -0.002 (-0.02,0.02) -0.1 (-0.7,0.4) 0.2 (-0.4,0.9) 0.03 (-0.6,0.7) -0.007 (-0.03,0.01) -0.2 (-0.6,0.08)
Total carbohydrate (g/day) 6.3 (-15.3,27.9) 12.6 (-11.6,36.7) 0.009 (-0.006,0.02) 5.7 (-3.6,14.9) 0.06 (-0.9,1.1) 0.3 (-0.6,1.2) 0.007 (-0.01,0.03) 0.3 (-0.3,0.9) 0.2 (-0.6,0.9) 0.1 (-0.6,0.8) -0.0006 (-0.02,0.02) -0.05 (-0.4,0.3)
Total energy (kcal/day) 8.2 (-14.5,30.8) 11.6 (-13.7,36.9) 0.007 (-0.010,0.02) 2.8 (-7.1,12.6) 0.3 (-0.7,1.4) 0.3 (-0.6,1.3) 0.003 (-0.02,0.02) 0.1 (-0.5,0.8) 0.3 (-0.5,1.1) 0.2 (-0.6,0.9) -0.003 (-0.03,0.02) -0.2 (-0.5,0.2)
 
Late Pregnancy n=508  
Total protein (g/day) 23 (2.8,43.2)* 16.6 (-5.7,38.9) 0.002 (-0.01,0.02) -4.1 (-12.8,4.6) 0.4 (-0.6,1.4) 0.3 (-0.6,1.2) 0.004 (-0.01,0.02) 0.1 (-0.5,0.7) 0.2 (-0.5,0.9) -0.02 (-0.7,0.6) -0.008 (-0.03,0.01) -0.2 (-0.6,0.1)
Total fat (g/day) 16.1 (-2.3,34.6) 12.3 (-8.1,32.7) 0.002 (-0.01,0.02) -0.03 (-7.9,7.9) -0.08 (-1.0,0.8) 0.2 (-0.5,1.0) 0.009 (-0.008,0.03) 0.3 (-0.2,0.8) -0.08 (-0.7,0.6) -0.1 (-0.7,0.5) -0.005 (-0.02,0.01) -0.1 (-0.4,0.2)
Total carbohydrate (g/day) 17.7 (-1.4,36.9) 13.8 (-7.3,35.0) 0.003 (-0.01,0.02) -0.5 (-8.7,7.6) 0.5 (-0.4,1.4) 0.5 (-0.3,1.3) 0.008 (-0.010,0.03) 0.4 (-0.2,0.9) 0.01 (-0.6,0.7) -0.2 (-0.8,0.4) -0.01 (-0.03,0.007) -0.2 (-0.5,0.09)
Total energy (kcal/day) 21.6 (0.7,42.6)* 16.7 (-6.4,39.9) 0.003 (-0.01,0.02) -0.9 (-9.8,8.1) 0.3 (-0.7,1.4) 0.5 (-0.4,1.4) 0.01 (-0.009,0.03) 0.4 (-0.2,1.0) 0.03 (-0.7,0.7) -0.2 (-0.9,0.5) -0.01 (-0.03,0.01) -0.2 (-0.6,0.1)
table shows ; *p<0.05, **p<0.01, ***p<0.001  74 
TABLE 19: Maternal micronutrient intake in pre, early and late pregnancy and bone mineral aged 6 years
Whole body  Lumbar spine Hip
BA, cm2 BMC,g BMD, g/cm2 vBMD, g BA, cm2 BMC,g BMD, g/cm2 vBMD, g BA, cm2 BMC,g BMD, g/cm2 vBMD, g
Pre Pregnancy n=526
Calcium mg/day 22.6 (6.7,38.5)** 27.2 (9.8,44.7)** 0.01 (0.004,0.03)* 2.9 (-3.9,9.6) 1.6 (0.8,2.3)*** 1.4 (0.7,2.0)*** 0.02 (0.002,0.03)* 0.3 (-0.1,0.8) 0.7 (0.2,1.2)** 0.7 (0.1,1.2)* 0.01 (-0.006,0.03) -0.01 (-0.3,0.2)
Vitamin D mcg/day 8.8 (-0.03,17.6)* 7.9 (-1.8,17.6) 0.003 (-0.004,0.009) -1.6 (-5.4,2.1) 0.3 (-0.1,0.7) 0.4 (0.02,0.8)* 0.007 (-0.0007,0.02) 0.08 (-0.2,0.3) 0.1 (-0.2,0.4) 0.1 (-0.2,0.4) 0.002 (-0.007,0.01) -0.02 (-0.2,0.1)
B12 mcg/day 15.6 (4.8,26.4)** 15 (3.1,26.8)* 0.006 (-0.002,0.01) -1 (-5.7,3.6) 0.7 (0.2,1.2)* 0.6 (0.2,1.1)*** 0.008 (-0.002,0.02) 0.09 (-0.2,0.4) 0.3 (-0.03,0.7) 0.3 (-0.03,0.7) 0.006 (-0.005,0.02) -0.003 (-0.2,0.2)
Folate mcg/day 5.5 (-7.2,18.2) 4.7 (-9.3,18.6) 0.001 (-0.008,0.01) -2.1 (-7.4,3.2) 0.7 (0.1,1.3)* 0.5 (-0.02,1.0) 0.003 (-0.008,0.01) -0.03 (-0.4,0.3) 0.1 (-0.3,0.5) 0.02 (-0.4,0.4) -0.004 (-0.02,0.009) -0.1 (-0.3,0.07)
Vitamin C mg/day 9.2 (0.7,17.7)* 6.8 (-2.5,16.1) 0.001 (-0.005,0.007) -0.3 (-3.8,3.3) 0.3 (-0.06,0.7) 0.3 (-0.01,0.7) 0.005 (-0.002,0.01) 0.1 (-0.10,0.4) 0.2 (-0.05,0.5) 0.2 (-0.08,0.5) 0.001 (-0.007,0.010) -0.03 (-0.2,0.1)
Total milk pts/day 6.6 (0.7,12.5)* 9.8 (3.4,16.3)** 0.006 (0.002,0.01)** 1.7 (-0.7,4.2) 0.4 (0.09,0.6)* 0.4 (0.1,0.6)*** 0.005 (0.00009,0.01)* 0.1 (-0.05,0.3) 0.2 (-0.02,0.4) 0.2 (0.04,0.4)* 0.006 (0.0006,0.01)* 0.06 (-0.03,0.2)
Early Pregnancy n=420
Calcium mg/day 9.6 (-6.1,25.3) 10.6 (-6.9,28.2) 0.005 (-0.006,0.02) -0.5 (-7.4,6.4) 0.6 (-0.2,1.3) 0.2 (-0.4,0.9) -0.003 (-0.02,0.01) -0.1 (-0.6,0.3) 0.4 (-0.1,1.0) 0.2 (-0.3,0.7) -0.004 (-0.02,0.01) -0.2 (-0.5,0.05)
Vitamin D mcg/day -6.4 (-15.4,2.5) -4.6 (-14.6,5.5) -0.001 (-0.008,0.005) 0.3 (-3.6,4.2) 0.08 (-0.3,0.5) -0.01 (-0.4,0.4) -0.002 (-0.010,0.007) -0.06 (-0.3,0.2) -0.05 (-0.4,0.3) -0.02 (-0.3,0.3) 0.0001 (-0.009,0.009) -0.03 (-0.2,0.1)
B12 mcg/day 2.4 (-8.7,13.5) 3.7 (-8.7,16.1) 0.003 (-0.005,0.01) -1.2 (-6.2,3.8) 0.5 (-0.05,1.0) 0.3 (-0.2,0.8) 0.002 (-0.009,0.01) -0.05 (-0.4,0.3) 0.2 (-0.2,0.6) 0.3 (-0.06,0.7) 0.01 (-0.0008,0.02) 0.05 (-0.1,0.2)
Folate mcg/day -0.4 (-16.2,15.3) -4.9 (-22.5,12.8) -0.005 (-0.02,0.006) -4 (-10.9,2.8) 0.2 (-0.5,0.9) -0.2 (-0.8,0.5) -0.007 (-0.02,0.007) -0.3 (-0.7,0.2) 0.1 (-0.4,0.6) -0.01 (-0.5,0.5) -0.006 (-0.02,0.009) -0.1 (-0.4,0.1)
Vitamin C mg/day 1 (-9.2,11.1) -0.1 (-11.5,11.3) -0.0008 (-0.008,0.007) 0.9 (-3.5,5.3) 0.1 (-0.4,0.6) 0.2 (-0.2,0.6) 0.004 (-0.006,0.01) 0.2 (-0.06,0.5) -0.2 (-0.5,0.2) 0.03 (-0.3,0.4) 0.008 (-0.003,0.02) 0.1 (-0.03,0.3)
Mg mg/day -5.5 (-26.1,15.2) 1.1 (-22.1,24.2) 0.004 (-0.01,0.02) 2.8 (-6.1,11.8) 0.2 (-0.8,1.1) -0.06 (-0.9,0.8) -0.005 (-0.02,0.01) -0.2 (-0.8,0.3) 0.1 (-0.6,0.8) 0.09 (-0.6,0.8) -0.0001 (-0.02,0.02) -0.1 (-0.5,0.2)
Total milk pts/day 5.4 (-0.07,10.9) 6.2 (0.07,12.4)* 0.003 (-0.0008,0.007) -0.2 (-2.6,2.2) 0.2 (-0.03,0.5) 0.2 (-0.08,0.4) 0.0006 (-0.004,0.006) -0.01 (-0.2,0.1) 0.1 (-0.05,0.3) 0.1 (-0.08,0.3) 0.0002 (-0.005,0.006)-0.05 (-0.1,0.04)
Late Pregnancy n=508
Calcium mg/day 16.3 (0.6,32.0) 13.5 (-3.8,30.8) 0.004 (-0.008,0.01) -1.1 (-7.8,5.5) 0.6 (-0.1,1.4) 0.4 (-0.3,1.0) 0.002 (-0.01,0.02) 0.04 (-0.4,0.5) 0.4 (-0.2,0.9) 0.05 (-0.5,0.6) -0.01 (-0.03,0.005) -0.2 (-0.5,0.01)
Vitamin D mcg/day 2.5 (-6.2,11.1) -2.9 (-12.4,6.6) -0.005 (-0.01,0.0010) -3.1 (-6.7,0.6) 0.3 (-0.1,0.7) -0.01 (-0.4,0.4) -0.005 (-0.01,0.003) -0.07 (-0.3,0.2) -0.07 (-0.4,0.2) -0.07 (-0.3,0.2) -0.002 (-0.01,0.007) -0.02 (-0.2,0.1)
B12 mcg/day 9.3 (-2.9,21.5) 5.7 (-7.8,19.2) -0.00006 (-0.009,0.009) -1.9 (-7.1,3.4) 0.4 (-0.2,1.0) 0.3 (-0.3,0.8) 0.001 (-0.010,0.01) 0.03 (-0.3,0.4) 0.09 (-0.3,0.5) 0.1 (-0.3,0.5) 0.003 (-0.009,0.02) 0.03 (-0.2,0.2)
Folate mcg/day 2 (-9.1,13.0) -3.6 (-15.8,8.5) -0.006 (-0.01,0.002) -2.8 (-7.5,1.9) 0.4 (-0.1,0.9) -0.07 (-0.5,0.4) -0.009 (-0.02,0.001) -0.2 (-0.5,0.1) -0.1 (-0.5,0.3) -0.2 (-0.5,0.2) -0.007 (-0.02,0.004) -0.09 (-0.3,0.09)
Vitamin C mg/day 5.4 (-4.5,15.3) -0.5 (-11.4,10.4) -0.004 (-0.01,0.003) -2.5 (-6.7,1.8) 0.2 (-0.2,0.7) 0.04 (-0.4,0.5) -0.002 (-0.01,0.007) 0.04 (-0.2,0.3) -0.01 (-0.3,0.3) -0.02 (-0.3,0.3) -0.002 (-0.01,0.008) -0.03 (-0.2,0.1)
Mg mg/day 14.1 (-6.1,34.2) 8.5 (-13.7,30.7) -0.0006 (-0.02,0.01) -2.9 (-11.5,5.7) 0.6 (-0.4,1.6) 0.3 (-0.5,1.2) 0.001 (-0.02,0.02) 0.1 (-0.5,0.7) 0.02 (-0.7,0.7) -0.2 (-0.8,0.5) -0.01 (-0.03,0.01) -0.2 (-0.6,0.1)
Total milk pts/day 4.2 (-1.1,9.6) 5.7 (-0.1,11.6) 0.003 (-0.0003,0.007) 1 (-1.3,3.3) 0.1 (-0.1,0.4) 0.1 (-0.10,0.4) 0.002 (-0.003,0.007) 0.02 (-0.1,0.2) 0.2 (-0.03,0.3) 0.08 (-0.09,0.2) -0.0007 (-0.006,0.005)-0.04 (-0.1,0.05)
table shows b; *p<0.05, **p<0.01, ***p<0.001  75 
 
 
4.6.3  Maternal lifestyle determinants of 6 year bone mineral 
There was no relationship seen between maternal social class, maternal qualifications 
obtained or parity and childhood bone mass. Smoking was positively associated with 
whole body aBMD and BMAD but not vBMD using method of prentice (table 20).  
 
TABLE 20: Maternal exercise and smoking status pre, early and late pregnancy 
and whole body bone mineral 
 
 
 
 
Smoking was positively associated with both total and percentage fat at all time 
points during pregnancy (Table 21).  It was conversely negatively associated with 
percentage lean mass (all p<0.0001) of the child at aged 6 years. 
 
Whole Body
BA BMC aBMD vBMD 
(cm
2) (g) (g/cm
2) Prentice (g)
Pre Pregnancy n=526
freq strenous activity week 1.6 (-1.4,4.7) 1.2 (-2.2,4.5) 0.0003 (-0.002,0.002) 0.3 (-0.9,1.6)
walking speed 2.6 (-5.4,10.6) 2.1 (-6.7,10.8) 0.00002 (-0.006,0.006) -0.7 (-4.0,2.6)
Current smoking 2.9 (-9.7,15.6) 8.9 (-5.0,22.8) 0.008 (-0.0009,0.02) 1.8 (-3.5,7.1)
Early pregnancy n-420
freq strenous activity week 1.2 (-1.2,3.5) 0.3 (-2.4,2.9) -0.0004 (-0.002,0.001) -0.6 (-1.5,0.4)
walking speed 4.6 (-3.7,12.9) 5.6 (-3.7,14.9) 0.002 (-0.004,0.008) 0.9 (-2.6,4.5)
Current smoking 2.6 (-13.4,18.6) 14.5 (-3.0,32.0) 0.01 (0.003,0.03)* 2 (-4.6,8.7)
Late pregnancy n= 508
freq strenous activity week 0.7 (-0.7,2.1) 0.9 (-0.6,2.4) 0.0005 (-0.0004,0.002) 0.4 (-0.2,1.0)
walking speed 0.5 (-6.3,7.4) -0.8 (-8.4,6.8) -0.002 (-0.007,0.003) -0.7 (-3.6,2.2)
Current smoking 6.3 (-10.0,22.6) 17.4 (-0.5,35.3) 0.01 (0.003,0.03)* 1.9 (-5.1,8.8)
table shows and 95% C; *p<0.05, **p<0.01, ***p<0.001  76 
TABLE 21: Maternal exercise and smoking status pre, early and late pregnancy 
and body composition 
Total lean Total fat % Fat % Lean
(g) Z trans of log (g)
Pre Pregnancy n=526
freq strenous activity week 33.8 (-59.1,126.7) -0.04 (-0.09,0.009) -0.05 (-0.10,-0.004)* 0.06 (0.008,0.1)*
walking speed 168.6 (-74.5,411.6) -0.09 (-0.2,0.04) -0.1 (-0.3,-0.002)* 0.1 (0.009,0.3)*
Current smoking 116.6 (-270.6,503.7) 0.3 (0.08,0.5)** 0.3 (0.1,0.5)** -0.4 (-0.5,-0.2)***
Early pregnancy n-420
freq strenous activity week 26.9 (-43.8,97.5) -0.03 (-0.06,0.01) -0.03 (-0.07,0.004) 0.03 (-0.006,0.07)
walking speed 202.1 (-51.2,455.3) -0.1 (-0.3,-0.0009)* -0.2 (-0.3,-0.07)** 0.2 (0.07,0.3)**
Current smoking 402.6 (-88.8,894.0) 0.5 (0.3,0.8)*** 0.5 (0.3,0.8)*** -0.6 (-0.9,-0.4)***
Late pregnancy n= 508  
freq strenous activity week 17.6 (-23.9,59.2) -0.02 (-0.04,0.005) -0.02 (-0.05,-0.002)* 0.02 (-0.001,0.04)
walking speed 88.8 (-117.6,295.2) -0.1 (-0.2,-0.01)* -0.2 (-0.3,-0.05)** 0.2 (0.05,0.3)**
Current smoking 503.2 (12.2,994.2)* 0.5 (0.2,0.7)*** 0.5 (0.2,0.7)*** -0.5 (-0.8,-0.3)***
table shows and 95% C; *p<0.05, **p<0.01, ***p<0.001  
 
Whilst maternal exercise and walking speed were not associated with childhood bone 
mass, they were negatively associated with percentage fat and positively associated 
with percentage lean mass (table 21). 
 
Increased frequency of strenuous activity in late pregnancy was positively associated 
with hip BMC (r=0.14, p=0.002), BA (r=0.09, p=0.04), aBMD (r=0.11, p=0.02) and 
vBMD (r=0.13, p=0.006). However no association with exercise levels was seen in 
either prior or during early pregnancy (table 20).  Exercise in late pregnancy was 
positively correlated with vigorous activity in the child at aged 6 years (r=0.15, 
p=0.03). 
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4.6.4  Maternal anthropometric influences 
  The relationship between maternal anthropometry and bone mineral is summarised 
in table 22. Pre pregnancy maternal height and weight were both positively 
associated with 6 year whole body BMC (r=0.28, p<0.0001; r=0.23, p<0.0001), BA 
(r=0.3, p<0.0001; r=0.17, p<0.0001) and aBMD (r=0.2, p<0.0001; r=0.24, p<0.0001) 
but not vBMD. A weaker association was seen between maternal BMI and whole 
body BMC (r=0.11, p=0.01) and aBMD (r=0.16, p<0.0001). A similar association 
was seen for weight in late pregnancy (all p<0.0001); however there was no 
relationship between weight gained during pregnancy and any measure of bone mass. 
 
A similar relationship was observed for pre pregnancy height and weight and 6 year 
lumbar spine BMC (r=0.23, p<0.0001; r=0.16, p<0.0001) , BA (r=0.3, p<0.0001; 
r=0.16, p<0.0001). However there was no relationship between BMI or triceps 
skinfold thickness and lumbar spine bone mass.  
 
 Whilst maternal height and weight remained significantly positively associated with 
6 year hip BMC (r=0.18, p<0.0001; r=0.18, p<0.0001) and BA (r=0.24, p<0.0001; 
r=0.16, p<0.0001), maternal height appeared to be negatively associated with vBMD 
(r=0.1, p=0.03) whilst BMI was positively associated with vBMD (r=0.1, p=0.03). 
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TABLE 22: Maternal anthropometry pre and during pregnancy and whole 
body, lumbar spine and hip bone mass in the child at age 6 years 
 
 
 
 
Whole body
BA (cm
2) BMC (g) aBMD (g/cm
2) vBMD (prentice g)
Pre Pregnancy
Weight (kg) 60.7 (30.7,90.7)*** 87.6 (55.1,120.2)*** 0.06 (0.04,0.08)*** 0.8 (-12.1,13.6)
Height (cm) 2.9 (2.1,3.7)*** 3 (2.1,3.9)*** 0.001 (0.0008,0.002)*** -0.3 (-0.6,0.09)
BMI (kg/m
2) 16.3 (-16.6,49.2) 46.3 (10.6,82.1)* 0.04 (0.02,0.07)*** 5.1 (-8.6,18.8)
Triceps skinfold (mm) 4.3 (-11.2,19.7) 13.1 (-3.9,30.1) 0.01 (0.002,0.02)* 0.3 (-6.2,6.8)
Early pregnancy
Grip strength (kg) 1.3 (-0.3,3.0) 0.9 (-0.9,2.7) 0.0001 (-0.001,0.001) -0.5 (-1.1,0.2)
Triceps skinfold (mm) 14 (-5.4,33.4) 16.3 (-5.4,38.0) 0.009 (-0.005,0.02) -5.1 (-13.5,3.2)
Late pregnancy
Weight (kg) 81.5 (48.7,114.4)*** 111.9 (76.3,147.6)*** 0.07 (0.05,0.10)*** 0.2 (-14.1,14.5)
Triceps skinfold (mm) 14.1 (-3.1,31.4) 18.4 (-0.5,37.4) 0.01 (-0.0003,0.02) -2.8 (-10.1,4.5)
Pregnancy weight gain (kg) 0.9 (-0.04,1.9) 0.8 (-0.3,1.8) 0.0003 (-0.0004,0.0010) -0.2 (-0.6,0.2)
Lumbar spine
BA (cm
2) BMC (g) aBMD (g/cm
2) vBMD (prentice g)
Pre Pregnancy
Weight (kg) 2.7 (1.2,4.1)*** 2.4 (1.1,3.7)*** 0.03 (0.002,0.06)* -0.1 (-1.0,0.7)
Height (cm) 0.1 (0.1,0.2)*** 0.1 (0.06,0.1)*** 0.0006 (-0.0001,0.001) -0.1 (-1.0,0.7)
BMI (kg/m
2) 0.6 (-1.0,2.1) 1 (-0.4,2.4) 0.02 (-0.009,0.05) 0.1 (-0.8,1.0)
Triceps skinfold (mm) 0.4 (-0.3,1.1) 0.2 (-0.4,0.9) 0.002 (-0.01,0.02) -0.1 (-0.5,0.3)
Early pregnancy
Grip strength (kg) 0.05 (-0.03,0.1) 0.02 (-0.05,0.09) -0.0002 (-0.002,0.001) -0.03 (-0.07,0.01)
Triceps skinfold (mm) 0.4 (-0.5,1.3) 0.2 (-0.6,1.1) 0.0005 (-0.02,0.02) -0.1 (-0.7,0.4)
Late pregnancy
Weight (kg) 3.5 (1.9,5.1)*** 3 (1.6,4.4)*** 0.03 (0.004,0.06)* -0.2 (-1.1,0.8)
Triceps skinfold (mm) 0.5 (-0.3,1.3) 0.09 (-0.6,0.8) -0.005 (-0.02,0.01) -0.3 (-0.8,0.2)
Pregnancy weight gain (kg) 0.04 (-0.008,0.08) 0.02 (-0.02,0.06) -0.00009 (-0.0010,0.0008) -0.008 (-0.04,0.02)
Hip
BA (cm
2) BMC (g) aBMD (g/cm
2) vBMD (prentice g)
Pre Pregnancy
Weight (kg) 1.9 (0.9,2.9)*** 2.1 (1.1,3.0)*** 0.05 (0.02,0.08)*** 0.3 (-0.2,0.8)
Height (cm) 0.08 (0.05,0.1)*** 0.06 (0.03,0.08)*** 0.0003 (-0.0006,0.001) -0.01 (-0.03,-0.001)*
BMI (kg/m
2) 0.7 (-0.4,1.8) 1.3 (0.3,2.4)* 0.05 (0.02,0.08)** 0.6 (0.06,1.1)*
Triceps skinfold (mm) 0.3 (-0.3,0.8) 0.4 (-0.04,0.9) 0.02 (0.002,0.03)* 0.2 (-0.07,0.4)
Early pregnancy
Grip strength (kg) 0.02 (-0.04,0.07) 0.001 (-0.05,0.05) -0.0005 (-0.002,0.001) -0.02 (-0.05,0.006)
Triceps skinfold (mm) 0.4 (-0.3,1.0) 0.5 (-0.1,1.1) 0.01 (-0.005,0.03) 0.2 (-0.2,0.5)
Late pregnancy
Weight (kg) 2.4 (1.3,3.5)*** 2.4 (1.4,3.5)*** 0.05 (0.02,0.09)** 0.2 (-0.2,0.5)
Triceps skinfold (mm) 0.3 (-0.3,0.9) 0.3 (-0.2,0.9) 0.008 (-0.009,0.02) -0.0007 (-0.3,0.3)
Pregnancy weight gain (kg) 0.01 (-0.02,0.04) 0.004 (-0.03,0.03) -0.0001 (-0.001,0.0008) -0.005 (-0.02,0.01)
table shows and 95% CI *p<0.05, **p<0.01, ***p<0.001  79 
4.7  Mutually independent maternal determinants of childhood 
bone mass 
The maternal factors that showed statistically significant associations with 6-year old 
bone mineral were explored in multivariate models. 
 
Since once again height and weight seemed to be most strongly linked to childhood 
bone mass, other significant predictors were considered first. Table 23 describes the 
mutually independent maternal influences on childhood bone mass, with table 24 
additionally showing height and weight as independent determinants. 
 
When the two dietary components, protein and calcium consumption were looked at 
in isolation, maternal pre pregnancy calcium intake remained positively associated 
with whole body BMC and aBMD (both p<0.05) and lumbar spine BMC and BA 
(both p<0.001) Protein intake was no longer significant for any measure of bone 
mass. When calcium, protein, late pregnancy strenuous exercise and smoking status 
were put into a combined model, calcium intake remained significant for spinal BMC 
and BA only (table 23). When height and weight were additionally added to the 
model (table 24) maternal calcium intake prior to pregnancy remained positively 
associated with whole body aBMD (β=0.02, p=0.05) and lumbar spine BMC (β=1.5, 
p=0.005) and BA (β=1.9, p=0.001). 
 
TABLE 23: Mutually independent maternal influences on childhood bone mass 
at age 6 years 
BA (cm
2) BMC (g) aBMD (g/cm
2) vBMD (prentice g)
Whole body
R
2 for model, % 1.9 2.3 2.3 1.2
Calcium (mg/day) 4.6 (-19.8,28.9)  18.3 (-8.4,45.0)  0.02 (-0.0002,0.03)* 8.1(-2.3,18.4) 
Protein (g/day) 24.0 (-6.8,54.9) 4.6 (-29.3,38.5) -0.01(-0.03,0.01 -10.4(-23.7,2.8)
LP Freq strenous activity 0.6 (-0.7,2.0) 0.9 (-0.6,2.4) 0.0006 (-0.1,1.0) 0.5 (-0.1,1.0)
LP smoking  4.7 (-11.6,21.0)  15.3 (-2.6,33.2) 0.01(0.002,0.03)* 1.5 (-5.4,8.5)
Lumbar spine
R
2 for model, % 3.2 2.6 1 0.5
Calcium (mg/day) 1.9 (0.7,3.0)**  1.5  (0.5,2.5)** 0.01 (-0.010,0.03)  0.3 (-0.4,1.0)
Protein (g/day) -0.6 (-2.0,0.9) -0.5(-1.8,0.8)  -0.002 (-0.03,0.03) -0.2 (-1.0,0.7)
LP Freq strenous activity 0.005 (-0.06,0.07) 0.02 (-0.04,0.08) 0.0006 (-0.0007,0.002) 0.02 (-0.02,0.06)
LP smoking  -0.2 (-0.06,0.07) 0.2 (-0.5,0.9) 0.01 (-0.005,0.02) 0.1 (-0.3,0.6)
Hip
R
2 for model, % 1.9 2.6 1.4 1.7
Calcium (mg/day) 0.6 (-0.2,1.4) 0.6 (-0.2,1.3)  0.008 (-0.02,0.03) 0.01 (-0.4,0.4)
Protein (g/day) 0.07 (-1.0,1.1) -0.06 (-1.0,0.9) -0.003 (-0.03,0.03) -0.1 (-0.6,0.4)
LP Freq strenous activity 0.05 (0.003,0.09)* 0.07 (0.03,0.1)** 0.002 (0.0003,0.003)* 0.03 (0.009,0.05)**
LP smoking  0.04 (-0.5,0.6) 0.1 (-0.4,0.7)  0.006 (-0.01,0.02) 0.09 (-0.2,0.4)
table shows and 95% CI; *p<0.05, **p<0.01, ***p<0.001; LP=late pregnancy  80 
Late pregnancy strenuous activity was positively associated with hip BMC (β=0.07, 
p=0.002), BA (β=0.05, p=0.04), aBMD (β=0.002, p=0.01) and vBMD (β=0.03, 
p=0.006) once adjusted for calcium, protein and smoking status. This association 
remained once additionally adjusted for height and weight (p<0.05). 
 Smoking in late pregnancy was positively associated with whole body aBMD 
(β=0.01, p=0.02) and remained statistically significant after adjusted for height and 
weight. 
 
 Both maternal height and weight were positively associated with whole body BMC, 
BA and a BMD (all p<0.001) lumbar spine BMC and BA (all p<0.001) and hip BMC 
and BA (all p<0.001). In addition maternal weight was also associated with lumbar 
spine and hip aBMD (both p<0.01) whereas maternal height remained negatively 
associated with hip vBMD (β-0.01, p=0.04). 
 
TABLE 24:  Mutually independent maternal influences on childhood bone mass 
at age 6 years additionally including maternal height and weight 
 
 
BA (cm
2) BMC (g) aBMD (g/cm
2) vBMD (prentice g)
Whole body
R
2 for model, % 10.9 12.3 10.2 1.4
log Calcium (mg/day) 4.6 (-19.8,28.9) 18.3 (-8.4,45.0) 0.02 (-0.0002,0.03)* 8.1 (-2.3,18.4)
log Protein (g/day) 24 (-6.8,54.9) 4.6 (-29.3,38.5) -0.01 (-0.03,0.01) -10.4 (-23.7,2.8)
LP Freq strenous activity 0.6 (-0.7,2.0) 0.9 (-0.6,2.4) 0.0006 (-0.0004,0.002) 0.5 (-0.1,1.0)
LP smoking  4.7 (-11.6,21.0) 15.3 (-2.6,33.2) 0.01 (0.002,0.03)* 1.5 (-5.4,8.5)
log maternal weight kg 65.1 (35.0,95.1)*** 96.7 (64.2,129.2)*** 0.07 (0.04,0.09)*** 3.1 (-10.1,16.4)
Height 2.8 (2.0,3.6)*** 3 (2.0,3.9)*** 0.001 (0.0008,0.002)*** -0.3 (-0.6,0.1)
Lumbar spine
R
2 for model, % 11.6 8.4 10.2 1.2
log Calcium (mg/day) 1.9 (0.7,3.0)** 1.5 (0.5,2.5)** 0.01 (-0.010,0.03) 0.3 (-0.4,1.0)
log Protein (g/day) -0.6 (-2.0,0.9) -0.5 (-1.8,0.8) -0.002 (-0.03,0.03) -0.2 (-1.0,0.7)
LP Freq strenous activity 0.005 (-0.06,0.07) 0.02 (-0.04,0.08) 0.0006 (-0.0007,0.002) 0.02 (-0.02,0.06)
LP smoking  -0.2 (-1.0,0.6) 0.2 (-0.5,0.9) 0.01 (-0.005,0.02) 0.1 (-0.3,0.6)
log maternal weight kg 2.9 (1.4,4.3)*** 2.7 (1.4,4.0)*** 0.03 (0.007,0.06)* -0.07 (-0.9,0.8)
Height 0.1 (0.10,0.2)*** 0.09 (0.06,0.1)*** 0.0006 (-0.0002,0.001) -0.02 (-0.04,0.004)
Hip
R
2 for model, % 9 8.4 3.6 3.6
log Calcium (mg/day) 0.6 (-0.2,1.4) 0.6 (-0.2,1.3) 0.008 (-0.02,0.03) 0.01 (-0.4,0.4)
log Protein (g/day) 0.07 (-1.0,1.1) -0.06 (-1.0,0.9) -0.003 (-0.03,0.03) -0.1 (-0.6,0.4)
LP Freq strenous activity 0.05 (0.003,0.09)* 0.07 (0.03,0.1)** 0.002 (0.0003,0.003)* 0.03 (0.009,0.05)**
LP smoking  0.04 (-0.5,0.6) 0.1 (-0.4,0.7) 0.006 (-0.01,0.02) 0.09 (-0.2,0.4)
log maternal weight kg 2.2 (1.2,3.2)*** 2.3 (1.4,3.3)*** 0.05 (0.02,0.08)*** 0.3 (-0.2,0.8)
Height 0.08 (0.05,0.1)*** 0.06 (0.03,0.08)*** 0.0003 (-0.0006,0.001) -0.01 (-0.03,-0.0008)*
table shows and 95% CI; *p<0.05, **p<0.01, ***p<0.001; LP=late pregnancy  81 
4.8  Mutually independent childhood and maternal predictors of 
bone mass.  
 
Since childhood height and weight appeared to have the largest effect on the bone 
mass of the child at aged 6 the other childhood and maternal factors were considered 
first. 
 
 Table 25 summarizes the associations between various maternal and childhood 
determinants of bone mass excluding the child‟s height and weight. Table 26 
additionally adjusts for the child‟s height and weight 
 
Maternal height was positively associated with whole body BA, BMC and lumbar 
spine BA (p<0.001) however it was also negatively associated with vBMD at all 
three sites measured. 
 
Maternal calcium intake was only associated with whole body aBMD (β=0.02, 
p=0.04), lumbar spine bone area (β=1.9, p=0.007) and BMC (β=1.6, p=0.006) when 
childhood vigorous activity was excluded from the model, allowing the number of 
observations to increase from 150 to 313.  Maternal protein intake had a small 
negative association with vBMD at the hip (β=-0.9, p=0.05) when maternal 
determinants were additionally adjusted for all four childhood factors. 
 
 Strenuous activity in late pregnancy remained significantly associated with hip BMC 
(β=0.06, p=0.03) when adjusted for grip strength, triceps thickness and milk intake; 
when vigorous activity was added to the model the association was lost. Maternal 
lifestyle appeared to predict childhood lifestyle; for example, maternal strenuous 
activity in pregnancy was correlated with vigorous activity at aged 6 years (r=0.15, 
p=0.03). Maternal smoking remained positively associated with whole body aBMD 
(β=0.02, p=0.05). 
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TABLE 25: Mutually independent childhood and maternal predictors of 6 year 
bone mass 
 
 
 
 
BA (cm
2) BMC (g) aBMD (g/cm
2) vBMD (prentice g)
Whole body
R
2 for model, % 38.2 49.1 49.6 29.3
Maternal determinants
Calcium (mg/day) -18.5 (-58.1,21.1) -0.09 (-40.5,40.3) 0.01 (-0.01,0.04) 16.1 (-1.9,34.1)
Protein (g/day) 24.6 (-25.7,74.8) -4 (-55.2,47.2) -0.02 (-0.05,0.01) -20.9 (-43.8,2.0)
LP Freq strenous activity 0.6 (-1.0,2.1) 0.7 (-0.9,2.3) 0.0004 (-0.0006,0.001) 0.07 (-0.6,0.8)
LP smoking  1.6 (-23.0,26.1) 15.8 (-9.2,40.8) 0.02 (0.0001,0.03)* 10.5 (-0.4,21.4)
Log. Maternal weight (kg) 45.3 (-7.7,98.3) 59.5 (5.5,113.5)* 0.03 (-0.0004,0.07)* 6.5 (-17.9,31.0)
Maternal Height (cm) 2.3 (0.9,3.7)** 2 (0.5,3.4)** 0.0007 (-0.0002,0.002) -0.6 (-1.3,0.008)*
Childs determinants
Vigorous activity mins/day -0.3 (-0.8,0.2) 0.1 (-0.4,0.6) 0.0003 (-0.00002,0.0006) 0.3 (0.1,0.6)**
Milk intake pints/day 14.9 (4.1,25.7)** 14.6 (3.6,25.6)* 0.007 (0.0004,0.01)* -0.2 (-5.1,4.6)
Grip strength (kg) 11.8 (8.0,15.6)*** 17.4 (13.6,21.3)*** 0.01 (0.009,0.01)*** 4 (2.3,5.7)***
Triceps thickness (mm) 3.9 (0.6,7.3)* 5.7 (2.3,9.2)* 0.004 (0.001,0.006)** -1.1 (-2.6,0.4)
Lumbar spine
R
2 for model, % 26 32.3 25.9 22.5
Maternal determinants
Calcium (mg/day) -0.04 (-2.0,1.9) 0.9 (-0.7,2.5) 0.03 (-0.008,0.06) 0.9 (-0.3,2.0)
Protein (g/day) 0.4 (-2.1,2.8) -1.2 (-3.3,0.9) -0.04 (-0.09,0.003) -1.3 (-2.8,0.2)
LP Freq strenous activity 0.001 (-0.08,0.08) 0.02 (-0.05,0.09) 0.0006 (-0.0008,0.002) 0.007 (-0.04,0.05)
LP smoking  0.1 (-1.1,1.4) 0.6 (-0.5,1.6) 0.01 (-0.009,0.04) 0.5 (-0.2,1.2)
Log. Maternal weight (kg) 1.6 (-1.0,4.2) 1.5 (-0.7,3.8) 0.01 (-0.03,0.06) 0.3 (-1.4,1.9)
Maternal Height (cm) 0.1 (0.04,0.2)** 0.04 (-0.02,0.10) -0.0005 (-0.002,0.0008) -0.06 (-0.10,-0.01)*
Childs determinants
Vigorous activity mins/day -0.02 (-0.04,0.009) -0.007 (-0.03,0.01) 0.00007 (-0.0004,0.0005) 0.006 (-0.009,0.02)
Milk intake pints/day 0.5 (-0.06,1.0) 0.3 (-0.2,0.8) 0.002 (-0.008,0.01) -0.01 (-0.3,0.3)
Grip strength (kg) 0.4 (0.2,0.6)*** 0.6 (0.4,0.7)*** 0.01 (0.007,0.01)*** 0.2 (0.10,0.3)***
Triceps thickness (mm) 0.2 (0.005,0.3)* 0.04 (-0.09,0.2) -0.001 (-0.004,0.002) -0.1 (-0.2,-0.05)**
Hip
R
2 for model, % 22 23.4 17.6 14.8
Maternal determinants
Calcium (mg/day) -0.9 (-2.4,0.6) -0.2 (-1.6,1.1) 0.02 (-0.02,0.06) 0.4 (-0.3,1.1)
Protein (g/day) 1.1 (-0.8,3.0) -0.2 (-2.0,1.6) -0.05 (-0.1,0.007) -0.9 (-1.9,-0.01)*
LP Freq strenous activity 0.03 (-0.03,0.10) 0.05 (-0.01,0.1) 0.001 (-0.0005,0.003) 0.02 (-0.01,0.05)
LP smoking  0.008 (-0.9,1.0) 0.3 (-0.6,1.2) 0.01 (-0.01,0.04) 0.2 (-0.2,0.7)
Log. Maternal weight (kg) 2.7 (0.6,4.7)* 2.7 (0.8,4.6)** 0.05 (-0.01,0.1) 0.4 (-0.6,1.4)
Maternal Height (cm) 0.04 (-0.01,0.10) 0.003 (-0.05,0.05) -0.001 (-0.003,0.0002) -0.04 (-0.06,-0.01)**
Childs determinants
Vigorous activity mins/day -0.002 (-0.02,0.02) 0.003 (-0.02,0.02) 0.0003 (-0.0003,0.0008) 0.006 (-0.003,0.02)
Milk intake pints/day 0.4 (-0.05,0.8) 0.4 (-0.03,0.8) 0.006 (-0.006,0.02) 0.05 (-0.2,0.3)
Grip strength (kg) 0.3 (0.1,0.4)*** 0.4 (0.2,0.5)*** 0.01 (0.005,0.01)*** 0.09 (0.02,0.2)*
Triceps thickness (mm) -0.02 (-0.1,0.1) -0.002 (-0.1,0.1) 0.0004 (-0.003,0.004) -0.02 (-0.08,0.04)
table shows and 95% CI; *p<0.05, **p<0.01, ***p<0.001  83 
 
The child‟s vigorous activity levels were positively associated with whole body 
vBMD when adjusted for all maternal and childhood factors in table 25 and 26. Milk 
intake remained positively associated with whole body BA, BMC, aBMD when 
adjusted for all factors in the current model. Grip strength remained a strong positive 
predictor of whole body, lumbar spine and hip BA, BMC, a BMD and vBMD (all 
p<0.0001 except hip vBMD p=0.01). Increased triceps skinfold thickness was 
positively associated with whole body BA (β=3.9, p=0.02), BMC (β=5.7, p=0.001), 
aBMD (β=0.004, p=0.001) and lumbar spine area (β=0.2, p=0.04); however a 
negative association was observed at the lumbar spine vBMD (β=-0.1, p=0.003). 
 
 Once childhood height and weight were added into the model, the main predictors of 
whole body BMC and BA were childhood height, weight, and grip strength. Triceps 
skinfold thickness was negatively associated with hip BA and BMC. Grip strength 
was also positively associated with vBMD at all three skeletal sites, however the 
child‟s height was negatively associated with whole body vBMD (β=-2, p=0.007). 
Vigorous activity remained positively associated with whole body aBMD (β=0.0003, 
p=0.03) and vBMD (β=0.3, p=0.02). 
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 TABLE 26: Mutually independent childhood and maternal predictors of 6 year 
bone mineral at age 6 including the child’s height and weight   
 
 
 
 
 
 
BA (cm
2) BMC (g) aBMD (g/cm
2) vBMD (prentice g)
Whole body
R
2 for model, % 62.1 72.6 69.7 33.6
Maternal determinants
Calcium (mg/day) -13.6 (-45.9,18.8) 3.5 (-27.1,34.2) 0.01 (-0.008,0.03) 13.5 (-4.2,31.2)
Protein (g/day) 20.2 (-20.9,61.3) -2.8 (-41.8,36.1) -0.02 (-0.04,0.009) -17.6 (-40.1,4.8)
LP Freq strenous activity -0.1 (-1.4,1.1) 0.09 (-1.1,1.3) 0.0002 (-0.0006,0.0010) 0.2 (-0.5,0.9)
LP smoking  4.4 (-15.7,24.5) 11.4 (-7.6,30.4) 0.008 (-0.004,0.02) 8 (-3.0,19.0)
Log. Maternal weight (kg) 20.6 (-24.9,66.1) 17.9 (-25.2,61.0) 0.002 (-0.03,0.03) 3.5 (-21.4,28.3)
Maternal Height (cm) 0.1 (-1.1,1.4) 0.02 (-1.1,1.2) -0.00009 (-0.0009,0.0007) -0.3 (-0.9,0.4)
Childs determinants
Child height (cm) 6.5 (3.9,9.1)*** 3.4 (0.9,5.8)** -0.0005 (-0.002,0.001) -2 (-3.4,-0.6)**
Log childs weight 81 (-40.5,202.5) 258.5 (143.4,373.6)*** 0.24 (0.2,0.3)*** 50.6 (-15.8,117)
Vigorous activity mins/day -0.04 (-0.5,0.4) 0.3 (-0.1,0.7) 0.0003 (0.00003,0.0006)* 0.3 (0.04,0.5)*
Milk intake pints/day 10.2 (1.3,19.0)* 7.3 (-1.1,15.7) 0.002 (-0.003,0.008) -0.2 (-5.1,4.6)
Grip strength (kg) 3.7 (-0.05,7.5)* 7.2 (3.6,10.7)*** 0.005 (0.003,0.008)*** 4.3 (2.2,6.3)***
Triceps thickness (mm) -0.07 (-3.6,3.5) -1.8 (-5.2,1.6) -0.002 (-0.004,0.00003)* -1.9 (-3.8,0.09)
Lumbar spine
R
2 for model, % 52.4 52 30.6 23.1
Maternal determinants
Calcium (mg/day) 0.2 (-1.4,1.9) 0.9 (-0.5,2.3) 0.02 (-0.01,0.06) 0.8 (-0.4,2.0)
Protein (g/day) -0.2 (-2.3,1.9) -1.3 (-3.1,0.6) -0.03 (-0.08,0.010) -1.2 (-2.7,0.3)
LP Freq strenous activity -0.03 (-0.10,0.04) -0.002 (-0.06,0.06) 0.0004 (-0.0010,0.002) 0.009 (-0.04,0.06)
LP smoking  0.1 (-0.9,1.1) 0.5 (-0.4,1.4) 0.01 (-0.01,0.03) 0.5 (-0.3,1.2)
Log. Maternal weight (kg) 0.3 (-2.1,2.7) 0.3 (-1.8,2.4) -0.004 (-0.05,0.05) 0.3 (-1.5,2.0)
Maternal Height (cm) 0.01 (-0.05,0.08) -0.03 (-0.09,0.03) -0.001 (-0.002,0.0004) -0.05 (-0.09,0.0009)*
Childs determinants
Child height (cm) 0.3 (0.2,0.4)*** 0.2 (0.05,0.3)** 0.0001 (-0.003,0.003) -0.04 (-0.1,0.05)
Log childs weight 5.4 (-0.8,11.6) 6.8 (1.4,12.3)* 0.1 (-0.004,0.3) 0.5 (-3.9,4.9)
Vigorous activity mins/day -0.003 (-0.03,0.02) 0.003 (-0.02,0.02) 0.0001 (-0.0003,0.0006) 0.005 (-0.01,0.02)
Milk intake pints/day 0.3 (-0.2,0.7) 0.1 (-0.3,0.5) 0.00009 (-0.010,0.010) -0.003 (-0.3,0.3)
Grip strength (kg) 0.004 (-0.2,0.2) 0.2 (0.07,0.4)** 0.007 (0.003,0.01)** 0.2 (0.09,0.4)**
Triceps thickness (mm) -0.02 (-0.2,0.2) -0.2 (-0.3,-0.003)* -0.005 (-0.008,-0.0007)* -0.2 (-0.3,-0.02)*
Hip
R
2 for model, % 48 42.4 20.8 15.8
Maternal determinants
Calcium (mg/day) -0.5 (-1.7,0.8) -0.04 (-1.3,1.2) 0.01 (-0.03,0.06) 0.3 (-0.4,1.0)
Protein (g/day) 0.5 (-1.1,2.2) -0.5 (-2.1,1.2) -0.05 (-0.1,0.01) -0.9 (-1.8,0.05)
LP Freq strenous activity 0.02 (-0.03,0.07) 0.04 (-0.02,0.09) 0.001 (-0.0007,0.003) 0.02 (-0.009,0.05)
LP smoking  -0.08 (-0.9,0.7) 0.1 (-0.7,0.9) 0.008 (-0.02,0.04) 0.2 (-0.3,0.6)
Log. Maternal weight (kg) 1.4 (-0.5,3.3) 1.4 (-0.5,3.2) 0.02 (-0.05,0.08) 0.3 (-0.8,1.3)
Maternal Height (cm) -0.03 (-0.08,0.02) -0.05 (-0.10,0.002) -0.002 (-0.003,0.00002)* -0.03 (-0.06,-0.003)*
Childs determinants
Child height (cm) 0.2 (0.09,0.3)*** 0.1 (0.02,0.2)* -0.0004 (-0.004,0.003) -0.04 (-0.10,0.02)
Log childs weight 5.6 (0.7,10.5)* 6.4 (1.5,11.2)* 0.2 (-0.01,0.3) 1.1 (-1.7,3.8)
Vigorous activity mins/day 0.006 (-0.01,0.02) 0.009 (-0.008,0.03) 0.0003 (-0.0003,0.0009) 0.005 (-0.005,0.01)
Milk intake pints/day 0.1 (-0.2,0.5) 0.2 (-0.2,0.5) 0.004 (-0.009,0.02) 0.05 (-0.2,0.3)
Grip strength (kg) -0.03 (-0.2,0.1) 0.07 (-0.08,0.2) 0.005 (0.0002,0.01)* 0.09 (0.005,0.2)*
Triceps thickness (mm) -0.2 (-0.3,-0.04)* -0.2 (-0.3,-0.04)* -0.003 (-0.008,0.001) -0.04 (-0.1,0.04)
table shows and 95% CI; *p<0.05, **p<0.01, ***p<0.001  85 
4.9  Discussion 
The most robust association observed was the relationship between childhood height 
and weight and 6-year bone mineral. This represents the fact that taller and heavier 
children have increased measures of bone size but not volumetric density. In our 
data, there was evidence to suggest that the taller children had lower volumetric 
density, which may be consistent with the skeletal envelope being forced ahead of 
the capacity to mineralise. 
 
Maternal calcium intake prior to pregnancy and childhood milk intake were 
independently associated with measures of bone size and areal not volumetric 
density. Whilst maternal calcium intake is strongly correlated with the child‟s milk 
intake, these relationships are consistent with the size of the skeletal envelope being 
influenced in utero, and with subsequent modification of bone mineralization by both 
childhood environmental and genetic factors. 
 
Mothers that smoked during pregnancy appeared to have children with a higher areal 
and bone mineral apparent density (BMAD). Maternal smoking was also associated 
with a higher percentage fat mass and lower lean mass at aged 6, even once adjusted 
for maternal educational status and social class. The relationship was attenuated by 
the child‟s BMI implying that although smoking results in smaller neonatal bone 
mass there is rebound adiposity resulting in increased weight through the skeleton 
and hence increased density. 
 
Grip strength is a good surrogate measure of muscle/lean body mass as well as 
muscle density. The results in this chapter show that even when adjusted for all 
maternal and childhood determinants, grip strength remains positively related to 
measures of both bone size and volumetric density at all three skeletal sites. Children 
with increased grip strength tended to drink more milk, were taller and had a lower 
percentage fat mass. Grip strength is an important determinant of disability and 
morbidity
 in later life. 
 
Higher levels of strenuous activity in childhood appeared to be positively associated 
with measures of volumetric bone density at all three skeletal sites. However when   86 
adjusted for all maternal and childhood factors only whole body vBMD remained 
significant. No interaction was seen with the child‟s milk intake and exercise levels. 
Although higher activity in the mother during late pregnancy was seen to be 
associated with increased bone mineral of the child‟s hip, the association was lost 
once adjusted for childhood factors. Mothers that exercised tended to have children 
that did higher intensities of exercise and had higher percentage lean mass. 
 
Triceps skinfold thickness was strongly related to BMI (r=0.58, p<0.0001), therefore 
whilst it was positively associated with measures of bone mass, adjustment for 
maternal height and weight led to a negative association with bone size and density 
being unveiled.   87 
 
5  MATERNAL AND CHILDHOOD DETERMINANTS OF VOLUMETRIC 
BONE MASS AND BONE STRENGTH 
 
5.1  Aims 
  To test the hypothesis that childhood lifestyle factors and body composition 
influence both childhood bone mineral structure and bone strength. 
  To test the hypothesis that maternal lifestyle factors (diet, smoking, exercise) 
and body composition influence both childhood bone mineral structure and 
bone strength. 
 
5.2  Methods 
After the child‟s DXA scan, the parents were invited to attend for a further scan of 
the child‟s right tibia using a pQCT machine in order to provide additional 
information about the child‟s bone structure. The methods are described in detail in 
chapter 3. 
 
5.3  Results 
5.3.1  Descriptive statistics 
All children that attended clinic visits after Sep 07 were given information about this 
part of the study. Of the 450 parents that were contacted 147 (32.6%) children 
attended for this further scan. 139 of these children had results available for their 
previous DXA scan. The main reason for non-participation in this phase of the study 
was that only a fixed number of appointments were available during the school 
holiday period, and once these appointments were filled no new appointments were 
made until the next holiday period. Children that had previously had DXA scan at 
birth and aged 4 years as well as children with a history of fracture were prioritised. 
In total 113 of the children had both 6 year and 4 year DXA scans available, whereas 
only 53 children had scans at all time points including birth. Tables 27 and 28 show 
the differences in both the maternal and childhood characteristics between the main 
group and the children that attended this second clinic visit. Hence mothers that 
brought their children to this second visit tended to be of higher social class (p=0.03) 
and drank slightly less alcohol (p=0.05).   88 
 
TABLE 27: Maternal characteristics between those that attended or not for 
pQCT visit 
Responders Non Responders
number number p value
Age at initial interview, years 28.6 (3.7) 139 28.4 (3.8) 391 0.76
Birthweight  (mean, sd) 3196 (571) 126 3260 (486) 360 0.11
Percentage nulliparous 42.5 59 47.8 187 0.86
Qualifications % None 1.4 2 2.1 8
CSE 7.2 10 9.7 38
O levels 21.6 30 32.5 127
A levels 36.7 51 25.6 100
HND 7.9 11 7.7 30
Degree 25.2 35 22.5 88
139 391 0.96
Social Class % I 8.3 11 3.6 14
II 44.4 59 36.3 140
IIIN 27.8 37 40.4 156
IIIM 9 12 6.2 24
IV 10.5 14 11.7 45
V 0 0 1.8 7
133 386 0.027
Height, cm (mean, sd) 163.2 (6.4) 139 163.7 (6.5) 389 0.22
PP weight (Median, IQR) 65.7 (59.5-76.6) 138 65.7 (59.1-73.1) 389 0.51
PP BMI  (Median, IQR) 24.6 (22.5-28.6) 138 24.3 (22.4-27.4) 388 0.34
PP triceps skinfold, mm  (Median, IQR) 19.8 (15.7-26.6) 139 19.3 (14.6-24.9) 388 0.14
EP triceps skinfold, mm  (Median, IQR) 19.2 (15.4-25.3) 122 19.4 (15.4-24.5) 300 0.81
LP triceps skinfold, mm  (Median, IQR) 20.4 (16.7-25.3) 131 21.3 (15.5-26.1) 381 0.69
PP smoking,% 20.9 29 27.4 107 0.067
EP smoking, % 12.3 17 14.8 57 0.23
LP smoking, % 13 17 13.4 51 0.45
Units of alcohol per week 4.3 (1.5-7.6) 139 4.5 (1.5-10.7) 391 0.05
living with partner % 87.1 121 83.9 328 0.81 
 
The characteristics of the children that came to this second appointment are shown in 
table 28. In general they had very similar anthropometry and lifestyle characteristics 
compared to the children that did not attend. However they had slightly higher 
aBMD at the hip (p=0.05) and they were more likely to have had a history of fracture 
(p<0.0001) as per the protocol design. Activity levels were only available for 49 
children (scans completed by the end of 2008). The average age of the child at this 
visit was 6.7 (6.6-6.9) years. 
 
There was no difference between boys and girls for any of the bone parameters 
measured with pQCT; however girls had significantly more subcutaneous fat at the 
66% site compared to the boys (p<0.0001) (table 29). There were numerous 
statistically significant associations between pQCT bone parameters and age of the 
child hence all data was adjusted for age. 
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TABLE 28: A comparison of anthropometry and lifestyle characteristics 
between children that attended for pQCT and those that did not 
Responders Non Responders
number number p value
Birth to age 1
Gestational age 39.6 (2.0) 139 39.7 (1.7) 391 0.2
Birthweight (g) 3477 (561) 137 3430 (527) 387 0.8
Crown heel length birth(cm) 49.9 (2.2) 134 49.8 (2.1) 379 0.7
Weight at one year (kg) 10.1 (9.3-10.7) 139 9.9 (9.2- 10.8) 387 0.5
Crown heel length age one(cm) 75.4 (2.8) 136 75.5 (2.7) 384 0.3
Age 6 from DXA clinic visit
Anthropometry
Height at age 6, cm (mean sd)  119.9 (5) 130 120.1 (5.1) 362 0.3
Weight at age 6, kg (median IQR) 23.2 (21.4-25.5) 132 23.5 (21.5-26.2) 367 0.4
Grip Strength (max) kg (mean sd) 10.0 (2.4) 132 9.8 (2.5) 325 0.5
Triceps skinfold thickness, mm (median IQR) 10.1 (8.4-12.9) 107 9.5 (8.0-12.0) 305 0.06
Total BMC, g (mean sd)  533.2  ( 72.6) 136  529.8 (69.4) 375 0.6
Total BA, g/cm
2 (mean sd) 896.2 (66.5)  136  896.1  (63.1)  375 1
Total aBMD, g/cm
2 (mean sd) (0.6 ) (0.05)  136 0.6  (0.05)  375 0.5
Spine BMC, g (mean sd) 18.0  2.7  139 17.8  (2.7)  387 0.6
Spine BA, g/cm2 (mean sd) 33.3 ( 3.3)  139  33.1 (3.0) 387 0.6
Spine aBMD, g/cm2 (mean sd) 0 .5 (0.06) 139  0 .5 (0.06 387 0.7
Hip BMC, g (mean sd) 11.5  (2.2)  139 11.1 (2.0)   387 0.06
Hip BA, g/cm2 (mean sd)  16.9 (2.2)   139  16.7 (2.1)  387 0.3
Hip aBMD, g/cm2 (mean sd)  0.67 (0.07)  139 0.66 (0.06) 387 0.05
Total lean, kg (mean sd) 17.3  (2.1) 132  17.2 (2.2)    367 0.8
Total fat kg, median IQR 5.3 (4.3-6.9) 132 5.2 (4.2-6.4) 367 0.4
Lifestyle
% of children with fracture 25.2 34 5.2 20 <0.0001
Vigorous activity, mins per day (mean sd) 43.5 (17.5) 49 43.9 (19.8) 167 0.9
Sedentary activity, mins per day (mean sd) 855.7 (80.2) 49 879.2 (79.7) 167 0.07
Moderate activity, mins per day (mean sd) 34.6 (12.0) 49 36.9 (12.6) 167 0.3
Milk intake, pints/day (median IQR) 0.5 (0.35-0.75) 112 0.5 (0.33-0.75) 315 0.9 
 
Of the 147 scans, a number were excluded due to movement artefact. The scans were 
only excluded if the cortex of the bone had been broken on the image obtained.  
 
 TABLE 29: Differences in pQCT parameters between boys and girls aged 6 
years 
Characteristic Boys Girls P value
n n
Trabecular content mg/mm (4%) 99.8 (26.5) 70 102.1 (22.6) 77 0.57
Trabecular density mg/mm3 (4%) 321.7 (59.3) 70 336.1 (51) 77 0.12
Trabecular content mg/mm (14%) 17.5 (5.1) 65 16.9 (4.7) 70 0.54
Trabecular density mg/mm3 (14%) 139.6 (38.4) 65 134.1 (35.6 70 0.39
Cortical content mg/mm (38%) 121 (17.7) 68 120.2 (17.1) 72 0.77
Cortical density mg/mm3 38% 1038 (34.5) 68 1038 (33.9) 72 0.92
Cortical thickness mm (38%) 2.8 (0.4) 68 2.7 (0.3) 72 0.16
Periosteal circumfernce mm 38% 51.2 (3.9) 68 51.9 (3.8) 72 0.25
Endosteal circumfernce mm 38% 33.9 (4.3) 68 35.2 (4.1) 72 0.07
Stress strain index 38% 443.5 (88.6) 68 453.6 (99.5) 72 0.53
Fracture load x (N)- 38% 952 (206) 68 983 (203) 72 0.38
Fracture load y (N) 38% 907( 178) 68 916 (209) 72 0.79
Muscle area mm2 (66%) 2886 (414) 64 2941 (424) 73 0.44
Subcutaneous fat area mm2 (66%) 1269 (327) 64 1554 (448) 73 <0.0001
table shows mean and standard deviation  90 
 
5.3.2  Childhood bone mass adjusted for 6 year anthropometry 
 
Table 30 shows the relationship between childhood height, weight, BMI, triceps 
skinfold thickness and grip strength on the various bone parameters at 4%, 14%, 38% 
and 68%. Trabecular content is shown at both 4 % and 14%. This was necessary 
because at the 4% site a number of scans involved the epiphyseal growth plate, which 
makes the density artificially high. Overall the data showed that height and weight 
were important determinants of trabecular and cortical content, as well as being 
associated with increased cortical thickness, increased periosteal and endosteal 
circumference as well as increased bone strength as shown by SSI and fracture load 
(all p<0.001) (Figure 10). A similar relation was observed for BMI and grip strength, 
except there was no relationship between grip strength and endosteal circumference. 
Triceps skinfold thickness was positively associated with trabecular content (14%) 
cortical content, periosteal and endosteal circumference, as well as a small association 
with fracture load in the x and y axis (p<0.05). It was negatively associated with 
cortical density (β=-2.4, p=0.03). 
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TABLE 30: Relationship between childhood anthropometry and lifestyle determinants of tibial structure and strength 
 
Trabecular content Trabecular density Trabecular content Trabecular density Cortical content Cortical density
4% per mm slice 4% mg/cm3 14% per mm slice 14% mg/cm3 38% per mm slice 38% mg/cm3
Anthropometry
Height (cm) 2.8 (2.2,3.5)*** 3 (1.3,4.7)*** 0.3 (0.1,0.5)*** 0.03 (-1.3,1.3) 1.8 (1.4,2.3)*** -0.3 (-1.5,0.8)
log: Weight (kg) 78.5 (54.5,102.6)*** 58.2 (-1.5,117.8) 13.1 (7.9,18.4)*** 29.6 (-13.1,72.3) 73.7 (59.7,87.7)*** -26.4 (-65.7,12.9)
BMI (kg/m2) 2.8 (0.6,5.0)* 0.2 (-4.7,5.1) 0.8 (0.4,1.3)*** 3.2 (-0.2,6.5) 4.4 (3.1,5.7)*** -2 (-5.2,1.2)
Triceps skinfold (mm) 0.6 (-0.9,2.1) -0.3 (-3.7,3.1) 0.3 (0.02,0.7)* 2 (-0.4,4.3) 1.6 (0.6,2.7)** -2.4 (-4.5,-0.2)*
Grip strength (kg) 3.8 (2.1,5.5)** 3.8 (-0.3,7.8) 0.4 (0.04,0.8)* 0.2 (-2.7,3.1) 2.7 (1.6,3.8)*** -0.4 (-3.0,2.2)
Lifestyle
Milk intake (pints /day) 1.1 (-11.7,13.9) -2.7 (-30.8,25.5) -1.8 (-5,1.4) -8.9 (-32,14.2) -3.1 (-12.1, 6) 2.2 (-16,20.4)
Vigorous activity (mins/day) -0.08 (-0.5,0.3) -0.2 (-1.1,0.7) 0.01 (-0.08,0.1) 0.008 (-0.7,0.7) 0.09 (-0.2,0.4) 0.6 (0.0006,1.2)*
Cortical thickness Periosteal circumference Endosteal circumference Stress Strain Index Fracture load x Fracture load y
38% (mm) 38% (mm) 38% (mm) 38% mm
3  38% N 38% N
Anthropometry
Height (cm) 0.02 (0.008,0.03)*** 0.4 (0.3,0.5)*** 0.3 (0.1,0.4)*** 10.6 (8.1,13.0)*** 23.9 (18.7,29.2)*** 22.5 (17.4,27.7)***
log: Weight (kg) 0.8 (0.5,1.2)*** 16.4 (13.0,19.8)*** 11.2 (6.6,15.8)*** 378.6 (297.3,459.9)*** 920.7 (760.2,1081.1)*** 810.7 (644.2,977.3)***
BMI (kg/m2) 0.05 (0.02,0.08)** 1 (0.6,1.3)*** 0.6 (0.2,1.0)** 19.6 (11.9,27.3)*** 51.3 (35.4,67.3)*** 42.7 (26.7,58.7)***
Triceps skinfold (mm) 0.01 (-0.009,0.04) 0.5 (0.2,0.7)*** 0.4 (0.1,0.7)** 4.6 (-1.5,10.6) 16.5 (3.8,29.3)* 12.8 (0.2,25.3)*
Grip strength (kg) 0.04 (0.01,0.06)** 0.5 (0.2,0.8)*** 0.3 (-0.05,0.6) 15.7 (9.7,21.7)*** 31.2 (17.8,44.6)*** 31 (18.2,43.9)***
Lifestyle
Milk intake (pints /day) -0.8 (-0.3,0.1) -0.1 (-2.2,2) 0.4 (-1.9,2.7) -19.5 (-69.9,30.9) -35.9 (-144.2,72.4) 59.7 (-164.9,45.4)
Vigorous activity (mins/day) 0.003 (-0.004,0.009) -0.02 (-0.09,0.05) -0.04 (0.1,0.04) -0.2 (-1.7,1.3) 0.2 (-3.1,3.4) -0.6 (-3.9,2.8)
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001  92 
 
 
Figure 10: The relationship of height and weight on trabecular and cortical 
content and Stress Strain Index 
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5.3.3  Childhood lifestyle factors 
Milk intake was positively associated with muscle area (β=243.7, p=0.04) and 
vigorous and very vigorous activity was positively associated with cortical density 
(β=0.6, p=0.05) and negatively associated with subcutaneous fat area (β=-6.3, 
p=0.05). No other lifestyle characteristics predicted bone strength. (Factors studied 
included fruit and vegetable intake and history of fracture). Whilst there was a 
suggestion that other measures of vigorous or very vigorous activity were also 
related to cortical density this did not reach significance in this small sample. 
 
5.4  Multivariate analysis of childhood predictors of bone mass 
using pQCT 
Since height and weight were the largest predictors of tibial bone mass and strength 
using pQCT, when adding significant childhood determinants to a multivariate 
regression model, height and weight were excluded in the first model. 
 
The relationships between triceps skinfold thickness, grip strength and vigorous 
activity are shown in table 31. Due to the low numbers of children that had 
measurements of physical activity, between 39-43 scans were included in each 
multivariate model.  
 
Grip strength was a significant positive predictor for trabecular content at 4% and 
14% site (β=5.7, p<0.001; β=1.4, p<0.001 respectively), cortical content (β=4.7, 
p<0.001), cortical thickness (β=0.08, p<0.01) and periosteal circumference at 38% 
site (β=0.7, p=0.01). It was additionally positively associated with the measures of 
bone strength (SSI: β=20.7, p<0.001; fracture load x: β= 42.3, p<0.001; fracture load 
y: β=44.8, p<0.001). Once height and weight were added to the model, the 
relationship was attenuated. However it remained positively associated with 
trabecular content at 4 and 14% site (β=4.5, p<0.01; β=0.8, p=0.04) cortical content 
(β=3.1, p<0.01), cortical thickness (β=0.06, p=0.02) stress strain index (β=11.7, 
p=0.04) and fracture load in the y axis (β=26.7, p=0.04). 
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TABLE 31: Mutually independent childhood determinants of tibial bone mass and strength at age 6 years
Trabecular content Trabecular density Trabecular content Trabecular density Cortical content Cortical density
4% per mm slice 4% mg/cm
3 14% per mm slice 14% mg/cm
3 38% per mm slice 38% mg/cm3
R
2 32 10 29 11 43 14
Triceps skinfold thickness 3.9 (-18.6,26.4) 3.3 (-54.8,61.3) 1.2 (-4.5,6.9) 19 (-27.1,65.1) 17.1 (1.4,32.9)* -30.4 (-71.7,10.9)
Maximal grip strength (kg) 5.7 (3.0,8.5)*** 7.4 (0.2,14.5)* 1.4 (0.6,2.1)*** 5.6 (-0.3,11.5) 4.7 (2.8,6.7)*** -0.7 (-5.8,4.4)
Vigorous activity per day (mins) -0.05 (-0.5,0.4) -0.1 (-1.2,0.9) 0.03 (-0.07,0.1) 0.1 (-0.7,0.9) 0.3 (-0.005,0.6) 0.6 (-0.2,1.3)
Number 43 43 39 39 42 42
Cortical thickness Periosteal circumference Endosteal circumference Stress Strain Index Fracture load x Fracture load y
38% (mm) 38% (mm) 38% (mm) 38% mm
3  38% N 38% N
R
2 24 22 5 28 29 28
Triceps skinfold thickness 0.2 (-0.2,0.6) 4.5 (0.2,8.9)* 3.3 (-1.9,8.6) 31.9 (-56.8,120.6) 145.3 (-47.0,337.7) 82.4 (-113.1,277.8)
Maximal grip strength (kg) 0.08 (0.03,0.1)** 0.7 (0.2,1.2)* 0.2 (-0.4,0.9) 20.7 (9.7,31.6)*** 42.3 (18.6,66.0)*** 44.8 (20.7,68.9)***
Vigorous activity per day (mins) 0.003 (-0.004,0.01) 0.04 (-0.04,0.1) 0.02 (-0.08,0.1) 0.7 (-0.9,2.3) 2.5 (-1.0,6.0) 1.6 (-1.9,5.2)
Number 42 42 42 42 42 42
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001: PP-Pre pregnancy EP-Early pregnanacy, LP-late pregnancy  95 
Triceps skinfold thickness was a positive predictor of cortical content (β=17.1, 
p=0.03) and periosteal circumference (β=4.5, p=0.04) only when adjusted for the 
determinants in table 31. Once height and weight were added to the models all 
associations were lost. If physical activity was excluded from the model to increase 
the numbers (92 participants per model) triceps skinfold thickness was additionally 
associated with endosteal circumference and fracture load in the x axis; however, 
once again, when height and weight were added all associations were attenuated.  
Vigorous activity did not predict any measure of tibial mass or strength when 
included in either multivariate model. 
 
Weight predicted increased cortical content (β=58.5, p=0.04), stress strain index 
(β=334, p=0.04) and fracture load in the x axis (β=745, p=0.02). When physical 
activity was excluded from the model, weight was additionally associated with 
cortical thickness (β=1, p=0.02), periosteal circumference (β=12.9, p<0.01) and 
fracture load in the y axis (β=736, p<0.001). Height did not predict any measure of 
tibial mass when put into the full multivariate model, (if activity was excluded height 
still only predicted trabecular content at 4% site (β=2.3, p<0.001). 
 
5.5  Maternal predictors of childhood bone pQCT bone parameters 
 
Table 32 shows the relationship between maternal determinants (lifestyle and 
anthropometry) and the child‟s tibial mass as measured by pQCT. 
 
 There were no significant relationships between maternal social class, educational 
attainment and smoking status with the child‟s bone mineral and strength.  
 
In the analysis concerning the mothers diet, macronutrient, micronutrient and dietary 
patterns were considered both before and during pregnancy. 
 
The only macronutrient that showed a positive relationship was pre pregnancy 
protein intake, which was positively associated with both trabecular content and 
density at the 14% site (p=0.007, p=0.005), however there was no association with 
the tibia‟s strength.  No association was seen between protein intake during 
pregnancy. 
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 Whereas the micronutrient calcium was associated with whole body BMC (Chapter 
4) there was no relationship seen with intake either prior or during pregnancy with 
any measure of tibial mass or strength. Vitamin C intake, was however positively 
associated with both trabecular content  (r=0.26, p=0.004) and density (r=0.2, 
p=0.02) at the 14% site in early pregnancy, and trabecular density at the 4% site 
(r=0.18, p=0.04) during late pregnancy.  
 
Analysing dietary patterns reduces problems of interactions and co linearity that can 
occur when analysing relations with single nutrients. One such pattern is the prudent 
diet score (a measure of healthy diet); in early pregnancy this was associated with 
trabecular content and density at 14%  (r=0.2, p=0.03, r=0.22, p=0.01) whereas late 
pregnancy prudent dietary score was positively correlated with 4% trabecular content 
and density (r=0.17, p= 0.02; r=0.23, p=0.002) and reduced subcutaneous fat at 66% 
(β= -109.4, p=0.006). 
 
Higher levels of maternal exercise prior to pregnancy were found to be positively 
associated with the periosteal circumference (r=0.19, p=0.03) and fracture load in the 
x axis (r=0.17, p=0.05) whereas faster maternal walking speed in late pregnancy was 
positively associated with trabecular content at the 4% site (r=0.17, p=0.05) cortical 
content and cortical thickness at 38% site (r=0.2, p=0.02; r=0.18, p=0.04) and 
fracture load in the y axis (r=0.18, p=0.05). 
 
 There were numerous relationships between maternal anthropometry and bone mass 
in the child (summarised in table 32). Maternal height was positively associated with 
trabecular content and density at 4% site, cortical content, periosteal circumference 
and measures of bone strength (SSI; r=0.31, p<0.001; fracture load x: r=27, p=0.002; 
fracture load y: r=0.25, p=0.003). Weight was positively associated with trabecular 
content at 4 and 14% sites, cortical content, cortical thickness, periosteal 
circumference and all measures of bone strength. BMI and biceps skinfold thickness 
were both associated with cortical content, cortical thickness and periosteal 
circumference. In addition BMI was weakly associated with increased fracture load 
in the x axis (r=0.19, p=0.03).   97 
 
 
TABLE 32: Maternal anthropometric and lifestyle determinants of 6 year bone mineral and strength measured by pQCT
Trabecular content Trabecular density Trabecular content Trabecular density Cortical content Cortical density
4% per mm slice 4% mg/cm
3 14% per mm slice 14% mg/cm
3 38% per mm slice 38% mg/cm3
Anthropometry
Logged Maternal weight (kg) 22.4 (1.7,43.0)* 23.1 (-23.4,69.6) 4.9 (0.6,9.2)* 22.2 (-10.3,54.6) 24.1 (10.3,37.8)*** -7.2 (-36.9,22.5)
Maternal height (cm) 1.2 (0.6,1.8)*** 2.1 (0.7,3.5)*** 0.06 (-0.07,0.2) -0.3 (-1.3,0.7) 0.5 (0.08,0.9)* 0.4 (-0.5,1.3)
Log: Body mass index, kg/m2) 7.9 (-15.0,30.8) -4.2 (-55.1,46.8) 4.8 (0.08,9.5)* 30.7 (-4.7,66.2) 20.9 (5.5,36.2)** -15.8 (-48.4,16.7)
Biceps skinfold thickness, mm 1 (-6.7,8.7) -2.7 (-19.9,14.4) 1.5 (-0.08,3.1) 10.7 (-1.1,22.5) 6.5 (1.3,11.6)* -7.7 (-18.6,3.1)
lifestyle
Late pregnancy walking speed 4.8 (0.03,9.5)* 10.3 (-0.6,21.2) 0.2 (-0.8,1.2) 0.6 (-7.0,8.1) 3.9 (0.5,7.2)* -0.5 (-7.7,6.8)
strenous activity pre pregnancy 0.7 (-1.4,2.7) -0.9 (-5.6,3.7) 0.4 (-0.06,0.8) 1.1 (-2.1,4.3) 0.9 (-0.6,2.3) -0.08 (-3.0,2.9)
log PP Total protein (g/day) 5.4 (-10.5,21.3) 12.2 (-23.2,47.5) 4.9 (1.6,8.1)** 37.1 (13.1,61.0)** 5 (-6.3,16.3) -8.1 (-31.4,15.3)
log EP Vit C intake mg/day 5.7 (-2.1,13.5) 8.8 (-8.6,26.2) 2.6 (1.0,4.2)** 15.8 (3.6,27.9)* 5.5 (0.2,10.8)* 1.3 (-9.6,12.3)
EP prudent diet score 3.6 (-1.0,8.2) 9.7 (-0.5,19.8) 1.1 (0.1,2.1)* 9.7 (2.5,16.9)** 1.2 (-2.1,4.4) -2.7 (-9.2,3.8)
LP prident diet score 5.2 (0.9,9.5)* 15.3 (5.6,24.9)*** 0.4 (-0.5,1.3) 4.5 (-2.3,11.3) -1.6 (-4.6,1.5)  1.5 (-5.0,8.0)
Cortical thickness Periosteal circumference Endosteal circumference Stress Strain Index Fracture load x Fracture load y
38% (mm) 38% (mm) 38% (mm) 38% mm
3  38% N 38% N
Anthropometry
Logged Maternal weight (kg) 0.4 (0.06,0.6)* 4.4 (1.2,7.6)** 2.2 (-1.6,5.9) 120.2 (43.9,196.5)** 284.1 (119.2,449.0)*** 175.4 (13.9,336.9)*
Maternal height (cm) 0.005 (-0.005,0.01) 0.1 (-0.001,0.2)* 0.07 (-0.04,0.2) 4.3 (2.0,6.6)*** 8.3 (3.2,13.4)** 7.3 (2.5,12.2)**
Log: Body mass index, kg/m2) 0.4 (0.03,0.7)* 3.7 (0.1,7.3)* 1.5 (-2.6,5.6) 77.2 (-8.7,163.1) 210.7 (25.1,396.4)* 95.5 (-84.4,275.4)
Biceps skinfold thickness, mm 0.1 (0.004,0.2)* 1.2 (-0.02,2.4)* 0.5 (-0.9,1.8) 14.9 (-14.0,43.7) 48 (-14.6,110.5) 14.5 (-45.8,74.7)
lifestyle
Late pregnancy walking speed 0.07 (0.002,0.1)* 0.4 (-0.4,1.2) -0.07 (-1.0,0.9) 14.9 (-4.2,34.0) 32.7 (-8.6,74.1) 39.2 (-0.2,78.5)*
strenous activity pre pregnancy 0.0001 (-0.03,0.03) 0.4 (0.04,0.7)* 0.4 (-0.008,0.7) 6 (-1.7,13.8) 16.5 (-0.3,33.3)* 10.2 (-5.9,26.3)
log PP Total protein (g/day) 0.06 (-0.2,0.3) 1.5 (-1.1,4.1) 1.1 (-1.9,4.0) 12.9 (-49.3,75.2) 34.6 (-100.8,170.1) 28.2 (-101.2,157.5)
log EP Vit C intake mg/day 0.1 (0.0001,0.2)* 0.6 (-0.6,1.8) -0.1 (-1.6,1.3) 12.7 (-15.9,41.4) 34 (-29.2,97.3) 35.5 (-23.6,94.6)
EP prudent diet score 0.02 (-0.05,0.09) 0.2 (-0.5,0.9) 0.05 (-0.8,0.9) -3.6 (-20.7,13.5) -4 (-41.8,33.8) 1.2 (-34.3,36.6)
LP prident diet score -0.03 (-0.09,0.04) -0.4 (-1.1,0.4) -0.2 (-1.0,0.6) -10.8 (-27.9,6.3) -27.8 (-64.8,9.1) -11.5 (-47.1,24.1)
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001: PP-Pre pregnancy EP-Early pregnanacy, LP-late pregnancy  98 
5.6  Multivariate analysis of maternal predictors of bone mass using 
pQCT 
Since once again maternal height and weight were the largest determinants of 
childhood bone mass and strength, these were excluded in the first multivariate 
model. 
 
Table 33 shows the independent relationships between biceps skinfold thickness, late 
pregnancy walking speed, strenuous activity pre pregnancy, pre pregnancy protein 
intake, early pregnancy vitamin C intake and prudent diet score in both early and late 
pregnancy. 
 
Higher maternal activity was associated with enhanced bone mineral in her offspring. 
Maternal walking speed in late pregnancy was associated with trabecular content at 
4% site, cortical content, cortical thickness, periosteal circumference, and all three 
measures of bone strength. Pre pregnancy strenuous exercise was associated with 
increased periosteal and endosteal circumference as well as SSI and fracture load in 
the x axis using the same model. When additionally adjusted for maternal height and 
weight, walking speed remained associated with trabecular content (β=5.8, p=0.03), 
cortical content (β=5.9, p=0.002), cortical thickness (β=0.1, p=0.02), and measures 
of bone strength (SSI: β=226, p=0.02; fracture load x: β=57.3, p=0.009; fracture load 
y: β=58.6, p=0.006). Pre pregnancy strenuous activity remained associated with 
increased periosteal and endosteal circumference (β=0.5, p=0.006; β=0.6, p=0.01 
respectively) and fracture load in the x axis (β=21.1, p=0.03). 
 
Maternal diet remained weakly associated with measures of trabecular content. Pre 
pregnancy protein intake was associated with trabecular content and density at the 
14% site (β=3.7, p=0.03; β=27.4, p=0.04 respectively) whereas late pregnancy 
prudent diet score was associated with trabecular content and thickness at the 4% site 
(β=8.6, p=0.02; β=20.2, p=0.01 respectively). Once height and weight were added to 
the multivariate model pre pregnancy protein intake remained positively associated 
with trabecular content and density at 14% site (β=3.7, p=0.03; β=28.1, p=0.04) and 
late pregnancy prudent diet score remained associated with trabecular content and 
thickness at the 4% site (β=7, p=0.05; β=17, p=0.04).   99 
 
 
 TABLE 33: Mutually independent maternal anthropometric and lifestyle determinants of 6 year bone mineral and strength 
Trabecular content Trabecular density Trabecular content Trabecular density Cortical content Cortical density
4% per mm slice 4% mg/cm
3 14% per mm slice 14% mg/cm
3 38% per mm slice 38% mg/cm3
R
2 as % 13 11 15 12 17 3
Anthropometry
Biceps skinfold thickness, mm 6.6 (-2.1,15.3) 2 (-18.0,22.0) 1.3 (-0.6,3.1) 1.7 (-13.1,16.5) 7.7 (1.6,13.8)* -3.2 (-17.1,10.7)
lifestyle
Late pregnancy walking speed 6.2 (1.0,11.4)* 9.6 (-2.3,21.6) 0.5 (-0.6,1.6) -1.1 (-9.6,7.5) 5.9 (2.3,9.5)** -0.8 (-8.9,7.3)
strenous activity pre pregnancy 1.8 (-0.5,4.1) 0.08 (-5.2,5.4) 0.2 (-0.2,0.7) -0.9 (-4.6,2.8) 1.2 (-0.4,2.8) -0.5 (-4.1,3.1)
log PP Total protein (g/day) 4.3 (-11.6,20.3) 11.3 (-25.5,48.2) 3.7 (0.3,7.1)* 27.4 (0.9,53.9)* 1 (-10.4,12.3) 0.3 (-25.5,26.1)
log EP Vit C intake mg/day -0.5 (-10.0,9.0) 0.4 (-21.6,22.4) 1.4 (-0.5,3.4) 10.6 (-4.8,25.9) 2.2 (-4.3,8.8) 6.3 (-8.6,21.1)
EP prudent diet score -5.8 (-13.5,1.9) -9.4 (-27.1,8.3) 0.009 (-1.6,1.6) 6.1 (-6.5,18.7) 0.4 (-5.0,5.7) -9 (-21.2,3.2)
LP prudent diet score 8.6 (1.7,15.6)* 20.2 (4.1,36.3)* 0.1 (-1.3,1.6) -1.4 (-12.8,10.1) -3 (-7.9,1.9) 6.3 (-4.8,17.3)
Cortical thickness Periosteal circumference Endosteal circumference Stress Strain Index Fracture load x Fracture load y
38% (mm) 38% (mm) 38% (mm) 38% mm
3  38% N 38% N
R
2 as % 11 14 8 11 15 10
Anthropometry
Biceps skinfold thickness, mm 0.1 (-0.04,0.2) 1.6 (0.09,3.0)* 0.9 (-0.9,2.7) 22.8 (-11.7,57.3) 69.1 (-5.2,143.5) 29.3 (-41.7,100.2)
lifestyle
Late pregnancy walking speed 0.09 (0.01,0.2)* 0.9 (0.02,1.7)* 0.3 (-0.8,1.3) 25.5 (5.4,45.7)* 60.5 (17.1,103.9)** 59.4 (18.0,100.8)**
strenous activity pre pregnancy -0.007 (-0.04,0.03) 0.6 (0.2,1.0)** 0.6 (0.2,1.1)** 9.7 (0.8,18.5)* 24.7 (5.6,43.8)* 17.2 (-1.0,35.4)
log PP Total protein (g/day) -0.07 (-0.3,0.2) 1.5 (-1.3,4.2) 1.9 (-1.4,5.2) 7.1 (-57.1,71.3) 14.1 (-124.2,152.4) 10.3 (-121.7,142.2)
log EP Vit C intake mg/day 0.1 (-0.05,0.2) -0.6 (-2.2,1.0) -1.2 (-3.1,0.7) -3.9 (-40.8,33.0) -8.5 (-88.0,71.1) -2.5 (-78.4,73.5)
EP prudent diet score 0.03 (-0.10,0.1) 0.2 (-1.1,1.5) 0.02 (-1.5,1.6) -4.4 (-34.8,26.0) -4.1 (-69.6,61.5) -4.4 (-66.9,58.2)
LP prudent diet score -0.08 (-0.2,0.03) -0.5 (-1.6,0.7) 0.02 (-1.4,1.4) -10.1 (-37.7,17.4) -32.1 (-91.5,27.3) -14.3 (-71.0,42.3)
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001: PP-Pre pregnancy EP-Early pregnanacy, LP-late pregnancy  100 
Biceps skinfold thickness was associated with cortical content (β=7.7, p=0.01) and 
periosteal  circumference  (β=1.6,  p=0.04)  in  the  first  model.  When  additionally 
adjusted for maternal height and weight the relationship was lost. 
 
 Although  maternal  height  and  weight  predicted  the  offspring‟s  bone  mass  on 
univariate  analysis,  once  adjusted  for  the  other  maternal  determinants  (including 
height and weight) in the multivariate model all associations were lost.  
 
 
5.7  Multivariate analysis of both childhood and maternal 
predictors of bone mass and strength using pQCT 
 
When we include all maternal and childhood determinants (except child‟s height and 
weight) into a model only 38 subjects were included (Table 34). This is due mainly 
to the small number of activity records available for this analysis. Table 35 
additionally shows the model including the child‟s height and weight. 
 
Childhood grip strength was the largest independent determinant of tibial mass and 
strength.  It was positively associated with trabecular content and density at the 4% 
site, trabecular content at 14%, cortical content, cortical thickness as well as all three 
measures of bone strength (SSI, and fracture load in the x and y axis). When 
additionally adjusting for the child‟s height and weight, 6 year grip strength remained 
positively associated with trabecular content at 4% (β=4.1, p=0.03) cortical content 
(β=4, p=0.004), cortical thickness (β=0.8, p=0.06) and SSI (β=14.6, p=0.04). 
 
Childhood vigorous activity was positively associated with cortical density (β=1.2, 
p=0.02). This remained once additionally adjusted for childhood height and weight 
(β=1.3, p=0.02). 
 
Of the maternal factors that remained significant, late walking speed was negatively 
associated with cortical density (β=-36.4, p=0.03), whereas strenuous activity was 
positively associated with endosteal circumference (β=1, p=0.04).  When 
additionally adjusted for height and weight, late walking speed remained negatively   101 
associated with cortical density (β=-21.8, p=0.03) and pre pregnancy strenuous 
activity was negatively associated with cortical thickness (β=-0.07, p=0.05).   
Of the maternal dietary components, pre pregnancy protein intake was associated 
with decreased cortical thickness but increased endosteal circumference (β=-0.5, 
p=0.04; β=8.9, p=0.008). This remained after additionally adjusting for the child‟s 
height and weight. 
  
To increase the number of subjects in the model, if we mutually adjusted excluding 
activity, triceps skinfold thickness was associated with increased cortical content 
(β=1.4, p=0.02), periosteal and endosteal circumference (β=0.4, p=0.003; β =0.4, 
p=0.02 respectively) and higher fracture load in the x and y axis (β=16.6, p=0.02; β 
15.7, p=0.03 respectively). Higher maternal prudent diet score was associated with 
trabecular content and density at the 4% site (β=9, p=0.02; β=24.9, p=0.01). In 
general, adjustment for the child‟s height and weight led to attenuation of these 
relationships.  102 
 TABLE 34:  Mutually independent maternal and childhood determinants of tibial bone structure and strength at age 6 (n=37) 
Trabecular content Trabecular density Trabecular content Trabecular density Cortical content Cortical density
4% per mm slice 4% mg/cm
3 14% per mm slice 14% mg/cm
3 38% per mm slice 38% mg/cm3
R
2 as a % 48 37 46 32 57 40
 Maternal determinants
Logged Maternal weight (kg) 8.7 (-49.2,66.6) 55.3 (-91.1,201.6) 8.5 (-8.1,25.1) 91.6 (-40.6,223.7) 33.5 (-9.8,76.8) 33.4 (-81.7,148.5)
Maternal height (cm) 0.7 (-0.5,2.0) 0.8 (-2.4,4.1) -0.1 (-0.5,0.2) -2.1 (-4.7,0.5) 0.3 (-0.6,1.2) 0.2 (-2.2,2.7)
Biceps skinfold thickness, mm 6 (-18.8,30.9) -18.8 (-81.7,44.0) -1.9 (-8.7,4.9) -17.8 (-71.8,36.3) -8.4 (-26.4,9.5) -36.4 (-84.0,11.3)*
Late pregnancy walking speed 4.5 (-5.2,14.2) 8.8 (-15.8,33.3) -0.2 (-2.6,2.2) -1.8 (-20.7,17.2) -0.4 (-7.4,6.6) -21.1 (-39.7,-2.4)
strenous activity pre pregnancy 2.6 (-1.6,6.9) -1.2 (-11.9,9.5) 0.1 (-1.0,1.2) -1.9 (-10.4,6.5) -1 (-4.1,2.0) -4.2 (-12.3,3.9)
log PP Total protein (g/day) -11.9 (-45.4,21.6) -30.7 (-115.3,54.0) 0.4 (-8.8,9.5) -17.4 (-90.1,55.3) -8.5 (-32.7,15.7) -12.9 (-77.2,51.4)
log EP Vit C intake mg/day -10.7 (-26.9,5.5) -13.1 (-54.1,27.9) 0.9 (0.6,4.9) 10.9 (-20.8,42.6) 1.2 (-10.6,13.0) 17.8 (-13.6,49.2)
EP prudent diet score 0.4 (-12.7,13.5) -1.2 (-34.4,31.9) 1.2 (-2.2,4.5) 12.4 (-14.1,38.9) 1 (-8.5,10.5) -13.2 (-38.4,12.0)
LP prudent diet score 2.1 (-9.0,13.3) 14.3 (-14.0,42.5) -0.2 (-3.0,2.6) 1.7 (-20.6,24.0) -3.4 (-11.7,4.8) 16.3 (-5.6,38.2)
Childhood determinants
Triceps skinfold thickness 0.2 (-3.1,3.6) 1 (-7.5,9.5) -0.2 (-1.0,0.7) -2.5 (-9.2,4.3) 2 (-0.5,4.4) 2.9 (-3.7,9.5)
Maximal grip strength (kg) 5 (1.5,8.6)** 9 (0.09,18.0)* 1.3 (0.4,2.2)*** 6.3 (-0.7,13.4) 5.1 (2.6,7.7)*** 4.4 (-2.4,11.2)
Vigorous activity per day (mins) -0.2 (-0.7,0.3) -0.3 (-1.6,1.0) -0.02 (-0.1,0.1) -0.3 (-1.3,0.7) 0.3 (-0.1,0.6) 1.2 (0.2,2.2)*
Cortical thickness Periosteal circumference Endosteal circumference Stress Strain Index Fracture load x Fracture load y
38% (mm) 38% (mm) 38% (mm) 38% mm
3  38% N 38% N
R
2 as a % 54 55 59 48 47 36
 Maternal determinants
Logged Maternal weight (kg) 0.9 (-0.03,1.8) -1.5 (-12.3,9.4) -7.2 (-18.6,4.2) 143.4 (-102.4,389.1) 193.3 (-338.0,724.6) 202.5 (-387.4,792.5)
Maternal height (cm) -0.004 (-0.02,0.02) 0.1 (-0.10,0.4) 0.2 (-0.08,0.4) 3.5 (-1.8,8.8) 9.3 (-2.1,20.7) 3.7 (-9.0,16.3)
Log: Body mass index, kg/m2) -1 (-54.9,52.8) -36 (-656.7,584.6) -29.5 (-684.5,625.5) -7191.6 (-20966.9,6583.8) -14152 (-44065.9,15761.9) -5161.4 (-38990.4,28667.7)
Biceps skinfold thickness, mm -0.2 (-0.6,0.2) 0.9 (-3.6,5.4) 2.1 (-2.6,6.8) -24.5 (-126.2,77.3) -3.6 (-223.6,216.5) -119.2 (-363.6,125.1)
Late pregnancy walking speed 0.03 (-0.1,0.2) 0.5 (-1.2,2.3) 0.4 (-1.5,2.2) -0.8 (-40.5,39.0) 14.6 (-71.4,100.5) -4.5 (-99.9,91.0)
strenous activity pre pregnancy -0.06 (-0.1,0.006) 0.6 (-0.1,1.4) 1 (0.2,1.8)* -4.2 (-21.5,13.1) 3.2 (-34.2,40.6) -10.5 (-52.0,31.0)
log PP Total protein (g/day) -0.5 (-1.1,-0.02)* 5.4 (-0.6,11.5) 8.9 (2.5,15.2)** -28.9 (-166.3,108.4) 19.1 (-277.9,316.1) 2.6 (-327.2,332.3)
log EP Vit C intake mg/day 0.04 (-0.2,0.3) -0.4 (-3.3,2.5) -0.6 (-3.7,2.5) -25.9 (-92.9,41.1) -37.2 (-182.0,107.6) -16.5 (-177.3,144.3)
EP prudent diet score 0.04 (-0.2,0.2) 0.3 (-2.1,2.7) 0.04 (-2.5,2.5) 6.7 (-47.2,60.5) 1.9 (-114.4,118.2) -12.8 (-142.0,116.4)
LP prudent diet score -0.06 (-0.2,0.1) -1.1 (-3.1,1.0) -0.7 (-2.8,1.5) -26.9 (-73.6,19.8) -58.8 (-159.9,42.2) -21.9 (-134.1,90.3)
Childhood determinants
Triceps skinfold thickness 0.004 (-0.05,0.06) 0.5 (-0.1,1.1) 0.5 (-0.2,1.1) 4.4 (-9.7,18.5) 16.7 (-13.8,47.1) 21 (-12.7,54.8)
Maximal grip strength (kg) 0.1 (0.05,0.2)*** 0.2 (-0.4,0.8) -0.5 (-1.1,0.2) 22.2 (7.7,36.6)** 35.2 (3.9,66.6)* 46.8 (12.0,81.6)*
Vigorous activity per day (mins) 0.002 (-0.006,0.010) 0.02 (-0.08,0.1) 0.004 (-0.09,0.1) 0.8 (-1.3,2.9) 2.3 (-2.2,6.9) 2.2 (-2.9,7.2)
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001: PP-Pre pregnancy EP-Early pregnanacy, LP-late pregnancy  103 
 TABLE 35: Mutually independent maternal and childhood determinants of tibial bone structure and strength at age 6 including child’s 
height and weight (n=37)
Trabecular content Trabecular density Trabecular content Trabecular density Cortical content Cortical density
4% per mm slice 4% mg/cm
3 14% per mm slice 14% mg/cm
3 38% per mm slice 38% mg/cm3
R
2 as a % 54 39 53 37 67 44
 Maternal determinants
Logged Maternal weight (kg) 4 (-57.4,65.4) 65.7 (-97.1,228.5) 3.6 (-14.1,21.4) 65.7 (-80.9,212.4) 23.1 (-19.3,65.5) 54.3 (-71.1,179.7)
Maternal height (cm) 0.4 (-0.9,1.8) 0.5 (-3.1,4.0) -0.2 (-0.5,0.2) -2.4 (-5.1,0.4) 0.09 (-0.8,1.0) 0.5 (-2.2,3.2)
Biceps skinfold thickness, mm 2.2 (-24.9,29.3) -29.7 (-101.6,42.1) -1.1 (-8.6,6.3) -16.4 (-78.2,45.3) -8.2 (-26.3,10.0) -39.8 (-93.5,13.9)
Late pregnancy walking speed 4.4 (-5.2,14.1) 7.6 (-18.0,33.2) -0.1 (-2.5,2.3) -1.5 (-21.1,18.0) 0.3 (-6.2,6.7) -21.8 (-40.9,-2.6)*
strenous activity pre pregnancy 1.3 (-3.4,5.9) -3 (-15.3,9.3) -0.02 (-1.2,1.2) -3.3 (-13.1,6.5) -1.8 (-4.9,1.3) -3.3 (-12.5,5.9)
log PP Total protein (g/day) -14.4 (-47.9,19.0) -30.1 (-118.8,58.6) -0.3 (-9.4,8.9) -19.5 (-95.4,56.4) -12.6 (-35.1,9.9) -6.3 (-72.8,60.2)
log EP Vit C intake mg/day -9.1 (-25.5,7.3) -9.5 (-52.9,34.0) 0.9 (-3.1,4.9) 11.7 (-21.6,45.0) 1.7 (-9.4,12.8) 18.5 (-14.2,51.3)
EP prudent diet score 1.4 (-11.7,14.5) 0.7 (-34.1,35.5) 1 (-2.3,4.3) 11.6 (-15.6,38.8) 1.2 (-7.6,10.0) -12.8 (-38.8,13.3)
LP prudent diet score 2.2 (-9.0,13.4) 13 (-16.8,42.7) 0.2 (-2.6,3.0) 3.8 (-19.3,26.9) -2.5 (-10.2,5.2) 14.2 (-8.5,36.9)
Childhood determinants
Childs height (cm) 1.1 (-1.5,3.7) 2.4 (-4.6,9.3) -0.09 (-0.8,0.6) 0.3 (-5.9,6.4) 0.2 (-1.6,2.0) 0.2 (-5.0,5.4)
Child's weight (logged) kg 15.4 (-92.9,123.7) -55.7 (-342.8,231.5) 18.1 (-12.3,48.6) 84.1 (-168.0,336.2) 54 (-18.6,126.5) -90.8 (-305.3,123.8)
Triceps skinfold thickness -1.3 (-44.7,42.1) 26.4 (-88.7,141.4) -5.7 (-17.6,6.2) -40.6 (-139.0,57.8) 6.1 (-23.7,35.9) 51.7 (-36.4,139.9)
Maximal grip strength (kg) 4.3 (0.4,8.1)* 9.3 (-1.0,19.5) 0.9 (-0.2,1.9) 4.1 (-4.4,12.6) 4.0 (1.4,6.6)** 6.3 (-1.4,14.0)
Vigorous activity per day (mins) -0.2 (-0.7,0.4) -0.1 (-1.5,1.3) -0.03 (-0.2,0.1) -0.3 (-1.4,0.8) 0.3 (-0.1,0.6) 1.3 (0.2,2.4)*
Cortical thickness Periosteal circumference Endosteal circumference Stress Strain Index Fracture load x Fracture load y
38% (mm) 38% (mm) 38% (mm) 38% mm
3  38% N 38% N
R
2 as a % 63 60 59 62 61 59
 Maternal determinants
Logged Maternal weight (kg) 0.6 (-0.3,1.6) -2.8 (-14.3,8.6) -6.8 (-19.5,6.0) 66.2 (-170.2,302.6) 57 (-456.1,570.2) 51.5 (-478.4,581.4)
Maternal height (cm) -0.008 (-0.03,0.01) 0.09 (-0.2,0.3) 0.1 (-0.1,0.4) 2.3 (-2.7,7.4) 6.3 (-4.8,17.3) -0.9 (-12.3,10.5)
Biceps skinfold thickness, mm -0.1 (-0.5,0.3) 0.8 (-4.2,5.7) 1.6 (-3.8,7.1) -13.1 (-114.3,88.1) 3.6 (-216.1,223.4) -123 (-349.9,103.9)
Late pregnancy walking speed 0.04 (-0.1,0.2) 0.6 (-1.1,2.4) 0.4 (-1.6,2.3) 3.8 (-32.2,39.9) 23.5 (-54.7,101.8) 6.7 (-74.1,87.5)
strenous activity pre pregnancy -0.07 (-0.1,-0.002)* 0.5 (-0.4,1.3) 0.9 (-0.007,1.9) -8 (-25.4,9.4) -7.5 (-45.2,30.3) -27.1 (-66.0,11.9)
log PP Total protein (g/day) -0.6 (-1.1,-0.1)* 4.8 (-1.3,10.9) 8.8* (2.1,15.6) -55.3 (-180.7,70.1) -33.4 (-305.5,238.8) -61.5 (-342.5,219.6)
log EP Vit C intake mg/day 0.03 (-0.2,0.3) -0.2 (-3.2,2.8) -0.4 (-3.8,2.9) -26.6 (-88.4,35.2) -32.9 (-167.1,101.3) -7.3 (-145.9,131.3)
EP prudent diet score 0.03 (-0.2,0.2) 0.4 (-2.0,2.7) 0.1 (-2.5,2.8) 6.4 (-42.8,55.5) 4.9 (-101.7,111.5) -5.5 (-115.6,104.7)
LP prudent diet score -0.03 (-0.2,0.1) -1 (-3.0,1.1) -0.7 (-3.0,1.6) -19.7 (-62.5,23.1) -46.8 (-139.8,46.1) -9.2 (-105.1,86.8)
Childhood determinants
Childs height (cm) -0.004 (-0.04,0.03) 0.07 (-0.4,0.5) 0.1 (-0.4,0.6) -0.5 (-10.3,9.4) 2.7 (-18.6,24.1) 7.3 (-14.7,29.3)
Child's weight (logged) kg 1.4 (-0.2,3.0) 7.7 (-12.0,27.3) -0.9 (-22.7,20.9) 379.4 (-25.1,783.9) 692.9 (-185.1,1570.9) 783.2 (-123.4,1689.8)
Triceps skinfold thickness -0.3 (-1.0,0.4) 3.2 (-4.9,11.2) 5.1 (-3.9,14.0) -55.7 (-221.8,110.5) -21.1 (-381.8,339.5) -19.5 (-392.0,352.9)
Maximal grip strength (kg) 0.08 (0.02,0.1)** 0.05 (-0.7,0.7) -0.5 (-1.2,0.3) 14.6 (0.1,29.1)* 20.2 (-11.2,51.6) 27.8 (-4.6,60.2)
Vigorous activity per day (mins) 0.001 (-0.007,0.009) 0.02 (-0.08,0.1) 0.01 (-0.10,0.1) 0.6 (-1.4,2.7) 2.2 (-2.2,6.6) 2.3 (-2.3,6.8)
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001: PP-Pre pregnancy EP-Early pregnanacy, LP-late pregnancy  104 
5.8  Discussion 
The most robust association observed was between childhood height and weight and 
measures of bone size and strength rather than volumetric bone density.  When 
adjusted for the other maternal and childhood determinants it appeared that weight 
was the more important predictor, particularly of measures of bone strength.  One 
might speculate this may represent the tibia adapting to increased loading; the data 
suggests that this is due to increased cortical thickness and content as a result of the 
increase in the periosteal circumference without a corresponding increase in the 
endosteal circumference. Whilst maternal height and weight also appeared to be 
positively associated with measures of bone size and strength, the relationship was 
no longer seen once adjusted for the child‟s height and weight implying that 
collinearity between maternal and childhood height may be operating.  
 
Grip strength, which was associated with a higher muscle area, was also associated 
with measures of bone size and bone strength rather than volumetric density in a 
similar manner observed for the child‟s weight. However as this relationship was 
independent of the child‟s weight, it suggests that muscle and lean body mass are 
important in the remodelling and adaptation of the bone to the stresses placed upon 
them, resulting in an increase in bone size, altered geometry and an increase the 
amount of mass within the periosteal envelope, giving the bone an overall increased 
strength. Triceps skinfold thickness, a measure of fat mass, was associated with 
increased measures of bone size. There was also a suggestion that it was additionally 
associated with reduced cortical density resulting in a relatively under mineralised 
skeleton. However once the numbers included in the multivariate model reduced, this 
association was no longer seen. 
 
It was difficult to ascertain the full relationship between childhood exercise and the 
outcomes observed due to the small number of subjects that had full data available. 
However the relationship between vigorous activity and cortical volumetric density 
remained after all adjustments. Increased time doing vigorous activity usually 
involves increased weight bearing exercise.  The increased forces placed on the bone 
may explain the increased cortical density seen.  Whilst there was no relationship 
between any measure of bone strength, maternal walking speed in late pregnancy, a   105 
surrogate marker for the child‟s exercise intensity, resulted in an increase in bone 
size and strength when adjusted for all maternal determinants.  
 
The relationship between diet and bone was less clear. Whilst maternal diet, in 
particular pre pregnancy protein intake, vitamin C consumption and dietary patterns 
during pregnancy resulted in higher trabecular content and volumetric density, the 
relationships were relatively weak particularly once adjusted for childhood height 
and weight. No relationship was seen between either maternal calcium intake or the 
child‟s milk intake and the child‟s bone size or density.  Whilst dietary patterns and 
individual macronutrient and micronutrient intake are likely to be important to the 
offspring‟s bone health, power was limited in this study to examine these 
relationships. 
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6  DETERMINANTS OF HIP GEOMETRY AND STRENGTH 
  
 
6.1   Aims 
  To test the hypothesis that childhood lifestyle and body composition 
influence femoral neck structure and bone strength at age 6 years. 
  To test the hypothesis that maternal lifestyle factors and body composition 
influence femoral neck structure and bone strength at age 6 years. 
 
6.2  Methods 
 
The femoral DXA scan images obtained from the 6 year children were analysed 
using an interactive computer program (hip structural analysis, HSA). This was used 
to derive a number of structural variables from the femoral DXA scans. Full methods 
are described in chapter 3.   
 
6.3  Results 
6.3.1  Descriptive statistics 
The summary statistics of the children are shown in the descriptive statistics tables in 
chapter 4. The HSA program was unable to analyse all scans of the femoral neck. 
Although it was unclear why this was the case, one reason may be that the edge 
detection of the bone mineral in the hip was unclear in some scans, a known problem 
in scanning young children. Table 36 compares all children who had scans of the 
femoral neck according to whether HSA analysis was possible. Of the 530 total 
scans, 478 could be used in further analysis, which left 52 excluded. The children for 
whom the program was unable to interpret the hip tended to be shorter (p=0.0009) 
and lighter (p=0.01). These children also had a lower grip strength, lower whole 
body and lumbar BMC, BA and aBMD, lower hip BA and lower lean mass. There 
was no difference between total fat mass and activity levels in these children. 
However they appeared to drink slightly more milk (p=0.006).  
There was no difference between any maternal anthropometric measures, including 
height and weight, or any other maternal dietary or lifestyle determinants in the 
children whose scans were excluded.   107 
TABLE 36: Differences in the characteristics of the children whose femoral 
neck scans were analysable/non-analysable  
 
 
Table 37 shows the differences between summary values in boys and girls.  Boys had 
significantly greater narrow neck BMD, cross sectional area (CSA), cortical 
thickness and had a higher section modulus (Z). At the intertrochanteric site, whilst 
the boys had a higher BMD and cortical thickness, the girls had a higher sub 
periosteal width and buckling ratio with no statistical difference in Z modulus. Boys 
had slightly greater BMD and cortical thickness at the femoral shaft. An increase in 
hip axis length, CSA and Z modulus were also seen with increasing age of the child 
at the time of scan in both sexes, hence all analyses in this chapter were adjusted for 
age and sex. 
 
Children with suitable scans Children with unsuitable scans
number number p value
Birth to age 1
Gestational age 39.7 (1.8) 478 39.5 (2) 52 0.4
Birthweight (g) 3449 (518) 472 3378 (682) 52 0.4
Crown heel length birth(cm) 49.9 (2.1) 462 49.5 (2.6) 51 0.2
Weight at one year (kg) 10.1 (9.3-10.8) 475 9.6 (8.8,10.2) 51 0.01
Crown heel length age one(cm) 75.6 (2.7) 468 74.5 (3) 52 0.007
Age 6 from DXA clinic visit
Anthropometry
Height at age 6, cm (mean sd) 120.3 (5) 444 117.8 (5.4) 48 0.0009
Weight at age 6, kg (median IQR) 23.4 (21.5,25.7) 451 21.9 (19.8,24.7) 48 0.01
Grip Strength (max) kg (mean sd) 10 (2.4) 411 8.9 (2.3) 41 0.008
Triceps skinfold thickness, mm (median IQR) 9.8 (8.1-12.1) 370 9.7 (7.9,11.6) 40 0.5
Total BMC, g (mean sd) 533.9 (67.7) 461 501 (85.4) 50 0.002
Total BA, g/cm
2 (mean sd) 899 (62.5) 461 869(71.1) 50 0.002
Total aBMD, g/cm
2 (mean sd) 0.59 (0.04) 461 0.57 (0.06) 50 0.006
Spine BMC, g (mean sd) 18 (2.7) 478 16.8 (3) 48 0.004
Spine BA, g/cm2 (mean sd) 33.3 (3) 478 32.1 (3.7) 48 0.009
Spine aBMD, g/cm2 (mean sd) 0.54 (0.06) 478 0.52 (0.06) 48 0.05
Hip BMC, g (mean sd) 11.2 (2) 478 10.7 (2.6) 48 0.08
Hip BA, g/cm2 (mean sd)  16.8 (2.1) 478 15.9 (2.6) 48 0.005
Hip aBMD, g/cm2 (mean sd) 0.66 (0.06) 478 0.66 (0.07) 48 0.9
Total lean, kg (mean sd) 17.3 (2.1) 16.7 (2.8) 0.05
Total fat kg, median IQR 5.2 (4.3,6.6) 451 5.1 (4.1,6.2) 48 0.21
Lifestyle
% of children with fracture 12.4 51 6.3 3 0.006
Vigorous activity, mins per day (mean sd) 44.1 (19.6) 196 38.1 (11.3) 19 0.7
Sedentary activity, mins per day (mean sd) 875 (80.4) 858 (84.6) 19 0.4
Moderate activity, mins per day (mean sd) 36.3 (12.6) 38.1(11.3) 19 0.5
Milk intake, pints/day (median IQR) 0.5 (0.25,0.5) 384 0.5 (0.35,0.75) 41 0.006
BMC: bone mineral content; BA: bone area; aBMD: areal bone mineral density  108 
TABLE 37: Differences between hip geometry and strength between boys and 
girls 
 
6.3.2  Childhood hip structure adjusted for 6 year anthropometry 
 Table 38 shows that height, weight and maximum grip strength were all positively 
associated with femoral neck, intertrochanter and femoral shaft BMD, CSA, sub-
periosteal width and Z modulus (p<0.001) and narrow neck and intertrochanter 
cortical thickness (p<0.01). Figure 11 shows scatter graphs of the relationship 
between the structure and strength at the three sites and the child‟s current height. 
Triceps skinfold thickness was associated with increased sub-periosteal width at all 
three sites (p<0.01). It was also associated with increased intertrochanteric and 
femoral shaft Z modulus, increased femoral shaft CSA and increased 
intertrochanteric and femoral shaft buckling ratios (p<0.05). In addition height 
(r=0.51, p<0.001), weight (r=0.47, p<0.001), grip strength (r=0.29, p<0.001), triceps 
skinfold thickness (r=0.11, p=0.02) and BMI (r=0.2, p<0.001) were all positively 
correlated with increased hip axis length.  Finally there was a small negative 
association between height and shaft neck angle (r=-0.1, p=0.04). 
 
 
Characteristic Boys Girls P value
n n
Hip axis length (mm) 77.6 (5.5) 269 75.8 (5.5) 251 0.0002
Shaft neck angle 131.2 (5.6) 148 133.4 (5.4) 225 <0.0001
Narrow neck BMD (g/cm
2) 0.77 (0.08) 249 0.71 (0.08) 229 <0.0001
Narrow neck cross section area (cm
2) 1.67 (0.26) 249 1.55 (0.22) 229 <0.0001
Narrow neck  sub periosteal width (cm) 2.27 (0.18) 249 2.27 (0.18) 229 0.81
Narrow neck average cortical thickness (cm) 0.15 (0.02) 249 0.14 (0.02) 229 <0.0001
Narrow neck section of modulus (cm
4) 0.58 (0.13) 249 0.54 (0.12) 229 0.0002
Narrow neck buckling ratio 8.13 (1.02) 249 8.82 (1.3) 229 <0.0001
Intertrochanter BMD  (g/cm
2) 0.76 (0.09) 248 0.69 (0.09) 225 <0.0001
Intertrochanter  cross section area (cm
2) 2.18 (0.33) 248 2.13 (0.32) 225 0.12
Intertrochanter sub-periosteal width (cm) 3.01 (0.27) 248 3.24 (0.3) 225 <0.0001
Intertrochanter cortical thickness (cm) 0.28 (0.04) 248 0.27 (0.04) 225 0.008
Intertrochanter section of modulus  (cm
4) 1 (0.2) 248 1 (0.2) 225 0.72
Intertrochanter  buckling ratio 5.9 (0.9) 248 6.7 (1.1) 225 <0.0001
Femur shaft BMD (g/cm
2) 0.96 (0.09) 248 0.94 (0.09) 225 0.02
Femur shaft cross section area (cm
2) 1.72 (0.23) 248 1.69 (0.22) 225 0.09
Femur shaft sub-periosteal width (cm) 1.89 (0.15) 248 1.9 (0.16) 225 0.85
Femur shaft  average cortical thickness (cm) 0.36 (0.05) 248 0.35 (0.05) 225 0.03
Femur shaft section of modulus (cm
4) 0.6 (0.12) 248 0.59 (0.12) 225 0.27
Femur shaft section buckling ratio 2.77 (0.5) 248 2.85 (0.5) 225 0.07
table shows mean and standard deviation, n:number  109 
Figure 11: Relationship between child’s height and hip structure at age 6 years 
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TABLE 38:  Childhood anthropometry as determinants of childhood hip structure at age 6 years using univariate regression analysis
Narrow Neck
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
Maximum grip strength  (kg) 0.008 (0.005,0.01)*** 0.03 (0.03,0.04)*** 0.02 (0.02,0.03)*** 0.002 (0.0010,0.002)*** 0.02 (0.01,0.02)*** -0.009 (-0.05,0.04)
log triceps skinfold thickness (mm) -0.007 (-0.04,0.02) 0.05 (-0.03,0.1) 0.09 (0.03,0.2)** -0.002 (-0.008,0.004) 0.03 (-0.010,0.07) 0.5 (0.1,0.9)
log. Weight (kg) 0.2 (0.1,0.2)*** 0.9 (0.7,1.0)*** 0.7 (0.6,0.8)*** 0.03 (0.02,0.04)*** 0.5 (0.4,0.5)*** 1.1 (0.3,1.8)**
Height (cm) 0.005 (0.004,0.007)*** 0.03 (0.02,0.03)*** 0.02 (0.02,0.02)*** 0.001 (0.0007,0.001)*** 0.01 (0.01,0.02)*** 0.03 (0.004,0.05)*
BMI,kg/m2 0.006 (0.002,0.01)** 0.03 (0.02,0.05)*** 0.03 (0.02,0.04)*** 0.001 (0.0002,0.002)* 0.02 (0.01,0.02)*** 0.07 (0.003,0.1)*
Intertrochanter
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
Maximum grip strength  (kg) 0.006 (0.003,0.010)*** 0.05 (0.04,0.06)*** 0.04 (0.03,0.05)*** 0.003 (0.001,0.004)*** 0.03 (0.02,0.04)*** 0.02 (-0.01,0.06)
log triceps skinfold thickness (mm) -0.02 (-0.04,0.01) 0.08 (-0.03,0.2) 0.2 (0.08,0.3)*** -0.01 (-0.02,0.003) 0.08 (0.004,0.2)* 0.7 (0.4,1.0)***
log. Weight (kg) 0.1 (0.06,0.2)*** 1.2 (1.0,1.3)*** 1.2 (1.0,1.3)*** 0.04 (0.02,0.07)** 0.9 (0.8,1.0)*** 1.7 (1.0,2.3)***
Height (cm) 0.004 (0.002,0.005)*** 0.03 (0.03,0.04)*** 0.03 (0.03,0.04)*** 0.001 (0.0006,0.002)*** 0.02 (0.02,0.03)*** 0.04 (0.02,0.06)***
BMI,kg/m2 0.004 (-0.0004,0.009) 0.05 (0.04,0.07)*** 0.06 (0.04,0.07)*** 0.002 (-0.0003,0.004) 0.04 (0.03,0.05)*** 0.09 (0.04,0.1)***
Femur shaft
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
Maximum grip strength  (kg) 0.007 (0.003,0.01)*** 0.03 (0.03,0.04)*** 0.04 (0.03,0.05)*** 0.002 (-0.0002,0.004) 0.02 (0.02,0.02)*** 0.02 (0.0009,0.04)*
log triceps skinfold thickness (mm) 0.01 (-0.02,0.04) 0.1 (0.05,0.2)*** 0.2 (0.08,0.3)*** -0.0004 (-0.02,0.02) 0.08 (0.04,0.1)*** 0.2 (0.03,0.4)*
log. Weight (kg) 0.2 (0.1,0.2)*** 0.9 (0.8,1.1)*** 1.2 (1.0,1.3)*** 0.05 (0.01,0.08)** 0.6 (0.5,0.6)*** 0.7 (0.4,1.0)***
Height (cm) 0.003 (0.002,0.005)*** 0.02 (0.02,0.03)*** 0.03 (0.03,0.04)*** 0.0005 (-0.0004,0.001) 0.02 (0.01,0.02)*** 0.03 (0.02,0.04)***
BMI,kg/m2 0.01 (0.007,0.02)*** 0.05 (0.04,0.06)*** 0.06 (0.04,0.07)*** 0.004 (0.002,0.007)** 0.03 (0.02,0.03)*** 0.02 (-0.010,0.04)
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001  111 
6.3.3  Childhood lifestyle determinants 
It was noted that children that had higher intensities of physical activity tended to be 
both smaller (r=-0.17, p=0.01) and lighter (r=-0.16, p=0.03) than the other children. 
Since height was such a large predictor of bone mass and geometry in the hip and 
hence a major confounder for childhood activity, the following results were 
additionally adjusted for childhood height. 
 
Table 39 shows the child‟s lifestyle as determinants of hip structure adjusted for the 
child‟s height. In addition Figure 12 shows barcharts to show the relationship 
between vigorous and very vigorous activity and the child‟s hip structure and 
strength. 
 
Very vigorous activity levels in the child were associated with increased narrow neck 
and intertrochanteric BMD (both p<0.05), CSA (both p<0.001), sub periosteal width 
(both p<0.05) and Z modulus (both p<0.01). In addition it was also associated with 
increased CSA and Z modulus at the femoral shaft (both p=0.02). Increased time 
spent in sedentary activity was negatively associated with narrow neck BMD and 
cortical thickness (both p =0.05). Whilst there was a suggestion that sedentary 
activity was also associated with decreased Z modulus at the narrow neck, this did 
not reach significance (p=0.1). 
 
Increased milk intake was positively associated with narrow neck and femoral shaft 
BMD and cortical thickness and femoral shaft CSA (all p<0.05). In addition milk 
intake was negatively associated with the narrow neck buckling ratio (r=-0.14, 
p=0.008).   112 
Figure 12: Barcharts to show the relationship between vigorous/very vigorous activity and section of modulus, cross sectional area and 
bone mineral density at the three sites measured in the femoral neck 
 
 
 
 
 
 
 
 
 
r=0.23
p = 0.001
.45
.5
.55
.6
.65
N
a
r
r
o
w
 
n
e
c
k
 
s
e
c
t
i
o
n
 
o
f
 
m
o
d
u
l
u
s
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
Mins per day vigorous or very vigorous activity
Narrow neck: Section of modulus
r=0.23
p = 0.001
.45
.5
.55
.6
.65
N
a
r
r
o
w
 
n
e
c
k
 
s
e
c
t
i
o
n
 
o
f
 
m
o
d
u
l
u
s
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
Mins per day vigorous or very vigorous activity
Narrow neck: Section of modulus
r=0.23
p = 0.001
.85
.9
.95
1
1.05
1.1
1.15
I
n
t
e
r
t
r
o
c
h
a
n
t
e
r
s
e
c
t
i
o
n
 
o
f
 
m
o
d
u
l
u
s
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
mins per day vigorous or very vigorous activity
Intertrochanter section of modulus
r=0.23
p = 0.001
.85
.9
.95
1
1.05
1.1
1.15
I
n
t
e
r
t
r
o
c
h
a
n
t
e
r
s
e
c
t
i
o
n
 
o
f
 
m
o
d
u
l
u
s
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
mins per day vigorous or very vigorous activity
Intertrochanter section of modulus
r=0.17
p = 0.02
.52
.54
.56
.58
.6
.62
.64
F
e
m
u
r
 
s
h
a
f
t
 
s
e
c
t
i
o
n
 
o
f
 
m
o
d
u
l
u
s
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Femur shaft section of modulus
r=0.17
p = 0.02
.52
.54
.56
.58
.6
.62
.64
F
e
m
u
r
 
s
h
a
f
t
 
s
e
c
t
i
o
n
 
o
f
 
m
o
d
u
l
u
s
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Femur shaft section of modulus
r=0.26
p = 0.0002
1.45
1.5
1.55
1.6
1.65
1.7
1.75
1.8
N
a
r
r
o
w
 
n
e
c
k
 
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
 
a
r
e
a
 
(
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Narrow neck cross-sectional area
r=0.26
p = 0.0002
1.45
1.5
1.55
1.6
1.65
1.7
1.75
1.8
N
a
r
r
o
w
 
n
e
c
k
 
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
 
a
r
e
a
 
(
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Narrow neck cross-sectional area
r=0.24
p = 0.0009
1.9
2
2.1
2.2
2.3
2.4
I
n
t
e
r
t
r
o
c
h
a
n
t
e
r
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
 
a
r
e
a
 
(
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Intertrochanter cross-sectional area
r=0.24
p = 0.0009
1.9
2
2.1
2.2
2.3
2.4
I
n
t
e
r
t
r
o
c
h
a
n
t
e
r
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
 
a
r
e
a
 
(
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Intertrochanter cross-sectional area
r=0.24
p = 0.0009
1.9
2
2.1
2.2
2.3
2.4
I
n
t
e
r
t
r
o
c
h
a
n
t
e
r
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
 
a
r
e
a
 
(
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Intertrochanter cross-sectional area
r=0.16
p = 0.02
1.6
1.65
1.7
1.75
1.8
F
e
m
u
r
 
s
h
a
f
t
 
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
 
a
r
e
a
 
(
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Femur shaft cross-sectional area
r=0.16
p = 0.02
1.6
1.65
1.7
1.75
1.8
F
e
m
u
r
 
s
h
a
f
t
 
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
 
a
r
e
a
 
(
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Femur shaft cross-sectional area
r=0.18
p = 0.01
.7
.72
.74
.76
.78
.8
N
a
r
r
o
w
 
n
e
c
k
 
B
M
D
 
(
g
/
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Narrow neck BMD
r=0.18
p = 0.01
.7
.72
.74
.76
.78
.8
N
a
r
r
o
w
 
n
e
c
k
 
B
M
D
 
(
g
/
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Narrow neck BMD
r=0.18
p = 0.02
.68
.7
.72
.74
.76
.78
I
n
t
e
r
t
r
o
c
h
a
n
t
e
r
B
M
D
 
(
g
/
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Intertrochanter BMD
r=0.18
p = 0.02
.68
.7
.72
.74
.76
.78
I
n
t
e
r
t
r
o
c
h
a
n
t
e
r
B
M
D
 
(
g
/
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Intertrochanter BMD
r = 0.11
p = 0.1
.88
.9
.92
.94
.96
.98
1
6
 
y
r
 
D
X
A
:
 
F
e
m
u
r
 
s
h
a
f
t
 
B
M
D
 
(
g
/
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Femur shaft BMD
r = 0.11
p = 0.1
.88
.9
.92
.94
.96
.98
1
6
 
y
r
 
D
X
A
:
 
F
e
m
u
r
 
s
h
a
f
t
 
B
M
D
 
(
g
/
c
m
2
)
to 27.8 to 37.3 to 47.0 to 58.0 > 58.0
6yr actiheart: Child - mins per day vigorous or very vigorous
Femur shaft BMD
Values are mean (95% CIs)   113 
TABLE 39: Childhood lifestyle as a determinant of childhood hip structure using univariate regression analysis
Narrow Neck
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
Sedentary activity -0.0001 (-0.0003,-0.000001)* -0.0003 (-0.0007,0.00002) -0.00008 (-0.0003,0.0002) -0.00003 (-0.00006,0.0000005)* -0.0001 (-0.0003,0.00007) 0.001 (-0.0008,0.003)
Light activity (mins per day) 0.0001 (-0.00006,0.0003) 0.0002 (-0.0003,0.0006) -0.00005 (-0.0004,0.0003) 0.00002 (-0.00001,0.00006) 0.00002 (-0.0002,0.0002) -0.001 (-0.004,0.001)
Moderate activity (mins per day) 0.0009 (0.00006,0.002)* 0.003 (0.0004,0.005)* 0.0009 (-0.0008,0.003) 0.0002 (0.0000009,0.0004)* 0.0009 (-0.0003,0.002) -0.008 (-0.02,0.005)
Vigorous activity (mins per day) 0.0008 (-0.00003,0.002) 0.003 (0.001,0.005)** 0.002 (0.0008,0.004)** 0.0001 (-0.00003,0.0003) 0.002 (0.0006,0.003)** -0.001 (-0.01,0.01)
Very vigorous activity (mins per day) 0.0007 (0.0002,0.001)** 0.003 (0.001,0.004)*** 0.001 (0.0004,0.003)** 0.0001 (0.00002,0.0003)* 0.001 (0.0005,0.002)** -0.003 (-0.01,0.005)
Total milk intake (pints/day) 0.009 (0.00002,0.02)* 0.01 (-0.01,0.03) -0.01 (-0.03,0.004) 0.002 (0.00006,0.004)* 0.002 (-0.010,0.01) -0.2 (-0.3,-0.05)*
Intertrochanter
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
Sedentary activity -0.0001 (-0.0003,0.00004) -0.0004 (-0.0009,0.00007) -0.0002 (-0.0006,0.0002) -0.00004 (-0.0001,0.00003) -0.0002 (-0.0005,0.0001) 0.0005 (-0.001,0.002)
Light activity (mins per day) 0.00006 (-0.0001,0.0002) 0.0002 (-0.0004,0.0008) 0.00003 (-0.0004,0.0005) 0.000007 (-0.00008,0.00009)0.0000007 (-0.0004,0.0004) -0.00004 (-0.002,0.002)
Moderate activity (mins per day) 0.001 (0.00003,0.002)* 0.004 (0.0010,0.007)* 0.002 (-0.0007,0.004) 0.0004 (-0.00003,0.0008) 0.002 (0.0002,0.004)* -0.005 (-0.02,0.006)
Vigorous activity (mins per day) 0.0008 (-0.00005,0.002) 0.004 (0.001,0.007)** 0.002 (0.0002,0.005)* 0.0005 (0.00006,0.0009)* 0.003 (0.0010,0.005)** -0.006 (-0.02,0.004)
Very vigorous activity (mins per day) 0.0007 (0.0001,0.001)* 0.003 (0.001,0.005)*** 0.002 (0.00009,0.003)* 0.0004 (0.00009,0.0006)** 0.002 (0.0008,0.003)** -0.005 (-0.01,0.002)
Total milk intake (pints/day) 0.004 (-0.005,0.01) 0.02 (-0.01,0.05) 0.01 (-0.01,0.04) 0.003 (-0.002,0.007) 0.007 (-0.01,0.03) -0.03 (-0.1,0.07)
Femur shaft
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
Sedentary activity -0.00002 (-0.0002,0.0002) -0.0002 (-0.0005,0.0002) -0.0001 (-0.0004,0.00007) 0.000008 (-0.00008,0.0001) -0.00007 (-0.0002,0.00009) -0.0002 (-0.001,0.0006)
Light activity (mins per day) -0.00005 (-0.0003,0.0002) 0.00003 (-0.0004,0.0004) 0.0001 (-0.0001,0.0004) -0.00004 (-0.0001,0.00007) -0.000005 (-0.0002,0.0002) 0.0005 (-0.0006,0.002)
Moderate activity (mins per day) 0.0008 (-0.0003,0.002) 0.002 (0.0003,0.004)* 0.001 (-0.0003,0.002) 0.0003 (-0.0003,0.0008) 0.001 (0.00008,0.002)* -0.001 (-0.007,0.004)
Vigorous activity (mins per day) 0.0004 (-0.0006,0.001) 0.001 (-0.0005,0.003) 0.0007 (-0.0005,0.002) 0.0002 (-0.0004,0.0007) 0.0008 (-0.0001,0.002) -0.0006 (-0.006,0.004)
Very vigorous activity (mins per day) 0.0005 (-0.0002,0.001) 0.002 (0.0002,0.003)* 0.0006 (-0.0002,0.001) 0.0002 (-0.0002,0.0006) 0.0008 (0.0001,0.001)* -0.001 (-0.005,0.002)
Total milk intake (pints/day) 0.01 (0.0008,0.02)* 0.02 (0.002,0.04)* 0.002 (-0.01,0.02) 0.005 (-0.00009,0.01)* 0.007 (-0.003,0.02) -0.04 (-0.09,0.02)
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001  114 
6.3.4  Independent childhood determinants of hip structure 
 
Table 40 shows the mutually adjusted childhood determinants of hip structure at 6 
years when childhood height, weight, grip strength, vigorous activity and milk intake 
were included in the multivariate model. 
 
 Height was a significant independent predictor of increased sub-periosteal width at 
all three sites (p<0.001), increased narrow neck and intertrochanteric CSA (β=0.02, 
p=0.002; β=0.02, p=0.03) and Z modulus (β=0.01, p<0.0001; β=0.02, p=0.001). In 
addition height was positively associated with both the femoral shaft Z modulus 
(β=0.008, p<0.001) and buckling ratio (β=0.04, p=0.003) and increased hip axis 
length (β=0.5, p<0.001). 
 
 Weight was independently associated with narrow neck CSA (β=0.4, p=0.03) and 
intertrochanteric and femoral shaft CSA (β=0.7, p=0.02; β=0.7, p<0.001), sub-
periosteal width (β=0.6, p=0.006; β=0.4, p=0.002) and Z modulus (β=0.02, p<0.001; 
β=0.008, p<0.001). In addition it was also positively associated with increased BMD 
at the femoral shaft (β=0.2, p=0.03) and hip axis length (β=10.2, p=0.04). 
 Grip strength was positively associated with narrow neck, intertrochanteric and 
femoral shaft BMD (β=0.01, p=0.001; β=0.01, p=0.004; β =0.008, p=0.04 
respectively), CSA (β=0.02, p=0.002; β=0.04, p=0.001; β=0.02, p<0.001 
respectively, and Z modulus (β=0.01, p=0.008; β=0.02, p=0.01; β=0.01, p<0.001). It 
was also positively associated with cortical thickness at the narrow neck (β=0.002, 
p<0.001) and intertrochanteric sites (β=0.004, p=0.01). 
 
Total milk intake showed a negative association between narrow neck buckling ratio 
(β=-0.3, p= 0.03) and an increased hip axis length (β=1, p=0.04). 
Since the various subtypes in intensities of physical activity were closely related, 
vigorous and very vigorous activity was chosen to put into this multivariate model. 
This was positively associated with narrow neck and intertrochanteric CSA 
(β=0.003, p=0.01; β=0.004, p=0.02) sub-periosteal width (β=0.003, p=0.06; β=0.003, 
p=0.04) and Z modulus (β=0.003, p=0.01; β=0.003, p=0.01). 
   115 
When triceps thickness was added to the multivariate model, the number of 
children‟s scans available for analysis reduced to 142. Triceps skinfold thickness was 
negatively associated with narrow neck CSA (β=-0.02, p=0.05) and Z modulus (β=-
0.01, p=0.03), Intertrochanteric CSA (=-0.02, p= 0.03), sub-periosteal width (β=-0.2, 
p=0.02) cortical thickness (β =-0.003, p=0.04) and Z modulus (β =-0.02, p=0.006) 
and femoral shaft BMD (β =-0.008 p=0.03) CSA (β =-0.01, p=0.04) and cortical 
thickness (β =-0.005, p=0.03). The relationship between grip strength and hip 
structure was significantly weakened after triceps skinfold was added to the model 
and the association between height only remained for narrow neck section modulus 
(β=0.007, p=0.01). The only association seen between physical activity and hip 
structure was for sub-periosteal width at the narrow neck (β=0.002, p=0.02); the 
associations between narrow neck and intertrochanteric CSA and z modulus did not 
quite reach significance but a trend remained (all p<0.1). It was noted that there was 
a significant negative association between triceps skinfold thickness and vigorous 
activity (r=-0.31, p<0.0001) suggesting that those with higher skinfold thickness did 
less vigorous activity. 
 
When looking at the multivariate model, without measures of physical activity, the 
number of participants included in the model increased to 293. Height was once 
again positively associated with narrow neck CSA (β=0.01, p=0.006) and Z modulus 
(β=0.006, p=0.001), intertrochanteric Z modulus (β=0.008, p=0.02) and femoral 
shaft z modulus (β=0.005, p=0.001) and buckling ratio β=0.04, p<0.001). Triceps 
skinfold thickness was negatively associated with all measures of hip structure and 
strength (except buckling ratio) at all three sites of the hip (all p<0.05). Grip strength 
was only associated with femoral shaft Z modulus (β=0.006, p=0.007) and total milk 
intake was positively associated with femoral shaft CSA (β=0.02, p=0.03) and 
negatively associated with narrow neck buckling ratio (β=0.02, p=0.03). 
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  TABLE 40: Mutually adjusted childhood determinants of childhood hip structure at age 6 years  
Narrow Neck
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
R
2 as a % 20 39 41 18 41 9
Childs height (cm) 0.001 (-0.003,0.005) 0.02 (0.006,0.02)** 0.02 (0.01,0.03)*** 0.00008 (-0.0007,0.0008) 0.01 (0.006,0.02)*** 0.05 (-0.005,0.1)
log. Child's weight (kg) 0.1 (-0.02,0.3) 0.4 (0.05,0.8)* 0.2 (-0.08,0.5) 0.03 (-0.004,0.06) 0.2 (-0.03,0.4) -0.01 (-2.2,2.2)
Maximum grip strength  (kg) 0.01 (0.005,0.02)*** 0.02 (0.009,0.04)** 0.004 (-0.008,0.02) 0.002 (0.0009,0.003)*** 0.01 (0.003,0.02)** -0.1 (-0.2,-0.02)*
Very vigorous activity (mins/day) 0.0005 (-0.0004,0.001) 0.003 (0.0007,0.006)* 0.003 (0.0008,0.005)** 0.0001 (-0.0001,0.0003) 0.002 (0.0004,0.003)** 0.003 (-0.01,0.02)
Total milk intake (pints/day) 0.01 (-0.005,0.03) 0.003 (-0.04,0.04) -0.03 (-0.06,0.005) 0.002 (-0.0010,0.005) -0.004 (-0.02,0.02) -0.3 (-0.5,-0.03)*
Intertrochanter
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
R
2 as a % 11 36 39 8 41 9
Childs height (cm) 0.0006 (-0.004,0.005) 0.02 (0.002,0.03)* 0.02 (0.009,0.03)*** -0.0003 (-0.002,0.002) 0.02 (0.007,0.02)*** 0.04 (-0.009,0.09)
log. Child's weight (kg) 0.05 (-0.1,0.2) 0.7 (0.1,1.2)* 0.6 (0.2,1.1)** 0.02 (-0.05,0.1) 0.4 (0.07,0.8)* 1.2 (-0.8,3.1)
Maximum grip strength  (kg) 0.010 (0.003,0.02)** 0.04 (0.02,0.06)*** 0.01 (-0.004,0.03) 0.004 (0.0008,0.007)* 0.02 (0.004,0.03)* -0.06 (-0.1,0.01)
Very vigorous activity (mins/day) 0.0006 (-0.0005,0.002) 0.004* (0.0006,0.007) 0.003 (0.0001,0.006)* 0.0004 (-0.0001,0.0008) 0.003 (0.0007,0.005)* -0.002 (-0.01,0.010)
Total milk intake (pints/day) 0.003 (-0.01,0.02) 0.03 (-0.03,0.08) 0.03 (-0.02,0.07) 0.002 (-0.006,0.010) 0.01 (-0.02,0.05) -0.02 (-0.2,0.2)
Femoral shaft
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
R
2 as a % 10 45 49 4 54 11
Childs height (cm) -0.002 (-0.007,0.003) 0.008 (-0.0002,0.02) 0.01 (0.008,0.02)*** -0.002 (-0.005,0.0005) 0.008 (0.004,0.01)*** 0.04 (0.01,0.06)**
log. Child's weight (kg) 0.2 (0.02,0.4)* 0.7 (0.4,1.0)*** 0.4 (0.1,0.6)** 0.08 (-0.02,0.2) 0.3 (0.2,0.5)*** -0.06 (-1.0,0.9)
Maximum grip strength  (kg) 0.008 (0.0004,0.01)* 0.02 (0.010,0.04)*** 0.009 (-0.0007,0.02) 0.003 (-0.001,0.007) 0.01 (0.006,0.02)*** -0.02 (-0.06,0.02)
Very vigorous activity (mins/day) 0.00004 (-0.001,0.001) 0.001 (-0.001,0.003) 0.001 (-0.0004,0.003) -0.00004 (-0.0007,0.0006) 0.0009 (-0.0002,0.002) 0.001 (-0.005,0.008)
Total milk intake (pints/day) 0.005 (-0.01,0.02) 0.02 (-0.01,0.06) 0.01 (-0.01,0.04) 0.0008 (-0.009,0.01) 0.01 (-0.005,0.03) 0.003 (-0.09,0.1)
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001  117 
 
6.3.5  Maternal determinants of childhood hip structure 
 
Table 41 shows the relationship between various anthropometric and lifestyle 
determinants of hip structure at 6 years.  
 
Figure 13 shows scattergraphs of the relationships between maternal height, weight 
and BMI and intertrochanteric section of modulus, cross sectional area and sub 
periosteal width. Maternal height was positively associated with narrow neck, 
intertrochanteric and femoral shaft CSA, sub-periosteal width and Z modulus (all 
p<0.001). In addition it was also positively associated with intertrochanteric and 
femoral shaft buckling ratio (p<0.01). Weight and BMI were positively associated 
with narrow neck, intertrochanteric and femoral shaft BMD, CSA and Z modulus. 
They were also associated with cortical thickness at the narrow neck and femoral 
shaft. In addition BMI was also associated with cortical thickness at the 
intertrochanteric region. Both height and weight were associated with the hip axis 
length (r=0.29, p<0.001, r=0.2, p<0.001 respectively). However there was no 
relationship seen with the shaft angle. 
 
There was no association between maternal social class, educational attainment and 
smoking status and any measure of hip structure in the child. The largest lifestyle 
predictor was the frequency of strenuous exercise in late pregnancy which was 
positively associated with narrow neck and intertrochanteric BMD, CSA and cortical 
thickness (all p<0.05), intertrochanteric Z modulus (r=0.12, p=0.009) and negatively 
associated with intertrochanteric buckling ratio (r=-0.07, p=0.02). The relatively few 
mothers that undertook regular strenuous activity during this part of their pregnancy 
appeared to drive this relationship. 
 
 Pre pregnancy calcium and vitamin B12 intake were both positively associated with 
hip axis length (r=0.14, p<0.001, r=0.13, p=0.004). When looking at the other 
parameters of hip structure there was a suggestion that both these nutrients were 
associated with CSA and Z modulus at all three sites, however this did not quite 
reach significance (all p<0.1). In addition pre pregnancy energy intake (β=2.1, 
p=0.01), protein (β=2.2, p=0.01) and vitamin D intake (β=0.8, p=0.03) were all 
associated with hip axis length.   118 
 
Figure 13: Effect of maternal pre pregnancy height, weight and BMI on intertrochanteric section modulus, cross sectional area, and 
sub-periosteal width  
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 TABLE 41: Maternal determinants of child’s hip structure at age 6 years in univariate regression analysis
Narrow Neck
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
Anthropometry
Woman's height (cm) 0.001 (-0.000009,0.002)* 0.007 (0.004,0.01)*** 0.006 (0.004,0.009)*** 0.0002 (-0.00003,0.0004) 0.004 (0.002,0.006)*** 0.01 (-0.006,0.03)
log: Woman's weight (kg) 0.07 (0.03,0.1)*** 0.3 (0.2,0.4)*** 0.2 (0.08,0.3)*** 0.01 (0.006,0.02)** 0.1 (0.08,0.2)*** -0.2 (-0.8,0.4)
log: Woman's body mass index 0.06 (0.02,0.1)** 0.2 (0.06,0.3)** 0.08 (-0.02,0.2) 0.01 (0.004,0.02)* 0.09 (0.03,0.2)** -0.4 (-1.0,0.2)
Lifestyle  
log: PP Total calcium (mg/day) 0.009 (-0.01,0.03) 0.05 (-0.02,0.1) 0.04 (-0.01,0.08) 0.002 (-0.003,0.006) 0.03 (-0.006,0.06) 0.04 (-0.3,0.3)
log PP :Total B12(mcg/day) 0.01 (-0.001,0.03) 0.04 (-0.002,0.08) 0.02 (-0.01,0.05) 0.003 (-0.0003,0.006) 0.02 (-0.0009,0.04) -0.1 (-0.3,0.1)
LP: Strenuous exercise per week (hr) 0.002 (0.0005,0.004)* 0.006 (0.0007,0.01)* 0.0008 (-0.003,0.005) 0.0005 (0.0001,0.0008)* 0.002 (-0.0005,0.005) -0.02 (-0.04,0.005)
Intertrochanter
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
Anthropometry
Woman's height (cm) 0.0005 (-0.0007,0.002) 0.007 (0.003,0.01)** 0.008 (0.005,0.01)*** -0.0002 (-0.0007,0.0004) 0.007 (0.004,0.01)*** 0.02 (0.007,0.03)**
log: Woman's weight (kg) 0.05 (0.009,0.09)* 0.3 (0.1,0.5)*** 0.2 (0.08,0.4)** 0.02 (-0.0009,0.04) 0.2 (0.1,0.3)*** 0.01 (-0.5,0.5)
log: Woman's body mass index 0.05 (0.002,0.09)* 0.2 (0.05,0.4)* 0.1 (-0.05,0.2) 0.02 (0.003,0.04)* 0.1 (0.008,0.2)* -0.3 (-0.9,0.2)
Lifestyle
log: PP Total calcium (mg/day) 0.007 (-0.02,0.03) 0.07 (-0.02,0.2) 0.06 (-0.01,0.1) 0.005 (-0.006,0.01) 0.05 (-0.008,0.1) 0.02 (-0.2,0.3)
log PP :Total B12(mcg/day) 0.01 (-0.003,0.03) 0.06 (0.002,0.1)* 0.04 (-0.01,0.08) 0.006 (-0.001,0.01) 0.03 (-0.006,0.07) -0.04 (-0.2,0.1)
LP: Strenuous exercise per week (hr) 0.003 (0.001,0.005)** 0.01 (0.005,0.02)** 0.003 (-0.003,0.009) 0.002 (0.0008,0.002)*** 0.006 (0.002,0.01)** -0.02 (-0.04,-0.002)*
Femur shaft
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
Anthropometry
Woman's height (cm) -0.00001 (-0.001,0.001) 0.006 (0.003,0.009)*** 0.007 (0.005,0.009)*** -0.0004 (-0.001,0.0002) 0.005 (0.003,0.006)*** 0.01 (0.008,0.02)***
log: Woman's weight (kg) 0.07 (0.02,0.1)** 0.3 (0.1,0.4)*** 0.1 (0.07,0.2)*** 0.03 (0.003,0.05)* 0.1 (0.07,0.2)*** 0.07 (-0.2,0.3)
log: Woman's body mass index 0.08 (0.03,0.1)** 0.2 (0.07,0.3)** 0.05 (-0.03,0.1) 0.04 (0.01,0.06)** 0.07 (0.005,0.1)* -0.2 (-0.4,0.09)
Lifestyle
log: PP Total calcium (mg/day) 0.01 (-0.01,0.04) 0.05 (-0.008,0.1) 0.03 (-0.02,0.07) 0.006 (-0.006,0.02) 0.03 (-0.005,0.06) -0.004 (-0.1,0.1)
log PP :Total B12(mcg/day) 0.005 (-0.01,0.02) 0.02 (-0.01,0.06) 0.02 (-0.01,0.04) 0.001 (-0.007,0.010) 0.02 (-0.003,0.04) 0.003 (-0.08,0.09)
LP: Strenuous exercise per week (hr) 0.001 (-0.0005,0.003) 0.002 (-0.002,0.007) -0.0003 (-0.003,0.003) 0.0007 (-0.0003,0.002) 0.0007 (-0.002,0.003) -0.006 (-0.02,0.004)
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001  120 
6.3.6  Independent maternal predictors of hip strength 
Maternal factors, which showed a significant association with the child‟s hip 
structure, were added to a multivariate model. When looking at whether any of the 
maternal macro or micronutrients should be included, the nutrients that were shown 
to be related to hip axis length in univariate regression were adjusted for each other 
using multivariate regression (pre pregnancy total energy, protein, vitamin B12, 
vitamin D and calcium). Whilst no relationship was observed for hip axis length, 
calcium was seen to be positively associated with femoral shaft CSA (β=0.1, p=0.02) 
and Z modulus (β=0.05, p=0.04). Vitamin B12 was additionally added to the model 
following the weak associations seen in the univariate analysis. 
 
Table 42 shows the independent relationship between maternal height, weight, pre 
pregnancy vitamin B12, pre pregnancy calcium intake and strenuous activity in late 
pregnancy and childhood hip structure at age 6 years. Whilst overall the R
2 for the 
models are small, the largest predictor was weight followed by height. Weight was 
positively associated with narrow neck, intertrochanteric and femoral shaft BMD, 
CSA, cortical thickness, Z modulus (all p<0.05). Maternal height was associated 
with narrow neck CSA (β=0.004, p=0.02), sub-periosteal width (β=0.005, p<0.001) 
and Z modulus (β=0.003, p=0.003), intertrochanteric sub-periosteal width (β=0.007, 
p=0.001) Z modulus (β=0.005, p=0.001) and buckling ratio (β=0.03, p=0.001) and 
femoral shaft CSA (β=0.003 p=0.04) sub-periosteal width (β=0.006, p<0.001), 
cortical thickness (β=-0.001, p=0.005), Z modulus (0.004, p<0.001) and buckling 
ratio (β=0.02, p<0.001). No relationship was observed between either pre pregnancy 
calcium, or vitamin B12 intake and hip structure. Strenuous activity in late 
pregnancy however remained significantly associated with narrow neck and 
intertrochanteric BMD (β=0.002, p=0.009; β=0.003, p=0.002), CSA 
(β=0.006,p=0.01; β=0.01, p=0.001) and cortical thickness (β=0.0005, p=0.009; 
β=0.002, p<0.001) in addition to a positive association between intertrochanteric z 
modulus (β=0.007, p=0.005) and a negative buckling ratio (β=-0.02, p=0.04). 
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TABLE 42: Mutually adjusted maternal determinants of childhood hip structure at age 6 years
Narrow Neck
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
R
2 as a % 5 8 7 4 8 2
Woman's height (cm) 0.0003 (-0.0010,0.002) 0.004* (0.0007,0.008) 0.005 (0.003,0.008)*** 0.00003 (-0.0002,0.0003) 0.003 (0.0009,0.004)** 0.02 (-0.002,0.03)
log: Woman's weight (kg) 0.07(0.02,0.1)** 0.2(0.10,0.3)*** 0.1 (0.01,0.2)* 0.01 (0.005,0.02)* 0.1 (0.05,0.2)*** -0.4 (-1.0,0.3)
log: PP Total calcium (mg/day) -0.002 (-0.03,0.02) 0.009 (-0.07,0.08) 0.02 (-0.04,0.07) -0.0005 (-0.006,0.005) 0.005 (-0.03,0.04) 0.1 (-0.3,0.5)
log PP :Total B12(mcg/day) 0.01 (-0.005,0.03) 0.03 (-0.02,0.08) 0.006 (-0.03,0.04) 0.003 (-0.0010,0.006) 0.01 (-0.01,0.04) -0.2 (-0.4,0.10)
LP: Strenuous exercise (hr/week) 0.002(0.0006,0.004)** 0.006* (0.001,0.01) 0.001 (-0.003,0.005) 0.0005 (0.0001,0.0008)** 0.002 (-0.0002,0.005) -0.02 (-0.04,0.006)
Intertrochanter
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
R
2 as a % 4 7 5 5 8 4
Woman's height (cm) -0.0001 (-0.001,0.001) 0.004 (-0.0007,0.009) 0.007 (0.003,0.01)** -0.0005 (-0.001,0.00008) 0.005 (0.002,0.009)** 0.03 (0.01,0.04)***
log: Woman's weight (kg) 0.05 (0.004,0.10)* 0.2 (0.08,0.4)** 0.1 (-0.01,0.3) 0.02 (0.004,0.04)* 0.2 (0.04,0.3)** -0.3 (-0.8,0.2)
log: PP Total calcium (mg/day) -0.004 (-0.03,0.02) 0.01 (-0.09,0.1) 0.03 (-0.06,0.1) 0.0005 (-0.01,0.01) 0.02 (-0.05,0.09) 0.04 (-0.3,0.4)
log PP :Total B12(mcg/day) 0.01 (-0.005,0.03) 0.05 (-0.02,0.1) 0.02 (-0.04,0.07) 0.006 (-0.002,0.01) 0.02 (-0.03,0.06) -0.08 (-0.3,0.1)
LP: Strenuous exercise (hr/week) 0.003 (0.001,0.005)** 0.01 (0.005,0.02)*** 0.003 (-0.002,0.009) 0.002 (0.0008,0.002)*** 0.007(0.002,0.01)** -0.02 (-0.04,-0.0007)*
Femur shaft
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
R
2 as a % 3 6 10 3 8 5
Woman's height (cm) -0.001 (-0.003,0.0002) 0.003 (0.0001,0.007)* 0.006 (0.004,0.009)*** -0.001 (-0.002,-0.0003)** 0.004 (0.002,0.005)*** 0.02 (0.01,0.02)***
log: Woman's weight (kg) 0.08 (0.03,0.1)*** 0.2 (0.10,0.3)*** 0.07 (-0.010,0.1) 0.04 (0.01,0.07)** 0.08 (0.02,0.1)** -0.1 (-0.4,0.1)
log: PP Total calcium (mg/day) 0.02 (-0.01,0.05) 0.03 (-0.04,0.1) 0.003 (-0.04,0.05) 0.009 (-0.006,0.02) 0.006 (-0.03,0.04) -0.04 (-0.2,0.1)
log PP :Total B12(mcg/day) 0.0009 (-0.02,0.02) 0.008 (-0.04,0.05) 0.008 (-0.02,0.04) -0.0008 (-0.01,0.009) 0.01 (-0.01,0.03) -0.0003 (-0.1,0.10)
LP: Strenuous exercise (hr/week) 0.002 (-0.0004,0.003) 0.003 (-0.002,0.007) 0.00004 (-0.003,0.003) 0.0007 (-0.0003,0.002) 0.0009 (-0.001,0.003) -0.006 (-0.02,0.004)
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001  122 
6.3.7  Independent childhood and maternal predictors of childhood hip 
strength                                                                    
 
The first multivariate model that was created included all childhood and maternal 
determinates described in tables 40 and 42 (maternal and childhood height and 
weight, maternal pre pregnancy calcium and vitamin B12 intake, strenuous activity 
in late pregnancy and the child‟s grip strength, total milk intake and amount of very 
vigorous activity). The results are shown in table 43. The total number of participants 
in this model was 135. 
 
The relationship between maternal height and weight and the child‟s hip structure is 
much weaker, in that height only negatively predicts intertrochanteric and femoral 
shaft  cortical thickness (β=-0.001, p=0.01 β=-0.002, p=0.005) and positively 
predicts buckling strength ratio (β=0.03, p=0.04; β =0.02, p=0.002).  Pre pregnancy 
vitamin B12  intake was negatively associated with femoral shaft BMD, cortical 
thickness and positively associated with an increased buckling strength ratio. 
Strenuous activity in late pregnancy remained positively associated with 
intertrochanteric CSA (β=0.01, p=0.008), cortical thickness (β=0.001, p=0.01) and Z 
modulus (β=0.008, p=0.02).  
 
Childhood height was associated with narrow neck, intertrochanteric and femoral 
shaft Z modulus, in addition to narrow neck CSA, whereas childhood weight was 
independently associated with intertrochanteric and femoral shaft CSA and Z 
modulus only. The child‟s grip strength was positively associated with narrow neck, 
intertrochanteric and femoral shaft BMD, CSA and Z modulus in addition to 
increased cortical thickness at the narrow neck and intertrochanteric sites. Milk 
intake was only associated with a reduced bucking strength ratio at the narrow neck 
(β=-0.3, p=0.03).  
 
Increased time spent doing vigorous or very vigorous activity was positively 
associated with increased narrow neck, intertrochanteric and femoral shaft Z 
modulus (β=0.002, p=0.008; β=0.003, p=0.005; β=0.001, p=0.04) in addition to 
increased CSA at the narrow neck and intertrochanteric sites (β=0.004, p=0.009; 
β=0.005, p=0.008 respectively).   123 
When triceps skinfold thickness was additionally added to the model the only 
difference in maternal factors was that pre pregnancy calcium intake was associated 
with increased cortical thickness (β=0.03, p=0.04) and a reduced buckling strength 
ratio (β=-0.3, p=0.05) at the femoral shaft. Triceps skinfold thickness remained an 
important negative independent predictor of narrow neck and intertrochanteric CSA 
(β =-0.02, p=0.04; β –0.03, p=0.02 respectively) and Z modulus (β =-0.01, p=0.02; 
β=-0.02, p=0.006 respectively), intertrochanteric cortical thickness (β=-0.004, 
p=0.03) and femoral shaft BMD (β=-0.008, p=0.04) and cortical thickness (β=-0.004, 
p=0.04). The relationship with the child‟s height was only significant for narrow 
neck Z modulus, femoral shaft buckling ratio and  hip axis length, however weight 
was positively associated with narrow neck, intertrochanteric and femoral shaft CSA 
and Z modulus (all p<0.01).The relationship between grip strength was once again 
significantly weaker. However an association remained between narrow neck BMD 
(β=0.009, p=0.01), CSA (β =0.02, p=0.04) and buckling ratio (β=-0.1, p=0.05), 
intertrochanteric BMD (β=0.008, p=0.03) and CSA (β=0.03, p=0.01) and femoral 
shaft CSA (β=0.02, p=0.006) and Z modulus (β=0.01, p=0.001). The relationship 
between vigorous activity was also significantly weakened, only narrow neck and 
intertrochanteric CSA remained significant (β=0.003, p=0.05; β=0.004, p=0.05). 
However the Z modulus at these sites showed a trend towards significance (p=0.08, 
p=0.06 respectively). 
 
To increase the numbers in the model, if physical activity was excluded, 282 
participants were included. The negative relationship between triceps skinfold 
thickness became stronger in that it was now associated with all measures of hip 
structure and strength (except buckling ratio) at all three sites. The relationship 
between maternal determinants remained very similar, as did childhood height and 
weight however grip strength was only associated with femoral shaft CSA (β=0.01, 
p=0.04). Milk intake was associated with increased narrow neck BMD (β=0.01, 
p=0.05), cortical thickness (β=0.002, p=0.05) and reduced buckling strength ratio 
(β=-0.2, p=0.004) and CSA at the femoral shaft (β=0.02, p=0.03). 
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TABLE 43:  Mutually adjusted maternal and childhood determinants of childhood hip structure 
Narrow Neck
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
R
2 as a % 22 40 42 20 42 11
Woman's height (cm) -0.001 (-0.003,0.001) -0.002 (-0.008,0.004) 0.0003 (-0.004,0.005) -0.0002 (-0.0007,0.0003) -0.0009 (-0.004,0.002) 0.01 (-0.02,0.05)
log: Woman's weight (kg) 0.007 (-0.07,0.09) 0.06 (-0.2,0.3) 0.06 (-0.10,0.2) 0.002 (-0.02,0.02) 0.05 (-0.06,0.2) 0.2 (-1.0,1.5)
log: PP Total calcium (mg/day) -0.01 (-0.06,0.03) -0.06 (-0.2,0.06) -0.05 (-0.1,0.04) -0.002 (-0.01,0.007) -0.04 (-0.10,0.02) 0.1 (-0.6,0.8)
log PP :Total B12(mcg/day) -0.005 (-0.04,0.03) 0.001 (-0.08,0.08) 0.02 (-0.04,0.09) -0.001 (-0.008,0.006) 0.008 (-0.04,0.05) 0.1 (-0.3,0.6)
LP: Strenuous exercise (hr/week) 0.002 (-0.0002,0.004) 0.004 (-0.002,0.010) -0.0005 (-0.005,0.004) 0.0004 (-0.00005,0.0009) 0.001 (-0.002,0.004) -0.02 (-0.06,0.01)
         
Childs height (cm) 0.001 (-0.003,0.005) 0.02 (0.004,0.03)** 0.02 (0.010,0.03)*** 0.0001 (-0.0008,0.0010) 0.01 (0.005,0.02)*** 0.05 (-0.02,0.1)
log. Child's weight (kg) 0.1 (-0.03,0.3) 0.4 (-0.004,0.9) 0.2 (-0.1,0.5) 0.03 (-0.006,0.06) 0.2 (-0.06,0.4) -0.3 (-2.9,2.2)
Maximum grip strength  (kg) 0.01 (0.004,0.02)*** 0.03 (0.010,0.04)** 0.005 (-0.007,0.02) 0.002 (0.0009,0.003)** 0.01 (0.003,0.02)** -0.1 (-0.2,-0.02)*
Total milk intake (pints/day) 0.01 (-0.005,0.03) 0.006 (-0.04,0.05) -0.02 (-0.05,0.008) 0.002 (-0.001,0.006) -0.002 (-0.02,0.02) -0.3 (-0.5,-0.03)*
Very vigorous activity (mins/day) 0.0007 (-0.0003,0.002) 0.004 (0.0010,0.006)** 0.003 (0.0008,0.005)** 0.0001 (-0.00009,0.0003) 0.002 (0.0005,0.003)** 0.0009 (-0.01,0.02)
Intertrochanter
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
R
2 as a % 14 4 41 16 44 15
Woman's height (cm) -0.001 (-0.004,0.0010) -0.004 (-0.01,0.003) 0.0002 (-0.006,0.007) -0.001 (-0.003,-0.0004)** 0.0003 (-0.005,0.005) 0.03 (0.002,0.06)*
log: Woman's weight (kg) 0.03 (-0.06,0.1) 0.04 (-0.2,0.3) -0.08 (-0.3,0.2) 0.01 (-0.03,0.05) 0.03 (-0.2,0.2) -0.5 (-1.6,0.5)
log: PP Total calcium (mg/day) -0.003 (-0.05,0.05) -0.06 (-0.2,0.09) -0.08 (-0.2,0.05) 0.003 (-0.02,0.03) -0.05 (-0.1,0.05) -0.2 (-0.8,0.4)
log PP :Total B12(mcg/day) -0.005 (-0.04,0.03) 0.01 (-0.10,0.1) 0.04 (-0.05,0.1) -0.004 (-0.02,0.01) -0.0004 (-0.07,0.07) 0.2 (-0.2,0.6)
LP: Strenuous exercise (hr/week) 0.002 (-0.0001,0.005) 0.01 (0.003,0.02)** 0.004 (-0.003,0.01) 0.001 (0.0003,0.003)* 0.008 (0.003,0.01)** -0.02 (-0.05,0.01)
         
Childs height (cm) 0.0005 (-0.004,0.005) 0.01 (-0.001,0.03) 0.02 (0.006,0.03)** 0.0002 (-0.002,0.002) 0.01 (0.003,0.02)* 0.03 (-0.02,0.08)
log. Child's weight (kg) 0.05 (-0.1,0.2) 0.7 (0.1,1.3)* 0.8 (0.3,1.3)** 0.03 (-0.06,0.1) 0.5 (0.09,0.8)* 1.5 (-0.6,3.6)
Maximum grip strength  (kg) 0.01 (0.003,0.02)** 0.04 (0.02,0.06)*** 0.01 (-0.007,0.03) 0.004 (0.0008,0.007)* 0.02 (0.006,0.03)** -0.08 (-0.2,0.002)
Total milk intake (pints/day) 0.003 (-0.01,0.02) 0.03 (-0.03,0.08) 0.02 (-0.02,0.07) 0.001 (-0.007,0.009) 0.02 (-0.02,0.05) -0.03 (-0.2,0.2)
Very vigorous activity (mins/day) 0.0007 (-0.0004,0.002) 0.005 (0.001,0.008)** 0.004 (0.0007,0.007)* 0.0004 (-0.0001,0.0009) 0.003 (0.0010,0.006)** -0.002 (-0.01,0.01)
Femur shaft
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
R
2 as a % 18 45 52 14 56 20
Woman's height (cm) -0.003 (-0.006,-0.0008)* -0.002 (-0.007,0.003) 0.005 (0.002,0.008)** -0.002 (-0.004,-0.0006)** 0.002 (-0.0002,0.005) 0.02 (0.009,0.04)**
log: Woman's weight (kg) 0.03 (-0.07,0.1) 0.01 (-0.2,0.2) -0.04 (-0.2,0.09) 0.02 (-0.03,0.07) -0.03 (-0.1,0.06) -0.1 (-0.6,0.4)
log: PP Total calcium (mg/day) 0.04 (-0.01,0.09) 0.008 (-0.09,0.1) -0.07 (-0.1,0.0005) 0.03 (-0.002,0.06) -0.04 (-0.09,0.01) -0.3 (-0.5,0.02)
log PP :Total B12(mcg/day) -0.04 (-0.08,-0.006)* -0.05 (-0.1,0.02) 0.03 (-0.02,0.08) -0.03* (-0.05,-0.005) 0.006 (-0.03,0.04) 0.2 (0.02,0.4)*
LP: Strenuous exercise (hr/week) 0.0009 (-0.002,0.004) 0.002 (-0.003,0.007) 0.0002 (-0.003,0.004) 0.0004 (-0.001,0.002) 0.0004 (-0.002,0.003) -0.004 (-0.02,0.010)
         
Childs height (cm) -0.00008 (-0.005,0.005) 0.009 (-0.001,0.02) 0.010 (0.003,0.02)** -0.0008 (-0.004,0.002) 0.006 (0.001,0.01)* 0.02 (-0.003,0.05)
log. Child's weight (kg) 0.2 (-0.005,0.4) 0.7 (0.4,1.1)*** 0.4 (0.2,0.7)** 0.08 (-0.03,0.2) 0.4 (0.2,0.6)*** 0.03 (-1.0,1.1)
Maximum grip strength  (kg) 0.008 (0.0002,0.02)* 0.02 (0.009,0.04)** 0.009 (-0.0007,0.02) 0.003 (-0.001,0.007) 0.01 (0.006,0.02)*** -0.02 (-0.06,0.02)
Total milk intake (pints/day) 0.004 (-0.01,0.02) 0.02 (-0.01,0.06) 0.02 (-0.007,0.04) 0.0003 (-0.01,0.01) 0.01 (-0.003,0.03) 0.01 (-0.08,0.1)
Very vigorous activity (mins/day) 0.0001 (-0.001,0.001) 0.002 (-0.0008,0.004) 0.001 (-0.00009,0.003) -0.00005 (-0.0007,0.0006) 0.001 (0.00008,0.002)* 0.002 (-0.004,0.008)
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001  125 
6.4  Discussion 
The most robust associations observed with the child‟s hip structure and strength, 
when all determinants were adjusted for, were childhood weight and triceps skinfold 
thickness. However whilst weight was a strong positive predictor, explained by the 
increased loads and forces placed through the growing hip, in contrast triceps 
skinfold thickness was associated with reduced strength, BMD and cross sectional 
area. Children with higher skinfold thickness tend to do less vigorous activity but are 
taller and heavier. The results seen suggest that we are identifying this subgroup of 
children. 
 
When excluding triceps skinfold thickness the importance of increased vigorous 
activity and grip strength become apparent. The activity monitors used in this study 
measure vertical movement (which tends to correspond to weight bearing activity). It 
is not surprising that increased amount of vigorous activity are associated with 
increased forces through the hip axis and bone adaptation resulting in increased 
strength. Grip strength, which is a good surrogate for muscle function and lean mass, 
was associated with increased BMD, cross sectional area and strength. One 
explanation for this is that the increased muscle gives advantageous loads onto the 
hip axis, supporting its growth. 
 
Maternal factors did not seem as important in determining hip structure although 
maternal height and weight were strongly related to the child‟s height and weight. 
The small numbers of mothers that did strenuous activity in late pregnancy had 
children with increased hip structure and strength, however much of this relationship 
can be explained by the association with increased intensities of activity in their 
offspring. Whilst weak associations were seen with maternal calcium and vitamin 
B12 intake, much of the relationship was lost once adjusted for childhood milk 
intake suggesting that the child‟s diet is more important. Milk intake was associated 
with  increased BMD and cortical thickness at the femoral neck and a reduced 
buckling strength ratio, although these relationships were not particularly strong it 
emphasises the importance of a diet rich in calcium in order  to maximise osteogenic 
adaptation. 
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7  PATTERN OF GROWTH AND BONE MASS OF THE CHILD AT AGE 6 
YEARS 
 
7.1  Aims 
  To  determine  maternal  and  childhood  factors  which  influence  childhood 
growth relative to peers 
  To explore the relationships between growth in childhood and bone size and 
density at 6 years 
  To determine how intra uterine growth predicts bone mineral  accrual  and 
bone strength at aged 6 years 
 
7.2  Statistical analysis 
Changes in body size at various time points are likely to be correlated, for example 
growth in height from 12-24 months is likely to predict growth from 24 to 36 
months. 
 
Conditional regression modelling derives uncorrelated measures of change over the 
total time period, thus reducing the problem of collinearity between measures. The 
first component is the birth z score (height or weight), next the residuals of the 
regression of the z score at age12 months on z score at birth are obtained. This 
represents the amount by which either the height or weight exceeds that which would 
have been predicted from the z score at birth. This is called the conditional gain from 
0-12 months. Next the residuals of the regression of the z score at age 2 years on 
both the z score at birth and z score at age 12 months simultaneously are obtained. 
These residuals are uncorrelated with both the z score at birth and at age 12 months 
and are called the conditional gain from 12 months to 2 years. This method was 
additionally used to obtain conditional growth scores between the ages of 2-3 years, 
3-4 years and 4-6 years using the anthropometric data that had been previously 
collected at these ages. 
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7.3  Results 
7.3.1  Birthweight and 6 year bone mineral 
Birthweight was associated with whole body BA (β=0.03, p<0.0001) and BMC 
(β=0.03, p<0.0001) but not vBMD. Similar results were observed for lumbar spine 
and hip bone mass. In addition birthweight was associated with increased cortical 
content (β=0.006, p=0.02), periosteal circumference (β=0.002, p=0.003), endosteal 
circumference (β=0.001, p=0.03) and measures of bone strength (SSI: β=0.03, 
p=0.02; fracture load x: β= 0.07, 0=0.02; fracture load y; β= 0.08, p=0.006). It was 
also associated with increased CSA, periosteal width and section modulus at the 
narrow neck, intertrochanteric and femoral shaft regions of the femoral neck (all 
p<0.01). 
 
When birthweight was divided into quartiles, there was a step increase in 6 year 
height, weight and BMI from the lowest to highest quartile (table 44). Thus babies in 
the lowest quartile remained shorter, lighter and thinner compared to babies in the 
highest quartile. 
 
TABLE 44: Birthweight and 6 year height, weight and BMI 
   6 year height (cm)   6 year weight (kg)  6 year BMI (kg/m
2) 
   mean sd  median IQR  median IQR 
Mean Birthweight gp1  117.3 (5)  21.8 (19.8-24.3)  15.4 (14.5-16.8) 
Mean Birthweight gp2  118.6 (5.2)  22.4 (20.8-25)  15.5 (14.8-16.5) 
Mean Birthweight gp3  119.9 (4.7)  23.2 (21.5-25.8)  15.9 (15.3-16.8) 
Mean Birthweight gp4  120.4 (4.9)  23.8 (22.1-26)  16.1 (15.3-17) 
P value for trend  <0.0001  0.0001  0.002 
 
 
7.3.2  Predictors of childhood growth 
 The predictors of the greatest gain in height and weight from birth to age 12 months 
were greater maternal height, being first born and being formula fed (table 45). There 
was no association with maternal class, however mothers that had   higher 
educational attainment had infants with a reduced height gain compared to their 
peers (β=-0.07, p=0.05). 
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 TABLE 45: Predictors of conditional change in growth between birth and aged 
12 months 
 
 
For the other age ranges children who grew at a faster rate than their peers between 
1-2 years had been been breastfed for longer (weight: β=0.02, p=0.007 height: 
β=0.02, p=0.06).  Furthermore children who grew faster between the ages of 3-4 
years had mothers with a higher educational attainment (height: β=0.1, p=0.002) . 
Childhood milk intake at age 3 years also predicted increased height and weight 
velocity between the ages of 2-3 years (weight: β=0.2, p=0.001; height: β=0.1, 
p=0.002), however there was no further effect of either 4 or 6 year milk on 
subsequent growth velocity. Mothers that smoked during pregnancy had children 
with more rapid weight gain between the ages of 2-3 years (β=1.1, p<0.001), 
however smoking did not predict weight gain at any other age. 
 
7.3.3  Childhood growth and whole body, lumbar spine and hip bone mineral 
accrual 
Of the children that had DXA scans at aged 6 years 316 of them had previous 
measurements for height and weight at all time points (birth, 12 months, 2, 3, 4 and 6 
years). 
 
Table 46 shows the independent relationships between the relative gain in height 
through childhood. Greater growth in height relative to peers was associated with 
increased whole body BA, BMC and aBMD (p<0.001) but not vBMD (at all time 
points during the first 6 years of life)(shown in figure 14). A similar pattern was 
observed for lumbar spine and hip BA and BMC (p<0.01). Whilst growth was 
important at all stages, the largest increases in BA and BMC were seen if there was 
increased growth during 0-12 months (β=27.7, p<0.001; β= 29.8, p<0.001) and 1-2 
years (β=21.4, p<0.001; β=26.1, p<0.001).  
Weight 0-12 months (sd) Height 0-12 months (sd)
(CI) p value (CI) p value
log: Woman's weight (kg) -0.01 (-0.9,0.8) 0.978 -1.0 (-1.8,-0.1) 0.027
Woman's height (cm) 0.03 (0.02,0.05) <0.0001 0.05 (0.03,0.07) <0.0001
log  Woman's triceps skinfold (mm) 0.09 (-0.3,0.5) 0.671 0.5 (0.1,0.9) 0.013
Parity, two groups -0.2 (-0.4,-0.04) 0.016 -0.2 (-0.4,-0.04) 0.014
Currently smoke (EP) 0.2 (-0.03,0.5) 0.078 0.1 (-0.1,0.4) 0.321
Months completed breastfeeding -0.03(-0.04,-0.01) 0.001 -0.03 (-0.05,-0.02) <0.0001
R
2 as % 9 13
EP = Early pregnancy  129 
 
TABLE 46: Mutually adjusted relationships between conditional change in 
height from birth to 6 years and whole body, lumbar spine and hip bone mass 
Conditional change in height  Whole body 
 (z score) BA (cm
2) BMC (g) BMD (g/cm
2) vBMD  (g)
0-12m  27.7 (22.5,32.9)*** 29.8 (24.3,35.4)*** 0.01 (0.01,0.02)*** -2.4 (-5.2,0.4)
1-2yr  21.4 (16.1,26.7)*** 26.1 (20.4,31.7)*** 0.01 (0.01,0.02)*** 2.6 (-0.3,5.4)
2-3yr  15.1 (9.8,20.3)*** 19.0 (13.4,24.6)*** 0.01 (0.008,0.02)*** 0.6 (-2.3,3.4)
3-4yr  13.5 (8.2,18.8)*** 15.4 (9.8,21.1)*** 0.008 (0.004,0.01)*** 0.3 (-2.5,3.2)
4-6yr  13.1 (7.8,18.4)*** 16.2 (10.5,21.9)*** 0.009 (0.005,0.01)*** -0.2 (-3.1,2.7)
R
2 as a % 47 51 37 2
Lumbar spine
BA (cm
2) BMC (g) BMD (g/cm
2) vBMD  (g)
0-12m  1.0 (0.8,1.3)*** 0.9 (0.7,1.1)*** 0.01 (0.004,0.02)*** -0.1 (-0.3,0.08)
1-2yr  0.9 (0.7,1.2)*** 1.0 (0.7,1.2)*** 0.01 (0.008,0.02)*** 0.2 (0.02,0.4)*
2-3yr  0.4 (0.1,0.7)** 0.5 (0.3,0.8)*** 0.010 (0.004,0.02)** 0.02 (-0.2,0.2)
3-4yr  0.4 (0.1,0.7)** 0.4 (0.1,0.6)** 0.005 (-0.0010,0.01) -0.03 (-0.2,0.2)
4-6yr  0.7 (0.4,1.0)*** 0.5 (0.2,0.7)*** 0.004 (-0.002,0.010) -0.1 (-0.3,0.08)
R
2 as a % 32 35 14 2
Hip
BA (cm
2) BMC (g) BMD (g/cm
2) vBMD  (g)
0-12m  0.8 (0.6,1.0)*** 0.6*** (0.4,0.8) 0.003 (-0.004,0.010) -0.1 (-0.2,-0.02)*
1-2yr  0.8 (0.6,0.9)*** 0.7*** (0.5,0.9) 0.01 (0.005,0.02)*** 0.07 (-0.04,0.2)
2-3yr  0.5 (0.3,0.7)*** 0.4*** (0.2,0.6) 0.007 (0.0005,0.01)* 0.005 (-0.1,0.1)
3-4yr  0.3 (0.1,0.5)** 0.3*** (0.1,0.5) 0.008 (0.001,0.01)* 0.06 (-0.04,0.2)
4-6yr  0.4 (0.2,0.6)*** 0.3*** (0.1,0.5) 0.005 (-0.001,0.01) -0.005 (-0.1,0.1)
R
2 as a % 38 32 8 2
table shows and CI; *p<0.05, **p<0.01, ***p<0.001  
 
 
TABLE 47: Mutually adjusted relationships between conditional change in 
weight from birth to 6 years and whole body, lumbar spine and hip bone mass 
Conditional change in weight  Whole body 
 (z score) BA (cm
2) BMC (g) BMD (g/cm
2) vBMD  (g)
0-12m  24.9 (19.1,30.8)*** 30.4 (24.9,36.0)*** 0.02 (0.01,0.02)*** -3.5 (-6.6,-0.4)*
1-2yr  16.2 (9.7,22.6)*** 25.0 (18.9,31.2)*** 0.02 (0.01,0.02)*** 0.9 (-2.5,4.4)
2-3yr  9.9 (3.9,15.9)** 16.7 (11.0,22.4)*** 0.01 (0.008,0.02)*** 2 (-1.2,5.2)
3-4yr  13.5 (7.5,19.5)*** 20.0 (14.3,25.7)*** 0.01 (0.01,0.02)*** 4.0 (0.7,7.2)*
4-6yr  13.3 (7.3,19.3)*** 20.9 (15.2,26.6)*** 0.01 (0.01,0.02)*** 1.1 (-2.1,4.4)
R
2 as a % 35 54 55 5
Lumbar spine
BA (cm
2) BMC (g) BMD (g/cm
2) vBMD  (g)
0-12m  1.2 (0.9,1.5)*** 0.9 (0.7,1.2)*** 0.009 (0.003,0.02)** -0.2 (-0.4,0.01)
1-2yr  0.7 (0.4,1.0)*** 0.9 (0.6,1.2)*** 0.02 (0.009,0.02)*** 0.1 (-0.09,0.4)
2-3yr  0.3 (-0.05,0.6) 0.4 (0.2,0.7)** 0.009 (0.002,0.02)** 0.05 (-0.2,0.3)
3-4yr  0.6 (0.3,0.9)*** 0.9 (0.7,1.2)*** 0.02 (0.01,0.03)*** 0.4 (0.2,0.7)***
4-6yr  0.3 (0.02,0.7)* 0.3 (0.04,0.6)* 0.004 (-0.003,0.01) -0.2 (-0.4,0.06)
R
2 as a % 26 36 20 8
Hip
BA (cm
2) BMC (g) BMD (g/cm
2) vBMD  (g)
0-12m  0.7 (0.5,0.9)*** 0.5 (0.3,0.7)*** 0.003 (-0.004,0.010) -0.1 (-0.3,-0.03)*
1-2yr  0.6 (0.4,0.8)*** 0.5 (0.3,0.8)*** 0.008 (-0.0002,0.02) -0.02 (-0.2,0.1)
2-3yr  0.4 (0.2,0.6)*** 0.4 (0.2,0.6)*** 0.009 (0.002,0.02)* 0.04 (-0.08,0.2)
3-4yr  0.3 (0.09,0.5)** 0.5 (0.3,0.7)*** 0.02 (0.008,0.02)*** 0.2 (0.05,0.3)**
4-6yr  0.4 (0.2,0.6)*** 0.4 (0.2,0.6)*** 0.008 (0.0007,0.02)* -0.0002 (-0.1,0.1)
R
2 as a % 27 26 11 5
table shows and CI; *p<0.05, **p<0.01, ***p<0.001  130 
Figure 14:  Graphs to show the relationship between change in conditional 
growth and whole body BMC, BA. aBMD and vBMD 
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BMC: bone mineral content; BA: bone area; aBMD; areal bone mineral density; 
 vBMD estimated volumetric bone mineral density   131 
 
 
Table 47 shows the independent relationships between the relative gain in weight 
through childhood and the bone mass of the child aged 6 years. Greater increases in 
weight relative to peers at all childhood timepoints were independently associated 
with increased whole body BA, BMC and a BMD (all p<0.01). A similar pattern was 
observed for the lumbar spine and hip. Increased weight gain during the ages 3-4 
years appears to be associated with increased vBMD at whole body (β=4.0, p=0.02), 
lumbar spine (β=0.4, p<0.001) and hip (β=0.2, p=0.008). Weight gain during 0-12 
months and 1-2 years were once again associated with the highest increases in BA 
and BMC at age 6 years. 
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7.3.4  Childhood growth as a determinant of tibial bone structure and strength 
at age 6 years 
Of the children who underwent a pQCT scan at age 6 years, 79 had previous 
measurements of height and weight at all time points (birth, 12 months, 2, 3, 4 and 6 
years). 
 
Table 48 shows the independent relationships between the relative gain in childhood 
height and weight and the tibial bone structure and strength of the child aged 6 years. 
Greater growth in height relative to peers, was independently associated with 
increased trabecular and cortical content, cortical thickness as well as measures of 
bone strength (stress strain index and fracture load in the x and y axis) at all 
increments of increasing age (except the gain between 3-4 years). There was no 
significant pattern observed for measures of true volumetric trabecular or cortical 
bone density. The relationship between bone size and strength appear to be greater 
for the relative gains seen at earlier ages. The results are shown graphically in figure 
15. 
 
The relative increases in weight at ages 0-12 months, 1-2 and 4-6 years were 
independently associated with increased measures  of cortical content (p<0.001), 
cortical thickness (p<0.05), stress strain index (p<0.01) and fracture load in the X 
and Y axis (p<0.01). In addition, increased weight gain between ages 2-3 years were 
associated with increased cortical content and fracture load in the X axis (both 
p<0.001). No relationship was observed between weight gain and either trabecular or 
cortical volumetric density.  Once again the relationship between bone size and 
strength appear to be greater for the relative weight gains seen at earlier ages; 
however the difference was not as great as that observed for change in conditional 
height.   133 
 
Figure 15: Conditional growth in height and weight (per sd increase) and 
cortical content, density and thickness and the subsequent bending strength 
measured by pQCT at 6 years 
 
 
 
 
Graphs show mean and 95% confidence intervals 
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TABLE 48: Mutually independent relationship between conditional change in height and weight (per sd increase) from birth to aged 6 
years and tibial bone structure and strength at age 6 years (n=79) 
Conditional change in height  Trabecular content Trabecular density Trabecular content Trabecular density Cortical content Cortical density
 (z score) 4% per mm slice 4% mg/cm
3 14% per mm slice 14% mg/cm
3 38% per mm slice 38% mg/cm3
0-12m  5.0 (1.0,9.0)* -3.8 (-13.9,6.3) -0.07 (-0.9,0.8) -8.1 (-15.0,-1.1)* 5.5 (2.6,8.4)*** -1.4 (-8.6,5.9)
1-2yr  10.3 (6.3,14.2)*** 19.1 (9.2,29.1)*** 1.5 (0.6,2.4)** 5.9 (-1.3,13.0) 6.5 (3.4,9.6)*** 3.5 (-4.1,11.1)
2-3yr  6.1 (1.4,10.7)* 6.1 (-5.6,17.8) 1.3 (0.3,2.3)* 8.3 (0.04,16.5)* 6.9 (3.4,10.5)*** -1.9 (-10.7,6.8)
3-4yr  -1.8 (-6.9,3.3) -0.5 (-13.4,12.5) -0.3 (-1.4,0.9) 5.8 (-3.5,15.1) -3.4 (-7.1,0.3) -11.6 (-20.8,-2.5)*
4-6yr  5.9 (1.4,10.5)* 11.5 (0.1,23.0)* 0.6 (-0.5,1.6) -0.7 (-9.2,7.8) 3.5 (0.3,6.8)* 1.4 (-6.7,9.6)
R
2 as a % 42 21 22 14 48 9
Cortical thickness Periosteal circumference Endosteal circumference Stress Strain Index Fracture load x Fracture load y
38% (mm) 38% (mm) 38% (mm) 38% mm
3  38% N 38% N
0-12m  0.09 (0.02,0.2)* 0.8 (-0.02,1.6) 0.2 (-0.7,1.2) 42.8 (27.0,58.6)*** 85.2 (48.6,121.9)*** 91.3 (58.2,124.4)***
1-2yr  0.10 (0.02,0.2)* 0.9 (0.008,1.7)* 0.3 (-0.8,1.3) 36.4 (19.7,53.0)*** 71.3 (32.7,109.8)*** 73.0 (38.2,107.8)***
2-3yr  0.1 (0.02,0.2)* 1.3 (0.3,2.2)* 0.6 (-0.6,1.8) 33.3 (14.1,52.4)*** 83.0 (38.7,127.3)*** 69.6 (29.6,109.6)***
3-4yr  -0.08 (-0.2,0.004) 0.4 (-0.6,1.4) 0.9 (-0.3,2.2) -18.9 (-38.8,1.1) -39.1 (-85.4,7.2) -38.3 (-80.1,3.5)
4-6yr  0.08 (0.005,0.2)* 0.1 (-0.8,1.0) -0.4 (-1.5,0.7) 22.0 (4.3,39.6)* 45.1 (4.2,86.1)* 44.3 (7.2,81.3)*
R
2 as a % 30 22 6 54 49 54
table shows and CI; *p<0.05, **p<0.01, ***p<0.001
Conditional change in weight  Trabecular content Trabecular density Trabecular content Trabecular density Cortical content Cortical density
 (z score) 4% per mm slice 4% mg/cm
3 14% per mm slice 14% mg/cm
3 38% per mm slice 38% mg/cm3
0-12m  7.0 (2.1,12.0)** 3.4 (-8.2,15.0) -0.1 (-1.2,1.0) -8 (-16.4,0.4) 9.5 (6.8,12.2)*** 2.6 (-5.6,10.8)
1-2yr  2.7 (-2.7,8.1) -3.8 (-16.5,8.9) 0.7 (-0.5,2.0) -1.6 (-11.2,7.9) 6.1 (3.1,9.1)*** -3.8 (-13.0,5.3)
2-3yr  4.9 (-0.3,10.1) 10.2 (-2.1,22.4) 1.2 (-0.006,2.3) 8.3 (-0.7,17.3) 3.8 (0.9,6.6)** -0.4 (-8.9,8.2)
3-4yr  -1 (-6.3,4.3) -2 (-14.5,10.5) 0.8 (-0.3,2.0) 6.4 (-2.4,15.2) 1.9 (-1.0,4.8) -7 (-15.7,1.7)
4-6yr  6.2 (0.9,11.6)* 9.7 (-2.8,22.2) 1.3 (0.2,2.5)* 5 (-3.9,13.9) 6.0 (3.0,8.9)*** 5.4 (-3.5,14.3)
R
2 as a % 21 8 18 15 56 7
Cortical thickness Periosteal circumference Endosteal circumference Stress Strain Index Fracture load x Fracture load y
38% (mm) 38% (mm) 38% (mm) 38% mm
3  38% N 38% N
0-12m  0.1 (0.07,0.2)*** 1.2 (0.4,1.9)** 0.3 (-0.7,1.2) 56.6 (40.7,72.4)*** 128.4 (95.4,161.4)*** 110.7 (77.7,143.6)***
1-2yr  0.09 (0.010,0.2)* 1.2 (0.4,2.1)** 0.7 (-0.4,1.8) 29.5 (11.7,47.2)** 73.7 (36.9,110.5)*** 58.1 (21.4,94.9)**
2-3yr  0.06 (-0.010,0.1) 0.6 (-0.2,1.4) 0.2 (-0.8,1.2) 15 (-1.5,31.6) 37.9 (3.5,72.3)*** 32.1 (-2.3,66.5)
3-4yr  0.07 (-0.005,0.1) 0.1 (-0.7,0.9) -0.3 (-1.3,0.7) 5.4 (-11.5,22.3) 11.3 (-23.7,46.4) 13.9 (-21.1,48.9)
4-6yr  0.1 (0.05,0.2)** 0.2 (-0.6,1.0) -0.5 (-1.6,0.5) 25.1 (7.9,42.3)** 56.9 (21.2,92.6)** 53.2 (17.5,88.9)**
R
2 as a % 36 24 7 51 56 49
table shows and CI; *p<0.05, **p<0.01, ***p<0.001  135 
7.3.5  Childhood growth as a determinant of hip structure and strength at age 
6 years 
Of the children that had a successful hip structural analysis on their femoral neck 
DXA scan at aged 6 years, 250 had previous height and weight measurements at all 
time points (birth, 12 months, 2, 3, 4 and 6 years). 
 
Table 49 shows the independent relationships between the relative gain in height at 
all childhood timepoints.  Greater growth in height relative to peers was associated 
with hip structure; in particular cross sectional area, sub-periosteal width and Z 
modulus at all three sites measured in the hip (except narrow neck sub periosteal 
width and Z modulus at 3-4 years). Increased height gain between ages 1-2 years 
were associated with increased narrow neck and intertrochanteric BMD (p<0.01) and 
cortical thickness (p<0.05) in addition to increased femoral shaft BMD. A small 
increase in the buckling strength ratio was observed at the intertrochanteric and 
femoral shaft sites with increased gain between 0-12 months (β=0.2, p<0.001; β=0.1, 
p<0.001 respectively). 
 
 
 
Table 50 shows the independent relationships between relative gain in weight and the 
hip structure and strength of the child aged 6 years. At all childhood timepoints, 
greater weight gain relative to peers was associated with increased cross sectional 
area, sub periosteal width and Z modulus at all three sites measured in the hip. 
Weight gain between the ages of 3-4 years was associated with increased BMD and 
cortical thickness at all three sites. Early gain in weight (0-12months and 1-2 years) 
was associated with increased buckling strength ratios (p<0.01). 
 
The relationships between conditional height and weight gain and narrow neck 
aBMD, CSA, periosteal width and Z modulus are shown in figure 16.   136 
TABLE 49: Mutually independent relationships between conditional change in height (per sd increase) from birth to age 6 years and hip 
structure and strength at aged 6 years 
 
 
 
Conditional change   Narrow Neck
in height (z score) BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
0-12m  0.01 (0.002,0.02)* 0.07 (0.05,0.09)*** 0.07*** (0.05,0.08) 0.002 (0.0001,0.004)* 0.04 (0.03,0.05)***  0.1 (-0.002,0.3)
1-2yr  0.02 (0.009,0.03)***  0.08 (0.06,0.1)***  0.06*** (0.04,0.08) 0.003 (0.002,0.005)***  0.04 (0.03,0.05)***  0.05 (-0.08,0.2)
2-3yr  0.006 (-0.003,0.01) 0.05 (0.03,0.07)***  0.05*** (0.03,0.07) 0.0009 (-0.0009,0.003) 0.03 (0.02,0.04)***  0.1 (-0.02,0.3)
3-4yr  0.008 (-0.0006,0.02) 0.03 (0.003,0.05)* 0.01 (-0.006,0.03) 0.002 (-0.0001,0.004) 0.008 (-0.003,0.02) -0.03 (-0.2,0.1)
4-6yr  0.009 (-0.00009,0.02) 0.03 (0.009,0.06)** 0.02* (0.0010,0.04) 0.002 (-0.0001,0.004) 0.02 (0.004,0.03)** -0.04 (-0.2,0.1)
R
2 as a % 10 29 34 8 32 3
Intertrochanter  
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
0-12m  0.003 (-0.007,0.01) 0.08 (0.05,0.1)***  0.1*** (0.08,0.1) 0.001 (-0.004,0.005) 0.07 (0.05,0.10)***  0.2 (0.09,0.3)*** 
1-2yr  0.02 (0.006,0.02)** 0.1 (0.07,0.1)***  0.08*** (0.06,0.1) 0.005 (0.0008,0.009)* 0.07 (0.05,0.09)***  0.06 (-0.04,0.2)
2-3yr  0.007 (-0.002,0.02) 0.06 (0.03,0.09)***  0.06*** (0.03,0.08) 0.003 (-0.002,0.007) 0.04 (0.02,0.06)***  0.07 (-0.04,0.2)
3-4yr  0.006 (-0.003,0.02) 0.05 (0.02,0.08)** 0.04** (0.02,0.07) 0.003 (-0.002,0.007) 0.03 (0.003,0.05)* 0.05 (-0.06,0.2)
4-6yr  0.005 (-0.004,0.01) 0.05 (0.02,0.09)** 0.05*** (0.02,0.08) 0.002 (-0.002,0.007) 0.04 (0.01,0.06)** 0.07 (-0.04,0.2)
R
2 as a % 5 25 32 3 28 6
Femur shaft  
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
0-12m  0.003 (-0.008,0.01) 0.06 (0.04,0.08)***  0.06*** (0.04,0.07) -0.003 (-0.008,0.003) 0.04 (0.03,0.05)***  0.1 (0.06,0.2)*** 
1-2yr  0.01 (0.002,0.02)* 0.07 (0.05,0.10)***  0.06*** (0.04,0.07) 0.002 (-0.003,0.008) 0.04 (0.03,0.05)***  0.06 (0.009,0.1)*
2-3yr  0.009 (-0.001,0.02) 0.05 (0.02,0.07)***  0.03*** (0.02,0.05) 0.002 (-0.003,0.008) 0.03 (0.02,0.04)***  0.03 (-0.02,0.08)
3-4yr  0.003 (-0.007,0.01) 0.03 (0.005,0.05)* 0.02** (0.009,0.04) 0.0003 (-0.005,0.006) 0.02 (0.004,0.03)** 0.04 (-0.02,0.09)
4-6yr  0.002 (-0.009,0.01) 0.03 (0.006,0.05)* 0.03*** (0.01,0.04) -0.001 (-0.007,0.005) 0.02 (0.009,0.03)***  0.05 (-0.009,0.1)
R
2 as a % 3 25 36 1 33 9
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001  137 
TABLE 50: Mutually independent relationships between conditional change in weight from birth to age 6 years and hip structure and 
strength at age 6 years 
 
Conditional change   Narrow Neck
in weight (z score) BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
0-12m  0.01 (0.003,0.02)** 0.08 (0.06,0.1)***  0.08*** (0.06,0.10) 0.002 (0.0003,0.004)* 0.05 (0.03,0.06)***  0.2 (0.07,0.3)**
1-2yr  0.01 (0.0008,0.02)* 0.08 (0.05,0.1)***  0.08*** (0.06,0.10) 0.002 (-0.0002,0.004) 0.04 (0.03,0.06)***  0.2 (0.06,0.4)**
2-3yr  0.007 (-0.003,0.02) 0.04 (0.01,0.07)** 0.04*** (0.02,0.05) 0.001 (-0.0008,0.003) 0.02 (0.008,0.03)** 0.06 (-0.09,0.2)
3-4yr  0.02 (0.01,0.03)***  0.08 (0.06,0.1)***  0.05*** (0.03,0.07) 0.004 (0.002,0.006)***  0.04 (0.03,0.05)***  -0.06 (-0.2,0.08)
4-6yr  0.009 (-0.0008,0.02) 0.05 (0.02,0.07)***  0.04*** (0.02,0.05) 0.002 (-0.0003,0.004) 0.02 (0.01,0.04)***  0.04 (-0.1,0.2)
R
2 as a % 12 35 45 10 37 7
Intertrochanter
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
0-12m  0.004 (-0.006,0.01) 0.09 (0.05,0.1)***  0.1*** (0.08,0.1) -0.001 (-0.006,0.003) 0.08 (0.06,0.1)***  0.3 (0.1,0.4)*** 
1-2yr  0.01 (0.00009,0.02)* 0.1 (0.07,0.1)***  0.1*** (0.08,0.1) 0.003 (-0.002,0.008) 0.08 (0.05,0.1)***  0.2 (0.06,0.3)**
2-3yr  -0.002 (-0.01,0.009) 0.04 (0.003,0.08)* 0.07*** (0.04,0.10) 0.001 (-0.004,0.006) 0.04 (0.01,0.06)** 0.1 (0.02,0.3)*
3-4yr  0.02 (0.008,0.03)***  0.1 (0.06,0.1)***  0.07*** (0.04,0.10) 0.010 (0.005,0.01)***  0.06 (0.03,0.08)***  -0.1 (-0.2,0.02)
4-6yr  0.004 (-0.006,0.01) 0.07 (0.04,0.1)***  0.09*** (0.06,0.1) 0.003 (-0.002,0.008) 0.06 (0.03,0.08)***  0.1 (0.008,0.3)*
R
2 as a % 6 28 42 7 33 14
Femur shaft
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
0-12m  0.01 (-0.001,0.02) 0.09 (0.07,0.1)***  0.08*** (0.06,0.09) -0.0002 (-0.006,0.006) 0.06 (0.05,0.07)***  0.1 (0.05,0.2)*** 
1-2yr  0.006 (-0.007,0.02) 0.08 (0.05,0.1)***  0.07*** (0.06,0.09) -0.001 (-0.008,0.005) 0.05 (0.04,0.06)***  0.1 (0.06,0.2)*** 
2-3yr  0.009 (-0.004,0.02) 0.04 (0.02,0.06)** 0.03*** (0.01,0.04) 0.003 (-0.003,0.010) 0.02 (0.010,0.03)***  0.02 (-0.04,0.09)
3-4yr  0.02 (0.006,0.03)** 0.05 (0.03,0.08)***  0.02** (0.009,0.04) 0.007 (0.0006,0.01)* 0.03 (0.01,0.04)***  -0.03 (-0.09,0.04)
4-6yr  0.007 (-0.005,0.02) 0.05 (0.03,0.07)***  0.04*** (0.03,0.06) 0.001 (-0.005,0.008) 0.03 (0.02,0.04)***  0.06 (-0.002,0.1)
R
2 as a % 6 38 48 2 49 11
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001  138 
Figure 16: Graphs to show the relationship of conditional change in growth and 
Narrow neck BMD, CSA, periosteal width and section modulus
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7.3.6  Foetal growth and bone mass of the child at 6 years 
Previous doctoral work by Dr Pam Mahon utilised 3D ultrasound techniques to 
measure the femur length and abdominal circumference, in the foetus at 19 and 34 
weeks gestation. In this final part of this anlysis we explored the relationships 
between these foetal measurements and bone mineral accrual in the child at aged 6 
years. 
 
In order to perform these analyses Royston models were fitted to foetal 
measurements of femur length and abdominal circumference at 19 and 34 weeks 
gestation to create Z scores for size and conditional growth
168. Correlation and linear 
regression models were used to explore the relationship between the foetal 
ultrasound measurements and bone size and density at aged 6 years using whole 
body, lumbar spine and hip DXA, pQCT of the tibia and hip structural analysis. 
 
7.3.6.1   Foetal growth and whole body, lumbar spine and hip bone mass 
After mothers who were uncertain of their late menstrual cycle were excluded, there 
was 205 mother child pairs with complete 11, 19 and 34 week data available; 327 
mother child pairs had data available for 19 and 34 weeks. 
 
Absolute femoral length and abdominal circumference were associated with whole 
body BA, BMC and aBMD at 19 and 34 weeks (table 51). Associations were 
generally stronger at 34 than 19 weeks.  Figure 17 show scatterplots between 
conditional change in femoral length and abdominal circumference and whole body 
BA, BMC and vBMD. There were strong statistically significant correlations 
between conditional change in femur length between 19-34 weeks and indices of 
skeletal size, but not volumetric density (BA: r=0.31, p<0.001; BMC: r=0.32, 
p<0.001; vBMD r=0.01, p=0.82). 
 
 
   140 
 
TABLE 51: Relationships between absolute and conditional  foetal abdominal 
circumference and femoral length during pregnancy and whole body BA, BMC, 
aBMD and estimated vBMD 
 
A weak association was seen for change in abdominal circumference between 19-34 
weeks for skeletal size (BMC: r=0.15, p=0.01). However once additionally adjusted 
for change in femoral length using multivariate regression modelling, only femoral 
length remained a significant determinant (BA: β=18.8, p<0.001; BMC: β=20.1, 
p<0.001).  No association was seen for absolute abdominal circumference at 11 
weeks; however, a weak association was seen for change in abdominal 
circumference between 11-19 weeks for BMC (r=0.14, p=0.05) and between femoral 
length and lumbar spine BA and BMC (p<0.05) at 19 weeks.  
 
Abdominal circumference at 19 weeks was associated with lumbar spine BMC only 
(p=0.02). There were strong statistically significant correlations between conditional 
change in femur length between 19-34 weeks and indices of lumbar spine and hip 
skeletal size, but not volumetric density (Lumbar spine BA: r=0.25, p<0.001; BMC: 
r=0.27, p<0.001; vBMD r=0.03, p=0.58: Hip BA: r=0.22, p<0.001; BMC: r=0.26, 
p<0.001; vBMD r=0.08, p=0.16). A weaker association was seen between change in 
abdominal circumference between 19-34 weeks for lumbar spine and hip bone size 
(p<0.05) however once additionally adjusted for change in femoral length at 19-34 
weeks using multivariate regression modelling, only femoral length remained a 
significant determinant (Lumbar spine BA: β=0.7, p<0.001; BMC: β=0.6, p<0.001: 
Hip BA: β=0.4, p<0.001; BMC: β=0.5, p<0.001). A weak association was seen 
between changes in abdominal circumference between 11-19 weeks for lumbar spine 
BMC only (r=16, p=0.02). 
Whole body 
BA (cm
2) BMC (g) BMD (g/cm
2) vBMD  (g)
Abdominal circumferenence
(z score)
11 weeks 5.3 (-4.0,14.5) 6.3 (-4.1,16.6) 0.003 (-0.003,0.01) -0.003 (-4.1,4.1)
19 weeks 7.7 (0.4,15.0)* 10.1 (2.0,18.1)* 0.006 (0.001,0.01)* -0.5 (-3.6,2.7)
34 weeks 11.1 (3.9,18.4)** 15.8 (7.8,23.8)*** 0.01 (0.005,0.02)*** 1.2 (-2.0,4.5)
 11-19 weeks 8.5 (-2.5,19.5) 12.2 (-0.04,24.5)* 0.008 (0.0002,0.02)* 1.6 (-3.3,6.5)
 19-34 weeks 6.5 (-0.2,13.1) 9.7 (2.3,17.0)* 0.006 (0.002,0.01)** 1.5 (-1.4,4.3)
Femoral length (z score)
19 weeks 9.8 (2.5,17.1)** 10.7 (2.6,18.9)* 0.006 (0.0008,0.01)* -1.2 (-4.4,2.1)
34 weeks 21.6 (14.9,28.3)*** 23.6 (16.2,31.0)*** 0.01 (0.007,0.02)*** -0.5 (-3.6,2.5)
 19-34 weeks 19.1 (12.5,25.8)*** 21.8 (14.5,29.1)*** 0.01 (0.007,0.02)*** 0.3 (-2.7,3.3)
table shows and CI; *p<0.05, **p<0.01, ***p<0.001  141 
 
Figure 17: Scatterplots to show the relationship between change in femoral 
length and abdominal circumference between 19-34 weeks and whole body 
BMC, BA and estimated vBMD 
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7.3.6.2  Foetal growth and tibial bone structure and strength at age 6 years 
After mothers that were uncertain of their late menstrual cycle were excluded there 
was 54 mother child pairs with complete 11,19 and 34 week data available; 86 
mother child pairs had data available for 19 and 34 weeks. 
 
Absolute femoral length at 34 weeks was associated with increased cortical content, 
periosteal circumference, stress strain index and fracture load in the x and y axis as 
shown in table 52 (p<0.001). A weak association was seen for absolute abdominal 
circumference at 34 weeks and increased periosteal circumference, endosteal 
circumference, stress strain index and fracture load in the x and y axis (p<0.05). No 
overall pattern was observed for the relationships between either trabecular or 
cortical density. There were strong statistically significant correlations between 
conditional change in femur length between 19-34 weeks and indices of skeletal size 
(cortical content: r=0.37, p<0.001; cortical thickness: r=0.23, p=0.04; periosteal 
circumference: r=0.3, p=0.006; stress strain index: r=0.44, p<0.001; fracture load x: 
r=0.43, p<0.001; fracture load y: r=0.39, p<0.001). The scatterplots showing these 
relationships are displayed overleaf (figure 18).      143 
 
 
 
TABLE 52: Relationships between absolute and conditional foetal abdominal circumference and femoral length during pregnancy and 
measures of tibial structure and strength at age 6 years
Trabecular content Trabecular density Trabecular content Trabecular density Cortical content Cortical density
4% per mm slice 4% mg/cm
3 14% per mm slice 14% mg/cm
3 38% per mm slice 38% mg/cm3
Abdominal circumferenence
11 weeks 3.2 (-5.5,11.8) -1.5 (-19.6,16.6) 0.08 (-1.9,2.1) -5.6 (-20.1,9.0) 3 (-2.9,9.0) 0.8 (-9.3,10.9)
19 weeks 4.9 (-0.1,10.0) 1.8 (-9.5,13.1) 0.7 (-0.5,1.8) -1.1 (-9.9,7.8) 1.4 (-2.5,5.2) -7.7 (-15.1,-0.3)*
34 weeks 3.7 (-1.5,8.9) -2.1 (-13.8,9.5) 0.7 (-0.4,1.8) -0.5 (-9.1,8.1) 2.8 (-1.0,6.6) -9.6 (-17.2,-2.1)*
 11-19 weeks 12 (3.3,20.7)** 18.5 (-0.2,37.2)* 1.6 (-0.5,3.7) 5.5 (-10.1,21.2) 4.1 (-2.2,10.5) -1.6 (-12.5,9.2)
 19-34 weeks 0.3 (-4.5,5.1) -4.6 (-15.2,6.0) 0.4 (-0.6,1.4) 0.4 (-7.5,8.4) 2.1 (-1.4,5.6) -5.4 (-12.5,1.8)
Femoral length
19 weeks 3.9 (-1.2,9.0) -1.3 (-12.5,10.0) -0.4 (-1.5,0.8) -9 (-17.5,-0.6)* 1.2 (-2.5,5.0) -3.7 (-11.1,3.8)
34 weeks 5.5 (0.5,10.4)* 0.2 (-11.0,11.3) 0.2 (-0.9,1.3) -8.2 (-16.3,-0.08)* 5.9 (2.4,9.4)*** -2.8 (-10.3,4.8)
 19-34 weeks 4.2 (-0.8,9.1) 0.8 (-10.3,11.8) 0.6 (-0.5,1.6) -3.7 (-11.8,4.5) 6.3 (2.9,9.7)*** -0.6 (-8.2,6.9)
Cortical thickness Periosteal circumference Endosteal circumference Stress Strain Index Fracture load x Fracture load y
38% (mm) 38% (mm) 38% (mm) 38% mm
3  38% N 38% N
Abdominal circumferenence
11 weeks 0.06 (-0.06,0.2) 0.3 (-1.0,1.6) -0.1 (-1.5,1.3) 16.2 (-15.1,47.5) 26.4 (-46.0,98.8) 48.6 (-13.1,110.3)
19 weeks -0.04 (-0.1,0.04) 1.2 (0.4,2.1)** 1.5 (0.6,2.4)** 17.2 (-3.5,37.9) 42.3 (-3.5,88.2) 45.1 (3.9,86.3)*
34 weeks 0.02 (-0.06,0.10) 1.2 (0.3,2.0)** 1.1 (0.1,2.0)* 21.9 (1.0,42.9)* 48.4 (2.4,94.5)* 49.5 (7.6,91.4)*
 11-19 weeks 0.04 (-0.08,0.2) 1.1 (-0.3,2.5) 0.8 (-0.6,2.3) 24 (-9.5,57.4) 54.3 (-22.7,131.3) 47.1 (-19.7,113.9)
 19-34 weeks 0.03 (-0.04,0.1) 0.5 (-0.3,1.3) 0.3 (-0.6,1.2) 10.6 (-9.0,30.3) 23.6 (-19.7,66.9) 19.7 (-19.9,59.2)
Femoral length
19 weeks -0.03 (-0.1,0.04) 1 (0.1,1.8)* 1.2 (0.3,2.1)* 15 (-5.6,35.5) 41.2 (-4.0,86.5) 38.6 (-2.4,79.6)
34 weeks 0.05 (-0.03,0.1) 1.5 (0.7,2.3)*** 1.2 (0.3,2.1)* 44.1 (25.7,62.5)*** 98.7 (58.4,139.1)*** 83.4 (45.7,121.1)***
 19-34 weeks 0.08 (0.004,0.2)* 1.2 (0.3,2.0)** 0.7 (-0.3,1.6) 41.8 (23.4,60.2)*** 89.2 (48.3,130.1)*** 74.5 (36.4,112.5)***
table shows and CI; *p<0.05, **p<0.01, ***p<0.001  144 
 
There were no relationships between change in abdominal circumference between 
19-34 weeks and any measure of bone structure or strength. Once adjusted for 
change in abdominal circumference, change in femur length remained associated 
with cortical content (β=6.3, p=0.001), periosteal circumference (β=1.1, p=0.01), 
stress strain index (β=43.6, p<0.001) and fracture load in the x and y axis (β=92.9, 
p<0.001; β=77.2, p<0.001). 
 
Figure 18:  Scatterplots to show the relationship between conditional change in 
femur length between 19-34 weeks pregnancy and cortical content, cortical 
thickness, periosteal circumference and stress strain index at age 6years 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
r = 0.27
P = 0.01
45
50
55
60
65
P
e
r
i
o
s
t
e
a
l
 
c
i
r
c
u
m
f
e
r
e
n
c
e
 
(
m
m
)
-2 0 2 4
19-34 week scan: Conditional Royston FL z-score
Conditional change in femur length and  periosteal circumference
r = 0.38
P = 0.0004
200
400
600
800
S
t
r
e
s
s
-
s
t
r
a
i
n
 
i
n
d
e
x
 
(
m
m
3
)
-2 0 2 4
19-34 week scan: Conditional Royston FL z-score
Conditional change in femur length and stress-strain index
r = 0.38
P = 0.0004
80
100
120
140
160
180
 
 
C
o
r
t
i
c
a
l
 
c
o
n
t
e
n
t
 
p
e
r
 
1
m
m
 
s
l
i
c
e
 
(
m
g
/
m
m
)
 
-2 0 2 4
19-34 week scan: Conditional Royston FL z-score
Conditional change in femur length and cortical content
r = 0.26
P = 0.02
2
2.5
3
3.5
4
 
C
o
r
t
i
c
a
l
 
t
h
i
c
k
n
e
s
s
 
(
m
m
)
-2 0 2 4
19-34 week scan: Conditional Royston FL z-score
Conditional change in femur lengh and cortical thickness  145 
 
7.3.6.3  Foetal growth and hip structure and strength at age 6 years  
After mothers that were uncertain of their late menstrual cycle were excluded there 
was 188 mother child pairs with complete 11,19 and 34 week data available; 297 
mother child pairs had data available for 19 and 34 weeks. 
 
Absolute femoral length and abdominal circumference at 34 weeks were positively 
associated with aBMD, CSA, cortical thickness and Z modulus at the narrow neck, 
intertrochanteric and femoral shaft regions (table 53).  The relationships between hip 
axis length, narrow neck BMD, CSA  and Z modulus are shown in scatterplots in 
figure 19. There were strong statistically significant correlations between conditional 
change in femur length between 19-34 weeks and measures of both hip structure at 
strength at all three sites (narrow neck: BMD r=0.26, p<0.001; CSA: r=0.3, p<0.001; 
subperiosteal width: r=0.18, p=0.002; cortical thickness: r=0.25, p<0.001; Z modulus 
r=0.3, p<0.001; intertrochanteric BMD: r=0.21, p<0.001; CSA: r=0.29, p<0.001; 
sub-periosteal width: r=0.2, p<0.001; cortical thickness r=0.16, p=0.005; Z modulus 
r=0.28, p<0.001; femoral shaft BMD: r=0.15, p=0.01; CSA r=0.28, p<0.001; sub-
periosteal width r=0.27, p<0.001; Z modulus r=0.31, p<0.001). Weaker but still 
significant positive associations between conditional change in abdominal 
circumference between 19-34 weeks were seen for most measures of hip structure 
and strength (see table 54), however once additionally adjusted for change in femoral 
length using a multivariate model, only femoral length remained associated with 
narrow neck BMD (β=0.02, p<0.001) CSA (β=0.06, p<0.001) cortical thickness 
(β=0.004, p<0.001) Z modulus (β=0.03, p<0.001) intertrochanteric BMD (β=0.2, 
p=0.003) CSA (β=0.08, p<0.001), sub-periosteal width (β=0.06, p=0.007) cortical 
thickness (β=0.005, p=0.03) Z modulus (β=0.05, p<0.001) femoral shaft BMD 
(β=0.01, p=0.05) CSA (β=0.05, p<0.001) sub-periosteal width (β=0.03, p=0.004)   
and z modulus (β=0.03, p<0.001). 
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TABLE 53: Relationships between absolute and conditional foetal abdominal circumference and femoral length during pregnancy and 
measures of hip structure and strength at age 6 years  
Narrow Neck
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
Abdominal circumferenence
11 weeks 0.004 (-0.009,0.02) -0.0008 (-0.04,0.04) -0.01 (-0.04,0.01) 0.0008 (-0.002,0.003) -0.005 (-0.02,0.01) -0.09 (-0.3,0.09)
19 weeks 0.005 (-0.005,0.01) 0.02 (-0.005,0.05) 0.02 (-0.003,0.04) 0.0009 (-0.001,0.003) 0.01 (-0.002,0.03) 0.01 (-0.1,0.2)
34 weeks 0.01 (0.003,0.02)* 0.05 (0.02,0.08)*** 0.03 (0.010,0.05)** 0.003 (0.0004,0.005)* 0.02 (0.010,0.04)** -0.04 (-0.2,0.1)
 11-19 weeks 0.007 (-0.008,0.02) 0.04 (0.002,0.09)* 0.04 (0.01,0.08)** 0.001 (-0.002,0.004) 0.03 (0.006,0.05)* 0.1 (-0.1,0.3)
 19-34 weeks 0.01 (0.0009,0.02)* 0.04 (0.01,0.06)** 0.02 (0.002,0.04)* 0.002 (0.00008,0.004)* 0.02 (0.004,0.03)* -0.04 (-0.2,0.09)
Femoral length
19 weeks 0.004 (-0.006,0.01) 0.02 (-0.007,0.05) 0.02 (-0.0005,0.04) 0.0006 (-0.001,0.003) 0.01 (-0.005,0.02) 0.05 (-0.09,0.2)
34 weeks 0.02 (0.01,0.03)*** 0.07 (0.05,0.1)*** 0.04 (0.02,0.06)*** 0.004 (0.002,0.006)*** 0.04 (0.02,0.05)*** -0.1 (-0.3,0.02)
 19-34 weeks 0.02 (0.01,0.03)*** 0.07 (0.05,0.10)*** 0.03 (0.01,0.05)** 0.004 (0.002,0.006)*** 0.04 (0.02,0.05)*** -0.2 (-0.3,-0.02)*
Intertrochanter
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
Abdominal circumferenence
11 weeks 0.01 (-0.003,0.02) 0.02 (-0.03,0.07) -0.01 (-0.05,0.03) 0.002 (-0.003,0.008) -0.004 (-0.04,0.03) -0.03 (-0.2,0.1)
19 weeks 0.01 (0.003,0.02)* 0.05 (0.01,0.09)* 0.02 (-0.02,0.05) 0.004 (-0.0002,0.009) 0.03 (0.004,0.06)* -0.04 (-0.2,0.08)
34 weeks 0.02 (0.006,0.03)** 0.08 (0.04,0.1)*** 0.04 (0.01,0.08)** 0.007 (0.002,0.01)** 0.05 (0.03,0.08)*** -0.06 (-0.2,0.06)
 11-19 weeks 0.01 (-0.0004,0.03) 0.05 (-0.003,0.1) 0.02 (-0.03,0.07) 0.007 (0.0007,0.01)* 0.03 (-0.006,0.07) -0.1 (-0.3,0.06)
 19-34 weeks 0.009 (-0.0008,0.02) 0.05 (0.02,0.09)** 0.04 (0.007,0.06)* 0.004 (0.0003,0.009)* 0.04 (0.01,0.06)** -0.04 (-0.1,0.07)
Femoral length
19 weeks 0.01 (-0.0001,0.02)* 0.05 (0.01,0.09)* 0.03 (-0.004,0.06) 0.003 (-0.002,0.007) 0.03 (0.003,0.06)* 0.03 (-0.09,0.2)
34 weeks 0.02 (0.01,0.03)*** 0.1 (0.07,0.1)*** 0.06 (0.03,0.09)*** 0.006 (0.002,0.01)** 0.07 (0.04,0.09)*** -0.01 (-0.1,0.1)
 19-34 weeks 0.02 (0.008,0.03)*** 0.09 (0.06,0.1)*** 0.05 (0.02,0.08)*** 0.006 (0.002,0.01)** 0.06 (0.04,0.08)*** -0.04 (-0.2,0.08)
Femur shaft
BMD (g/cm
2) Cross sectional area (cm
2) Sub periosteal width (cm) Cortical thickness (cm) Section of modulus (cm
4) Buckling ratio
Abdominal circumferenence
11 weeks 0.009 (-0.005,0.02) 0.02 (-0.01,0.05) 0.005 (-0.02,0.03) 0.004 (-0.003,0.01) 0.005 (-0.01,0.02) -0.02 (-0.09,0.05)
19 weeks 0.005 (-0.006,0.02) 0.03 (-0.001,0.05) 0.02 (-0.002,0.04) 0.001 (-0.005,0.007) 0.01 (-0.0009,0.03) 0.02 (-0.04,0.08)
34 weeks 0.01 (0.003,0.03)* 0.05 (0.02,0.08)*** 0.03 (0.008,0.04)** 0.006 (0.00004,0.01)* 0.03 (0.01,0.04)*** 0.000004 (-0.06,0.06)
 11-19 weeks 0.009 (-0.007,0.03) 0.02 (-0.02,0.06) 0.005 (-0.02,0.03) 0.004 (-0.004,0.01) 0.01 (-0.01,0.03) -0.03 (-0.1,0.05)
 19-34 weeks 0.01 (0.0006,0.02)* 0.03 (0.010,0.06)** 0.02 (-0.00009,0.03)* 0.005 (-0.0003,0.01) 0.02 (0.005,0.03)** -0.008 (-0.06,0.05)
Femoral length
19 weeks 0.0004 (-0.01,0.01) 0.02 (-0.003,0.05) 0.03 (0.008,0.05)** -0.002 (-0.008,0.004) 0.02 (0.0008,0.03)* 0.06 (0.002,0.1)*
34 weeks 0.01 (0.0005,0.02)* 0.06 (0.04,0.09)*** 0.05 (0.03,0.07)*** 0.003 (-0.003,0.009) 0.04 (0.03,0.05)*** 0.06 (0.002,0.1)*
 19-34 weeks 0.01 (0.003,0.03)* 0.06 (0.04,0.09)*** 0.04 (0.02,0.06)*** 0.005 (-0.0007,0.01) 0.04 (0.02,0.05)*** 0.03 (-0.03,0.09)
table showsand 95% CI *p<0.05, **p<0.01, ***p<0.001  147 
Figure 19: Scatterplots to show the relationship of conditional growth of femur 
length and abdominal circumference between 19-34 weeks gestation and hip 
axis length, narrow neck BMD, cross sectional area, and section modulus 
r = 0.12
P = 0.03
60
70
80
90
 
H
i
p
 
a
x
i
s
 
l
e
n
g
t
h
 
(
m
m
)
-4 -2 0 2 4
19-34 week scan: Conditional Royston AC z-score
Conditional change in abdominal circumference and hip axis length
r = 0.16
P = 0.005
60
70
80
90
H
i
p
 
a
x
i
s
 
l
e
n
g
t
h
 
(
m
m
)
-2 0 2 4
19-34 week scan: Conditional Royston FL z-score
Conditional change in femur length and Hip axis length 
r = 0.23
P = <0.0001
.5
.6
.7
.8
.9
1
N
a
r
r
o
w
 
n
e
c
k
 
B
M
D
 
g
/
c
m
2
-2 0 2 4
19-34 week scan: Conditional Royston FL z-score
Conditional change in femur length and narrow neck BMD
r = 0.10
P = 0.08
.5
.6
.7
.8
.9
1
N
a
r
r
o
w
 
n
e
c
k
 
B
M
D
 
(
g
/
c
m
2
)
-4 -2 0 2 4
19-34 week scan: Conditional Royston AC z-score
Conditional change in abdominal circumference and narrow neck BMD
r = 0.29
P = <0.0001
1
1.5
2
2.5
N
a
r
r
o
w
 
n
e
c
k
 
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
 
a
r
e
a
 
(
c
m
2
)
-2 0 2 4
19-34 week scan: Conditional Royston FL z-score
Conditional change in femur length and narrow neck cross-sectional area,
r = 0.14
P = 0.01
1
1.5
2
2.5
N
a
r
r
o
w
 
n
e
c
k
 
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
 
a
r
e
a
 
(
c
m
2
)
-4 -2 0 2 4
19-34 week scan: Conditional Royston AC z-score
Conditional change in abdominal circumfernce and narrow neck cross-sectional area,
r = 0.29
P = <0.0001
.2
.4
.6
.8
1
N
a
r
r
o
w
 
n
e
c
k
 
s
e
c
t
i
o
n
 
o
f
 
m
o
d
u
l
u
s
 
(
c
m
4
)
-2 0 2 4
19-34 week scan: Conditional Royston FL z-score
Conditional change in femur length and narrow neck section modulus
r = 0.12
P = 0.03
.2
.4
.6
.8
1
N
a
r
r
o
w
 
n
e
c
k
 
s
e
c
t
i
o
n
 
o
f
 
m
o
d
u
l
u
s
 
(
c
m
4
)
-4 -2 0 2 4
19-34 week scan: Conditional Royston AC z-score
Conditional change in abdominal circumference and narrow neck section  modulus  148 
  
7.4  Discussion 
Despite relative catch up in small babies and catch down in large ones, the general 
pattern overall was that small babies became small 6 year olds whereas large babies 
became large 6 year olds. Greater catch up growth was associated with maternal 
height, however it is likely the height is a marker of an inherited drive towards 
tallness. Increased milk intake during early childhood may help the accrual of 
calcium in the skeleton and hence growth. Although catch down growth was 
observed in children born to mothers with a higher educational attainment and in 
those that were breastfed, catch up growth was observed later in infancy so that at 
aged 6 there was no difference between the height and weight of children that were 
breastfed/not breastfed. 
 
Increases in height and weight during childhood that exceeded that expected were 
associated with increased bone size (BA and BMC) rather than volumetric density. 
This was supported by the information gained from pQCT of the tibia and HSA of 
the femoral neck. The pQCT study showed that the increase in bone strength was as 
a result of increased trabecular and cortical content, increased periosteal 
circumference and cortical thickness. Similarly the increased strength observed at the 
femoral neck after the HSA analysis resulted from an increase in periosteal 
expansion and hence cross sectional area, rather than an increase in density although 
it should be noted that the created variables were for areal not volumetric density. 
 
Change in femur length during 19-34 weeks gestation was associated with increased 
whole body BA, BMC and aBMD but not volumetric density. This remained after 
adjustment for abdominal circumference. The increased strength observed in both the 
pQCT scan of the tibia and HSA scan of the femoral neck confirm that the increased 
strength observed with increased growth of the femur during this pre natal period 
was as a result of  increased cross sectional area, periosteal circumference and 
cortical thickness rather than an increase in trabecular or cortical density. This is 
consistent with previous data suggesting that late intrauterine growth may have 
persisting effects on postnatal skeletal development. 
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8  GRAND DISCUSSION  
 
8.1  Principal findings 
  Maternal height, pre pregnancy calcium intake and time spend in strenuous 
activity in late pregnancy were associated with 6 year bone mineral accrual in 
the offspring; however the association was removed by adjustment for 
childhood lifestyle determinants. 
  Increased growth of the femur during late pregnancy was associated with 
enhanced skeletal size at age 6 years 
  Breastfeeding was associated with reduced growth during the first year of life 
but enhanced growth during the second year, hence no difference was seen in 
bone mass at age 6 years. 
  Children born small remained smaller, lighter and thinner at age 6 years 
   Increased growth relative to peers was associated with increased maternal 
height   and increased milk drank during early childhood. Maternal smoking 
was associated with increased weight gain. 
  Catch up growth was important at all stages of early childhood growth and 
determined 6 year bone mass and strength. However maximal increases were 
seen when height velocity was greatest. 
  Children with increased total fat mass had evidence of increased skeletal size 
but reduced volumetric density. 
  Children with increased grip strength had evidence of increased skeletal size, 
volumetric density and increased bone strength at all sites measured.  
  Children with increased triceps skinfold thickness had evidence of increased 
whole body skeletal size, but reduced volumetric density.  
  Childhood milk intake was associated with increased skeletal size, 
independent of maternal calcium intake. 
  Increased time spent doing vigorous activity was associated with increased 
volumetric density at all sites measured. At the tibia an increase in cortical 
density was observed and at the femoral neck there was an increase in the 
bones bending strength.   150 
8.2  Maternal predictors of childhood bone mass 
8.2.1  Maternal height 
Consistent with previous studies, maternal height was associated with increased 
skeletal size in the offspring at age 6 years. Maternal and childhood height were 
positively correlated, reflecting the fact that taller mothers have taller children. 
However, there was also evidence in this study to suggest that this increase in height 
was associated with reduced volumetric density. Tall maternal height has previously 
been documented as an independent risk factor for hip fracture. Whether this reflects 
the skeletal envelope being pushed beyond its capacity to mineralise, or whether it is 
due to these children having a longer hip axis length is unclear. Our data also 
reported an increase in the buckling ratio (ratio to the outer radius to the cortical 
thickness) in children born to taller mothers; While a large buckling ratio may help to 
preserve strength with increased periosteal expansion on aging, a ratio of over 10 can 
result in a precipitous loss of strength as a result of cortical instability and buckling 
can occur on the compressive surface. 
 
8.2.2  Maternal adiposity 
Whilst maternal weight was associated with increased skeletal size much of this 
association was a result of co linearity with maternal height, rather than fat mass per 
se. Since any association was removed once adjusted for childhood BMI it is likely 
that this can be explained by the fact that mothers with an increased BMI have 
children with increased BMI at age 6. They also have children with increased triceps 
skinfold thickness and increased percentage fat mass with proportionally less lean 
mass and bone mineral. Whilst it is important to have a normal adipose fat stores 
during pregnancy in order to potentiate intrauterine skeletal growth, increased fatness 
may lead to higher fat mass at the expense of lean and bone mass in the offspring 
which may have implications for other aspects of health, especially taking into 
account the current epidemic of childhood obesity. 
 
8.2.3  Maternal diet 
Isolated epidemiological studies have reported that greater childhood skeletal size 
and mineral density might be associated with higher maternal intakes of calcium
169, 
magnesium, potassium and folate
170.Whilst we found higher consumptions of both   151 
milk and calcium prior to becoming pregnant were associated with increased skeletal 
size in the offspring, the effect was attenuated by the child‟s milk intake at age 6 
years, implying mothers that drink more milk have children who also drink more 
milk. We found no effect with either magnesium or folate intake at any time point 
during pregnancy.  Since many nutrients are collinear and single nutrients may 
potentiate or attenuate the effects of other dietary patterns, principal component 
analysis was used as an alternative way of assessing maternal diet. We have 
previously shown in an earlier mother cohort study that healthier patterns of eating 
during pregnancy are associated with increased bone mass of the offspring at age 9 
years
74. Whilst we did not find these strong associations in this cohort, a higher 
dietary score, consistent with healthy eating, was associated with increased lean 
mass, decreased fat mass and increased trabecular content and density at age 6 years. 
 
8.2.4  Maternal smoking 
It is well known that maternal smoking during pregnancy is associated with 
reductions in both birth weight and length and increased risk of intrauterine growth 
retardation
133. Whilst we were able to show that mothers who smoked during 
pregnancy had children with higher BMC adjusted for bone area, the relationship 
was attenuated once adjusted for height and weight. At birth the children in our study 
born to mothers that smoked in late pregnancy had reduced fat stores. However these 
children had increased catch up in terms of weight gain, but not corresponding height 
during early childhood resulting in 6 year olds with increased percentage fat and 
reduced percentage lean and bone mass. Maternal smoking and increased risk of 
obesity has been widely reported
171. Whether this rebound adiposity is a result of 
being small for gestational age or whether it is due directly to the effects of cigarette 
smoking is unclear but is probably a combination of the two since the results were 
the same once adjusted for birthweight. 
 
 Possible explanations for the physiological effects of cigarette smoking during 
pregnancy  are nicotine, which is transported across the placenta, and carbon 
monoxide which may influence placental vascular function and cause foetal hypoxia. 
Nicotine acts centrally and peripherally to reduce appetite and body weight; 
withdrawal can result in hyperphagia and weight gain
172. Children of smokers also 
tend to be less physically active and have poorer diets
173. Investigations of other   152 
mediators for example insulin like growth hormone, growth hormone and leptin have 
not been studied.  
 
8.2.5  Maternal physical activity 
Strenuous activity and increased walking speed in late pregnancy have previously 
been associated with reduced neonatal bone mass
130;174. We found that at age 6 years 
the reverse was true. Maternal constraint during late intrauterine life was thought to 
be the reason for the reduced birthweight and bone mass. Mothers that exercise, 
particularly during late pregnancy, had children that participated in higher amounts 
of vigorous activity on a daily basis. Hence once the results were adjusted for this, 
the relationship was attenuated. It may be reassuring that any detrimental effects of 
late pregnancy strenuous activity are no longer seen at age 6 years. 
 
8.2.6  Maternal parity, social class and education 
Whilst increasing maternal parity was associated with increased birthweight and 
neonatal bone mass in line with previous studies
174, decreased growth relative to 
peers during the first two years of life resulted in no effect on any measure on bone 
mass or body composition at aged 6 years. Mothers with a higher level of education 
had children with reduced growth during the first year of life.  However these 
children subsequently caught up by the age of four. Mothers with higher educational 
attainment were more likely to breastfeed; increased duration of breastfeeding 
determined early childhood growth. Mothers of higher educational attainment were 
also more likely to feed their children healthy diets,
175 since they themselves may eat 
healthier diets. This results in reduced fat mass and increased lean mass at age 6. 
Whilst there was no effect on bone mass at age 6 years it is important that young 
mothers are given the appropriate information in order to choose healthy choices for 
themselves and family in order to reduce the increased burden of obesity.   153 
 
8.3  Childhood predictors of bone mass 
8.3.1  Infant and childhood diet 
By the age of 6 years we were unable to detect any influence in pattern of infant 
feeding and the child‟s bone mass. Children who were exclusively bottle-fed 
appeared to have accelerated weight gain during early infancy. This is well 
recognized and compared to formula feed infants, breast-fed term infants grow 
slower during the first few months of life and then have an accelerated growth, such 
that by the age of 6 years there was no overall measurable difference in height. 
However the duration of breastfeeding was associated with reduced fat mass in the 
child at age 6 in line with previous studies
176. Energy intakes have previously been 
shown to be higher in formula fed infants
177 compared to breast fed babies, it has 
also been suggested that breastfed babies are better at self regulating their total 
energy intake by reducing their milk intake when solids are introduced. These early 
feeding patterns may explain why children who were formula fed are at more risk of 
obesity in later life. 
 
The association between 6 year total daily milk intake and increased skeletal bone 
mass supports previous studies suggesting that calcium and milk intake are important 
for skeletal growth. However unlike previous studies we were unable to find an 
association with height. Greater bone mineral gains were seen at cortical skeletal 
sites, in particular the femoral shaft compared to the narrow neck and 
intertrochanteric regions of the femoral neck
62. This increase in cortical thickness 
reduces the buckling ratio, an indicator of cortical instability and risk of buckling on 
the compressive surface. Milk intake during childhood has previously shown 
persisting beneficial effects during adulthood
68. Low intakes are associated with an 
increased risk of both childhood
111 and adult fracture
68. Whilst we were only able to 
study milk intake as a surrogate for calcium, recent evidence suggests that it is milk 
rather than other dairy products or food rich in calcium that results in increased 
skeletal size
178. Milk contains calories, protein, and calcium, among other nutrients, 
and bioactive components such as insulin-like growth factor-I (IGF-I), all of which 
may facilitate bone growth.  
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Individual nutrient data was not available.  However dietary patterns were assessed 
using principal component analysis at ages 6, 12 and 3 years. Children with a high 
score (high consumption of fruit, vegetables, wholemeal bread, rice and pasta) had an 
increased skeletal size once adjusted for the weight of the child. Whilst dietary 
patterns and bone mass have not previously been studied in children, previous 
literature may support our findings. In particular recent work has studied dietary 
scores of the mother during pregnancy and bone mass of her offspring
74and other 
studies have shown that increased fruit and vegetable intakes are associated with 
increased bone mass
71;72. Whilst micronutrient interventions, such as calcium might 
be effective in improving skeletal health to some degree, the alteration of both 
maternal and child choice and behaviour to a healthier eating pattern, might yield 
greater health dividends. 
 
8.3.2  Physical activity 
The beneficial effects of exercise on bone mass have been well documented. Bone 
adapts to increased loading in order to maintain structural and functional support to 
the skeleton without injury or fracture. There are two ways in which the skeleton can 
adapt. The first is by increasingly the size of the skeleton through periosteal 
expansion and the second is to increase the amount of mass within the periosteal 
envelope by increasing the density of the bone mineral. 
 
 We found that in our cross sectional study of habitual exercise, children that 
participated in high amounts of daily vigorous activity had increased whole body, 
lumbar spine and hip volumetric density (using method of Prentice), but no increase 
in bone area. In contrast children that spent more time in sedentary activity had lower 
volumetric density. Tibial bone mass was only associated with increased cortical 
density, while there was no evidence of periosteal expansion, the numbers in this part 
of the study were very small and it is difficult to draw negative conclusions. When 
measuring the femoral neck, increased cross sectional area, sub-periosteal width and 
bending strength were only present once adjusted for the child‟s height. Together 
these results suggest that habitual vigorous activity increases bone mass by 
increasing density. At sites where loading is higher (for example the femoral neck), 
increases in skeletal size are relative to the overall size of the child. Children that 
participated in increased amount of activity also had higher percentage lean mass and   155 
a corresponding decrease in fat mass. Whilst children that participated in increased 
activity at aged 4 years also participated in more activity at aged 6, there was no 
effect of 4 year exercise on 6 year bone mass. This may be due to higher levels of 
habitual exercise in 4 year olds compared to 6 year old children who are now in 
school.  
 
8.3.3  Obesity 
Children with increased fat mass had a larger overall skeletal size. However the data 
from both DXA and pQCT suggests that these bones are under mineralised. For a 
given weight, children with increased adiposity had a relatively smaller and weaker 
skeleton. Whilst children that are overweight have an increased total lean mass, one 
of the strongest determinants of bone mass throughout life, this is not enough to 
compensate for the increased adiposity. The mechanostat model proposed by Harold 
Frost in the 1960s suggests that the growing skeleton is sensitive to mechanical strain 
and responds by increasing periosteal apposition. This results in wider bones and 
increased trabecular bone mass
179.With a reduction in total body BA relative to body 
size and BMC relative to lean mass in obese children, obesity appears to impair the 
normal response of the growing skeleton to mechanical loading, effectively resulting 
in an intrinsic bone abnormality This may  explain the increased risk of fracture 
reported in the literature, although we did not have the power to show this in our 
study.  
 
Several potential mechanisms have been proposed to explain the complex 
relationship between fat and bone mass. Studies of adipocyte function have revealed 
that adipose tissue is not just an inert organ for energy storage. It expresses and 
secretes a variety of biologically active molecules, such as oestrogen, resistin, leptin, 
adiponectin, and interleukin-6 (IL-6). These molecules affect human energy 
homeostasis and may be involved in bone metabolism, which may contribute to the 
complex relationship between fat mass and bone. The secretion of bone-active 
hormones from the pancreas (including insulin, amylin, and preptin) may also 
explain part of the relationship between fat mass and bone mass. Finally, adipocytes 
and osteoblasts originate from a common progenitor, the pluripotential mesenchymal 
stem cell
180. These stem cells display an equal propensity for differentiation into 
adipocytes or osteoblasts, and the balance of the differentiation is regulated by   156 
several interacting pathways that may contribute to the final effect of fat mass on 
bone
181. Further work is needed to elucidate these complex mechanisms. 
 
8.3.4  Lean mass and muscle strength 
Studies investigating the relationship between growth in early life and muscle mass 
have demonstrated consistent findings linking low birthweight with reduced muscle 
mass
182. An association between low birthweight and reduced muscle strength was 
first reported in the Hertfordshire aging study
183. The association was replicated in a 
younger Hertfordshire cohort
184 and in a national birth cohort of middle aged men 
and women born in 1946 and participating in the national survey of health and 
development
185. More recent work has demonstrated a similar effect size of 
birthweight on adult muscle strength in young women aged 20-34 years, taking part 
in the Southampton Women‟s Survey, suggesting an association between early size 
and peak muscle strength rather than decline
186. Grip strength is a simple measure of 
muscle function, but is a powerful predictor of disability and morbidity
187. It is 
highly correlated with muscle mass
188 and reflects a complex mixture of contractions 
between hand and forearm muscles. 
  
In this study, we were able to confirm that increased birthweight was associated with 
increased grip strength at age 6 years and that grip strength was independently 
related to both increase in size and density of the skeleton at age 6 years. The only 
other study to examine the relationship between grip strength and bone mineral 
density in children was one performed in Hong Kong by Chan et al on 10-12 year old 
girls and boys. In this study prediction models by grip strength and weight explained 
about 60% and 40% of the variations in BMC of different sites and in BMD of hip 
and spine respectively
189. Our own data extends this work; the pQCT analysis might 
suggest that there was a differential effect with increased density at trabecular rather 
than cortical sites. However overall bone strength was increased at all sites among 
children with higher grip strength.  
 
 
8.3.5  Childhood growth 
Growth appears to follow a predetermined path, probably set out by genetic factors, 
which may be temporally or permanently modified by environmental influence. The   157 
tracking of skeletal development begins in the pre natal period.  Hence factors that 
influence growth during this period have lasting effects on skeletal growth. Only 
maternal and paternal height predicted the conditional gain in femur length during 
19-34 weeks in contrast other maternal influences such as smoking status, fat stores 
and walking speed affected the conditional gain in abdominal circumference during 
the same period. This suggests that intrauterine growth may differentially influence 
postnatal skeletal size in keeping with other studies
134. 
 
 Whilst there is a tendency for an individual to stay in the same position relative to 
peers over the growth period in the distribution of bone mineral, factors such as 
physical activity
78;80 and milk intake
68;69have been shown to permanently alter bone 
mineral accrual postnatally and lead to higher bone mass in later life. Since the 
genetic component to peak bone mass around 60% of the variance is explained by 
inheritance
190, it is not surprising that other environmental factors are important in 
determining skeletal growth. This supports the phenomenon termed “programming” 
in which persisting changes in structure and function result from environmental 
influences at critical stages of early development. 
 
Unlike some of the previous literature, we found that children born light (lowest 
quartile of birthweight) remained light at age 6 years and did not appear to under go 
catch up growth relative to their peers. However, most of the literature relates to 
children that were born small for gestational age. This definition terms SGA as 
neonates whose weight at birth is below 2 standard deviations from the mean for the 
infants gestational age
191. Among our group, of the 99 children in the lowest quartile 
for birthweight, only 15 of them fall into the category of SGA. Since maternal height 
was a strong predictor of catch up growth, and the observation that the children in the 
lowest quartile had smaller mothers, the findings in our study may just reflect the 
genetic influences of body size. Whilst we found no effect of catch up weight, in the 
children born smaller we did see relative catch up growth in terms of height during 
the first year. In contrast the children born in the highest quartile had relative catch 
down growth in terms of both height and weight; however they remained larger than 
their peers at aged 6 years.  
  
Increases in height and weight during childhood that exceeded the expected rate were 
associated with increased bone size rather than volumetric density. There were   158 
corresponding increases in bone strength. The data from this study suggests that the 
increased bone mass and strength was through periosteal expansion, increased 
cortical thickness and increased trabecular and cortical content.  
Whilst increased peak bone mass is an important predictor of the risk of osteoporotic 
fracture in later life, both tall maternal height and poor growth has previously been 
associated with the risk of hip fracture
118. Taller adults have an increased risk of 
fracture
192 possibly because they have a longer femoral neck length, or a greater 
tendency to fall, despite overall greater skeletal mass. Thus children with tall mothers 
who grow quickly may end up with relatively undermineralised bones and thus an 
increased risk of fracture. This may suggest that the cause of catch up growth is 
important, as if it is genetically driven by a taller mother, in the absence of adequate 
nutrition, poorer skeletal mineralization may result. In contrast, if the catch up is 
driven by nutrition, then healthier bones may result. 
 
 
 
8.4  Limitations  
This study utilised a prospective cohort, with comprehensive assessment of mothers 
before and during pregnancy and follow up of the children from birth. However, 
there are a number of limitations during the stages of this study. 
 
8.4.1  Interpretation of multiple analyses and exposures 
This thesis has used multiple testing due to the multiple outcomes and exposures. As 
a result there is a higher risk of incorrectly rejecting the null hypothesis and getting 
high false positive rates. There are several methods that have been developed to deal 
with the problem of multiple testing. A commonly used method is the Bonferroni 
correction, which multiplies the p value by the number of tests performed. However 
this method can be too conservative and results in an inflation of false negatives. For 
this reason the data in this thesis has not been corrected statistically for multiple 
testing. Instead,our strategy on interpreting multiple analyses was to give weight for 
a priori hypotheses and  overall patterns of association for bone size, density or 
strength. 
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8.4.2  Parental data 
 Self report of maternal lifestyle factors such as alcohol intake, smoking and exercise 
may have been influenced by women tending to under report behaviour known to be 
associated with poorer health outcomes and over report beneficial habits. 
 Food frequency questionnaires (FFQ) were used to assess diet over the preceding 3 
month period. Whilst there could have been significant recall bias, nutrient intakes 
assessed by FFQ have previously been validated against prospective 4 day diaries 
early in the second trimester.
193 
 
Intrauterine ultrasound measurements are a standard part of the care pregnant women 
receive. The measurements we used in this study (abdominal circumference and 
femur length) were standard measurements, in order to reduce error we used two 
experienced operators whose repeatability was good. The coefficient of variation for 
triplicate measurements of femur length was 0.6% at 19 weeks and 0.9% at 34 
weeks. 
 
 
8.4.3  Anthropometry 
The anthropometic measurements taken of the mother and of her offspring at birth, 
aged 6 months, 12 months, 2, 3, 4 and 6 years were performed by trained research 
nurses. These nurses underwent regular training in anthropometric measurements in 
order to optimise accuracy and precision and minimise measurement bias. Accuracy 
is the degree of closeness of the measurement to its actual value whilst precision is 
the degree of reproducibility. To maximise accuracy, staff were trained to measure 
from specific landmarks and record the results appropriately. Maximising the sample 
size in this study improved precision. Precision was improved further by repeating all 
measurements three times and averages were used in the analyses. 
 
8.4.4  6 year follow up 
The study cohort was a subset of the Southampton women‟s survey. Whilst attempts 
were made to contact all parents that had initially taken part in the study and whose 
child was now 6 years, mothers whose children underwent DXA scanning were on 
average more educated, of higher social class, were less likely to smoke and were   160 
taller and heavier. However our results are based on internal comparisons, so will not 
have been biased by these differences.  
 
8.4.4.1  Dietary data 
Although diet was assessed using a FFQ that assessed 100 foods or food groups 
which will ultimately allow us to look at nutrient derivations and dietary patterns, the 
only information available at the time of writing was the consumption of various 
food items. Although there
 is concern that FFQs can be prone to measurement 
error
194,
 they have been shown to identify similar patterns of diet as
 other dietary 
methods, and dietary pattern scores determined
 using different dietary methods are 
highly correlated
195.  
 
Milk intake was used as a surrogate of calcium intake. However other dairy products 
or foods containing calcium were not included. Whilst it would have been useful to 
look at total calcium intake and bone mass, milk intake per se is important due to the 
additional nutrients, and bioactive components such as insulin-like growth factor-I 
(IGF-I), all of which may facilitate bone growth.  
 
 
8.4.4.2  Actiheart 
The actiheart monitor has previously been validated, showing high linearity with 
acceleration and agreement within 5 beats per minute of ECG monitoring during rest 
and treadmill exercise
196. 
 
Only the accelerometery data was available for analysis, (Since the devices also 
measure heart rate it should be possible to calculate daily total expenditure). 
Mathematical algorithims are currently being developed at the MRC Epidemiology 
Unit in Cambridge to optimally clean the data in order to account for times when the 
data was lost. Actiheart measurements were not performed on all children and at the 
time of writing only a small proportion of children with PQCT data had clean data 
available for use. This was due in part to the high frequency of skin rashes with the 
electrodes used. If the child was unable to wear the device for less than 4 days the 
data was excluded. 
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8.4.4.3  DXA measurements 
DXA is highly reproducible, easy to perform and uses minimum radiation.  
Although this technique has been well validated in adults, it is beset by technical 
limitations when used in children. These can be broadly classified as difficulties in 
scan acquisition due to the limitations in the bone edge detection software in children 
with low bone mass
197, inadequacy of paediatric reference data across maturational 
stages, ethnic groups and gender in healthy children and difficulties in the 
interpretation of DXA in children with impaired growth.  
 
The reduced amounts of bone mineral lead to increased proportional error
198; in 
particular any artefact such as movement or foreign objects result in 
disproportionately large discrepancies. Whilst movement was not a major problem at 
aged 6 years, with the majority of children being able to lie still, all study movement 
was graded and any child with excessive movement or those with visible foreign 
objects on the scan were excluded. Edge detection of bones is more difficult in 
smaller children due to the lower absolute BMD. However specific paediatric 
software was used with increased sensitivity for edge detection. The DXA measures 
of bone mass have been shown to correlate well with whole body calcium content in 
ashing studies of piglets and DXA lean and fat mass validated against the chemical 
lean and fat contents
199.  Another known problem is variability between the 
proportions of intraosseous marrow fat and that in lean tissue; in osteopenic 
individuals, accuracy errors in estimation in BMC could be as much as much as 
20%
200. DXA calculates aBMD from 2D images. However whilst this is suitable for 
use in adult populations, in children as the child grows so does the volume of bone. 
Whilst adjustments can be made for body size in order to calculate estimated 
volumetric density, all incorrectly assume the bone to be cylindrical in shape. pQCT 
which uses 3D images is therefore more appropriate for assessing true volumetric 
density and was thus incorporated into our study methodology. 
  
Finally DXA imaging could be improved with further refinement of the algorithms 
used for its body composition modeling. It is not able to differentiate muscle from 
other lean tissues, such as liver, spleen and other organ tissue, nor can it distinguish 
adipose tissue from bone marrow fat or fat within solid viscera. Regional fat mass 
analysis with DXA does not give a reliable assessment of visceral fat, particularly  in   162 
smaller children. However, despite these limitations DXA is widely available and has 
the largest body of research and clinical data associated with it. 
 
8.4.4.4  Peripheral quantitative tomography 
Few studies have investigated factors influencing bone geometric measurements in 
young children. However it has been validated in children as young as 3 years
94. In 
our study whilst movement occurred frequently; good positioning , tibial restraint 
and distraction of the child using television significantly all reduced movement. 
Scans where the cortex was interrupted were excluded, but this was only a small 
proportion of the total scans done (4.6% at 38% site). Whilst it would have been 
beneficial to have also had radial scans, movement artefact was so high at this site 
the procedure was abandoned from the protocol to concentrate on the tibia. 
 
In children of this age the growth plate is still visible. Therefore the reference line 
should be positioned to bisect the medial border of the distal dense metaphysis.  
Our reference line was positioned to bisect the medial border of the articular surface 
of the tibia. Hence for a number of scans, the 4% site went through the growth plate, 
giving artificially high density. For this reason trabecular content and density was 
presented from both the 4% and 14% site. Accurate and consistent positioning 
accurate and positioning of this reference line is essential in any longitudinal or 
multi-centre studies for comparable results
201. 
 
At the tibia the most common sites scanned include 4%, 38%, 50% and between 60% 
and 68% regions
202. We used 4%, 14%, 38% and 66%, which were the machine‟s 
preset values. Both the 4% and 14% were used to measure the trabecular bone whilst 
the 38% site used to measure cortical bone and 66% the muscle bone unit. This 
variety and inconsistency of sites scanned, particularly in children, make comparison 
of results between studies problematic. However since our results were based on 
internal comparisons this was not a major problem. 
 
As with other bone densitometry techniques pQCT require skilled and dedicated 
technical staff to perform the scans with optimal precision. The technical staff and 
nurses using this machine had regular training from experts in the field. 
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8.4.4.5  Hip structural analysis  
Though the HSA program is commonly used in adults and more recently in children, 
however there are limitations to its use
203.  
 
In particular, bending strength indices are measured only in the plane of the scan 
image; bending strength differences in other directions may exist; however, they 
cannot be determined by this method
204.  Cortical thickness measurements were 
made after making assumptions regarding the shape and symmetry of the bone in 
cross section. It is not always clear what assumptions are made and hence the results 
should be treated with caution. 
 
In addition, the HSA algorithm assumes average mineralization of 1.05 g/cm
3 which 
is appropriate for adults
205, but lower mineralization densities would be expected in 
children and, therefore, a systematic underestimation of (absolute) CSA and Z 
modulus is assumed. We found edge detection in the smaller less mineralised hips to 
be a major problem. The HSA software was unable to analyse these images and 
despite discussion with the program designer 52 images were excluded.  Although 
the children that were excluded were smaller than the rest of the cohort, their lifestyle 
characteristics were similar and hence it is unlikely that the results would have been 
biased by these differences. 
 
Inconsistent positioning in sequential scans can change projected dimensions so that 
it can be difficult to distinguish dimensional changes from positional area. The scans 
were therefore obtained by  trained technicians in paediatric densitometry and the 
scans  analysed using  dedicated technical staff.  
 
 It should be noted that whilst HSA has previously been validated in adults against 
quantitative CT of the hip
206 there are no such validation studies in children of this 
age. 
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8.5  Further work 
There are two main aspects to future work. Firstly a greater understanding of the 
mechanisms behind the results obtained is required. Secondly, there needs to be 
translation of the observations seen into clinical practice. In particular interventional 
trials, which improve the lifestyle of both mothers and children, might be envisaged. 
To this end we are currently planning a study to improve the self-efficacy and 
perceived control of women attending Sure Start Children‟s Centres in Southampton 
by training the Children‟s Centre staff in holding „healthy conversations‟ with their 
clients. In the first pilot we aim to assess dietary quality, physical activity levels and 
emotional well-being of the women in the women in both control and the 
interventional arms. In the longer term we plan to extend this trial out to other 
primary health care trusts and follow up women who become pregnant. 
 
Furthermore, as the dataset is enhanced using data obtained during this fellowship, 
there are many potential areas of investigation. 
 
  The detailed dietary data at aged 6 years might be further explored to 
determine the relationships between both nutrient intake and dietary patterns. 
This could be further explored using the previous dietary data to see whether 
there is an optimum age for dietary effects and to look at the effect on 
longitudinal growth. 
  More detailed analysis of our physical activity data, looking at the 
relationships with maternal physical activity and the total energy expenditure 
in both mother and child might be planned. This could be explored further by 
comparing the results against the dietary data, in particular looking at how the 
diet matches up with the energy expenditure and the effect on body 
composition and also any individual nutrient interactions. 
  Hip structural analysis is currently being performed on the 4 year hip scans. 
Longitudinal analysis has never been carried out in children this young. 
Hence it would be very interesting to see the predictors of relative hip 
geometry in various subgroups, particularly the very active and the 
overweight children.   165 
  Further scans using pQCT are being obtained. The relationship between 
physical activity needs to be explored further and additional analysis to see 
how the results match with the results seen for hip structural analysis 
performed. 
  Detailed body composition data is available for this cohort using the DXA 
images.  Whilst we showed a relationship between total fat mass, the role of 
regional fat and lean mass needs to be further explored. 
  Further work to look at the difference between children that do and don‟t 
fracture is needed. We did not have enough power in this current study to 
detect this but further data collection is underway. 
 
Finally, as the children get older we plan to reassess them using DXA at aged 8 
and 10 years. This will give further opportunities to look at longitudinal growth. 
It will also give us information about the importance of puberty and how this 
relates to both current and previous body composition. This work will be linked 
to a follow up of the mothers and fathers, in which DXA and pQCT measurement 
will be obtained. This will help us understand the role of the genetic influences 
which determine bone mass.   166 
 
8.6  Conclusions 
 
In summary, our study showed that the childhood physical activity, milk intake and 
diet and body composition were all important predictors of bone mass at aged 6 
years. Maternal height and smoking were associated with variation in the childhood 
growth trajectory relative to their peers from birth to aged 6 years. Maternal lifestyle  
and educational attainment in turn predicted  childhood lifestyle determinants in 
particular diet and activity. These observations suggest that a lifestyle approach 
starting from preconception is appropriate to increase bone mass in the offspring and 
reduce the burden of osteoporotic fracture in later life.  
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Developmental influences on childhood respiratory health 
SWS cohort study at age 6 years 
 
Protocol 
 
A. Research questions and hypotheses 
The study has four main research questions.  
1.  What are the links between asthma and obesity in childhood? Is the link: 
  Common antenatal environmental exposures? 
  Common postnatal environmental exposures? 
  Common genetics? 
2.  Do maternal genotype and phenotype impact on the child’s phenotype independent of 
infant genotype. 
3.  Does pre- and post-natal nutrition affect the development of asthma and other 
wheezing illnesses in the child? 
4.  Is there a link between asthma and obesity in childhood and impaired bone growth 
 
The research questions will be addressed by investigating the following hypotheses: 
1.  The association between asthma and obesity is the result of particular prenatal environmental 
influences (maternal high fat mass, low energy intake and smoking during pregnancy) that 
increase the risk of both disorders. 
2.  The association between asthma and obesity is the result of particular postnatal 
environmental influences (high infant weight gain and low childhood physical activity) that increase 
the risk of both disorders. 
3.  The association between asthma and obesity is the result of polymorphisms in particular 
candidate genes that increase the risk of both disorders.  
4.  Maternal genotype and phenotype determine obesity and asthma in the child independent of 
the child‟s genotype.   
5.  Impaired maternal nutrition during pregnancy (specifically low maternal fat and/or muscle 
mass and low intakes of vitamins A and/or C) is associated with impaired lung function (defined by 
spirometry) at 6 years of age  
6.  High maternal fat mass, high vitamin D status and low maternal vitamin E intake in pregnancy 
are associated with atopy (positive skin prick test) at 6 years of age 
7.  Maternal nutrition and faltering of fetal growth in late gestation relate to each of the childhood 
wheeze syndromes (transient viral induced wheeze, atopic asthma and non-atopic asthma). 
8.  The association of asthma and obesity with the increased risk of childhood fractures is the 
result of postnatal environmental influences such as low childhood activity which impairs the 
growth of bone.  
 
   
 
 
B. Background 
The prevalence of asthma and obesity increased in parallel during the 1980s and 90s, and 
mounting evidence suggests a link between obesity and the development of 
asthma(Wannamethee, Shaper, and Whincup;Weiss and Shore). It has been proposed that 
environmental or genetic factors common to both disorders are responsible(Schaub and von 
Mutius). The proposed study will investigate whether particular aspects of the pre-natal 
environment (maternal high fat mass, low energy intake and smoking during pregnancy) and/or 
postnatal environment (high infant weight gain and low physical activity) are associated with 
asthma and obesity at 6 years of age. It will also investigate the genetic influences that determine 
asthma and obesity. It has been suggested that polymorphisms of the beta-2-adrenergic receptor 
(ADRB2), ADAM33, IL6, leptin, TNFA and PPARG genes may contribute to both asthma and 
obesity, but there is currently little evidence to support or refute a role for these candidate genetic 
influences. 
The proposed study will use prospectively collected, longitudinal growth and respiratory data in 
950 6 - 7-year olds enrolled in the Southampton Women‟s Survey(Inskip et al.). The children‟s 
mothers were extensively characterised before and during pregnancy; body composition (detailed 
anthropometry), dietary intakes (food frequency questionnaires and food diaries), physical activity, 
atopic disorders and smoking were recorded. Longitudinal fetal growth measurements were 
collected by ultrasound at 11, 19 and 34 weeks. Children have been monitored for growth and 
features of respiratory morbidity and atopy at 6 months and 1, 2 and 3 years. Additionally, 131 of 
the cohort had lung function measured in early infancy, showing impaired lung development in 
infants that had had lower rates of fetal growth and higher weight gain in the first weeks after 
birth(Lucas et al.). The assessment at 6 years will allow us to collect a detailed dataset that 
combines information on asthma, body composition and physical activity in childhood.  To add to 
information that is being collected on lung function and respiratory symptoms, we will measure 
adiposity and regional body composition (anthropometry, densitometry and DXA scanning), to 
collect objective physical activity data using a combined accelerometer and heart rate monitor, 
and to characterize the genetic variation of particular candidate genes linked with asthma and/or 
obesity. For 6 candidate genes, haplotype tagging sets of Single Nucleotide Polymorphisms 
(SNPs) will be selected based on information available from the Seattle SNPs variation discovery 
resource (http://pga.mbt.washington.edu/) (ADRB2, IL6, PPARG, TNFA and leptin) and from our 
own data (TNFA and ADAM33). These SNPs together with putative functional SNPs (e.g. PPARG 
Pro12Ala and IL-6 -174) will be typed in child and parental DNA by a combination of methods.  
Collection of these data will allow us to relate pre-natal (maternal high fat mass, low energy intake 
and smoking during pregnancy) and postnatal (high infant weight gain and low physical activity) 
exposures and genotypes to respiratory outcomes and adiposity at age 6 years, and to examine 
whether maternal genotype and phenotype impact on the child‟s phenotype independent of infant  
 
   
genotype. We hope that understanding the links between these disorders will enable us to develop 
strategies to reduce the chance of individuals developing asthma. 
C. Study design and methodology 
 
The Southampton Women's Survey 
 
The Southampton Women's Survey (SWS) was started in 1998. It is a study of a population 
sample of non-pregnant women aged 20 to 34 years resident in the city of Southampton, UK. 
They are representative of the British population in terms of ethnicity and deprivation. From this 
group, 1477 of those who have become pregnant and delivered infants would be eligible for the 
assessment of the children at age 6 years proposed in this study. We conservatively estimate that 
65% will participate, giving 950 children.   
 
Existing data from the SWS cohort 
 
Maternal nutritional data  
 
Uniquely, maternal body composition and diet have been assessed before and during pregnancy. 
Body composition is assessed by 4-site skinfold thicknesses and other anthropometric measures, 
allowing estimation of fat and muscle mass. Diet is assessed using a 100-item administered food 
frequency questionnaire to record the average frequency of consumption over a 3-month period 
preceding the interview.  Although such questionnaires can be subject to bias, validation using 4-
day food diaries and measurement of maternal micronutrient concentrations has indicated that our 
questionnaire gives an assessment of diet that can be used to rank the nutrient intakes of 
individuals.  Dietary supplement use is assessed in detail over the same period, allowing us to 
derive maternal intakes of vitamins A, C, D and E during pregnancy. Vitamin intakes in a previous 
cohort of Southampton pregnancies showed marked variability. Maternal 25-OH vitamin D 
concentrations in early and late pregnancy are being measured and are combined with information 
on ultraviolet B exposure calculated from the hours of sunshine from a local Meteorological Office 
weather station with an adjustment for seasonal energy variation in ultraviolet B radiation 
(http://www.soda-is.com/index.html); in our previous study, the correlation coefficient between this 
measure of ultraviolet B exposure and maternal 25-OH vitamin D concentration in late pregnancy 
was 0.60, P<0.0001 (unpublished data).  
 
Fetal growth data 
 
Longitudinal fetal growth measurements have been collected by ultrasound at 11, 19 and 34 
weeks, together with detailed neonatal anthropometry. Using the method of Royston, we will 
generate Z-scores of crown-rump length, head and abdominal circumferences adjusted for 
duration of gestation in early, mid and late pregnancy and at birth, and calculate the velocities of 
growth unconditional and conditional upon the initial measurement of size. We will use longitudinal 
ultrasound measurements of fetal anthropometry at 11 and 19 weeks gestation to define the 
velocity of the initial trajectory of growth, and the change in abdominal measurements between 34 
weeks and delivery to describe growth faltering in late pregnancy.  
 
   
 
Other information available about this cohort from birth to 4 years of age 
 
At 6, 12, 24 and 36 month visits, the principal carer has been questioned about the child's 
illnesses since the previous visit. These questions focused on respiratory, allergic and 
gastrointestinal symptoms and illness. Specifically, the questionnaire asked about episodes of 
wheezing or whistling in the chest.  We also have prospectively collected data about other 
important exposures, including environmental cigarette smoke, pets and childcare. Skin prick 
testing has been undertaken at 1 and 3 years of age at a time when subjects had not taken any 
anti-histamine for at least 72 hours. Testing to cat, dog, grass pollens, house dust mite, milk and 
egg allergens (ALK, Horsholm, Denmark) was undertaken with a single headed lancet. Weal 
diameters were measured and a positive result defined as one that is at least 3mm in diameter in 
the presence of valid controls. The controls are valid if the negative (saline) control was zero and 
positive control (histamine) is at least 3mm. Additionally, we have DNA stored for each subject. 
Premorbid infant lung function data, domestic dust samples and urinary cotinine measurements 
are available from a subset of 150 participants. At aged 4 years 650 children underwent body 
composition measurement by DXA. A number of these children have also had their physical 
activity measured using an actiheart monitor.  
 
Respiratory and growth data to be collected at age 6 years 
 
Recruitment 
 
All families are already recruits of SWS. Families currently enrolled with the SWS, whose child is 
between 6 and 7 years during the period of recruitment will be identified from the SWS database. 
Some families will have moved house and not informed the SWS of their change of contact 
details. We will therefore have a press release aimed at local media to inform them of the aims of 
the 6 year old assessment, and to encourage families to contact the team if they need to update 
contact information. 
Families who are enrolled with SWS will be contacted by post to inform them of the 6 year follow-
up. A member of the research team will then contact the family by telephone or email to ask if they 
would like to participate in this part of the study. This follows the format of previous SWS contacts 
and appointment making. No undue pressure will be placed on families to participate.  
Children will be recruited between the ages of six and seven years. They will have a home visit 
from a SWS nurse and will be invited for further investigations to the Wellcome Trust Clinical 
Research Facility (WTCRF), Southampton, with paediatric facilities for more detailed respiratory 
and body composition investigations.  
A number of parents and children will be invited back for an additional study at the osteoporosis 
centre. These children will be given the relevant information at the initial clinic visit and contacted 
by telephone at a later date to arrange this further visit. 
  
 
   
Inclusion criteria 
 
All children enrolled on the SWS who will be between 6 and 7 years old during the study period. 
Exclusion criteria 
All carers will be invited to complete the questionnaire.  
Exclusions for specific investigations are as follows: 
  Methacholine challenge: Baseline FEV1< 75% predicted; unstable asthma; current respiratory 
infection. 
  Skin testing: antihistamine use within 72 hours. 
Consent 
Consent will be taken by a nurse or doctor who has a detailed understanding of the study protocol. 
Prior to consent, the child and parent will have received age-appropriate information sheets 
(appendix) at least a week before the appointment. The person taking consent will ensure that the 
parent and child understand the aims and procedures. The parent and child will have as much 
time as is necessary to ask questions. If both the child and parent are in agreement that the 
research should proceed we will ask the parent to sign a consent form (appendix).  
Where will the studies take place? 
Home  WTCRF 
Questionnaire  DXA 
Height, Weight, skin folds  Methacholine breathing test OR 
reversibility studies using salbutamol 
Simple spirometry  Exhaled nitric oxide 
Buccal brushing (genetics)  Blood pressure and heart rate 
Actiheart  Allergy tests if food allergic 
Allergy tests (at WTCRF if food allergic)  Grip Strength 
  Peripheral quantitative CT scan 
(pQCT) at separate visit 
 
 
Questionnaire 
 
  The questionnaire will be administered by a member of the research team to the child‟s carer 
at home. 
  If carers live outside the Southampton area, the questionnaire will be administered over the 
telephone. 
  The questionnaire is attached in the appendix. It is primarily designed to assess the child‟s 
respiratory and atopic status. It also includes questions to assess current diet and activity. 
Body composition 
 
  Measurements of height, weight and skinfold thicknesses, will be made by a trained nurse or 
doctor.  
 
   
  DXA scan. This will be performed by technicians trained and experienced in its use. 
Approximately 500 of the children have had previous DXA measurements in the SWS. 
  Measurement of grip strength using a dynamometer . The child will be asked to grip this meter 
very tightly in each hand separately  three times in order to register the best score 
  PQCT scan. This will be performed as an extra optional procedure in up to 250 children This 
visit takes about 30 minutes and involves a short scan of the forearm and lower leg. The 
procedure is completely painless but does involve the child sitting very still for 5 minutes whilst 
each scan is being done. 
 
Activity 
 
  Physical activity over a 5-7 day period using an Actiheart combined accelerometer and heart 
rate monitor; we have successfully used these in over 50 SWS children at age 4 years.  
  The Actiheart will be applied by small stickers to the child‟s torso during the home visit and 
instructions describing reapplication will be given. The child will be asked to wear the monitor for 
up to a week, during which time they should pursue their normal activities. They will be provided 
with a pre-paid package to return the Actiheart to the research team for analysis, or it can be 
returned when they attend the WTCRF for a visit. 
  The Actiheart will be accompanied by a questionnaire about activity and exercise for the 
parent/carer to complete and return in the pre-paid package with the Actiheart monitor 
Atopy 
 
  Skin prick testing to house dust mite, cat, dog, mixed grass pollen, mixed tree pollen, egg and 
milk. Subjects with a test result ≥3mm with a negative saline control will be defined as atopic. Up 
to 3 additional allergens will be tested if clinically indicated. 
 
Lung Function 
 
  Lung function, including flow volume loops will be measured using Koko incentive software.  
  Within the WTCRF, children will be invited to have a more detailed assessment of their lung 
function by either (a) methacholine challenge or (b) reversibility with salbutamol. All children with a 
history of wheeze and approx 100 children without wheeze will be invited to have a methacholine 
challenge. Those who decline, and all other patients will be invited to have reversibility studied 
using salbutamol. 
  Children prescribed 6 puffs of salbutamol to be administered via metered-dose-inhaler (MDI) 
and spacer (100mcg per puff) to access reversibility of airway obstruction. Lung function 
measurement will be repeated 20 minutes after the salbutamol dose. 
  Methacholine challenge will be used to document bronchial hyperresponsiveness as an 
objective marker for asthma. In this test, the patient inhales an aerosol of one or more 
concentrations of methacholine. Results of lung function tests (e.g. FEV1) performed before and  
 
   
after the inhalations are used to quantify the response.  A positive test is defined as a decrease 
from the baseline forced expiratory volume in the first second (FEV1) or of the post-diluent FEV1 
value of at least 20%. 
 
Exhaled nitric oxide  
 
  Exhaled NO, as a non-invasive marker of airway inflammation will be measured using  the 
single expiratory breath method with a chemiluminescence analyser (Niox desktop system, 
Aerocrine, Solna, Sweden) set at a rate of 50 ml/s.  Measurements are repeated until two 
consecutive results within 10% were obtained; this generally requires 2–4 attempts. All 
measurements will be undertaken before spirometric testing. Exhaled NO values will be discarded 
if the ambient level was above100 ppb. 
 
Clinical Samples  
 
  DNA buccal swabs will be taken from children and parents who consent. 
  Samples will be collected by trained nurses and doctors. 
  Samples will be labelled with the child's unique SWS identification number for subsequent 
linking with information in the SWS database. The results will not be linked to individual names. 
  The samples will be stored in the SWS freezers in the MRC Epidemiology Resource Centre, 
SGH. They will be stored until all analyses are completed. Prof Cyrus Cooper, Director of the 
Centre, and subsequent Directors will have custodial responsibility. 
  Stored cord blood and parental DNA (LREC 340/97; 307/97; 018/99) as well as newly 
collected DNA specimens will be analysed for asthma and obesity genotyping. Stored linked-
anony
1mised samples will be analysed for all eligible children, whether or not they are recruited for 
this 6 year assessment. This will allow linking of the genotype data to respiratory and growth 
outcomes in early life as well as at 6 years. 
 
Analysis  
 
Primary outcome measures will be current wheeze at age 6-years, estimated fat mass and 
distribution, bone mass and strength, atopy and FEV1, together with FEF50-75 (more sensitive to 
small airway disease, although less reproducible). Controlling for potential confounders, binary 
outcomes (wheeze, atopy) will be analysed by logistic regression, and continuous outcomes 
(FEV1, FEF50-75) by linear regression after transformation to normalize them as necessary.  As 
secondary outcomes, we will investigate clinical wheeze phenotypes defined as (1) transient viral 
induced wheeze: presence of wheeze only with viral upper respiratory tract infections within the 
first 5 years of life; (2) atopic asthma: wheeze between viral upper respiratory tract infections or 
with exercise that responds to a bronchodilator in an atopic child; (3) non-atopic asthma: as for 
atopic asthma but in a child who is not atopic.    
                                                 
  
 
   
 
Hypothesis 1 
Primary prenatal exposure variables will be maternal pre-pregnancy fat mass, energy intake in 
pregnancy and smoking. To investigate the secondary exposures of low early trajectories of fetal growth 
and faltering of growth in late gestation, we will generate Z-scores of fetal size adjusted for duration of 
gestation in early, mid and late pregnancy and at birth, and calculate velocities of growth unconditional 
and conditional upon the earlier measurement of size(Royston). In those with infant lung function data
(10) 
we will explore whether any relationship between maternal influences and childhood asthma was 
already apparent in early postnatal life. 
 
Hypothesis 2 
Primary postnatal exposure variables will be rapid weight gain in infancy (change in Z-score of weight for 
height, conditional and unconditional upon size at birth) and lower physical activity at age 6 years.  
Secondary postnatal exposures will be infant feeding mode, duration of breast-feeding and postnatal 
smoke exposure.  Cord blood leptin will be used as a measure of adiposity at birth, to examine whether 
any associations truly reflect postnatal influences. 
 
Hypotheses 3 & 4 
We will relate genotypes directly to outcomes, and analyse associations between the 
environmental exposures and outcomes, stratifying for category of genotype. We will also utilise 
the parental DNA to undertake family-based analyses of association that avoids potential 
confounding by population stratification using FBAT methodology.  
 
Hypothesis 5 
FEV1 and FEF50-75 will be transformed to normalize them as necessary. Multiple regression 
analysis will be used to investigate whether they are influenced by low maternal fat and/or muscle 
mass and low maternal intake of vitamins A and C. We will explore whether the children whose 
fetal growth faltered in late gestation (as measured by serial ultrasound scans) are those whose 
impaired maternal nutrition during pregnancy most affects their childhood lung function, and 
whether there is an interaction between vitamin C intake and smoking. Lastly, we plan to use the 
infant lung function data, available for a subgroup, to allow us to explore whether any relationship 
between maternal nutrition in pregnancy and childhood lung function is already apparent in the 
first few weeks of life.   
 
Hypothesis 6 
Logistic regression will be used to investigate the effects of high maternal fat mass and high 
vitamin D status, and of low maternal intake of vitamin E during pregnancy on atopic status at age 
6 years. Atopy will be defined as at least one positive skin prick test. 
  
 
   
Hypothesis 7 
The clinical wheeze phenotypes will be defined as (1) transient viral induced wheeze: presence of 
wheeze only with viral upper respiratory tract infections within the first 5 years of life; (2) atopic 
asthma: wheeze between viral upper respiratory tract infections or with exercise that responds to a 
bronchodilator in an atopic child; (3) non-atopic asthma: as for atopic asthma but in a child who is 
not atopic. Children with history of wheeze will be assigned to one of these categories according 
to the timing of symptoms and the presence of atopy. An exploratory analysis will be undertaken 
to examine how maternal nutrition (as defined by body composition, vitamin D status and vitamin 
A, E and C intakes) and fetal growth (as measured by serial ultrasound scans) differ between 
these three wheeze phenotypes and atopic and non-atopic children who have no history of 
wheeze. This will allow us to explore whether impaired maternal nutrition during pregnancy and 
impaired fetal growth are important in the development of each of these wheeze phenotypes. 
Lastly, the infant lung function data, available for a subgroup, will allow us to explore how impaired 
lung function develops in each of these childhood wheeze phenotypes.  
 
Hypothesis 8 
The inital analysis will focus on differences in bone mass and strength between asthmatic and non 
asthmatic children. regression will be used to confirm an association between bone mass, density 
and bone strength in children with asthma and obesity. Multiple regression analysis will be used to  
investigate whether this in influenced by  postnatal exposure variables (physical activity levels, 
muscle and fat mass, childhood diet and use of inhaled steroids). We will then explore prenatal 
exposure variables such as pre-pregnancy maternal fat mass, smoking and activity levels to look 
at how the growth trajectory of bone is set during early life. 
 
Sample size and power calculations 
Assuming a 65% follow-up of the 1477 children gives a sample size of about 950. Our experience 
of similar longitudinal cohorts indicates that we may well achieve a higher follow-up, giving greater 
statistical power than shown here.  Assuming a 5% level of significance, for objectives 1 and 2, we 
have 97% power to detect a difference of 0.25 SDs in the continuous outcomes of FEV1 and 
estimated fat mass, between the top and bottom halves of the distribution of each continuous 
exposure variable (maternal fat mass, energy intake, infant weight gain and physical activity). This 
falls to 90% power for a 1% level of significance.  Analysis of the continuous outcomes without 
dichotomisation will provide greater power. For objectives 1, 3 and 4, in relation to the 
dichotomous exposure variables of smoking and genetic polymorphisms, the table below gives the 
power to detect a difference of 0.25 SDs in the same continuous outcomes for various different 
prevalences of the exposure variable.  We anticipate that the prevalence of the genetic 
polymorphisms ranges from 50%-10%; the prevalence of smoking in pregnancy in this population 
is 17%: 
  
 
   
Frequency of exposure  Statistical power 
50%  97% 
40%  97% 
30%  94% 
20%  87% 
17%  83% 
15%  79% 
10%  64% 
 
For hypothesis 5, we have 87% power to detect a difference of 0.2 standard deviations (SDs) in 
FEV1 between the top half and the bottom half of the distribution of each exposure variable. 
Defining impaired fetal growth or impaired maternal nutrition as those in the lowest 20% of the 
distribution, we have 87% power to detect a difference of 0.25 SDs in FEV1 between these groups 
and the remaining children.  
 
For hypothesis 6, for any normally distributed exposure measurement we have 81% power to 
detect a difference of 0.25 SDs between the exposure of those with atopy (assuming a 16% 
prevalence of atopy at age 6 years) and those without. Dichotomising the exposure gives 80% 
power to detect a relative risk of atopy of 1.55 for those in the bottom half of the exposure 
distribution compared with the top half.  
 
For hypothesis 7, we will perform an exploratory analysis. As an example of our power, if we 
measure lung function at six years in 70 children with infant lung function data and the prevalence 
of wheezing at six years is 20%, we will have 80% power to identify a 20% difference in infant 
FEV0.4 between those who wheeze at six years of age and those who do not.   
 
For hypothesis 8 we have 90% power to detect a difference of 5% in whole body bone mineral 
content between the highest and lowest quartiles of the distribution for each exposure variable. 
 
D. Key Milestones 
Respiratory and body composition assessments at 6 years of age will occur during the initial 27 months. 
During year 1 the whole cohort will be genotyped. A final report, and drafts of publications will be 
submitted to LREC by October 2011.  
 
E. The research team 
Drs Lucas, Roberts and Holloway are academic researchers within the Infection, Inflammation and 
Repair (IIR) Division of Southampton School of Medicine. Professors Godfrey and Cooper and Dr 
Inskip work within the MRC Epidemiology Resource Centre. The applicants have a track record of 
successful collaboration(Lucas et al.). Dr Lucas is a respiratory paediatrician with a research 
interest in lung development. Professor Godfrey‟s research within SWS is characterizing the 
interactions between prenatal, postnatal and genetic influences on health outcome. Dr Holloway  
 
   
heads the Asthma Genetics Group and recently reported ADAM33 as an asthma-susceptibility 
gene. Dr Inskip, a statistician/epidemiologist, coordinates the SWS, studying the effects of pre-
conceptional factors on fetal and postnatal growth. Dr Roberts is a respiratory paediatrician, with 
an expertise in epidemiology.  Professor Cooper is Director of the MRC Epidemiology Resource 
Centre and has expertise in developmental influences on body composition. 
The team will include  nurses from the WTCRF who are experienced in research with children. 
Training will be provided to the nurses in any aspects of the protocol, as necessary. Home visits 
will generally be conducted by SWS nurses who have been involved in earlier visits to SWS 
families and have developed and nurtured relationships between the participants and the Survey. 
We have employed Dr Katy Pike as a Clinical Research Fellow to assist in the clinical 
investigation of the cohort and the analysis of the data, under the supervision of the PI. Dr Pike is 
a Paediatric SpR with an interest in paediatric respiratory medicine. Dr  Zoe Cole, clinical research 
fellow and rheumatology SpR will  be working with the team assisting with DXA, pQCT 
assessment and activity monitoring, Her PhD will focus on the developmental influences of body 
composition. Training in research governance, ethics, child protection, respiratory physiology etc 
will be provided. 
Appendices 
1.  Questionnaire 
2.  Parent information sheets   
a.  Home visit 
b.  WTCRF visit 
3.  Children information sheets 
a.  Home Visit 
b.  WTCRF visit 
4.  Consent/ Assesnt forms 
5.  Peripheral Quantitaive Computed Tomography Optional Study Protocol 
a.  Parent information sheet 
b.  Child information Sheet 
c.  Consent form 
d.  Ionising radiation form 
 
 
 
  
 
   
Investigators 
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Dr Jane Lucas, Senior Lecturer/ Honorary Respiratory Paediatrician 
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6 Year  
QUESTIONNAIRE 
HOME VISIT 
Part 1 
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APPENDIX  D: SWS Home visit questionnaire  
                                                                                                      
 
Mother's forename only:  _____________________________ 
 
 
Child's forename only:   _____________________________ 
 
 
[Nurse to refer to six-year visit record card to ensure child's name is correct, 
and  record  any  changes  thereon.    Also  to  request  additional  telephone 
numbers, email addresses etc, for tracing purposes if family move] 
 
 
         d      d         m     m        y      y 
Child's date of birth 
 
 
Sex     M=Male 
   F=Female 
 
         d      d         m     m        y      y 
Date of interview 
 
 
Interviewer 
 
 
 
____________________________________________________________________ 
 
Discuss the visit with the mother and child and obtain completed consent and assent 
forms 
 
 
To be completed by the nurse if the mother was not the person interviewed: 
 
1.  Why was the mother not available? 
2.  Has left the family home 
3.  Still lives in family home, but was unavailable for interview 
4.  Has died 
5.  Is ill or in hospital 
6.  Other, specify  _______________________________ 
7.  Don‟t know 
 
Who was interviewed? 
1.  Study child‟s father 
2.  Mother‟s partner (if not father) 
3.  Study child's grandparent 
4.  Other family member 
5.  Mother “figure” (eg father‟s partner/step-mother) 
6.  Family friend 
7.  Other, specify  _______________________________ 
 
 
  
                                                                                                      
 
Food frequency 
Now I am going to ask you about the foods your child has eaten, and the drinks they have had in the past 3 
months.  I will ask you how often your child has had certain foods and drinks.  Please include meals and 
snacks eaten away from home if possible, including school meals.  (Define the 3 month period) 
 
   
 
food 
 
 
 
never 
less 
than 
once 
per 
month 
 
1-3 
times 
 per 
month 
 
number of times per week 
more 
than 
once 
per 
day 
 
no. of 
times 
per 
day   
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
BREAD, CRACKERS AND CEREALS 
1  white bread  0  0.3  0.5  1  2  3  4  5  6  7  8   
2  brown & wholemeal 
bread 
0  0.3  0.5  1  2  3  4  5  6  7  8   
3  savoury biscuits  0  0.3  0.5  1  2  3  4  5  6  7  8   
4  Breakfast cereals and 
porridge 
0  0.3  0.5  1  2  3  4  5  6  7  8   
POTATOES, RICE & PASTA 
5  boiled & baked 
potatoes 
0  0.3  0.5  1  2  3  4  5  6  7  8   
6  chips, waffles and 
potato shapes 
0  0.3  0.5  1  2  3  4  5  6  7  8   
7  roast potatoes  0  0.3  0.5  1  2  3  4  5  6  7  8   
8  tinned pasta and 
instant noodles 
0  0.3  0.5  1  2  3  4  5  6  7  8   
9  pasta and noodles – 
fresh and dried  
0  0.3  0.5  1  2  3  4  5  6  7  8   
10  rice – white & brown  0  0.3  0.5  1  2  3  4  5  6  7  8   
MEAT 
11  chicken & turkey in 
breadcrumbs/batter 
0  0.3  0.5  1  2  3  4  5  6  7  8   
12  chicken and turkey 
roast meats  
0  0.3  0.5  1  2  3  4  5  6  7  8   
13  chicken and turkey 
casseroles & curries 
0  0.3  0.5  1  2  3  4  5  6  7  8   
14  beef, pork & lamb - 
roast meats 
0  0.3  0.5  1  2  3  4  5  6  7  8   
15  beef, pork & lamb  
casseroles & curries  
0  0.3  0.5  1  2  3  4  5  6  7  8   
16  beefburgers   0  0.3  0.5  1  2  3  4  5  6  7  8   
17  bacon & gammon   0  0.3  0.5  1  2  3  4  5  6  7  8   
18  sausages   0  0.3  0.5  1  2  3  4  5  6  7  8   
19  liver, kidney & 
faggots 
0  0.3  0.5  1  2  3  4  5  6  7  8    
                                                                                                      
 
 
   
 
food 
 
 
 
never 
less 
than 
once 
per 
month 
 
 
 
1-3 
per 
month 
 
number of times per week 
more 
than 
once 
per 
day  
no. of 
times 
per 
day   
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
20  meat pies and 
sausage rolls 
0  0.3  0.5  1  2  3  4  5  6  7  8   
21  ham & processed 
cold meats 
0  0.3  0.5  1  2  3  4  5  6  7  8   
FISH 
22  fish in batter or 
breadcrumbs 
0  0.3  0.5  1  2  3  4  5  6  7  8   
23  other white fish  0  0.3  0.5  1  2  3  4  5  6  7  8   
24  tuna fish  0  0.3  0.5  1  2  3  4  5  6  7  8   
25  oily fish  0  0.3  0.5  1  2  3  4  5  6  7  8   
OTHER MEAL ITEMS 
26  quiche & savoury 
flans 
0  0.3  0.5  1  2  3  4  5  6  7  8   
27  pizza   0  0.3  0.5  1  2  3  4  5  6  7  8   
28  processed meat 
replacements  
0  0.3  0.5  1  2  3  4  5  6  7  8   
29  quorn and soya 
casseroles & mince 
0  0.3  0.5  1  2  3  4  5  6  7  8   
30  eggs  0  0.3  0.5  1  2  3  4  5  6  7  8   
31  cottage cheese  0  0.3  0.5  1  2  3  4  5  6  7  8   
32  cheese  0  0.3  0.5  1  2  3  4  5  6  7  8   
33  soup  0  0.3  0.5  1  2  3  4  5  6  7  8   
34  savoury white sauce  0  0.3  0.5  1  2  3  4  5  6  7  8   
35  tomato pasta sauce   0  0.3  0.5  1  2  3  4  5  6  7  8   
VEGETABLES 
36  tinned vegetables  0  0.3  0.5  1  2  3  4  5  6  7  8   
37  carrots   0  0.3  0.5  1  2  3  4  5  6  7  8   
38  peas & green beans   0  0.3  0.5  1  2  3  4  5  6  7  8   
39  Sweetcorn, mush-
rooms & mixed veg  
0  0.3  0.5  1  2  3  4  5  6  7  8   
40  broccoli,cauliflower 
courgettes, marrow 
0  0.3  0.5  1  2  3  4  5  6  7  8   
41  green leafy 
vegetables 
0  0.3  0.5  1  2  3  4  5  6  7  8    
                                                                                                      
 
   
 
food 
 
 
 
 
never 
 
less 
than 
once 
per 
month 
 
 
 
1-3 
per 
mont
h 
 
number of times per week 
more 
than 
once 
per 
day 
no. of 
times 
per 
day   
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
42  parsnips, turnip and 
swede 
0  0.3  0.5  1  2  3  4  5  6  7  8   
43  tomatoes  0  0.3  0.5  1  2  3  4  5  6  7  8   
44  salad  0  0.3  0.5  1  2  3  4  5  6  7  8   
45  baked beans  0  0.3  0.5  1  2  3  4  5  6  7  8   
46  other beans and 
pulses 
0  0.3  0.5  1  2  3  4  5  6  7  8   
FRUIT 
47  tinned fruit   0  0.3  0.5  1  2  3  4  5  6  7  8   
48  apples & pears   0  0.3  0.5  1  2  3  4  5  6  7  8   
49  bananas   0  0.3  0.5  1  2  3  4  5  6  7  8   
50  oranges, satsumas 
and grapefruit 
0  0.3  0.5  1  2  3  4  5  6  7  8   
51  peaches, nectarines 
and melon 
0  0.3  0.5  1  2  3  4  5  6  7  8   
52  berry fruit and 
tropical fruit  
0  0.3  0.5  1  2  3  4  5  6  7  8   
53  plums, cherries & 
grapes 
0  0.3  0.5  1  2  3  4  5  6  7  8   
54  dried fruit  0  0.3  0.5  1  2  3  4  5  6  7  8   
55  cooked/stewed fruit  0  0.3  0.5  1  2  3  4  5  6  7  8   
56  nuts   0  0.3  0.5  1  2  3  4  5  6  7  8   
 DESSERTS 
57  yoghurt & fromage 
frais 
0  0.3  0.5  1  2  3  4  5  6  7  8   
58  other ready made 
desserts in pots  
0  0.3  0.5  1  2  3  4  5  6  7  8   
59  ice-cream  0  0.3  0.5  1  2  3  4  5  6  7  8   
60  ice lollies  0  0.3  0.5  1  2  3  4  5  6  7  8   
61 
custard, sweet white 
sauce & instant 
whip 
0  0.3  0.5  1  2  3  4  5  6  7  8 
 
62  other puddings  0  0.3  0.5  1  2  3  4  5  6  7  8    
                                                                                                      
 
 
 
 
Now I would like to ask in more detail about some specific foods 
 
1.2  *  Which types of milk has your child used regularly in drinks and added to breakfast cereals over the 
past 3 months? (list up to 3 below) 
 
0 None       
1 Whole pasteurised  4 Whole UHT  7  Whole organic   10  whole omega 3 
2 Semi-skimmed 
pasteurised 
5 Semi-skimmed UHT  8  Semi-skimmed 
organic 
11  Semi-skimmed 
omega 3 
3 Skimmed 
pasteurised 
6 Skimmed UHT  9  Skimmed organic  12  Other 
 
                 Milk 1                    If "Other", specify  ___________________________________   
  
  Milk 2                    If "Other", specify   ___________________________________   
                          
                 Milk 3                    If "Other", specify  ___________________________________   
 
 
1.3  * On average over the last 3 months how much of each milk has he/she consumed per day?     
         (1 average cup = 0.35 pints; 1 pint = 20oz; 1 cup milkshake per wk – liquid = 0.05, powder = 0.01) 
 
     Milk 1                    .              pints                                         
  
      Milk 2                    .    pints 
  
        Milk 3                     .    pints       
       
 
1.4  Does your child have sugar added to his/her breakfast cereals,  
  tea & coffee, etc ?  
    0. No   go to 1.6        
    1. Yes                       
 
1.5  Approximately how many teaspoons of sugar are added to his/her                                  
     food and drinks each day?                                
                                                        
   
     
      
                                                                                                      
 
1.6  *How often does your child eat organic foods        Freq 0 – 8        . 
(not including milk or fat spreads)?   
(Use food frequency categories, 0, 0.3, 0.5, 1 - 8)       Freq >1/d 
                     
 
1.7  *Just thinking about the past week, how many servings did your child have of vegetables and 
vegetable-containing dishes?  (Including pulses, baked beans and salad but not potatoes) 
 
 
1.8  *Just thinking about the past week, how many servings did your child have of fruit? 
(Including fresh, cooked and tinned but not dried fruit) 
 
 
1.9  *In an average week over the past 3 months, how many meals per week did your child have away 
from home (do not include packed lunches provided by you, or snacks, such as biscuits or crisps, etc)? 
 
0. None  go to 1.11                                           No. of times 
 
1.10  * How many of these meals away from home were you able to include in the previous questions? 
  0. None 
  1. Some 
  2. Most 
  3. All 
 
1.11  During the past 3 months have you given him/her any vitamins or minerals, including iron and fluoride 
drops? 
No    go to section 2         
Yes 
 
1.12    Please state which: 
 
Supplement Name                                                   Code 
 
How 
many 
days in 
the last 
90? 
If not a 
tablet or 
capsule 
what is 
the dose   
No. of 
tablets 
or 
stated 
doses 
per day 
     
 
 
   
     
 
 
   
     
 
 
   
     
 
 
   
     
 
 
   
     
 
 
    
                                                                                                      
 
2.  NEONATAL HISTORY 
 
Now I‟m going to ask you some questions about what happened to your child around the time of birth. 
 
2.1  Was your child admitted to a Special Care Baby Unit? 
0.  No  go to section 3 
1.  Yes 
 
 
2.3   Was he/she admitted for breathing problems?   
0.  No  
1.  Yes 
9.   Don‟t know 
       
2.3   How long was your child in the Special Care Baby Unit?               mths          wks           days 
 
 
 
2.4   Did he/she need any help with his/her breathing (ventilator / life-support machine / CPAP)? 
0.  No  go to section 3 
1.  Yes 
 
2.5   Did he/she require invasive ventilation (tube into lungs) or non-invasive (e.g.CPAP)? 
0.  Non- invasive (e.g. CPAP) 
1.  Invasive (e.g. tube into lungs) 
2.  Both 
 
 
2.6   For how long was he/she ventilated?                mths          wks            days 
 
 
(Note if ventilated both non-invasively and invasively, give combined time here)  
 
  
                                                                                                      
 
3      FAMILY HISTORY 
 
 
3.1 *Have you or any other members of the child‟s family (mother, father, siblings or half-siblings) ever 
been diagnosed by a doctor with any of the disorders on the list?   
 
                         0.   No  go to section 4 
    1.   Yes 
 
     Complete each box with a 0 for No or a 1 for Yes) 
 
IF ANY ANSWERS TO 3.2 OR 3.3 ARE ‘YES’ PLEASE ADD A RED DOT TO THE CARD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prompts 
Asthma: wheeze or whistling in the chest with exercise or other triggers that is rapidly relieved with a 
reliever inhaler. Only if doctor diagnosed. 
Wheeze: whistling in the chest when breathing out. 
Eczema: A skin condition resulting in dry, itchy, red skin. If it is infected the skin may become wet. 
(Doctor diagnosed only). 
Hayfever: runny, itchy eyes or/and nose in the spring or summer, not caused by a cold. 
 
 
Note: Only record ‘Yes’ if the person has definitely had the problem.  If the person has, for 
example, never been stung by a bee or a wasp then the answer is ‘No’. 
 
 
 
Mother  Father  Sibling  Half - sibling 
3.2  Asthma 
 
 
       
3.3  Wheezing 
 
 
       
3.4  Eczema 
 
 
       
3.5  Hayfever 
 
 
       
3.6  Food allergy 
 
 
       
3.7  Drug allergy 
 
 
       
3.8  Bee or wasp sting allergy 
 
 
       
3.9  Cystic Fibrosis 
 
 
        
                                                                                                      
 
4  ASTHMA 
 
I would now like to ask a few questions about illnesses your child has had   
 
4.1.     Has your child ever had asthma? 
0.  No       go to section 5 
1.  Yes     ADD RED DOT TO CARD 
 
4.2      Was the asthma diagnosed by a doctor? 
         0. No       go to section 5 
         1. Yes  
 
4.3     How old was he/she when he/she was first diagnosed?         yrs               mths               wks 
 
 
4.4      Has he/she ever been admitted to hospital for asthma?   
0.   No        
1.   Yes  
 
4.5      Has he/she received inhalers or other medication for asthma prescribed by a doctor in the past 12 
months? 
0.  No        
1.  Yes  
 
 
5  OTHER RESPIRATORY ILLNESSES AND SYMPTOMS 
 
 
5.1.     Has he/she ever been diagnosed as having bronchiolitis by a doctor? 
0.  No       go to 5.4 
1.  Yes  
 
5.2        How old was he/she when he/she was first diagnosed?           yrs                 mths                wks 
 
 
5.3  Has he/she ever been admitted to hospital for this?   
0.  No        
1.  Yes  
 
5.4  Has he/she ever been diagnosed as having pneumonia or a  
chest infection by a doctor? 
0.  No       go to 5.8 
1.  Yes  
 
5.5  Has he/she ever been admitted to hospital for this?   
0.  No        
1.  Yes 
 
  
5.6       Has he/she been diagnosed as having pneumonia or a  
chest infection by a doctor in the past  12 months? 
     0.  No       go to 5.8 
                    1.  Yes  
 
 
5.7       Has he/she been admitted to hospital for pneumonia or a chest infection in the past 12 
months?   
0.  No      
1.  Yes  
  
                                                                                                      
 
5.8   Has he/she ever had a persistent cough every day for more than 3 weeks? 
      0.    No       go to 5.12 
                     1.   Yes  
 
 
5.9   Has he/she ever been admitted to hospital for this?   
0.  No        
1.  Yes  
 
5.10   Has he/she had a persistent cough every day for more than 3 weeks in the past 12 months? 
     0.  No       go to 5.12 
                   1.  Yes  
 
 
5.11   Has he/she been admitted to hospital for a persistent cough in the past 12 months?   
0.  No      
1.  Yes  
  
 
5.12    Does your child have any other respiratory problems (eg cystic fibrosis)? 
0.  No      
1.  Yes if yes specify________________________________________________________ 
 
5.13   Has your child regularly snored at night (3 nights a week or more) for at least 6 months over the 
past year? 
0.  No      
1.  Yes  
 
5.14   *Has your child had his/her adenoids or tonsils removed? 
0.  No 
1.  Adenoids only 
2.  Tonsils only 
3.  Adenoids and tonsils 
 
 
 
  
                                                                                                      
 
6   FURTHER QUESTIONS ABOUT ASTHMA AND WHEEZE 
       (based on core ISAAC questions and proposed standardised BPRS questionnaire)  
 
6.1  Has your child ever had wheezing or whistling in the chest  
at any time in the past? 
0.  No  go to 6.13 
1.    Yes  ADD RED DOT TO CARD 
 
6.2  Were these wheezy or whistling episodes associated with colds? 
0.    No  go to 6.4 
1.    Yes 
 
6.3  Has he/she ever wheezed or whistled in the chest between colds? 
0.    No  
1.    Yes 
 
6.4  Has your child had wheezing or whistling in the chest in the last 12 months? 
0.    No  go to 6.12 
1.    Yes 
 
6.5  *How many attacks of wheezing has your child had in the last 12 months?  
0.  None 
1.  1-3 
2.  4-12 
3.  more than 12 
 
6.6  *In the last 12 months, how often, on average, has your child‟s sleep been disturbed due to 
wheezing? 
0.  Never woken with wheeze            
1.  Woken less than one night per week        
2.  One or more nights per week 
 
 
6.7   In the last 12 months, has your child‟s chest sounded wheezy during or after exercise? 
       0.       No 
       1.      Yes 
 
         
6.8   In the last 12 months has wheezing ever been severe enough to limit your child‟s speech to  only 
one or two words at a time between breaths? 
0.  No   
1.  Yes 
 
 
6.9  *Does your child wheeze?  (please put 0 for No or 1 for Yes in each box) 
 
In winter    
In spring   
In summer    
In autumn   
 
  
                                                                                                      
 
6.10   *What else makes him/her wheeze? (please put 0 for No or 1 for Yes in each box) 
 
Change of weather   
Emotion (eg. excited / upset)   
Smoky rooms   
Exercise   
Pollen Season   
During vacuum cleaning or bed making   
Perfume   
Certain foods (specify):   
Moulds   
Hairy / furry animals (specify):   
Other (specify):   
 
 
6.11  *In the last 12 months how many of the following has your child had? (please complete with 0s if 
none have occurred) 
 
Hospital admissions with asthma/wheeze   
Visits to Casualty Dept with asthma/wheeze   
Visits to GP or „out of hours‟ doctor with asthma/ wheeze   
Days off school due to asthma/wheeze   
Nights woken with asthma / wheeze (with or without colds) – approximate number   
 
Go to 6.13 
 
6.12   At what age did your child last wheeze?                        yrs                         mths 
   
 
 
6.13  In the last 12 months, has your child had a cough at night, apart from a cough associated with a 
cold or chest infection? 
0.    No   
1.    Yes 
 
6.14 Has your child ever been prescribed an asthma reliever inhaler? 
0.    No  go to section 7 
1.    Yes  ADD RED DOT TO CARD 
 
6.15 Did it help his/her breathing (wheezing or coughing) to improve? 
0.    No   
1.    Yes 
2.    Never Used   
                                                                                                      
 
7   ECZEMA  
 
7.1     Has he/she ever had an itchy skin condition - by itchy we mean scratching or rubbing the skin a lot 
?        (exclude chicken pox, if asked to clarify “itchy skin condition” then ask “Has he/she had any 
episodes lasting more than 2 weeks when he/she scratched or rubbed his/her skin a lot”) 
0.  No   go to 7.3 
1.  Yes  
       
(Note if the woman says „No‟ to this, you will not need to ask questions 7.6-7.8 when you come to them) 
 
7.2     How old was he/she when the rash first appeared ?                 yrs                     mths            wks         
  
 
7.3   *Has he/she ever had a scaly, or red and weeping skin rash affecting any of the following 
          areas: 
 
  A) the scalp or behind the ears (including "cradle cap") 
0.  No  
1.  Yes 
      
  B) around the neck                        
0.  No  
1.  Yes 
 
       C) the cheeks or forehead             
0.  No  
1.  Yes                   
 
       D) either the folds of the elbows or behind the knees 
0.  No  
1.  Yes 
 
       E) the forearms, wrists, shins or ankles 
0.  No  
1.  Yes 
        
  F) the shoulders, chest, tummy or back     
                      0. No   
                     1. Yes 
  
      G) in the armpits                              
0.  No  
1.  Yes 
 
      H) the nappy area (including nappy rash)  
0.  No 
1.  Yes 
 
   
7.4    Has he/she ever suffered from a generally dry skin ? 
0. No go to 7.6 (but see note above question 7.6)  
1. Yes  
8. To a minor degree 
 
 
7.5    In the past twelve months, has he/she suffered from a generally dry skin ? 
0.  No  
1.  Yes   
8.  To a minor degree  
                                                                                                      
 
 
 
¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤ 
(If the answer to question 7.1 was ‘No’ – ie the child has never had an itchy skin condition – then 
go to section 8) 
¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤ 
 
 
7.6 In the past twelve months, has he/she suffered from an itchy skin condition? 
                  (exclude chicken pox) 
0.  No   go to section 8 
1.  Yes  
 
7.7  *In the last 12 months how often, on average has your child been kept awake at night by this itchy 
rash? 
0.  Never in the last 12 months 
1.  Less than one night per week 
2.  One or more nights per week 
 
 
7.8   Has this skin condition affected the cheeks, the outer arms or legs, or the skin creases in the 
        past twelve months - by skin creases we mean the folds of the elbows, behind the knees, the 
        fronts of the ankles, or around the eyes ?                      
0.  No  
1.  Yes 
 
 
 
 
  
                                                                                                      
 
8   RHINITIS/HAYFEVER (Core ISAAC questions) 
 
I‟m now going to ask some questions about problems which occur when your child does not have a cold 
or „flu. 
 
8.1 Has your child ever had a problem with sneezing, or a runny, or blocked nose 
when he/she did not have a cold or the „flu? 
0.  No go to 8.8 
1.  Yes 
 
8.2 In the past 12 months, has your child had a problem with sneezing, or a runny, or blocked nose 
when he/she did not  have a cold or the „flu? 
0.  No go to 8.8 
1.  Yes 
 
8.3  In the past 12 months was this nose problem accompanied by itchy-watery eyes? 
0.  No   
1.  Yes 
 
 
8.4  *In which of the past 12 months did this nose problem occur?    
(For each month record 0 for No or 1 for Yes) 
 
January      July   
February      August   
March      September   
April      October   
May      November    
June      December   
 
8.5  *In the past 12 months, how much did this nose problem interfere with your child's daily activities? 
0.  Not at all 
1.  A little 
2.  A moderate amount 
3.  A lot 
 
8.6 Is there any particular time of day that sneezing and nasal symptoms occur?  
0.    No  go to 8.8 
1.    Yes 
 
8.7 At which times do they occur?  (more than one box can have the answer yes, code 0 for No and 1 for 
Yes) 
Mornings   
Afternoons   
Evenings   
Night   
 
8.8  Has your child ever had hayfever? (Prompt: Hayfever: runny, itchy eyes or/and nose in the 
spring or summer, not caused by a cold). 
0.    No   
1.    Yes 
 
  
                                                                                                      
 
9  FOOD ALLERGY 
 
9.1  Has your child ever had a reaction to particular foods? 
0.    No  go to section 10 
1.    Yes  ADD RED DOT TO CARD 
 
9.2  *What sort of problems has he/she had? (Code 0 for No and 1 for Yes for each problem) 
 
Food that always makes him/her vomit   
Swelling of the face, lips or throat when eating certain food(s)   
Tingling of the mouth   
Rashes with a certain food   
Wheeze with a certain food   
Breathing difficulties caused by foods   
Collapse/faint with certain food   
Other symptoms (specify)   
 
 
9.3  *Which foods have caused these problems?  (0 for No, 1 for Yes for each food) 
 
01  Cows 
milk 
    07  Kiwi fruit   
02  Egg      08  Fish   
03  Peanuts      09  Shellfish   
04  Tree 
nuts 
    10  Other (specify)   
05  Wheat      11  Other (specify)   
06  Seeds      12  Other (specify)   
 
The following questions ask about the reaction to up to three foods.  If the child reacts to more than three 
foods ask which three give the most severe problems and answer the questions in relation to those three. 
 
9.4  Food 1  (Give code as in table above)  
 
 
9.5   *Does the reaction always happen when he/she eats <food 1 – name the food>? 
1.  Yes, it always happens 
2.  No, he/she is sometimes OK 
3.  He/She used to have problems but has now outgrown them 
4.  He/She never now eats the food 
 
 
9.6 How long after he/she is first in contact with <food 1 – name the food> does he/she start to get 
symptoms? 
Immediately?             0.  No  give hours and/or minutes below  
        1. Yes 
 
Hours                             Minutes 
  
                                                                                                      
 
 
9.7  Food 2 (Give code as in table above)  
 
9.8  *Does the reaction always happen when he/she eats <food 2 – name the food>? 
1.  Yes, it always happens 
2.  No, he/she is sometimes OK 
3.  He/She used to have problems but has now outgrown them 
4.  He/She never now eats the food 
 
9.9  How long after he/she is/was first in contact with <food 2 – name the food> does/did he/she start to 
get symptoms? 
 
Immediately               0.  No  give hours and/or minutes below  
        1. Yes 
 
Hours                             Minutes 
    
 
 
9.10  Food 3 (Give code as in table above)  
 
9.11   *Does the reaction always happen when he/she eats <food 3 – name the food>? 
1.  Yes, it always happens 
2.  No, he/she is sometimes OK 
3.  He/She used to have problems but has now outgrown them 
4.  He/She never now eats the food 
 
 
9.12   How long after he/she is/was first in contact with <food 3 – name the food> does/did he/she start 
to get symptoms? 
 
Immediately              0.  No  give hours and/or minutes below  
        1. Yes 
 
Hours                             Minutes 
 
 
 
  
10  MEDICATION  
 
Now I would like to ask about medicines and other treatments your child has taken 
 
Oral steroids 
 
10.1  Has he/she ever taken Oral steroids for any condition? (eg Prednisolone) 
 
0.    No  go to 10.5 
1.    Yes 
 
10.2   How many courses has he/she ever taken? 
 
 
 
10.3   How many courses has he/she taken in the last 12 months? 
 
 
10.4    How long ago did the last course finish?           years                       months             weeks      
 
          (Complete all 4 boxes above with 8s if the course is still on-going) 
                                                                                                      
 
Antihistamines 
 
10.5  Has he/she taken antihistamines in the last 12 months?  
              (e.g. Ketotifen, Loratidine, Piriton, Zirtek etc.) 
0.  No  go to 10.7 
1.  Yes 
 
10.6   How often does he/she use these ? 
1.  All the time? 
2.  During hayfever season only? 
3.  Only occasionally? 
 
 
Current/recent asthma or medication 
 
10.7  In the past three months has he/she used any inhalers or antihistamines, or taken any medicines for 
asthma, or any chest symptoms 
            0.    No  go to 10.9 
1.    Yes 
 
10.8  Please ask the mother/carer for all those medicines that the child has taken and ask to see them if 
possible.  Then fill in the table below, using the FFQ codes for how often they have been taken 
 
Name of medicine                                                    Medicine Code 
 
Number of 
puffs/spoons/
tablets/etc 
taken for 
each dose 
How often 
does he/she 
take this 
dose? 
FFQ code 1-8 
 
Number of 
times per day, 
if more than 
once a day 
   
 
 
   
            . 
 
   
 
 
   
            . 
 
   
 
 
   
            . 
 
   
 
 
   
            . 
 
   
 
 
   
            . 
 
   
 
 
   
            . 
 
   
 
 
   
            . 
 
   
 
 
   
            . 
 
   
 
 
   
            . 
  
                                                                                                      
 
10.9  Has your child taken any other medications in the past three months?  Please include both 
prescribed medicines and those bought over the counter.  (Note: do not include vitamins or food 
supplements, but do include cough remedies, paracetamol etc). 
0    No  go to section 11 
1    Yes 
 
10.10     What medicines has he/she taken? (please specify) 
 
Medicine 1_______________________________________________________ 
 
Medicine 2_______________________________________________________ 
 
Medicine 3_______________________________________________________ 
 
Medicine 4_______________________________________________________ 
 
Medicine 5_______________________________________________________ 
 
Medicine 6_______________________________________________________ 
 
Medicine 7_______________________________________________________ 
 
Medicine 8_______________________________________________________ 
 
 
 
 
 
11  SMOKING 
 
11.1  Are you/child‟s main carer currently smoking? 
0. No      go to 11.5   
1. Yes  
 
11.2  If yes, and offered, is it: 
1. Only in a separate room? 
2. Only outside the house? 
 
11.3   How many per day? 
  
 
11.4   What is your current brand?   _______________________________  
 
11.5   Does anyone else smoke in the home, or is he/she ever looked after more than once a week by 
anyone who smokes? 
0.  No  go to 11.8 
1.  Yes    
 
11.6    If yes, and offered, is it: 
1.  Only in a separate room 
2.  Only outside the house 
 
11.7  How many smokers live in the same house as the child? 
 
 
11.8      Is your child regularly exposed to non-household smoking? 
0.  No   
1.  Yes    
  
                                                                                                      
 
11.9      Has he/she been exposed to smoke in the last 24 hours? 
0.  No  go to section 12 
1.  Yes  
 
11.10  *Where?  (please enter 0 for no and 1 for yes) 
 
Family home 
 
 
Car 
 
 
Relative/friends‟ house 
 
 
Public place 
 
 
Other (specify) 
                       -------------------------------------------------------- 
 
 
 
 
 
 
12  ANIMAL EXPOSURE DURING PREGNANCY 
 
Now I‟m going to ask you about pets and animals at home when you were pregnant with this child. 
 
12.1  Did you have any pets at home at that time? 
0.  No  go to section 13 
1.  Yes    
 
12.2  How many of each of the pets on the list did you have at the time? 
 
Cats 
 
 
Dogs 
 
 
Birds 
 
 
Other (specify) 
                        -------------------------------------------- 
 
 
 
12.3  *Please tell me where these pets were allowed: 
 
 
  Your bedroom  Living room  Kitchen  Garden 
Cats 
 
       
Dogs 
 
       
Birds 
 
       
Other 
 
       
 
Please score through lines for pets that the woman did not have.  For pets she has, put 0 for No and 1 for 
Yes.  If she had more than one ‘other’ pet, please put 1 if any of these pets is allowed in the area.  
  
                                                                                                      
 
 
13  PETS AND ANIMALS NOW 
 
Now I‟d like to move on to ask about pets and animals in your house now 
 
13.1  Do you have any pets at home now? 
0.  No  go to 13.4 
1.  Yes    
 
13.2   How many of each of the pets on the list do you have? 
 
Cats 
 
 
Dogs 
 
 
Birds 
 
 
Other (specify) 
                        -------------------------------------------- 
 
 
 
13.3  *Please tell me where these pets are allowed: 
 
 
  Child‟s bedroom  Living room  Kitchen  Garden  Other 
Cats 
 
         
Dogs 
 
         
Birds 
 
         
Other 
 
         
 
Please score through the lines for pets that they do not have.  For pets they do have, put 0 for No and 1 
for Yes.  If they have more than one ‘other’ pet, please put 1 if any of these pets is allowed in the area.  
 
 
13.4   Does your child have regular (ie. more than once a week) contact with pets in other people‟s 
homes? 
0  No  go to section 14 
1  Yes 
 
13.5  What pets is he/she in contact with?  (please enter 0 for No and 1 for Yes for each type of pet) 
 
Dogs 
 
 
Cats 
 
 
Birds  
 
 
Other (specify) 
                          -------------------------------------------------------------------- 
 
  
                                                                                                      
 
14  RESPIRATORY SYMPTOMS ON DAY OF SPIROMETRY 
 
14.1   Has your child had a cold in the last 3 weeks? 
0.  No go to 14.4 
1.  Yes 
 
14.2  Does he/she still have symptoms of the cold? 
0.  No 
1.  Yes  go to 14.4 
 
14.3   How many days is it since he/she last had symptoms of the cold?  
 
 
14.4   Has your child coughed in the last 7 days? 
0.  No go to 14.6 
1.  Yes 
 
14.5  *What type of cough was it? 
1.  A cough that produced sputum 
2.  A cough that sounded “wet” but didn‟t produce sputum 
3.  A cough that sounded dry 
(may need to explain that we mean coughing something up from the chest) 
 
14.6  Has your child wheezed in the last 7 days? 
0.  No 
1.  Yes 
 
14.7  Has your child used a bronchodilator (eg. ventolin, bricanyl, salbutamol, terbutaline) in the last 12 
hours? (Nurse: please note that many mothers will have said that their children do not use such 
medication in their answers to section 10.  Be aware of this but nonetheless please confirm 
prior to spirometry that there has been no bronchodilator use). 
 
0.   No  go to section 15 
1.  Yes 
 
14.8  How long ago was it used?                                hours                      minutes                       
 
 
(If less than four hours ago, do not do spirometry and go to section 16) 
 
15  SPIROMETRY 
 
Please record the room temperature                                                                    .           
oC 
  
Please record the child’s ethnic group by asking the mother/carer which ethnic group the child 
belongs to: 
 
  *  1.  White                                 
        2.   Black Caribbean                           
        3.    Black African                           
  4.    Black Other 
  5.    Indian 
  6.    Pakistani 
  7.    Bangladeshi 
  8.    Chinese 
  9.    Other Asian group 
  10.    Other (specify)______________________________ 
 
Perform the spirometry on the laptop using the Koko incentive software. 
 
    
                                                                                                      
 
APPENDIX E: Actiheart instruction sheet 
  
                                                                                                      
 
 
 
  
                                                                                                      
 
 
 
APPENDIX F: SWS Parent clinic information sheet 
  
                                                                                                      
 
 
 
  
                                                                                                      
 
 
APPENDIX G: SWS Child‟s clinic information sheet 
 
  
                                                                                                      
 
 
 
 
  
                                                                                                      
 
 
 
 
APPENDIX H: Directions to osteoporosis centre 
  
                                                                                                      
 
 
 
APPENDIX I: DXA Consent form 
  
                                                                                                      
 
APPENDIX J: Bone questionnaire and grip strength 
measurement
 
  
                                                                                                      
 
 
 
 
  
                                                                                                      
 
APPENDIX K: Parent information sheet for pQCT study 
 
  
                                                                                                      
 
 
 
 
  
                                                                                                      
 
APPENDIX L: Child‟s information leaflet on pQCT study 
 
 
  
                                                                                                      
 
 
  
                                                                                                      
 
APPENDIX M: Copy of the DXA results given to 
child
 
 
  
                                                                                                      
 
 
 
 
  
                                                                                                      
 
 
 
 
 
  
                                                                                                      
 
 
 
  
                                                                                                      
 
APPENDIX N: Certificate of achievement for DXA scan 
 
  
                                                                                                      
 
APPENDIX O: Consent for pQCT 
scan
 
  
                                                                                                      
 
 
APPENDIX P:  pQCT images given to 
parents
  
                                                                                                      
 
 
 
 
  
                                                                                                      
 
APPENDIX Q: Certificate of achievement for pQCT 
study
 
  
                                                                                                      
 
 
APPENDIX R: Ethics and R&D 
approval
  
                                                                                                      
 
 
 
  
                                                                                                      
 
 
 
 
  
                                                                                                      
 
 